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In  recent years measurements of cerebral perfusion using bolus-tracking MRI have 
become common clinical practice in the diagnosis and management of patients with 
stroke and cerebrovascular disease.  An active area of research is the development of 
methods to identify brain tissue that is at risk of irreversible damage, but amenable to 
salvage using reperfusion treatments, such as thrombolysis.  However, the specificity 
and sensitivity of these methods are limited by the inaccuracies in the perfusion data.
Accurate measurements of perfusion are difficult to obtain, especially in patients with 
cerebrovascular diseases.  In particular, if the bolus of MR contrast is delayed and/or 
dispersed  due  to  cerebral  arterial  abnormalities,  perfusion  is  likely  to  be 
underestimated  using  the  standard  analysis  techniques.  The  potential  for  such 
underestimation is often overlooked when using the perfusion maps to assess stroke 
patients.  Since thrombolysis can increase the risk of haemorrhage, a misidentification 
of ‘at-risk’ tissue has potentially dangerous clinical implications.
This thesis presents  several methodologies which aim to improve the accuracy and 
interpretation  of  the  analysed  bolus-tracking  data.  Two  novel  data  analysis 
techniques are proposed, which enable the identification of brain regions where delay 
and dispersion of the bolus are likely to bias the perfusion measurements.  In this way 
true hypoperfusion can be distinguished from erroneously low perfusion estimates.
The  size  of  the  perfusion  measurement  errors  are  investigated  in  vivo,  and  a 
parameterised characterisation  of the bolus delay and dispersion is obtained.  Such 
information  is  valuable  for  the  interpretation  of  in  vivo  data,  and  for  further 
investigation into the effects of abnormal vasculature on perfusion estimates.
Finally,  methodology  is  presented  to  minimise  the  perfusion  measurement  errors 
prevalent in patients with cerebrovascular diseases.  The in vivo application of this 
method highlights the dangers of interpreting perfusion values independently of the 
bolus delay and dispersion.TABLE OF CONTENTS
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“True freedom is not freedom from responsibility to God and others in order to live 
life for myself but freedom from myself in order to live for God and others'’
John StottChapter 1: Introduction -13-
1  INTRODUCTION
Stroke is one of the most frequent causes of morbidity and disability in the developed 
world.  Therapeutic  treatments  that  are  targeted  at  compromised  brain  tissue 
emphasise  the  importance  of  early  and  accurate  diagnosis  (Baird  et  al  1998). 
However,  routine  clinical  evaluations  often  provide  unreliable  information, 
potentially  resulting  in  poor  patient  management.  In  recent  years,  Magnetic 
Resonance Imaging (MRI) has proved a powerful technique for evaluating patients 
with  stroke  and cerebral  arterial  diseases.  As  well  as being non-invasive,  the key 
strength of MRI is its ability to probe not only the tissue structure (using Ti- and T2- 
weighted imaging), but also the bioenergetic tissue status (using diffusion MRI), the 
vascular  anatomy  (using  MR  angiography),  and  the  haemodynamic  tissue  status 
(using perfusion MRI, which measures the rate of delivery of blood to the tissue), all 
within a single examination.
In combination the different MRI techniques are a valuable selection tool for acute 
stroke therapies.  The concept of the diffusion-perfusion mismatch (an area observed 
to be abnormal on perfusion MRI but with normal diffusion properties) has received 
great interest in the last decade, and has shown great promise in distinguishing tissue 
that is not yet infarcted but is at risk of progressing to irreversible infarction (Sobesky 
et al 2005; Gonzalez 2006; Kidwell et al. 2004).  Abnormal regions on structural and 
diffusion MR images are thought to indicate tissue regions that are the  ‘core’  of the 
infarct (Sobesky et al 2005; Gonzalez 2006).  Although it may be possible to reverse 
these  abnormalities  (Bardutzky  et  al  2007),  such  tissue  is  usually  irreversiblyChapter 1: Introduction -14-
destined for infarction.  Perfusion measurements are thought to be main indicator of 
the  ‘at-risk’  brain tissue.  Depending on the  severity and duration of the perfusion 
abnormality, it may be possible to salvage such tissue using reperfusion treatments 
such as thrombolysis (Schellinger et al. 2000).  Therefore, in combination, these MRI 
techniques  can  be  used  to  predict  the  final  patient  outcome,  thus  raising  the 
possibility  of  identifying  acute  stroke  patients  most  likely  to  benefit  from 
intervention.
Within  this  context,  the  ultimate  goal  has  been  the  development  of algorithms  to 
predict  the  fate  of the  affected  tissue  in  a  patient  with  stroke.  These  so-called 
predictor-models  combine  all  the  imaging  information  available  to  infer  the  most 
probable clinical and radiological outcome for the brain tissue from the acute imaging 
data in a patient-specific way (Wu et al. 2001; Wu et al. 2007; Rose et al. 2001; Rose 
et al. 2004; Gottrup et al. 2005).  Because reperfusion treatments can increase the risk 
of haemorrhage (Trouillas et al. 2006), it is important to balance the risk of treatment 
against the potential benefits.  These models aim at improving patient management in 
this way.  Furthermore, such patient-specific predictions would allow the current rigid 
and  short  therapeutic  time-window  to  be  replaced  with  a  patient-specific  time- 
window  for therapeutic  intervention,  potentially  increasing  the  number  of patients 
receiving treatment.
Since  the  haemodynamic  information  provided  by  perfusion  MRI  is  the  most 
sensitive MRI indicator of ‘at-risk’ brain tissue, it is also the main determinant of the 
outcome  of  predictor-models.  Consequently,  it  is  also  the  main  source  error. 
Inaccuracies  in  the  perfusion  MRI  data  limit  the  prediction  capabilities  of  these 
models,  and  could  lead  to  patients  being  treated  inappropriately,  with  potentially 
serious clinical consequences.
The  most  widely  employed  clinical  MRI  method  used  for  measuring  cerebral 
perfusion  is  dynamic  susceptibility-contrast  (DSC-)  MRI  or  bolus-tracking  MRI 
(Calamante  et al.  1999b).  The  technique involves the fast injection  of a bolus  of 
magnetic resonance (MR) contrast agent and the rapid measurement of the resultingChapter 1: Introduction -15-
image signal changes.  Over the last decade there has been a great deal of research 
into  the  development  of both  the  acquisition  and  analysis  of DSC-MRI  data.  In 
addition, the technique has been very popular for clinical studies.  However, several 
studies have revealed that in current implementations of DSC-MRI, large errors may 
be  present  in  the perfusion  measurements.  In  particular,  in  patients  with  cerebral 
arterial diseases, abnormal blood flow patterns result in delay and dispersion of the 
bolus,  which  can  introduce  severe  underestimations  (up  to  60-70%)  in  perfusion 
measurements (Calamante et al. 2000).
The work performed for this thesis focuses on the use of DSC-MRI in the patients 
with  cerebrovascular  disease,  with  a  view  to  identify  and  minimise  the  errors 
associated  with  these  perfusion  measurements.  The  necessary background  to  the 
work is given in Chapters 2 to 5, Chapters 6 to 9 present the original  work conducted 
for this thesis, concluding with a general discussion in Chapter 10.
Chapter 2 presents an overview of some of the fundamental principles of MRI.  In 
particular, attention is given to those aspects that are employed in imaging ischaemic 
stroke.
In Chapter 3 a summary of the current thinking concerning the pathogenesis of tissue 
in  stroke  is  given.  This  provides  the  necessary  background  to  understanding  the 
changes in structure, diffusion and perfusion that can be observed using MRI.  There 
are also many non-MRI clinical imaging techniques currently being used to  assess 
perfusion.  The strengths and weaknesses of these techniques are discussed in context 
of their utility to manage stroke patients.  In addition, an overview of the alternative 
perfusion  MRI  method  of  Arterial  Spin  Labelling  is  presented.  Although  this 
technique  is  not  currently  robust enough  for routine  clinical  use,  it  has  promising 
potential  to  obtain  absolute  perfusion  measurements.  It is  consequently  an  active 
field  of  research,  and  may  eventually  prove  to  be  a  robust  alternative  clinical 
perfusion  MR  methodology.  Further  background  is  also  given  concerning  the 
prediction of ‘at-risk’ tissue and therapeutic treatments, providing the clinical contextChapter 1: Introduction -16-
to the largely methodological and theoretical work presented in the remainder of the 
thesis.
Chapter 4 of this thesis describes the core theory of perfusion quantification using 
DSC-MRI, and the commonly used analysis methods.  The caveats, limitations, and 
sources  of  error  in  the  acquisition  and  analysis  of these  data  are  discussed.  In 
particular, errors that are prevalent in data from patients with vascular abnormalities 
are highlighted, together with the errors endemic in the analysis of DSC-MRI data. 
This discussion provides the necessary background to understand the motivation for 
the methods and analysis presented in the proceeding chapters, which seek to improve 
the quantification of perfusion in patients with cerebrovascular diseases.
In  Chapter 5, the framework for the development and testing of the novel analysis 
methods is described.  Although this chapter is short, it is of primary importance in 
understanding  the  assessment  of perfusion  measurement  errors  that  can  adversely 
influence the prognosis of stroke patients.
Chapter 6 presents a new DSC-MRI analysis method (modified maximum-likelihood 
expectation-maximisation or mML-EM analysis), which seeks to overcome some of 
these limitations to provide an improved quantification of perfusion and an indication 
of  the  reliability  of  the  perfusion  measurements.  If  brain  regions  of  unreliable 
perfusion  (due  to  delay  and/or  dispersion  of the  bolus)  can  be  identified  on  the 
perfusions maps, then the results of predictor-models using these input data can be 
interpreted  in  light  of the  possible  errors.  Identifying  regions  where  perfusion  is 
likely to  be  underestimated  could  avoid the  potential  misclassification  of  ‘at-risk’ 
tissue.
In Chapter 7, the methodology introduced in Chapter 6 is developed further with a 
view  to  make  the  analysis  less  sensitive  to  the  MR  imaging  parameters  and  the 
quality of the data.  It is important that analysis techniques are robust, automated, and 
suitable for equipment from any of the MRI manufacturers.  This would enable theChapter 1: Introduction -17-
widespread use of these more accurate methods.  In this chapter, accurate perfusion 
quantification is sought by implementing wavelet analysis of the data.
Chapter  8  presents  an  in  vivo  investigation  into  vascular transport  (i.e.  delay  and 
dispersion) of the bolus and the size of the associated perfusion measurement errors 
in  DSC-MRI,  using  the  methodology  developed  in  Chapter  6.  A  parameterised 
model  for  the  vascular  transport  is  proposed,  which  has  potentially  important 
applications  for the  investigation  of perfusion  errors  and  development  of analysis 
techniques  (and consequently a better awareness  of the reliability of predictions of 
tissue infarction).
In  Chapter  9,  two  methods  are  presented,  which  seek  to  minimise  perfusion 
measurement  errors  resulting  from  vascular  transport.  The  first  method  seeks  to 
relate delay and dispersion in vivo, with a view to correct for dispersion by means of 
the  more  easily estimated delay.  The  dispersion parameter is  measured using the 
parameterised vascular transport model presented in Chapter 8.  The second method 
utilises the analysis technique presented in Chapter 7 to identify regions on perfusion 
maps, which are subject to bolus delay and dispersion.  A methodology is presented 
to correct for delay and dispersion within these regions, and as a result minimise the 
associated errors.  The ability to correct for perfusion measurement errors would be a 
significant advancement for the accuracy of predictor-models.
Therefore this thesis investigates  several aspects  of perfusion quantification, which 
aim  to  improve  the  accuracy  and  robustness  of  perfusion  MRI  in  stroke  and 
cerebrovascular disease, and ultimately improve the identification of patients likely to 
benefit from reperfusion treatment.  Furthermore, these improvements should help to 
further our understanding of the pathophysiology of brain tissue in stroke patients.Chapter 2: Background to MR Imaging -18-
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2.1  Introduction
Magnetic Resonance Imaging (MRI) is very well suited to imaging soft tissue, such 
as  the brain,  due to the mechanisms  governing  image  contrast.  Using  a carefully 
designed MR image acquisition, the image contrast can be made sensitive to specific 
properties of the tissue (e.g. Ti, T2, BOLD and diffusion), which are indicative of its 
physiological condition.  The purpose of this chapter is to introduce the MR imaging 
theory that is  necessary  to understand MRI in  acute  stoke.  Particular  attention  is 
given to the MRI concepts that are most relevant to cerebral-perfusion imaging.  The 
chapter outlines some of the important mechanisms governing image contrast, some 
of the methods used to create and sample the MR signal, and current methodology for 
reconstructing the MR image.
2.1.1  M agnetic Resonance
Only nuclei  with  intrinsic  nuclear spin  angular momentum exhibit the property  of 
magnetic resonance.  In most medical applications, the proton (!H) is the nucleus of 
most interest because of its high natural  abundance in biological tissue (e.g. in fat, 
water and other organic molecules).  In particular, in the MR imaging of stroke, the 
blood and tissue-water protons are manipulated.  The proton has charge +1, and an 
intrinsic  spin  angular  momentum  J=l/2,  resulting  in  a  magnetic  dipole  moment
= P ,  (where y is  the  gyromagnetic  ratio).  Consequently,  on  application  of an
external magnetic field  B0, the magnetic moment of the proton, or spin ju, is subject
to a torque:
^  = »2xJ0  [2.1]
at
As  a  result  /2  precesses  about  the  B0  direction  (or  z-direction)  at  an  angular 
frequency co0, known as the Larmor (resonant) frequency:Chapter 2: Background to MR Imaging -20-
^ 0 = ^ 0 [ 2.2 ]
The resonant frequency of protons in a 1.5T magnetic field is 63.9 MHz.
From a quantum mechanical perspective, there are two available quantum states for 
the spins.  In the lower energy state the magnetic moment is aligned parallel to the 
field,  and  in  the  higher energy  state,  the  alignment  is  antiparallel.  The  quantum 
energy difference between these two states is  fico0  (where  fi  is the Planck constant).
In the human body, the temperature T is such that the average thermal energy of the 
protons, kbT (where kb is the Boltzmann constant) is millions of times larger than the 
quantum energy difference.  Consequently,  according to the Boltzmann probability 
distribution, the spin population difference between the two quantum states, the ‘spin 
excess’, is small.
spin  excess ~ N
r ho)0  A
,2 V ;
[2.3]
where N is the number of spins in the sample.  Even though the spin excess is small 
compared with the number of spins in the sample, the ensemble average of all the 
spins, gives rise to a measurable macroscopic longitudinal equilibrium magnetisation, 
Mo:
M Q  ~ Pq W o
\  J\^kbT j
[2.4]
where  p0  is number of spins per unit volume (proton density),
ft
is the proton
magnetic  moment  component  along  the  direction  of the  field,  and
%
is  the
fractional  spin  excess.  This  equilibrium magnetisation,  which  scales  linearly with 
field strength, provides a measurable MR signal.Chapter 2: Background to MR Imaging -21-
2.2  M R R elaxation T heory
In  equilibrium, the macroscopic  magnetisation vector  M =  precesses  around
i
the main  static  longitudinal  external field  B0  at  angular frequency  coQ.  When  an 
additional external magnetic field  BA   is applied,  M  is made to precess around the 
vector-sum of the two fields.  In MR imaging, the externally applied field  BA   is  a 
radiofrequency (RF) pulse, orientated perpendicular to  B0.  As a result M  precesses 
simultaneously about B0  at  c d q   and about Bx   at  a\ =  .  The effect becomes easier
to  visualise from the perspective of a reference  frame that rotates  around the  B0 - 
direction at the frequency of the applied field  (0M.  In this frame the direction of the 
Bx   field is stationary during the pulse.  In the simplest case where  (0R F   is equal to the 
Larmor frequency  coQ,  M  appears to precess only about  51   at a rate  cox   during the 
pulse.  At the end of a pulse of duration  t p,  M  will have rotated away from the  B0
by  c o x tp  radians.  Short, high-amplitude RF pulses with a rectangular  Bx(t)  profile 
are typically referred to as  ‘hard pulses’.  In contrast,  ‘soft pulses’  have modulated 
Bx  (r)  profiles  often  designed to give a rectangular frequency-response for accurate 
slice-selection (Section 2.4.1).  The application of an RF pulse or  ‘excitation’  pulse is
essential to all modem MR imaging experiments (see Section 2.3).  Once  the RF field
has been removed, various processes take place on the microscopic level, which cause
M  to relax back to its equilibrium value (see Section 2.2.2).
2.2.1  T! and T2 Relaxation Times
The contrast seen in a conventional MR image is determined by both the spin density 
Pq  ,  and the rate of spin relaxation.  The relaxation of the aggregated collection of
spins, or M , is characterised by two time-constants, Ti and T2:Chapter 2: Background to MR Imaging -22-
1.)  Spin-lattice  relaxation  time  Ti:  the  Ti  time-constant  characterises  the
recovery  of the  magnetisation  along the  direction  of  B0.  Longitudinal
equilibrium magnetisation is restored via the exchange of energy between 
the spins and the lattice (local environment).
2.)  Spin-spin relaxation time T2: the T2 time-constant characterises the decay 
of  the  magnetisation  perpendicular  to  the  main  field.  Transverse 
magnetisation is lost via the exchange of energy between the  spins  (i.e. 
there is no net loss of energy from the spin system), which causes a loss in 
phase coherence of the precessing spins.
In  the  same  way  as  an  applied RF field  affects  the macroscopic magnetisation by 
changing its precessional path, various other field perturbations that are intrinsic to 
the  spin  ensemble,  act  to  restore  thermal  equilibrium.  The  following  sections 
describe  some  of  the  possible  field  perturbations  and  mechanisms  by  which 
equilibrium  is  restored.  These  concepts  are  key  to  understanding  the  MR  image 
contrast that arises from the relaxation of the spins.
2.2.2  Correlation Time and Spectral Energy density
After the applied RF field has been removed, a spin will relax back to its equilibrium 
state  by  exchanging  energy  with  either  its  surroundings  or  another  spin.  Energy 
transfer  is  mediated  by  fluctuations  in  the  local  magnetic  field  vector  AB0, 
experienced by the spin,  and is most effective when the frequency of fluctuation is 
close  to  the  Larmor frequency  of the  spin.  The  effect  of  AB0  on  the  Ti  and  T2  
relaxation processes is most easily understood in the rotating reference frame (x\ y\ 
z), which rotates around the z-direction (B0 -direction) at the Larmor frequency,  O )0.Chapter 2: Background to MR Imaging -23-
In  this  frame  the  torque  experienced  by  an  individual  spin  /2,  due  to  the  field 
perturbation AB0 is:
'dflz /dt'
dfly/dt = 7 [2.5]
^d fijd t, ABy.fix. -A
Changes in p z, which are synonymous with the longitudinal or Ti relaxation process, 
are only associated with changes in  ABy.  and  ABx..  In the laboratory (stationary)
frame  these  fluctuations  appear  as  frequencies  close  to  the  Larmor  frequency. 
Changes in  fix.  and  // ., which are synonymous with the transverse or T2 relaxation
process, are associated with field fluctuations in all three directions.  In the laboratory 
frame, the ABz  fluctuations appear as frequencies close to zero frequency.
Therefore,  both  Ti  and  T2  relaxation  processes  are  mediated  by  fluctuations  in 
frequency close to  co0  (the ‘dynamic contribution’).  T2 relaxation processes are also
mediated  by  field  fluctuations  that  are  close  to  0) = 0  (the  ‘static  contribution’). 
Consequently, because of the additional sensitivity of the transverse relaxation to low 
frequencies,  T2  is  often  considerably  shorter  than  Ti.  Furthermore,  since  the 
frequency of the  ‘dynamic contribution’  is dependent on the external field strength 
Bo, Ti relaxation has a much greater dependence on field strength than T2.
The  above  analysis  reveals  that  the  spin  relaxation  processes  are  frequency- 
dependent.  Consequently,  the spectral density  j(a))  of the field fluctuations is  an 
important factor in determining the efficiency of energy transfer.  Furthermore, since 
field  fluctuations  originate  from  the  motion  of  other  magnetic  sources  (e.g. 
molecules)  in  the  local  environment,  j(d))  is  governed  by  the  time  constant 
associated with molecular motion: the correlation time  tc  .  This time depends on the 
molecule weight and size.  For example, in a non-viscous fluid, such as free water, 
tc   ~10-11s,  whereas  for  a  bound  water  molecule  the  correlation  time  is  longer,Chapter 2: Background to MR Imaging -24-
Tc ~ 10^s, because the surrounding molecules are less mobile.  The spectral density 
j(co) is related to the correlation time rc  via (Farrar et al.  1971):
The  relaxation  rate  of  the  spins  within  a  substance  therefore  depends  on  the 
correlation times of molecules within that substance.  Figure 2.1  shows a schematic 
diagram of J(c d) for solids, viscous and non-viscous liquids.  For the solid, there is a 
very  small  spectral  component  at  co0,  and  a  large  low-frequency  component.
Consequently, the spin-lattice relaxation process is inefficient (long Ti),  whilst the 
spin-spin  relaxation  process  is  very  efficient  (short  T2),  owing  to  the  large  static 
component.  As the spins become more mobile, the breadth of the spectrum increases, 
causing Ti  to  shorten,  and T2 to lengthen.  For the  viscous  liquid there is  a large 
spectral  component  around the  Larmor frequency  co0,  leading  to  short Ti  and T2
values.  As the spins become increasingly dispersed, the spectrum flattens further, and 
Ti will lengthen.
This  qualitative  understanding  has  been  quantified  by  Bloembergen,  Purcell  and 
Pound (BPP theory) (Bloembergen et al.  1948), who expressed Ti and T2 relaxation 
time in terms of the spectral density,  j(co)  and the correlation time rc:
^  = K[j(a>0)+4j(2co0)]  [2.7]
■ M
^  = ^ [3 rc + 5 ]{<o0)+ 2  J(2<o0)]  [ 2.8 ]
2  ^
where K is a constant.  These expressions describe the situation for simple dipole- 
dipole interactions between spins (e.g. two protons of water).  The term in Equation
[2.8]  that is independent of coQ   represents the static component of T2.Chapter 2: Background to MR Imaging -25-
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Figure  2.1:  Schematic  plot  showing  the  spectral  densities  j(d))  as  a  function  of 
frequency  0),  for a  solid  (solid line),  viscous  liquid  (dashed  line),  and non-viscous 
liquid (dash-dot line).  The shaded area indicates that the viscous liquid contains the 
highest proportion of protons with correlation time that match the resonant frequency
The terms in 2 co0  account for the relaxation occurring as a result of field fluctuations 
at twice the  Larmor frequency,  which in quantum-mechanical terms corresponds  to 
the exchange of two energy quanta.
Figure  2.2  illustrates  the  BPP  dependency  of Ti  and  T2  on  zc.  When  O )0tc  « 1  
(liquids), Ti  and T2 relaxation times are predicted to be equal,  — = —  = 5Kzc, and
t2
independent of field  strength.  When  co0t c  » 1   (solids), Ti  is predicted to be long 
and dependent on the field strength (owing to the small dynamic contribution), and T2 
is predicted to be short (owing to the large static component).  Since  co0  is dependent
on field strength, and  Tc  is dependent on temperature, the relaxation properties of a 
system  are  also  field-  and  temperature-  dependent.  It  should  also  be  noted  BPP 
theory is only valid for  rc <T2, which corresponds to spins in the liquid sate, where 
dipole-dipole interactions dominate the relaxation (see Section 2.2.3).Chapter 2: Background to MR Imaging  - 26 -
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Figure  2.2:  The  dependence of Ti  and T2 on the  correlation time  Tc  given  by the 
relationships in Equations [2.7]  and [2.8].  The effect of varying the field strength is 
also  shown.  The  magnetic  field  strength  is  in  Tesla,  T,  and  the  proton  resonant 
frequency fo, is in MHz.  Reproduced from (Fullerton 1992).
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In complex biological systems such as brain tissue, the situation is far more complex 
owing to multiple compartments, macromolecules, and chemical species present.
2.2.3  Relaxation M echanisms
In  standard MR imaging, the principle source of relaxation for water protons  arises 
from  the  rotational  motion  of the  water  molecules.  These  generate  an  additional 
magnetic  field  AB0,  such  that  the  magnetic  dipole on  a neighbouring  water proton
experiences  a  field  B0 + AB0.  This  coupling  of magnetic  dipoles  is  known  as  theChapter 2: Background to MR Imaging -27-
dipole-dipole interaction.  However, there are other sources of fluctuation in the local 
magnetic and electric fields that are not accounted for in BPP theory.  Any fluctuation 
is a means for energy transfer, and hence a potential source of spin relaxation.  The 
five  major mechanism  of interaction  for  magnetic  dipoles  are:  electric-quadrupole 
interactions, chemical-shift anisotropy, scalar-coupling, spin-rotation interaction, and 
interactions with unpaired elections (Harris 1983).
Aside  from  dipole-dipole  protons  interactions,  the  other  significant  source  of 
relaxation and hence image contrast (especially in DSC-MRI) is the interaction of the 
water  protons  with  unpaired  electrons.  Since  the  electric  dipole  moment  of the 
electron is  much larger than the magnetic  dipole  moment of a proton, the induced 
field  fluctuations  are correspondingly larger.  Therefore  unpaired  electrons  (e.g.  a 
paramagnetic  material)  are  very effective  sources  of relaxation.  The effect  of the 
paramagnetic contrast agent used in DSC-MRI is described further in Chapter 4.
2.2.4  Bloch Equations
The evolution of the macroscopic magnetisation of a system of spins can be described 
in  terms  of  the  torque  exerted  on  the  macroscopic  magnetisation  vector
M = (m  X,M y,M ZY ,  by  the  external  field  B = (bx, By ,Bzf .  Including  terms
accounting  for  the  longitudinal  Ti,  and  transverse  T2,  relaxation,  the  equation  of 
motion is:
unit vectors  along the  x,y,z  axes.  This equation is known  as the Bloch equation 
(Bloch  1948).  The external field  B  may include contributions from an applied RF
[2.9]
where Mq  is the equilibrium longitudinal  (z-direction)  value of  M ,  and  i,j,k   areChapter 2: Background to MR Imaging -28-
field  , or a gradient field.  In their absence, when  B = B0 • k , (the static magnetic 
field), the Bloch equation can be simplified to:
[ 2.10]
[ 2.11]
dMz  _ M 0 —M
[ 2.12]
dt  T
These  equations  describe  the  exponential  decay  of  the  transverse  magnetisation 
towards zero and exponential recovery of the longitudinal relaxation towards Mq.
A  measurable  MR  signal  is  obtained  by  perturbing  the  main  magnetic  field 
experienced by the spins using an  ‘excitation’  RF pulse,  such that the macroscopic 
magnetisation vector is tipped away from the Bo axis (longitudinal direction) and is 
set into precession.  The contrast in an MR image can be manipulated by changing the 
nature and timing of perturbations to the magnetisation,  and the time  at which the 
signal is acquired.
23.1  Free Induction Decay
The  simplest  MRI  experiment  involves  detecting  the  MR  signal  after rotating  the 
magnetisation into the transverse plane (using for example a 90° RF pulse), where the 
spins freely precess and relax.  The time-varying field of this Free Induction Decay 
(FID) induces an emf in an RF coil tuned and orientated to detect the field changes.
2.3  I mage C ontrastChapter 2: Background to MR Imaging -29-
As well as Ti and T2 relaxation, field inhomogeneities cause additional dephasing of 
the transverse magnetisation, leading to further signal loss.  The decay time, T2*  for 
the transverse magnetisation represents  a combination  of the external  field-induced 
relaxation T2’ and the thermodynamic T2 effects:
The time-constant T2’ is dependent on the homogeneity of the external field and the 
field distortions caused by the  sample.  T2’  signal loss is recoverable  (see  Section 
2.3.2), whereas the T2 relaxation is an intrinsic thermodynamic property of the spin 
ensemble and cannot be reversed.
2.3.2  Spin-Echo
In a Spin-Echo (SE) experiment, the sampled MR signal is the ‘echo’ formed at time 
TE (the echo time) using a 180° RF pulse applied at time TE/2 after the application of 
an excitation pulse.  In the time TE/2 following the excitation pulse and preceding the 
180° pulse, the magnetisation in the transverse plane dephases due both external field 
inhomogeneities fiy  decay) and spin-spin energy exchange (T2 decay).  The effect of 
the  180°  RF  pulse  at  time  TE/2  is  to  invert  the  phases  of the  precessing  spins. 
Consequently, the phases accumulated due to static field inhomogeneities in the first 
TE/2 time period (prior to the  180° pulse) are rephased during the proceeding TE/2 
time period (after the 180° pulse), to produce an ‘echo’ at time TE.  Therefore, the T2’ 
signal loss is recovered and the signal strength at echo time TE is determined by the 
T2 relaxation time.
In order to acquire an image with T2-weighted contrast, the echo should be acquired 
when there is near maximum difference in the T2 signal suppression of the two tissue 
types (e.g. grey-matter (GM) and white-matter (WM)).  Furthermore, to produce an 
image, the SE experiment usually needs to be repeated in a repetition time TR, where 
TR is long enough to allow the longitudinal magnetisation to recover (ideally) to itsChapter 2: Background to MR Imaging -30-
steady-state.  In a 1.5T main field, typical Ti values for nonpathological GM and WM 
are  1300ms  and 660ms respectively (Vymazal  et al.  1999).  Typical T2  values  for 
nonpathological GM and WM are 93ms and 76ms respectively (Vymazal et al. 1999). 
Therefore, a T2-weighted SE sequence with TE~80ms and TR~2s results in an image 
where the GM is brighter than the WM (Vymazal et al.  1999).
2.3.3  Gradient-Echo
In a Gradient-Echo (GE) experiment, the sampled MR signal is the  ‘echo’  typically 
formed  by  applying  a  constant  magnetic  field  gradient  for  a  time  interval  x/ 2  
immediately  following the  excitation  pulse,  and  then  reversing  this  gradient  for  a 
time,x.  The phase accumulated by the spins during the first gradient lobe is reversed 
by  the  second  gradient  lobe,  and  an  echo  is  formed  halfway  through  the  second 
gradient.  The signal is suppressed according to the T2*  relaxation time, since only the 
dephasing caused by the gradient is rephased in the echo.  Dephasing due to field 
inhomogeneities remains.
A  common  application  of GE imaging  is  to  measure the blood-oxygenation-level- 
dependent (BOLD) MR signal.  The magnetic properties of blood are dependent on 
the  oxygenation  state  of  the  haemoglobin  (Ogawa  et  al.  1990).  Because 
deoxyhaemoglobin  is  paramagnetic  (whereas  oxyhaemogloblin  is  diamagnetic),  it 
promotes both T2 and T2* signal loss (see Section 2.2.3).  The BOLD phenomenon is 
widely  used  in  functional  MRI  (fMRI).  This  involves  the  rapid  and  repeated 
acquisition of T2*-weighted (or GE) images, so that any changes between activation 
(where the subject is given a task to perform) and rest can be observed.  In this way, 
the areas of the brain involved in that particular task can be mapped, e.g. (Gore 2003).
GE  imaging  can  also  be  used  to  generate  a  Ti-weighted  image  of  the  brain  by 
acquiring the echo at a very short TE (~10ms), so that there is minimum T2/T2*  decay, 
and repeating the  experiment at  a short TR,  i.e.  TR~ls,  so that there is  maximum 
difference in the Ti signal suppression of GM and WM.Chapter 2: Background to MR Imaging -31-
23.4 Inversion Recovery
An  alternative  way  to  generate  Ti-weighted images  is  by the  so  called  Inversion- 
Recovery (IR) experiment, in which a 180° RF pulse is used to invert the longitudinal 
magnetisation  so that it is  aligned  antiparallel to the  main  field.  The inversion is 
followed by  a delay,  or inversion time TI,  during which the magnetisation relaxes 
back towards equilibrium with time-constant Ti.  The application of a 90° pulse flips 
the remaining longitudinal magnetisation into the transverse plane enabling the signal 
to be measured using either a GE or SE readout.  If TI is varied over an appropriate 
range, Ti can be measured by fitting the recovery curve to:
1 - 2 crexp
t  Tl\\
[2.14]
1)
where  a  is  the  inversion  efficiency  that  is  determined  by  the  longitudinal 
magnetisation immediately following the RF pulse.
It should be noted that any in vivo Ti  measurement is contaminated by blood-water 
protons flowing into the region of interest (ROI) and exchanging with the tissue water 
during the period between the inversion and the excitation pulses.  The measurement 
is  further  complicated  by  the  fact  that  blood  and  tissue  have  different  Ti  values. 
Although the effect on the measured Ti  is small, it is these  small changes that are 
exploited  to  provide  the  desired  perfusion  contrast  in  the  Arterial  Spin  Labelling 
(ASL) technique (see Section 3.5.2).
An image of the brain with Ti  contrast can be obtained from an inversion recovery 
sequence by applying the excitation pulse at time TI when the Ti  generated signal 
difference between GM  and WM is  greatest,  i.e.  TI~ls.  The echo  should then be 
measured as soon as possible after to minimise T2/T2*  contrast.Chapter 2: Background to MR Imaging -32-
An  alternative  application  of  the  IR  experiment  is  to  null  the  signal  from  one 
component.  For example, in the fluid-attenuated IR (FLAIR), the TI is chosen such 
that the signal from the cerebral spinal fluid (CSF) is nulled (White et al  1992).
2.3.5  Stimulated Echoes
In  addition  to  images  with  predominantly  Ti,  T2,  and  T2*   weighting,  a  mixed 
weighting can be achieved by making use of stimulated echoes. 1  Stimulated echoes 
arise when three or more RF pulses are present in the experiment.  For example, five 
echoes can be observed with three RF pulses: four spin-echoes with T2-weighting and 
one stimulated-echo with mixed Ti- and T2-weighting.  This is illustrated in Figure 
2.3.  The concept of stimulated echoes can be understood by recognising that for any 
RF pulse (other than a perfect 180°) there is a 0°, 90°, and 180° component, regardless 
of their rotation angle.  The four spin-echoes are formed from the rephasing of the 
transverse magnetisation by the  180° component of the RF pulses.  The stimulated- 
echo  is  formed  from  magnetisation  rotated  into  the  transverse  plane  with  the  90° 
component of the first pulse, then into the longitudinal plane by the 90° component of 
the second pulse.  Here, it retains the phase information from the transverse plane, but 
decays with time constant Tj.  The longitudinal magnetisation is rotated back into the 
transverse plane by the 90° component of the third pulse, where it rephases to produce 
a stimulated echo.
23.6  Diffusion-Weighted Imaging
The  MR  image  can  also  be  given  another  contrast  weighting  indicative  of  the 
diffusion properties of the tissue.  Diffusion is the thermally driven random motion of 
particles,  or  Brownian  motion.  The  effect  of diffusion  on  the  MR  signal  can  be 
understood from the simple pulse sequence illustrated in Figure 2.4.  There are two
1  A mixed weighting can of-course also be achieved by manipulating TE and TR of GE and SE 
sequencesChapter 2: Background to MR Imaging -33-
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Figure 2.3:  Schematic  diagram illustrating the  formation  of four spin-echoes  (SE) 
and one stimulated-echo (StE) from three RF pulses, ai, a2, and  013.  The echoes are 
labelled according to which RF pulses contributed to their formation.  The intensity 
of the stimulated echo is Ti- and T2- weighted, whilst the spin-echoes have pure T2- 
weighting.  The time t\  =TE/2, and the time t2 is usually known as the mixing-time 
(TM).  ___________
‘diffusion’  gradients with strength G, duration 8 , and separation A, either side of the 
refocusing  180° RF pulse.  The first diffusion gradient induces a position dependent 
phase shift, which for static spins is undone by the second gradient pulse.  However, 
for  spins  that  have  moved  along  the  direction  of the  diffusion-encoding  gradient 
between the application of the two gradient pulses, the phase shift induced by the first 
gradient pulse will not be completely cancelled by the second.  The dephasing and 
hence signal loss resulting from diffusion is increased by increasing the amplitude of 
the  diffusion  gradients  G,  increasing  the  gradient  duration  8 ,  increasing  the  time 
interval between the gradients  A,  (i.e.  allowing more diffusion-time),  or increasing 
the molecular diffusivity.  This final parameter enables useful image contrast between 
different types of soft tissue, especially in the pathogenesis of cerebrovascular disease 
(see Section 3.7).Chapter 2: Background to MR Imaging -34-
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Figure 2.4:  The  Stejeskal-Tanner or pulse-field  gradient  spin-echo  sequence.  The 
spin-echo sequence is made sensitive to diffusion by additional diffusion gradients, 
Gdiff,  of duration  8  and  separation  A.  The magnitude  of the echo  depends  on  the 
degree of diffusion in the direction of the additional gradient during A._____________
Einstein  showed  that  the  diffusion  coefficient  D,  relates  the  variance  of the  spin 
displacement (z2}, to the diffusion-time t.  For one-dimensional free diffusion:
(.z2) = 2Dt  [2.15]
This linear relationship between diffusion-distance and time is not applicable when 
the diffusion is restricted.  In this situation an ‘apparent’ diffusion coefficient (ADC) 
is measured, which is actually dependent on the diffusion-time (Norris et al  1994). 
For  diffusion  within  a  closed  space,  the  measured  diffusion-distance  eventually 
saturates as a function of diffusion-time as more molecules reach the boundaries, and 
therefore the ADC progressively decreases to zero.  In tissue, the measured diffusion 
will not only depend on the diffusion properties of the molecule (i.e.  ‘free’ diffusion 
coefficient D), but  also  on the presence  and permeability of boundaries  within the 
tissue structure, and the diffusion-time.  Therefore the measured coefficient in MRI is 
often referred to as the ADC.
Stejeskal  and  Tanner  (Stejskal  et  al.  1965)  related  the  signal  attenuation  in  the 
diffusion-weighted sequence (Figure 2.4) to the  diffusion coefficient:Chapter 2: Background to MR Imaging -35-
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[2.16]
where  S(0)  is  the  signal  strength  in  the  absence  of  G.  For  a  general  imaging 
sequence, Equation [2.16] can be written:
where the b- value indicates the sensitivity of the sequence to (diffusion) motion.
An  anisotropic  (directionally  dependent)  medium  cannot  be  characterised  with  a 
single ADC measurement, which is only sensitive to the diffusion properties in the 
direction  of the  diffusion  gradient.  A  full  characterisation  requires  the  diffusion 
tensor  D  (Basser  et  al  1994).  At  least  seven  measurements  are  required  to 
characterise the tensor (compared with two for the ADC).
Alternatively, the directionality of ADC maps can be circumvented by measuring the 
trace  of the  diffusion  tensor  Tr(D )=(D „+D 2 2  + D33),  which  indicates  the  mean
diffusivity,  averaged uniformly  over all  directions.  To measure the trace,  it is not 
necessary to characterise the full tensor.  By suitably applying multiple gradients with 
different  directions  within  the  same  sequence,  the  off-diagonal  elements  of  the 
diffusion tensor can be cancelled (Mori  et al  1995).  The resulting trace-weighted 
image can be calculated with just two images.2
In order to obtain an MR image, there must be spatial encoding of the MR signal.  By 
superimposing  onto  the  main  longitudinal  magnetic  field  Bo,  a  field  gradient
S(G) = S(0)exp(-i>D) [2.17]
2.4  Image Acquisition
2 Acquiring images in 3 orthogonal directions also allows you to compute the trace without calculating 
the full tensorChapter 2: Background to MR Imaging -36-
, the MR signal from the sample will have a
spatially varying frequency according to:
[2.18]
where  r = (x, y, z).  The resonant frequency of the spins is now position dependent. 
For example, frequency analysis of the FID in the presence of a gradient field in the 
dB
x-direction,  Gx = — L,  shows  a  distribution  of frequencies  representing  the  spin- 
ox
density  profile  of  the  sample  along  the  Jt-axis  (ignoring  relaxation  effects).  By 
applying field gradients along a range of angles, a number of spin-density profiles can 
be acquired and the internal distribution of spins within the sample can be deduced by 
means  of  the  ‘back-projection’  algorithm.  Image  reconstruction  using  back- 
projection formed the basis of the original MRI methods (Callaghan 1991). There are 
many  drawbacks  associated  with  the  back-projection  method,  including  inefficient 
data  sampling  and  smearing  of off-resonance  signals.  Consequently,  most  of the 
modem  techniques  encode  the  object co-ordinates  by  applying  the  gradient  fields 
along just three perpendicular axes.  2 or 3D image reconstruction  is  achieved by 
performing the 2D/3D Fourier transform of the  ‘reciprocal space’, which is defined 
from the integral of the encoding gradients over their corresponding durations.  This 
reciprocal space is termed &-space, and will be described in detail in Section 2.4.2.
example, to select an axial slice, a field gradient is applied in the z-direction, such that 
the  resonant  frequency  of  the  spins  in  the  sample  is  a  linear  function  of  the  z 
coordinate:
2.4.1  Slice Selection
MR images are often acquired in the form of a series of two-dimensional slices.  This 
is  achieved  by  only  exciting  spins  within  a  specified  section  of the  sample.  ForChapter 2: Background to MR Imaging -37-
w{z)=r{Bl> +GI z)  [2.19]
A  slice of thickness  Az  at location z can then be excited by applying a frequency 
selective RF pulse with a central frequency co(z) and bandwidth Aco:
Az = —   [2.20]
)GZ
The  thickness  of the  slice  is  therefore  determined  by  the  magnitude  of the  field 
gradient and the RF pulse bandwidth.3  The excitation of a slice of spins leaves two 
spatial  dimensions  unresolved.  2D  spatial  encoding  is  described  in  the  following 
section using £-space and the 2D Fourier Transform.
2.4.2  Concept of K-Space
Ignoring the effects of relaxation, the MR  signal from location  r  as  a function of 
time is:
5(f) = j p i r y ^ ^ d 1?  I 2.21 ]
where p(r) is the spin density, (f>{r,t) is the phase of spins at location  r , and V is the 
sample volume.  The phase increases according to the spin’s resonant frequency:
t
</{r,t)=\a(r,t')dt'  [ 2 .2 2 ]
0
The  spatial dependence  of the resonant frequency is governed by the  applied field 
gradients according to Equation [2.18].  The Bo contribution to the Larmor frequency 
is  much larger than  the gradient induced field,  and is identical  for all  spins in the 
sample.  Since only the phase-differences are important for spatial encoding, the Bo 
term can be ignored.  The relative phase is given by:
3  It should be noted that the finite duration of the RF pulse and field imperfections result in imperfect 
slice-profiles.Chapter 2: Background to MR Imaging -38-
[ 2.23 ]
Accordingly, the &-space vector is defined as:
[2.24]
By combining Equations [2.21] to [2.24], the MR signal can be expressed as:
s(fc)= Jp(r>r*r ~d3r [ 2.25 ]
Equation [2.25] states that the MR signal  s(fc) is the Fourier Transform of the spin 
density distribution p(r).
Many imaging sequences are based on the 2D Fourier Transform.  If a single slice is 
excited (as described in Section 2.4.1), the MR signal  s(fc) becomes:
s(fc)= Az jp(r)e  ird 2r [ 2.26 ]
where  Az  is the  slice thickness, A is the sample area,  and  r  is  a two dimensional 
vector in the image plane.  The application of gradients in the x and y dimensions will 
change the position within £-space, in order to sample all spatial frequencies.
A  typical  2D-FT  gradient-echo  imaging  sequence  and  its  corresponding  fc-space 
sampling scheme are illustrated in Figure 2.5.  The simultaneous application of the 
excitation pulse (labelled a) and a gradient in the z-direction (s/ic^-direction)  Gsuce, 
results  in  the  excitation  of only  a  slice  of spins.  Following  the  a pulse,  GsiiC e,  is 
reversed, which rephases the gradient induced phase-variation across the slice during 
the application of the RF pulse.  This ensures the spins are in-phase across the slice, 
thereby  minimising  signal  loss.  A  gradient  is  then  applied  along  the  negative x- 
direction, Gread, shifting the position of the &-space vector along the kx-axis, orChapter 2: Background to MR Imaging -39-
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Figure 2.5: A basic gradient-echo (GE) pulse sequence (left) and the corresponding 
k-space trajectory (right).  In the left diagram, Gsuce, Gpe and Gread, are the gradients 
applied  in  the  slice,  phase-encoding,  and  read  (frequency-encoding)  directions 
respectively.  TE is the echo time, and Nm is the number of phase-encoding steps.  In 
the right diagram, kx corresponds the read direction of £-space, and ky corresponds to 
the phase-encoding direction.  One line of &-space (solid grey arrow) is acquired per 
excitation pulse.  The dashed grey arrows indicate the effect of the phase-encoding 
and read-dephase gradients in moving the fc-space vector along the kx and ky axes.
frequency-encoding direction.  The positive lobe of Gread moves the /c-space vector to 
positive kx passing through the central kx= 0  axis (corresponding to zero phase), where 
the gradient-echo occurs.  One line of A>space is sampled in the period following the 
excitation pulse.  The & y-axis or phase-encoding (PE) axis is traversed by applying a 
gradient in the y-direction, Gpe.  The PE gradient is incremented at each TR in order 
to sample a new line of &-space.  Multiple excitation pulses are required to achieve 
full  £-space  coverage.  The  sequence  is  repeated  Npe  times  before  Fourier 
Transformation.
The signal intensity in the image resulting from the Fourier Transform of the  space 
data  depends  on  the  relaxation  properties  of  the  sample.  For  the  gradient-echoChapter 2: Background to MR Imaging -40-
sequence illustrated in Figure 2.5, the sampled echo has a peak amplitude along the
-7 %* central line of &-space proportional to  e  7  2  .
A  spin-echo  imaging  sequence  and  corresponding  /c-space  trajectory  are  shown  in 
Figure 2.6.  As discussed in Section 2.3.2, the effect of the 180° pulse is to invert the 
phase of the transverse magnetisation.  Since A:-space has conjugate symmetry, this
corresponds to reversing the position in ^-spacer  k — » -k .  The sampled echo has a
-TE /
peak amplitude along the central line of k-spa.ce proportional to  e  /Tl.
2.4.3  Properties of K-Space
During an MR imaging experiment, the MR signal will be sampled at discrete time 
points.  The Nyquist criterion states that in order to accurately represent the original 
signal,  the  sampling  rate  must  be  higher  than  twice  the  maximum  frequency 
represented in the sample:
—  >2 
At 2  7t
[ 2.27 ]
where  At  is the time between successive samples.  If this sampling criterion is not 
satisfied,  frequencies higher than the sampling rate will be aliased,  such that their
original angular frequency  C O   will be interpreted as  co  ^
l7t
When Gread and Gpe are applied to the sample, the relative frequency of the MR signal 
from the spins is higher at the edges of the sample where the effect of the gradients is 
greatest.  On one  side the  frequency is negative  with respect to the other,  and the 
centre  of the  sample  has  zero  frequency  off-set.  In  MRI,  differentiation  between 
positive and negative frequency is achieved using quadrature detectionChapter 2: Background to MR Imaging -41 -
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Figure 2.6: Basic spin-echo (SE) sequence (left) and corresponding &-space trajectory 
(right).  The labelling is the same as in Figure 2.5.  The application of the 180° pulse 
reverses the position in &-space, as indicated by the dashed curved arrow.  The dashed 
lines are only shown for one of the phase-encoding steps.________________________
(Gadian  1995).  The Nyquist criterion can be used to determine the &-space sampling
rate  — ,  required  to  image  a  particular  spatial  extent  (field  of  view,  FOV). 
Ak
Ak
Considering  the  jc-dimension,  since  co^  = }Gread •   and  At = -----— ,  it  follows
iG read
from Equation [2.27] that:
2  7t
FOV = —   [2.28]
Ak
where the FOV extends -Jtm ax to +jcm ax,  such that the factor of 2 is dropped.  If the 
sample is larger than the FOV, the signal emanating from the outlying regions will be 
aliased, such that they appear to originate from a region displaced by one FOV.
The extent of the sampled &-space, & m ax determines the maximum spatial frequency 
that can be correctly represented in the image, and is related to the image resolution:Chapter 2: Background to MR Imaging -42-
[ 2.29 ] k  — max
71
Ax
Data  acquired  in  the  centre  of k-space  contain  information  about  the  low  spatial 
frequency components of the spin density distribution, and therefore give the image 
its gross contrast.  Whereas regions further away from the centre of k-space contain 
information about the higher spatial frequency components, and therefore provide the 
fine  detail  and edge information.  If the edge of k-space is  discarded the resulting 
image will have very low spatial resolution (see Equation [2.29]).  If the centre of k- 
space is discarded, the image will primarily contain edge information.
2.4.4  Echo-Planar Imaging
In the 2D-FT technique described in Section 2.4.2, one line of k-space is acquired per 
excitation and so image acquisition is slow (~2mins).  Many applications, including 
perfusion imaging, require much faster imaging methods.  In Echo-Planar-Imaging 
(EPI), a complete image can be formed from a single excitation pulse in a few tens of 
milliseconds  (Mansfield et al.  1977).  Figure 2.7  shows  a schematic GE-EPI pulse 
sequence,  with  ‘blipped’  phase-encoding  gradient,  and  the  corresponding  k-space 
trajectory.  In order to acquire all of the k-space data from a single excitation, during 
the sampling of a spin- or gradient-echo, the polarity of Gread is rapidly switched, and 
at the reversal of Gread, Gpe is ‘blipped’.  The ‘effective’ echo time TEe jf, is defined as 
the time to the maximum echo amplitude, which coincides with the acquisition along 
the central line of k-space.  Providing that the signal is only sampled when Gread is 
constant, a Cartesian grid of sample points in k-space is achieved with the ‘blipped’ 
Gpe scheme.  In practice, since such a scheme would incur a large time penalty from 
the  gradient  ramp-up  time,  data  are  also  acquired  during  the  gradient  ramps. 
Consequently, to preserve a Cartesian grid, and hence use the 2D Fourier Transform, 
the echoes must be sampled non-linearly in time.Chapter 2: Background to MR Imaging -43-
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Figure 2.7:  Schematic GE-EPI  sequence  diagram  (left)  and corresponding ft-space 
trajectory (right).  The labelling is the same as Figure 2.5.  TEe ff is the effective echo­
time.  The  whole  of ft-space  is  acquired  following  a  single excitation  pulse.  The 
horizontal  solid grey arrows on the ft-space trajectory change direction at each line 
according  to  the  polarity  Gread-  The  short  vertical  grey  arrows  move  the  ft-space 
vector along the phase-encoding direction at each Gpe ‘blip’._____________________
2.4.4.1  Artefacts in EPI
Despite the obvious advantage of high temporal resolution images, EPI is more prone 
to artefacts than conventional MRI (Morgan et al 2004; Jezzard et al  1999).  Many 
of the artefacts in EPI are related to the fact that the frequency difference between 
adjacent  voxels  (or bandwidth  per pixel)  in  the  phase-encoding  direction  is  much 
smaller  than  in  the  frequency-encoding  direction.  The  bandwidth  per  pixel  is 
inversely proportional to the dwell time (the time between adjacent samples).  Along 
the  frequency-encoding  axis  the  dwell  time  At  is  very  short,  whereas  along  the 
phase-encoding it is approximately NAt, where N is the number of samples along the 
frequency-encoding  axis.  Consequently,  the  bandwidth  per pixel  is  much  smaller 
along  the  phase-encoding  direction.  Typically,  for  an  EPI  ft-space  matrix  size  of 
128x128, there is a 5jus dwell time, corresponding to a 12Hz bandwidth per pixelChapter 2: Background to MR Imaging - 44 -
along the phase-encoding direction.  This small bandwidth per pixel is the cause of 
the image distortion that is common along the phase-encoding direction, due to for 
example, the frequency offset resulting from field inhomogeneities or chemical shifts. 
Artefacts along the frequency-encoding direction are insignificant in comparison.
Because of the long dwell time along the phase-encoding direction, the A;-space data 
along  the  phase-encoding  direction  is  also  modulated  by  the  T2*   decay  envelope, 
which  for  typical  sampling  schemes  attenuates  the  high  frequencies.  The  image 
resolution  is  determined by the point-spread-function  (PSF),  which  determines  the 
smallest resolvable structure, and therefore blurs the ideal representation of an object 
in the observed image.  Ignoring the effects of relaxation, the width of the PSF width 
is  inversely  proportional  to  the  finite  extent  of sampled  A>space.  In  EPI  there  is 
additional  blurring  along the phase-encoding  direction,  because the  PSF  along  the 
phase-encoding  direction  is  the  convolution  of the  original  PSF  with  the  Fourier 
Transform of the T2*  envelope (Jesmanowicz et al  1998).  Relaxation effects along 
the frequency-encoding direction can be ignored.
Another common  artefact in  EPI is  the  Nyquist  ghost image,  which  is  often  seen 
displaced half a FOV from the main image in the phase-encoding direction.  In EPI, 
alternate lines of &-space along the frequency-encoding axis are acquired in opposite 
directions.  Inconsistencies between alternate lines introduce an additional frequency 
component  at  exactly  half the  sampling  frequency,  resulting  in  the  ghost  image. 
Inconsistencies can arise from timing errors in the synchronisation of the RF receiver 
with the A:-space trajectory, or delays caused by eddy currents induced by the rapidly 
switching  gradients  (Schmithorst et al  2001).  Several techniques  are  available to 
minimise the Nyquist ghost,  e.g.(Chen et al  2004; Grieve et al  2002;  Yang et al 
1996;  Schmithorst  et  al  2001).  Receiver  timing  errors  can  be  minimised  by 
repeatedly acquiring the central line of A;-space in opposite directions to estimate the 
delay, and the effects of eddy-currents can be alleviated using ‘gradient pre-emphasis’ 
(Jehenson etal.  1990).Chapter 2: Background to MR Imaging -45-
It should also be noted that because of the rapid traversal of &-space, and consequent 
high  sampling  rate,  the  bandwidth  of the  receiver  must be  correspondingly  large.
Since the  SNR scales  as      , where BW is the receiver bandwidth, EPI images
y/BW
have a reduced SNR compared with conventional imaging.  However, the SNR per 
unit time is much higher than conventional imaging.
2.4.5  Parallel Imaging
The artefacts mentioned in Section 2.4.4.1  are particularly problematic for high-field 
imaging.  In  addition,  scanning the whole  of  space  following  a single excitation 
pulse  imposes  considerable  demands  on  the  scanner  hardware,  for  example,  high 
gradient slew-rates and high currents for the gradient amplifier.  Parallel imaging is 
one of the most promising recent advances in scanner technology, which attempts to 
circumvent hardware limitations and accelerate MRI.
In parallel  imaging,  fewer phase-encoding  steps  are necessary for a desired  spatial 
resolution,  and  image  acquisition  time  can be  accelerated  compared  with  standard 
imaging.  A correct image reconstruction is achieve from the sparsely sample phase- 
encoding direction by using multiple independent receiver coils.  The spatial variation 
of the coils’  sensitivity is used in conjunction with gradient-based image-encoding to 
determine the missing data.  The reduction in phase-encoding time can be utilised to 
either achieve a higher temporal resolution or to increase the spatial resolution.  In 
EPI, the echo train length will be shortened, therefore reducing image distortion and 
blurring.  However, one disadvantage of parallel imaging is a lower SNR.  Some of 
the popular parallel imaging techniques are SMASH (Sodickson et al  1997), SENSE 
(Pruessmann et al  1999), and GRAPPA (Griswold et al 2002).  A review of clinical 
parallel imaging can be found in (Bammer et al 2004).Chapter 3: Perfusion Imaging in Stroke -46-
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3.1  In tro d u ctio n
The  vitality  of cerebral  tissue  depends  upon  the  sufficient delivery  of oxygen  and 
nutrients;  this  is  controlled by the  microvascular blood  flow,  or perfusion.  When 
perfusion is significantly reduced, due to for example vascular stenosis or occlusion, 
the physiology and biochemistry of the brain tissue is  altered.  The interruption of 
blood  flow  to  a region  of brain,  which results in  neurological  injury,  is  known  as 
ischaemic  stroke.  Without prompt  diagnosis  and  appropriate  treatment,  the tissue 
damage may be permanent.  The size and severity of the ischaemic region depends on 
collateral flow and the sufficiency of regulatory mechanisms which seek to meet the 
metabolic  needs.  This  chapter  aims  to  provide  an  overview  of  the  cerebral 
haemodynamics  and  autoregulation  in  healthy  tissue,  and  in  the  pathogenesis  of 
cerebrovascular disease.
Haemodynamic and pathological changes can be identified using MR and non-MR 
imaging  methodologies.  Some  commonly  used  non-MR  imaging  techniques  are 
reviewed, and their usefulness in the assessment and management of stroke patients is 
discussed.  In addition, the MR perfusion techniques used in humans are described. 
Complementary  to  these  MR  perfusion  measurements,  information  about  the 
pathophysiological tissue status can be obtained using other MR techniques such as 
diffusion-weighted  (DWI)  and  blood-oxygenation-level-dependent  (BOLD)
measurement.  The  utility  of  combining  these  techniques  to  assess  patients  with 
cerebrovascular  disease  is  described,  in  particular  their  application  in  identifying 
patients likely to benefit from reperfusion treatments.
The sensitivity and specificity of these techniques to identifying tissue that is likely to 
become irreversible  damaged,  is  dependent on the imaging  (delay) time  following 
stroke,  and  is  limited  by  accuracy  of  the  imaging  methods.  Understanding  the 
limitations is an important first step towards improving patient outcome in stroke, and 
is one of the primary objectives of this thesis.Chapter 3: Perfusion Imaging in Stroke -48-
3.2  Cerebral Haemodynamics and Autoregulation
Cerebral perfusion refers to the rate of flow of blood through the capillaries, where 
the exchange of oxygen and nutrients between the blood and tissue occurs.  Cerebral 
perfusion, also known as the cerebral blood flow (CBF), is determined by the ratio of 
cerebral  perfusion  pressure  (CPP)  and  cerebrovascular  resistance  (CR)  (Powers
1991).  CPP is the difference in pressure between the forward arterial pressure into 
the cerebral circulation and backward venous pressure.  In healthy vasculature, the 
venous pressure is small, and the arterial pressure is constant.  In this situation, the 
CBF is primarily determined by the CR, which is itself controlled by the diameter of 
the small arteries (vasodilation and contraction).  The volume occupied by the small 
capillaries  indicates  the  microvascular  blood  volume,  or  cerebral  blood  volume 
(CBV).  CBV is therefore determined by the capillary density within a voxel and the 
diameter  of these  capillaries.  For  a  given  capillary  density,  an  increase  in  CBV 
(vasodilation) causes a decrease in CR.  Both CBV and CBF will increase as vessels 
dilate  and both  decrease  as vessels  contract,  such that the ratio  CBV/CBF remains 
relatively constant.  This ratio, known as the mean transit time (MTT), represents the 
average time taken for the blood to flow from the arterial input to the venous output 
of the tissue capillary bed.  A larger MTT corresponds to slower cerebral circulation. 
Under normal physiological conditions, changes in CPP have little effect on CBF due 
to the autoregulatory mechanisms of vasodilation (in response to a decrease in CPP) 
and  contraction  (in  response  to  an  increase  in  CPP),  which  ensure  the  adequate 
delivery of metabolites to the functioning neurons.
3.3  P erfusion in Cerebrovascular Disease
CPP  is  reduced  in  cerebrovascular  diseases  due  to  impediment  of  arterial  flow. 
Autoregulatory  vasodilation  (increasing  CBV  and  reducing  CR)  in  response  to 
reductions  in  CPP  endeavours  to  maintain  CBF.  However,  this  autoregulatory 
vasodilation  impairs  the  ability  of the  blood  vessels  to  react  to  other  vasoactiveChapter 3: Perfusion Imaging in Stroke -49-
stimuli.  When the capacity for vasodilation is exceeded, autoregulation fails and any 
further  reduction  in  CPP  will  result  in  a  decrease  in  CBF,  and  consequently  an 
increase in MTT (a slower cerebral circulation).
When the oxygen supply to the tissue is reduced because of a decreasing CBF, the 
brain  responds  by becoming  more  efficient in  extracting  oxygen  from  the  limited 
blood  flow.  An  increased  Oxygen  Extraction  Fraction  (OEF)  helps  to  maintain 
cerebral  oxygen  metabolism  (CMRO2).  Hudetz  et  al.  (Hudetz  et  al.  1996) 
demonstrated that a graded decrease in CPP causes progressive loss of the high flow 
components of the blood flow.  A slower and more homogeneous flow distribution 
was shown to improve the effectiveness of oxygen transport (increased OEF).  The 
haemodynamic parameter of flow heterogeneity (FH) indicates the heterogeneity (or 
conversely the homogeneity)  of the  velocity  distribution  in  the tissue  element.  A 
decreased FH  therefore appears to assist in maintaining sufficient gradients to drive 
the diffusion of oxygen and nutrients from the blood to the cells (Kuschinsky et al.
1992).
This phase of ischaemia, where CBF is low, OEF is raised, and CMRO2 is normal, is 
termed  oligemia,  and  is  clinically  silent.  However,  if CPP  continues  to  fall,  the 
reduction in CBF will eventually be too great to be compensated by the OEF, and so 
insufficient oxygen and nutrients are exchanged with the brain tissue to drive normal 
neuronal function.  As a result CMRO2 will fall.  This phase, when CBF is very low, 
OEF has reached a plateau, and CMRO2 has fallen, is termed cerebral ischaemia.  If 
the circulation is  not rapidly restored, permanent tissue  damage  will  occur.  Once 
tissue damage has  occurred, the normal  autoregulatory mechanisms may no longer 
work even if the CPP returns to normal.  When the impairment of neuronal function 
becomes irreversible the tissue is infarct, and any relationship between CBF, CBV and 
OEF is lost.
In  summary,  regional  haemodynamics in  cerebrovascular disease  can  be  separated 
into five stages: (1) (Normal) CPP is normal, FH, CBF, MTT, OEF and CMRO2 are 
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dilate causing CBV and MTT to increase, but CBF, OEF and CMRO2 remain normal. 
(Recent work has  suggested that  CBF may  actually decrease  slightly in  this  stage 
(Dohmen et al. 2007))  (3) (Oligemia) CPP is reduced further and the compensatory 
vasodilation capacity is exceeded:  CBF begins to fall;  MTT continues to increase. 
OEF  starts  to  increase,  maintaining  normal  CMRO2.  (4)  (Ischaemia)  CPP  is 
decreased  still  further,  and  since  the  capacity  for  vasodilation  has  already  been 
exceded,  the  continual  fall  in  CPP causes  MTT increases  further  and  CBF to  fall 
further.  Consequently, the compensatory mechanism of increased OEF is exhausted 
and  CMRO2  begins  to  fall.  (5)  (Infarction)  The  relationship  between  the 
haemodynamic and metabolic parameters is lost.  Figure 3.1  shows schematic graphs 
representing  the  dynamic  change  of  the  various  haemodynamic  and  metabolic 
parameters in cerebrovascular disease.
With  the  aim  of identifying  suitable  patients  for treatment,  there  is  much  current 
research into the accurate identification of ischaemic tissue at risk of infarction e.g. 
(Wu et al.  2001; Wu et al. 2007; Shen et al. 2004; Shen et al. 2005; Sorensen et al. 
1996; Rose et al. 2001) (see Section 3.12).  Such tissue is marked by prolonged MTT, 
reduced CBF, and decreased FH.  An accurate quantification of these haemodynamic 
parameters  is  the  first  stage  towards  a  more  accurate  diagnosis  and  prognosis  in 
cerebrovascular diseases.  For this reason, numerous neuroimaging techniques have 
been developed and applied to evaluate brain haemodynamics.  A selection of these 
techniques is summarised the proceeding sections.
3.4  M easuring P erfu sion  using N on MR T echniques
Amongst the techniques in clinical use for the evaluation of brain haemodynamics are 
Positron  Emission  Tomography  (PET),  Single  Photon  Emission  Computer 
Tomography  (SPECT),  Xenon-enhanced  Computer  Tomography  (XeCT),  and 
dynamic Computer Tomography (dynamic CT).  All these techniques give similarChapter 3: Perfusion Imaging in Stroke -51 -
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Figure 3.1:  Qualitative changes  during brain ischaemia in  CBF,  CBV, MTT,  OEF, 
CMRO2,  and  FH.  The  dashed  lines  divide  the  stages  of  normal  blood  flow, 
autoregulation, oligemia, ischaemia and infarction.  After the  ‘normal’  section, CPP 
decreases from left to right across the diagram. The graphs should not be interpreted 
quantitatively.  In addition, the graphs should be interpreted in light of the fact that 
the exact progression of the various haemodynamic and metabolic parameters is still 
an active area of research.
information in the form of parameters such as CBF or CBV.  Most of them rely on 
mathematical models that make certain assumptions that may or may not be accurate 
approximations.  The  techniques  use  different tracers  (diffusible  or non  diffusible, 
exogenous) and have different technical requirements, data collection and processing 
times,  spatial resolutions,  coverage  and quantitative  accuracies.  These  differences 
constitute  both  advantages  and  disadvantages  in  various  clinical  situations.  An 
outline of each of the aforementioned techniques together with a brief discussion of 
the strengths and weaknesses are given below.  The most accurate of these non-MR 
techniques, PET will be described in more detail, since it is generally considered the 
‘gold-standard’ of in vivo perfusion imaging.
3.4.1  Positron Emission Tomography
PET imaging of CBF involves a radioactive tracer such as  15 0 2,  C1S0 2  or  H2150  . 
The  short-lived  oxygen  isotope  15 O,  which  decays  by  emitting  a  positron,  is 
incorporated into  a metabolically active molecule such as  H2  50 ,  15 0 2   or  C1S0 2   . 
H2 50   is administered via intravenous injection, whilst  15 0 2  and  C1S0 2   are inhaled 
continuously over a few minutes.
The  positron  emitted  during  the  15 O decay  travels  a  few  millimetres  before  it 
annihilates with an electron.  This annihilation creates a pair of gamma photons (511 
keV),  which  in  order to  conserve  momentum,  move in  almost opposite  directions. 
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avalanche photodiodes (Si APD) in the PET scanner.  The technique depends on the 
coincident detection of a pair of photons; photons that do not arrive in pairs (to within 
a  few  nanoseconds)  are  ignored.  The  position  at  which  the  annihilation  event 
originated  can  be  estimated  by  measuring  the  time  of flight  of the  two  photons. 
Using  statistics  collected  from  tens-of-thousands  of  coincidence  events,  a  set  of 
simultaneous equations for the total activity of each voxel as a function of time along 
many line paths can be solved, indicating the amount of isotope present.
For the intravenously injected  H2l50  , an arterial blood sample is measured to serve 
as an input function, and combined with a series of consecutive images taken at short 
time intervals (~1  second), to give quantitative CBF (Herscovitch et al  1983).  For 
the inhaled isotope (1 5  0 2  and  C 150 2  ), the image is acquired after a steady-state is 
reached in the blood, to give quantitative CBV (Martin et al  1987) .  In addition the 
OEF can be estimated from the ratio of the local cerebral radioactivity obtained from
an  150 2  inhalation  experiment  to  that  obtained  in  the  same  region  from  H250 
administered intravenously (Hatazawa et al  1995).  And the product of CBF,  OEF 
and  arterial  15 0 2  provides  an  estimate  of the  cerebral  metabolic  rate  of  oxygen, 
CMRO2 (Herscovitch  1989).  Thus  PET imaging can produce maps  estimating the 
CBF, CBV, OEF and CMRO2 values.
The  strength  of the  PET  technique is  its  quantitative  accuracy  (Herscovitch  et al 
1983;  Raichle  et  al  1983)  In  fact,  the  current  in  vivo  “gold  standard”  for  the 
quantitative evaluation of CBF is  H2 50   PET.  It is mainly used clinically in chronic 
cerebrovascular disorders  to  try  and identify the  autoregularity phase  of ischaemia 
where elevated OEF values (combined with normal CBF, see Figure 3.1) are thought 
to indicate higher risk of future infarction (Young et al  1996).  The short half-life of 
the  radioactive  tracers  makes  repeated  measurements  possible,  although  repeated 
exposure to these small doses of radiation is not desirable.  The radiation risk is just 
one of many substantial disadvantages in the PET methodology, including the need 
for an  arterial  catheter to measure the  arterial tracer concentration,  and the limitedChapter 3: Perfusion Imaging in Stroke -54-
availability of PET centres with a cyclotron to create the isotopes.  In addition, the 
spatial resolution of PET is poor.
3.4.2  Single Photon Emission Computer Tomography
SPECT  (Warwick  2004)  is  a  technique  similar to  PET.  However,  in  SPECT  the 
radioactive  substances  used  (often  " mT c- HMPAO) have longer decay times than 
those used in PET, and emit lower energy single photons, rather than double gamma 
rays. As a result, SPECT images have lower sensitivity and are less detailed than PET 
images.  Unlike  PET,  SPECT  measurements  are  approximate  and  relative
measurements of perfusion.  However, SPECT is less expensive and more accessible 
than PET since the tracer is not formed in a proton accelerator.  In addition, since the 
tracer is retained in the tissue, it can be administered at the bedside and the imaging 
can be performed later.  This  makes it a particularly useful technique for studying 
perfusion during an epileptic seizure.
3.4.3  Xenon-Enhanced Computer Tomography
In XeCT, nonradioactive Xe is inhaled and rapidly dissolves in blood, freely crossing 
the BBB, and entering the brain.  The Xe attenuates the x-rays providing additional 
contrast  enhancement  in  regions  where  the  Xe  has  accumulated.  CT  images  are 
acquired at successive intervals  and before and during the Xe inhalation:  the time- 
course concentration of Xe in the blood (arterial input) and brain and the blood-brain 
partition coefficient for Xe are used to calculate the CBF (Drayer et al  1978).  The 
technique  gives  accurate  quantitative  results,  but  as  with  PET,  one  of  the  main 
sources of error in XeCT is the measurement of the arterial concentration.  Because of 
the long acquisition time (~10mins) XeCT is prone to motion artefacts.  Additionally, 
because of the radiation risk, XeCT is not recommended for children.Chapter 3: Perfusion Imaging in Stroke -55-
3.4.4  Dynamic Perfusion Computer Tomography
Dynamic CT involves the intravenous injection of a non-diffusible tracer of iodinated 
material that attenuates the x-rays, and therefore provides additional contrast as the 
tracer passes through the capillary bed.  Typically images are acquired at a rate of one 
per second.  Deconvolution analysis similar to that used in bolus tracking MRI (see 
Section  3.5.1)  can  lead  to  quantitative  perfusion  measurements.  While  the  wide 
availability  of  CT  scanners  makes  this  a  popular  technique  in  a  clinical  setting, 
dynamic  CT  has  limited  spatial  coverage,  tends  to  over  estimate  CBF  in  voxels 
including large vessels, and radiation exposure makes it non-ideal for repeated scans 
(Wintermark et al 2004).
3.5  M easuring Perfusion using MRI
Perfusion changes can be identified non-invasively in MRI using either an exogenous 
or  endogenous  tracer.  The  first  technique  called  bolus-tracking  or  dynamic 
susceptibly contrast MRI (DSC-MRI) requires the intravenous injection of a contrast 
agent  (Section  3.5.1).  The  second technique called Arterial  Spin  Labelling  (ASL) 
uses RF pulses to magnetically label the moving protons (Section 3.5.2).  There are 
several  advantages  over  other  techniques  in  using  MRI  to  assess  cerebral 
haemodynamics.  Importantly,  it  can  be  combined  with  fine  anatomical  MRI  to 
resolve structure,  diffusion MRI to measure the molecular mobility of water in the 
tissue  (see  Section  2.3.6  and  Section  3.7),  blood  oxygenation  measurements  (via 
BOLD  imaging,  Section  2.3.3  and  Section  3.8),  magnetic  resonance  angiography 
(MRA)  to  inspect  the  integrity  of the  cerebral  arteries  (Zhang  et  al  2007),  and 
magnetic resonance spectroscopy (MRS) to investigate chemical changes within the 
brain (Baird et al  1998).  Thus it is possible to provide a very comprehensive set of 
information  in  a  single  examination.  Combining  this  information  into  predictive 
algorithms  is  an  active  area  of  research  that  seeks  to  foretell  the  fate  ofChapter 3: Perfusion Imaging in Stroke -56-
haemodynamically-compromised tissue  (Section  3.12),  and  so  assist the  diagnosis, 
prognosis, and possible treatment plan.
3.5.1  Bolus-Tracking MRI
This thesis  solely is concerned with the accurate measurement and interpretation of 
perfusion values obtained using bolus-tracking or DSC-MRI data, the most common 
clinical MR perfusion technique.  This  technique, together with its limitations  and 
application  in  cerebrovascular  diseases  is  described  in  detail  in  Chapter  4.  In 
summary,  DSC-MRI relies on the measurement of T2/T2* changes  during the first 
pass of an intravascular paramagnetic tracer through the capillary bed (0stergaard et 
al.  1996b; 0stergaard et al.  1996a).  The technique requires a fast imaging technique 
in order to acquire images at adequate temporal resolution (~l-2s) to characterise the 
concentration  time-course  of  the  first-pass  of the  tracer  both  in  the  tissue  and  a 
feeding  artery.  Similar  to  dynamic  CT,  the  quantification  of  CBF  requires  the 
deconvolution of the tissue and arterial curves.  Unlike dynamic CT, the relationship 
between the signal intensity and tracer concentration is not linear.  The whole brain 
can  however  be  covered  and  there  is  good  spatial  resolution  (typically 
~1.5xl.5x4mm).  In  addition,  because  there  is  no  ionising  radiation  involved,  the 
examinations  can  be  repeated  periodically  without  further risk to  the  patient,  thus 
enabling the evolution of haemodynamically compromised tissue to be studied (i.e. 
acute, subacute, and chronic phases).  However, in order to avoid residual effects of a 
previous injection of paramagnetic tracer on the tissue relaxation rate, it is necessary 
to leave  an interval  of several hours between injections.  In a study involving two 
time-separated  injections,  a discemable difference in the concentration time-course 
was  observed with  a two  hour interval, but not a four hour interval  (Levin et al. 
1995).  Such residual  effects  can be minimised using a smaller pre-dose of tracer, 
which appears to stabilised subsequent measurements (Levin et al.  1995).Chapter 3: Perfusion Imaging in Stroke -57-
3.5.2  Arterial Spin Labelling
An  alternative  perfusion  MRI  technique  to  DSC-MRI  is  Arterial  Spin  Labelling 
(ASL), where perfusion is measured by monitoring the flow of magnetically labelled 
water through the tissue.  Since this technique is less robust than DSC-MRI, it has not 
entered  widespread  clinical  use,  although  its  utility  has  been  demonstrated  for  a 
variety of acute and chronic cerebrovascular diseases (Detre et al.  1999), as well as in 
tumours (Weber et al  2004), dementia and Alzheimer’s (Du et al.  2006) and brain 
activation (Wong et al.  1997).  The design and development of accurate, robust and 
sensitive ASL techniques is an active area of research and numerous ways to do ASL 
have been described e.g. (Calamante et al.  1999b; Golay et al. 2004).  In view of the 
fact that ASL is a major competitor to the DSC-MRI perfusion methodology used in 
this  thesis,  the  underlying  principles,  assumptions,  and  limitations  of  ASL  are 
summarised in this section.
ASL techniques do not require a contrast agent; rather they use endogenous water as a 
tracer.  The perfusion measurements are based on the fact that the magnetisation and 
relaxation characteristics of the tissue-water protons are affected by the magnetisation 
of the inflowing blood-water protons in the capillaries.  In general, CBF is quantified 
by  acquiring  two  images:  one  in  which  the  blood-water  protons  flowing  into  the 
capillary bed have been magnetically labelled using an RF pulse (termed the labelled 
image) and one in which the blood-water protons flowing into the capillary bed have 
the same magnetic state as the tissue (termed the control image).  Subtraction of these 
two images results in an image intensity proportional to the blood flow.
Quantitative measurements of perfusion are obtained by modelling how the relaxation 
rates of the tissue-water protons are affected by the inflow of magnetically labelled 
blood-water protons.
Neglecting the effects of flow, the longitudinal relaxation in the tissue is described by 
the Bloch equation (see Section 2.2.4).Chapter 3: Perfusion Imaging in Stroke -58-
dM7(t) 
dt  Tx
where  Mz(t)  is the longitudinal magnetisation per gram of brain tissue water at time 
t, M  z   is the fully relaxed value of Mz(t)  and T\ is the longitudinal relaxation time. 
Equation  [3.1]  can  be  modified to  include the  effects  of blood  flow /  (ml/g/s),  to 
account for the gain in magnetisation caused by the inflowing (arterial) blood-water 
protons fMa(t), and the loss of magnetisation due to the outflowing (venous) blood- 
water protons fMv  (r).
dM j) = Mz°-M z(t) + fM^  (?) _ ^  (<)  [32]
dt  1  j
Assuming the longitudinal  magnetisation of the venous blood can be related to the 
longitudinal  magnetisation  of the tissue  water  Mt(t)  via the blood brain  partition
coefficient A, i.e.,  Mv  (t) =  , Equation  [3.2]  can be written (Herscovitch et al.
X
1985):
\
[3.3]
The  magnetisation  of  the  inflowing  arterial  blood  Ma(t)  modifies  the  apparent 
relaxation and magnetisation of the tissue water Mt(t).  If Ma(t) is known, Equation
[3.3]  can be solved for the blood flow,/.
3.5.2.1  Continuous Arterial Spin Labelling
The  original  ASL  technique  (Williams  et al.  1992;  Detre  et al.  1992),  known  as 
CASL (Continuous Arterial Spin Labelling), involves the continuous inversion of the 
blood-water protons for a period of several seconds as they flow into the brain.  InChapter 3: Perfusion Imaging in Stroke -59-
Figure 3.2:  Schematic diagram illustrating the pairs of images  acquired in a simple 
CASL experiment.  The axial  imaging  slices are indicated by the diagonally striped 
regions.  The  dashed  lines  indicate  the  plane  of inversion  for  arterial  spins  by  the 
adiabatic fast passage RF pulses (see Section 3.5.2.1.1).  The left hand image is the 
label and the right hand image the control.
this  way,  a  flow  dependent  steady-state  tissue  magnetisation  evolves.  Figure  3.2 
illustrates the continuous  labelling  method,  where in the labelled image  the  arterial 
spins  are  inverted  as  they  flow  through  a plane  (dashed  line).  In  the  steady-state,
^ , ( 1)  gjven  jn  Equation  [3.3]  is  equal  to  zero.  Solving  this  equation  for  both 
dt
images, leads to an equation for cerebral blood flow (Williams et al.  1992):
0  \ 4 com  a 4 label
7  ]app  2  aM™ ,
/is  dependent on the steady-state magnetisations of the labelled  A  and control
image  M con‘, ( t ) , the  spin  inversion  efficiency  (see  Section  3.5.2.1.1),  and  the
apparent  longitudinal  relaxation  time  Tlappof  the  brain  tissue.  This  apparent
relaxation  rate  determines  how  the  longitudinal  relaxation  time  of the  tissue-water 
protons is affected by the inflowing labelled blood-water protons:Chapter 3: Perfusion Imaging in Stroke -60-
1  f = — + 4   [3.5]
^lapp  ^1  ^
T\app  can therefore be related to perfusion,/.
3.5.2.I.I.  Adiabatic Fast Passage
In  CASL,  spin  inversion  is  achieved  using  adiabatic  fast  passage  (AFP) 
radiofrequency (RF) pulses (Abragam 1968).  The AFP technique produces a rotation 
of the  macroscopic  vector.  This  rotation  can  be  achieved  either by  sweeping  the 
frequency of the ‘inverting’ RF pulse through the resonance frequency or by changing 
the strength of the local magnetic field (such that the resonant frequency is changed). 
I.e.  rotation  of  the  macroscopic  magnetisation  vector  results  from  sweeping  the 
relative frequency (with respect to the Larmor frequency) of RF pulse from positive 
to  negative,  such  that  the  effective  field  experienced  by  the  blood-water  protons 
changes being parallel to the main field (when the RF pulse is far off-resonance) to 
being perpendicular (when the RF is on-resonance in the inversion plane) to being 
anti-parallel (when the RF is far off-resonance).  In CASL, the RF pulse is applied 
off-resonance (to the imaging slice) in the presence of a magnetic field gradient in the 
direction of blood flow.  As the blood water spins flow up the artery and into the 
brain, the effective magnetic field they experience sweeps from being parallel to the 
main field to antiparallel.  As long as the sweep is slow enough for the spins to keep 
precessing around the effective field, they will switch from fully relaxed to become 
fully inverted.  Furthermore,  the duration  of the inversion process  should be  short 
compared with the longitudinal and transverse relaxation times of the arterial blood 
water spins.  This process is illustrated in Figure 3.3.  The adiabatic condition to be 
satisfied for inversion to occur is:Chapter 3: Perfusion Imaging in Stroke -61 -
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Figure  3.3:  Schematic  illustration  of  adiabatic  inversion  in  CASL.  The  six  axes 
labelled  (A,  z\)  show  the  macroscopic  magnetisation  vector  M  (black  arrow) 
precessing  with  the  effective  magnetic  field  vector  Beff  (red  arrow)  in  the  rotating 
frame (x’,y’,z) rotating with  angular frequency  *y(zf)= y{BQ  +GZ  -zf).  From left to 
right  the  diagrams  represent  adjacent  points  i,  along  the  artery  in  the  direction  of 
blood flow vz.  ABz  (blue arrow) is the magnetic field  Gz ■  z  that is generated by the 
applied  field  gradient  Gz  in  the  direction  of flow,  z.  This  field  difference  sweeps 
from  positive  to  negative  through  the  inversion  plane  and  along  the  artery  in  the 
direction  of flow.  Bx   (green  arrow)  is  the  low-power continuous  RF  field  that  is 
applied  perpendicular  to  the  main  field.  Beff  is  the  vector  sum  of  ABz  and  Bx. 
Provided  the  adiabatic  condition  is  satisfied,  M  will  follow  Beff  and  adiabatic 
inversion will occur.
where  7ja and  Ti,a  are the longitudinal  and transverse relaxation times of the  arterial 
blood water,  5,  is the amplitude of the RF pulse,  G  is the magnetic field gradient,  v 
is the velocity of the blood (in the direction of the gradient) and y the gyromagnetic 
ratio of the proton.  When a range of arterial blood velocities is present, this condition 
may not be completely satisfied and consequently there is imperfect inversion.  The 
inversion coefficient a in Equation [3.4] is defined as 1  for perfect inversion and 0 forChapter 3: Perfusion Imaging in Stroke -62-
no inversion.  The condition in Equation  [3.6] is most likely satisfied in the major 
arteries, where the blood velocity is sufficiently large.  In a typical CASL experiment, 
inversion  is  achieved  by  AFP  in  major  arteries  (such  as  the  carotid  and  vertebral 
artery) and typically a has an in vivo value in the range 0.7-0.8.
3.5.2.1.2.  Magnetisation Transfer
The  accuracy  of  perfusion  quantification  using  CASL  is  also  affected  by 
magnetisation transfer (MT) effects caused by the off-resonance (with respect to the 
imaging slice) RF pulse used for the AFP.  This RF can affect the magnetisation of 
tissue-water protons bound to macromolecules within the imaging slice (Wolff et al
1989).  The resonance peak of the water protons bound to the macromolecules is very 
wide  (see  Figure  3.4).  Magnetisation  transfer between  the  free  and bound  tissue- 
water protons causes the MRI signal to decrease.  In order to circumvent this effect, 
the control image must also include an off-resonance pulse combined with a magnetic 
field gradient of reverse polarity: the plane of inversion is above rather than below the 
imaging slice so that the RF does not affect the inflowing arterial water blood spins 
(see Figure 3.2).  In this way the MT effects are cancelled out in the subtraction of the 
control image from the labelled image.
3.5.2.1.3.  Transit Time
One of the main problems with CASL is related to the presence of the long arterial 
delays for the arterial blood travelling from the labelling plane to the imaging slice, 
such as those related to collateral flows to stroke regions.  During the time taken for 
the blood to flow  from the point where it was inverted to the capillary bed in the 
imaging  slice, relaxation  of the  spins  causes the effective inversion efficiency a to 
decrease.  This effect is accounted for by incorporating a transit time into the Bloch 
equation analysis (Zhang et al  1992).  However, in general there is a range of transit 
times due to the different vascular paths of the blood-water protons to the slice.Chapter 3: Perfusion Imaging in Stroke -63-
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Figure 3.4: Schematic frequency spectrum illustrating the frequency response of the 
two  different  pools  of  protons  (free  water  and  bound  (immobile)  water).  The 
immobile protons are saturated by an off-resonance pulse (respresented by the zig-zag 
arrow on the left) whereas the free water protons are largely unaffected.  In CASL, 
the  RF pulse  applied  in  the  inversion  plane  is  off-resonance  in  the  imaging  slice, 
affecting the bound, but not the free water protons.  The magnetisation of the free 
water protons is indirectly affected by magnetisation transfer between the two pools.
Therefore  any  global  correction  will  not  be  accurate.  Transit  time  insensitive 
approaches e.g.  (Alsop et al.  1996) utilise a delay between the end of the labelling 
period and the image acquisition, which must be longer than the longest transit time 
present.  This approach is  shown to give perfusion estimates that are insensitive to 
transit time, on the assumption that the Ti values of blood- and tissue-water protons 
are approximately the same.  Although the transit time insensitivity results in better 
perfusion maps, the extra delay time reduces the SNR.
3.5.2.I.4.  Vascular Artefacts
The  tissue  magnetisation  M,  used  in  the  perfusion  quantifying  equation,  Equation
[3.4], may be contaminated by blood signal from larger vessels.  If the labelled blood 
in the vessels does not actually perfuse into the tissue in that voxel, but is just passing 
through  en  route  to  perfuse  some  more  distant  tissue,  then  its  contribution  to  theChapter 3: Perfusion Imaging in Stroke -64-
signal difference between the labelled and control images will introduce an error in 
the  perfusion  measurement.  Vascular  signal  contamination  can  be  eliminated  by 
inserting a delay between the end of the labelling period and the image acquisition (as 
described above, (Alsop et al.  1996)).  This allows time for the fast moving blood to 
flow through the  slice before the image is  acquired.  However,  a residual vascular 
artefact may  still  be  present  in  regions  fed by  collateral  flow,  which  have  longer 
transit times.  As the post-labelling delay in CASL imaging is increased, the vascular 
contamination  and  transit  time  sensitivity  are  reduced,  resulting  in  more  accurate 
perfusion  maps.  However,  SNR  is  sacrificed.  Alternatively,  bipolar  crusher 
gradients  can  be  used  to  eliminate  the  signal  from  the  large  feeding  arteries  in  a 
CASL experiment (Ye et al.  1997).
3.5.2.I.5.  Multislice Imaging
Since it is  necessary  to  balance  the  MT  effects  in  the  labelled  and  control  CASL 
images, multiple slices cannot be acquire for a single control slice; a separate control 
image is required for each labelled image.  Multi-slice CASL may be achieved if spin 
inversion is performed using a small surface coil placed on the neck.  In this situation, 
the MT effects do not occur since the B\ fields from a small coil have small extent and 
do  not  reach  the  imaging  slice  (Silva  et  al.  1995).  Alternatively,  a  control 
(amplitude-modulated  double-inversion)  RF  pulse  designed  to  give  MT  effects 
equivalent to the inversion RF pulse (Alsop et al.  1998), could be used at the same 
location as the labelling plane.
3.5.2.2  Pulsed Arterial Spin Labelling
PASL  (Pulse  Arterial  Spin  Labelling)  is  an  alternative  ASL  technique,  where  a 
relatively short RF pulse lasting  10-20ms is used to invert the  arterial blood-water 
protons just before they enter the imaging slice.  Since this inversion process does not 
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A time TI (cf. Inversion-Recovery sequence in Section 2.3.4) is allowed for the blood 
to inflow from the inversion region into the slice,  after which the labelled image is 
acquired.  A control image of the slice is also acquired with no spin inversion.  The 
subtraction  of  these  two  images  results  in  an  image  whose  signal  intensity  is 
proportional  to  the  blood  flow.  Through  using  shorter  RF  pulses,  PASL  has 
considerably reduced power deposition compared with CASL.
3.5.2.2.I.  PASL Techniques
The  two  main  PASL  techniques  are  EPISTAR  (Echo-planar  imaging  and  signal 
targeting  with  alternating  radiofrequency)  (Edelman  et al.  1994)  and FAIR  (Flow- 
sensitive alternating inversion recovery) (Kwong et al.  1995).  Since the introduction 
of these techniques, many other methods have been proposed based on the concept of 
PASL.  For example,  UNFAIR  (Helpem  et al.  1997),  STAR-HASTE (Chen et al. 
1997), TILT (Golay et al.  1999), SMART (Kao et al.  1998), and FAIRER (Zhou et 
al.  1998).  Since all of these methods are based on  variations of EPISTAR and FAIR, 
only these will be discussed here.  Details of the other methods can be found in the 
references given above.
Figure 3.5 illustrated an EPISTAR experiment.  The imaging slice is first saturated to 
reduce unwanted signal from the static tissue water.  A slab proximal to this slice is 
inverted and a time TI is allowed for the inverted blood to inflow before the labelled 
image is acquired.  Equivalent MT effects must be present in the control image.  This 
is  achieved  either  by  applying  an  equivalent  inversion  slab  that  is  distal  to  the 
imaging slice or by applying a double inversion pulse in the same  ’inversion’  slab. 
The difference between the labelled and control image magnetisation is (Kwong et al. 
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Figure 3.5:  Schematic diagram illustrating the pairs of images  acquired in  a simple 
EPISTAR  experiment.  The  axial  imaging  slices  are  indicated  by  the  diagonally 
striped regions.  The  shaded areas indicate the regions  with inverted magnetisation. 
The left hand image is the label and the right hand image the control.  In each case the 
image is acquired at time TI after the inversion pulse.____________________________
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If T\ is assumed to be the same for blood and tissue, and if a- 1  and f/X «  1, then
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Although Equation  [3.8] is often used to calculate PASL blood flow, the T\ in blood 
and tissue may be significantly different, and this can be a significant source of error.Chapter 3: Perfusion Imaging in Stroke  - 67 -
Figure 3.6:  Schematic  diagram illustrating the pairs  of images  acquired in  a simple 
FAIR experiment.  The  axial  imaging  slices  are  indicated by the diagonally striped 
regions.  The shaded areas indicate the regions with inverted magnetisation.  In each 
case the image is acquired at time TI after the inversion pulse._____________________
In FAIR, a slice-selective inversion pulse is applied before the first image is acquired 
after a time TI.  The second image is similarly acquired after a global inversion pulse. 
Figure 3.6 illustrates the FAIR experiment.  In both images, the signal from the static 
tissue  in  the  slice is  the  same,  and the  difference in  magnetisation  comes  from the 
inflowing blood, which is fully relaxed in the first image and inverted (but relaxing) 
in the second.  In the first image, the inflowing relaxed blood increases the apparent 
relaxation  rate  of  the  tissue  water.  In  the  second  image,  the  initially  inverted 
inflowing blood relaxes during time TI, and so affects the relaxation rate of the tissue, 
but to a lesser extent than the inflowing blood in the first image.  The quantification 
of perfusion with FAIR is identical to EPISTAR,  since the signal difference in both 
derives from the inflowing blood being inverted in one image and fully relaxed in the 
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In  practice,  a,  Mt°(t)  and  Tlapp  are  determined  by  fitting  a  slice  selective
monoexponential  inversion  recovery  curve  to  the  first  image  series  acquired  at  a 
range of inflow times TI.  /  and T\a are then fitted to the biexponential of Equation 
[3.7].  In this way a proper estimate of CBF is obtained.
3.5.2.2.2.  Slice Profile
One  of the  main  advantages  of PASL  over  CASL  is  that  transit  time  effects  are 
minimised owing to the close proximity of the inversion region  and imaging slice. 
The  distance  the  spins  need  to  travel  after  inversion  is  only  limited  by  the  slice 
profiles of the labelled region and imaging slice.  Ideally the slice profiles of both the 
imaging  and  inversion  pulses  would  be  infinitely  sharp  so  that the  inversion  slice 
would be placed immediately adjacent to the imaging slice.  Slice profile effects can 
be minimised by using adiabatic hyperbolic secant pulses, which have sharply defined 
edges.  However there  is  still  a necessary gap of a few  millimetres  to  avoid  slice 
overlap (compared with several centimetres in CASL).  Even this small distance can 
still  cause  transit  time  effects.  Sharper  inversion  pulses  such  as  FOCI  pulses 
(Ordidge et al  1996) can reduce this sensitivity to some degree.
3.5.2.2.3.  Inflow Effects
In  PASL  experiments  it  is  important  to  consider  the  width  of the  labelled bolus, 
which must be wide enough to ensure that fresh spins that have not been inverted do 
not  flow  into  the  imaging  slice  during  the  inversion  time  TI.  If this  occurs,  the 
perfusion signal will be less than predicted by the standard ASL model.Chapter 3: Perfusion Imaging in Stroke -69-
3.5.2.2.4.  Vascular artefacts
Since a proper calculation of CBF requires a range of inflow times TI, it is possible 
that for some measurements, an insufficient time will have elapsed for all the spin- 
labelled blood to have either exchanged with the tissue or passed through the slice. 
This  effect  can  be  reduced  by  using  crusher  gradients  to  destroy  the  signal  from 
moving spins (Ye etal.  1997).
3.5.2.2.5.  Multislice Imaging
In both  EPISTAR  and  FAIR,  the  introduction  of multi-slice  imaging introduces  a 
range  of  transit  times.  In  EPISTAR,  slices  are  acquired  further  away  from  the 
inversion  slab,  and  in  FAIR,  the  slice-selective  inversion  slab  is  widen  to 
accommodate more slices.  For multi-slice imaging transit time insensitive techniques 
are therefore preferable, for example QUIPPS (see Section 3.5.2.2.6).
3.5.2.2.6.  Transit Times
In PASL, various approaches have been explored to reduce the sensitivity to transit 
delays.  One  popular  approach  involves  modifying  the  PASL  pulse-sequence  to 
include saturation pulses that control the time-duration of the labelled bolus (Wong et 
al.  1998).  In a technique named QUIPSS (quantitative imaging of perfusion using a 
single subtraction) a saturation pulse is applied to the imaging slice at a time TIi that 
is longer than the longest transit time delay, and an image is acquired at time TL that 
is shorter than the time-duration of the labelled bolus.  In this way, the leading edge 
of the labelled bolus is  ‘cut off, and the perfusion signal depends on the amount of 
blood entering the slice between TIi and TI2.  In an alternative technique QUIPSS n, 
a saturation pulse is applied to the inversion slab at time TIi  that is shorter than the 
time-duration of the labelled bolus, and an image is acquired at TI2 that is longer than 
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‘cut  off,  and  the  perfusion  signal  depends  on  the  amount  of blood  entering  that 
leaves the inversion slab in TIi.  Both these techniques have been shown to minimise 
the  dependency  of  perfusion  measurement  on  transit  delays,  since  the  bolus  of 
labelled blood has  a well  defined  length.  These techniques  may however become 
impractical in cases of pathology where very long transit times are present.
3.6  Comparison of M R P erfusion T echniques
DSC-MRI and ASL are the most common MR perfusion imaging modalities.  They 
are both non-invasive,  i.e.  they do not require ionising radiation,  a property that is 
very  desirable  for  imaging  children,  and  when  multiple  scans  are  required. 
Additionally,  there  is  no  need  for  intravenous  access  in  ASL.  The  endogenous 
contrast  agent  enables  multiple  repeated  measurements  to  be  made  in  quick 
succession.  This is a useful property for functional MRI studies (Wang et al 2003). 
In  DSC-MRI  however,  repeated  doses  of  contrast  agent  in  multiple  DSC-MRI 
experiments is associated with persistent effects on image intensity from the previous 
contrast injections  (Runge  et al  1994).  Additionally it is important the maximum 
dose (known  as  “triple-dose” or 0.3  mmol/kg) is not exceeded.  For this reason,  a 
single dose (0.1  mmol/kg) is  often used for repeated measurements  (Grandin et al 
2005).
Typically, the signal difference between the label and control image acquisitions in 
ASL is only -1% of the control image.  Therefore perfusion monitoring using ASL 
requires  a  very  high  SNR  and  multiple  signal  averaging.  Because  the  signal 
difference  is  so  low,  it  is  difficult  to  accurately  measure  blood  flow  lower  than 
~10ml/100g/min.  In addition, ASL tends to underestimate high blood flow, which is 
partly attributable to the labelled blood having left the voxel at the time of imaging, 
and an incomplete exchange having occurred (Silva et al  1997; Barbier et al 2001). 
The SNR in ASL experiments can be improved by increasing the number of averages, 
but this increases the scan time.  Although there is much higher SNR in a DSC-MRI 
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However, both techniques perform well in the range of normal CBF values and in the 
absence of pathology.
The difficulty in accurately quantifying low blood flow in CASL is also exacerbated 
in stroke regions due to collateral circulation resulting in long transit times for the 
arterial blood.  These additional delays can be several seconds in the ischaemic tissue, 
and  so  the  SNR  is  further reduced.  This  is  a  fundamental  limitation  of the ASL 
technique, which in the extreme situation would result in no labelled blood arriving at 
the  tissue  and  consequently  no  perfusion  would  be  measured.  The  only  way  to 
improve this is to use higher field strengths where the Ti is longer.
The  equivalent  problem  in  DSC-MRI  is  the  distribution  of  transit  times  for  the 
contrast  agent  between  where  the  arterial  input  to  the  tissue  is  measured  and  the 
where  the  tissue  signal  itself  is  measured.  This  is  a  particular  problem  in 
cerebrovascular disease, particularly in cases of collateral flow to ischemic areas (see 
Section 4.7.2).  If this effect is not accounted for, CBF is underestimated, and arterial 
dispersion is not distinguished from intravoxel dispersion by tissue microvasculature. 
Correcting for these effects is an active area of research, and the primary focus of this 
thesis.
There  is  a  limit  on  the  regional  coverage  achievable  in  both  ASL  and  DSC-MRI 
acquisitions.  In DSC-MRI, there is a trade-off between the number of slices and the 
time  resolution.  Typically  10-15  slices  can  be  acquired  using  EPI  at  a  temporal 
resolution  of  -1.5s.  Three-dimensional  acquisitions  are  also  possible,  but  at  the 
expense of spatial resolution.  In ASL, the number of slices is also limited by length 
of the labelled bolus.  Typically 8-10 slices are acquired.
It is interesting to note that ASL and DSC-MRI actually measure a different effect. 
The labelled water in an ASL experiment is a diffusible tracer (similar to H2150   used 
in  PET).  On the other hand,  the intravascular contrast agent used in DSC-MRI is 
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different.  However, it has been observed that both ASL and DSC-MRI yield highly 
comparable perfusion values in normal brain (Weber et al. 2004).
Currently the most robust MR perfusion technique is DSC-MRI, especially in patients 
with  cerebrovascular diseases.  However,  although  it is  a commonly used  clinical 
technique,  there  is  still  much  development  necessary  to  make  it  quantitatively 
accurate.  Many of the analysis methods in popular use neglect to take into account 
some important factors that may lead to a misinterpretation of the acquired perfusion 
maps.  This thesis seeks to address some of these issues, and as a result, provide the 
information needed for more accurate diagnosis, prognosis,  and treatment plans for 
patients with stroke.
3.7  D iffusion MRI in C e re b ro v a s c u la r D isease
Perfusion  MRI  can  be  used  to  identify  ischaemic  tissue  that  may  be  at  risk  of 
infarction.  On progression to infarction, the structure of the tissue can also change, 
affecting the mobility of the tissue water.  Therefore, water diffusion is another useful 
indicator of tissue status.  This section describes the changes in water diffusion that 
accompany the changes in cerebral haemodynamics.  MRI can be made sensitive to 
detect such changes using diffusion-weighted MRI (DWI) images (see Section 2.3.6). 
Busza et al. (Busza et al.  1992) found that DWI signal enhancement occurred when 
the  CBF  fell  below  a  value  similar  to  the  threshold  necessary  to  drive  normal 
neuronal function.  It has been suggested that dysfunction occurs at a blood flow of 
around 20ml/100g/min (Baird et al.  1998).  When the CBF is severely reduced and 
the  compensatory  mechanisms  are  overwhelmed,  less  oxygen  and  glucose  are 
delivered to the tissue (see Section 3.3).  This results in a decrease in the amount of 
available  adenosine  triphosphate  (ATP),  which  is  the  main  source  of cell  energy. 
Energy is required to pump Na+ ions out of the cell and K+ ions into the cell in order 
to  maintain  homeostasis.  When  the  ATP  supply  is  diminished  there  is  an 
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water.  This  leads  to  cell  swelling  (cytotoxic  oedema)  and  eventually  cell  death 
(Moseley et al.  1990).  Although still a point of debate, the enhanced DWI signal is 
thought  to  be  a  consequence  of the  oedema,  since  the  cell  swelling  restricts  the 
diffusion in the extracellular space.
Serial DWI studies in  animal models have demonstrated the evolution of the DWI 
lesion  volume  changes  over time,  which is  often  quantified by using the  apparent 
diffusion coefficient (ADC) (see Section 2.3.6).  These experiments have shown that 
although the lesion size has nearly fully evolved at around 2 hours, the magnitude of 
the  ADC  reduction  continues  to  increase  for up to 4-6  hours  (Knight et al.  1994; 
Roussel et al.  1994).  At about 24-48 hours, the ADC increases again, returning to 
normal after about 3 days (known as “pseudonormalisation”), and actually rises above 
normal values in the subsequent week (Knight et al.  1994).  This elevated diffusion of 
tissue  water is  thought to be  associated  with  the  loss  of cell  membrane  structure. 
Knowledge  of  the  temporal  evolution  of  the  DWI  signal  can  be  used  to  help 
discriminate  between  acute  and  chronic  tissue  lesions.  In  animal  models  of 
ischaemia, both  a time-threshold  and  an ADC-threshold for the reversibility of the 
DWI lesion have been demonstrated.  In humans, although reversibility of ischaemic 
lesions has been reported e.g. (Marks et al.  1996), the abnormal ADC area is usually 
so severely affected that it is likely to infarct regardless of treatment.
3.8  Blood-Oxygenation in Cerebrovascular Disease
In  addition  to  detecting  changes  in  perfusion  and  diffusion,  MRI  can  be  made 
sensitive  to  changes  in  regional  tissue  oxygenation  status  using  the  blood- 
oxygenation-level-dependent  (BOLD)  MRI  signal  (Ogawa  et  al.  1990).  Since 
deoxyhaemoglobin is paramagnetic it promotes T2/T2* relaxation of the water tissue 
protons.  Therefore, BOLD signal intensity, usually measured by T2*-weighted MRI, 
drops  immediately  upon  onset  of  ischaemia  when  the  ratio  of  oxy  to 
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In a mild hypoperfusion condition, the T2 values  are depressed but the DWI signal 
remains unchanged (Calamante et al.  1999a).  In a severe hypoperfusion condition, T2 
values are shorter and DWI signal is enhanced.  Changes in T2 are immediate and not 
always related to vasodilatation compensation mechanisms.  The early T2 change may 
therefore provide useful information as to the progression of the pathophysiological 
status  of the  affected tissue.  However,  the  effect is  small  at the field  strength  of 
typical clinical studies.
3.9  P enumbral T issue
The brain has very little capacity to store energy,  and consequently cell viability is 
compromised within 3 minutes of a complete interruption of blood flow.  Normally 
collateral flow preserves areas of incomplete ischaemia (and equally, these areas may 
have incomplete ischaemia because of collateral flow).  Such areas of ischaemic but 
not infarcted tissue (which is  still at risk of irreversible damage), are known as the 
ischaemic  penumbra  (Astrup  et  al.  1981).  The  concept  of  penumbral  tissue 
surrounding  a core  of densely ischaemic  and irreversibly damaged tissue  was  first 
demonstrated in experiments  performed on baboons  (Astrup et al.  1981).  In these 
experiments, brain tissue that  was  identified  as having lost electrical  functionality, 
regained its function and did not undergo necrosis if CBF was restored early enough. 
In later studies, it was found that the duration of ischaemia  and residual  CBF was 
crucial in determining the fate of ischaemic tissue.  In work conducted by Jones et al. 
(Jones  et  al.  1981),  the  tissue  in  the  macaque  monkey  with  CBF  around 
15ml/100g/min could survive about three hours of occlusion, whilst tissue with CBF 
of 5ml/100g/min could survive only about  two hours.
With  reduced  CBF,  tissue  may  remain  structurally  intact  whilst  the  neurons  are 
functionally (electrically) silent.  But if the CBF falls further, cytotoxic oedema may 
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(Jones et al  1981).  The penumbral area is general thought to correspond to where the 
CBF levels are somewhere between the electrical (neuronal) failure threshold and the 
membrane failure threshold (i.e. cell swelling resulting from energy failure).
3.10  Diffusion-Perfusion M ism atch
The extent of the final DWI lesion volume (indicative of cytotoxic oedema) may be 
larger or smaller than the acute abnormality.  In a study of 13 patients with ischaemic 
stroke,  Baird et al.  (Baird  et al  1997)  discovered that when  the  size of the initial 
perfusion  abnormality  (reduced  CBF)  exceeded  the  size  of the  initial  DWI  lesion 
volume, the extent of the final DWI lesion volume was larger than the initial DWI 
lesion  volume.  This  suggests  that  the  peripheral  region  of  the  observed  acute 
perfusion deficit was  not great enough to cause  energy failure,  and therefore went 
unnoticed on initial DWI images.  The change in DWI lesion size with time depends 
on the underlying perfusion and possible collateral flow.
This mismatch of abnormal regions is known as the “diffusion-perfusion mismatch”. 
The concept of diffusion-perfusion mismatch has been developed as a possible way of 
identifying potentially salvageable tissue in humans.  It is thought that tissue that is 
abnormal on DWI, and has low perfusion is destined to infarction.  Conversely, tissue 
that is  normal  on DWI but has  reduced  CBF (at penumbral  levels)  could possibly 
recover if the flow is restored.  Studies in patients receiving thrombolysis (see Section 
3.11) provide further evidence that the mismatch region is not irreversibly damaged 
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3.11  R eperfusion
The  duration  of  ischaemia  is  a  crucial  consideration  when  treating  humans. 
Treatment is most likely to be beneficial when administered as early as possible, since 
small changes in the energy demand may accelerate the progression to cell death or 
prolong the survival.  Given that irreversible infarction of penumbral tissue can occur 
within a few hours, the therapeutic window for intervention may be very short.
Perfusion deficits caused by the obstruction of blood flow (e.g. a blood clot) may be 
treated with thrombolytic agents, such as the tissue plasminogen activator drug, tPA 
(Adams,  Jr.  et al.  1996).  Such  drugs  act to break down the clot  and unblock the 
artery.  However, the use of tPA in  acute stroke is controversial,  since irreversibly 
damaged tissue will not benefit from reperfusion, and tPA may actually increased the 
risk of haemorrhage (Adams, Jr. et al  1996).
In addition to the neuronal and cell membrane failure resulting from ischaemia and 
infarction,  there  can  also  be  a  loss  of  structural  integrity  of  the  blood  vessels 
(breakdown  of the  BBB),  partly  through  the  release  of enzymes  that  break  down 
connective  tissues.  Additionally,  ischaemia  induces  the  production  of  reactive 
oxygen  species  that  promote  cell  membrane  failure  and  BBB  breakdown. 
Antioxidant neuroprotective drugs have been shown to be effective in reducing the 
region  of  damaged  tissue  in  rodents,  but  their  efficacy  has  not  been  confirmed 
clinically.  However,  such treatment offers a promising approach to limiting infarct 
tissue damage without increasing haemorrhage risk (Goldberg 2007).
In light of the severe complications of thrombolysis, such treatment must be balanced 
against  the  potential  benefits.  For  this  reason  it  is  important  to  assess  the 
pathophysiological  tissue  status  with  accuracy,  and  to  know  how  to  combine  and 
interpret the measurements from the various imaging modalities.  Such information 
would enable an early and accurate identification of patients most likely to benefit 
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3.12  P re d ic tio n  M o d els using MR D a ta
Much current research is being conducted into predicting tissue outcome in stroke by 
combining DWI, perfusion and T2 parameter maps (e.g. (Hjort et al 2005; Wu et al 
2001; Wu et al  2007; Rose et al 2001)).  Such work involves the creation of tissue 
signature algorithms based on thresholding, for example ADC,  CBF and T2 values. 
These  algorithms  are  'calibrated’  using  a  so-called  training  data  set  (the  DWI, 
perfusion  and  T2  MRI  data),  which  has  been  obtained  acutely  from  a  group  of 
patients, and for whom the final radiological outcome is known.  A comparison of the 
acute and final data enables parameters for a predictive algorithm to be determined. 
These can then be used to infer the likelihood of infarction in  subsequent patients. 
The  output  of these  models  is  therefore  a  map  of probability  of tissue  infarction, 
based  on  the patient's  acute  MRI data.  In  this  way,  they  are  aimed  at  helping to 
identify the patients that are more likely to benefit from therapy.
Models based on a voxel by voxel analysis rather than comparing volumes of tissue 
are more sensitive for identifying salvable tissue (Wu et al 2001; Welch et al  1995). 
However, the sensitivity and specificity remains somewhat limited, primarily because 
of errors in the CBF measurements.  If either the training data or input data into the 
predictor-models  is  erroneous,  then  the  predictions  made  by  these  models  will  be 
unreliable.
Of all the information used by these models, the input provided by perfusion MRI is 
the main determinant of the tissue at risk, while the remaining data (e.g. DWI and T2 
MRI) are mainly used to determine the so-called 'core' of the infarct (which is usually 
so severely affected that it is likely to infarct regardless of treatment (Sobesky et al 
2005)).  Therefore, the main source of error in the predictor-models originates from 
inaccuracies introduced by the perfusion MRI data; this  can  lead to patients being 
treated  inappropriately,  with  potentially  serious  clinical  consequences.  The  work 
presented in this thesis investigates methods to improve the accuracy of the perfusion 
input  data  used  in  these  predictive  algorithms.  An  improved  quantification  ofChapter 3: Perfusion Imaging in Stroke -78-
perfusion  in  patients  with  cerebrovascular  disease  is  an  important  first  step  in 
providing a robust means to assess and successfully treat such patients.
3.13  P redicting 6  At R isk’ T issue using Non-M R M ethods
An  essential  medical  consideration  when  imaging  a  stroke  patient  is  the  speed  at 
which  the  patient  data  can  be  obtained  and  processed.  It  has  been  shown  that 
reperfusion treatments are more effective in salvaging tissue if they are administered 
as soon as possible after the ischaemic event (Hacke et al  1999).
The ability of PET imaging to provide estimates of OEF and CMRO2 in addition to 
CBF and CBV, leads to the concept (which is peculiar to PET) of ‘misery perfusion’: 
ischaemic/penumbral tissue characterised by a preserved CMRO2, combined with a 
reduced CBF and increased OEF.  After the first hour, the extent of the PET-defined 
penumbra  generally  decreases  with  time  (Heiss  2001).  Although  PET  has  been 
shown to be a valuable tool for evaluating the perfusion and haemodynamic reserves 
of cerebral tissue, the main limitation in using PET in application to acute stroke is 
that the delay between tracer injection and imaging usually takes about 2 hours (Read 
et al  1998).  Furthermore,  as discussed in Section 3.4.1, the availability of PET is 
limited, there is poor spatial resolution, and it uses radioactive tracers.
Both  multimodal  MR  imaging  (DWI,  PWI,  BOLD  etc)  and  dynamic  CT  can  be 
acquired easily and quickly.  Hypodensity in non-enhanced CT scans is believed to 
indicate  that the  tissue  is  irreversibly infarct,  but conventional  CT  cannot identify 
tissue that is  at risk  (Tomandl et al  2003).  The pixel-by-pixel time-density curve 
achieved using dynamic-CT can be used to extract quantitative CBF, MTT,  and CBV 
data, although absolute values are unreliable.  Therefore, it has been suggested that 
combining non-enhance CT and enhanced-dynamic CT, could be used to identify  the 
infarct core and the ischemic penumbra (Wintermark 2005).  CT offers a number of 
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availability,  low cost and  short  scanning time.  However,  a major disadvantage  of 
using CT to image stroke is its limited spatial coverage.  It is therefore not well suited 
to imaging a small stenosis or occlusion.  Furthermore, in addition to the undesirable 
radiation risk, the methodology for identifying at-risk tissue is not as well established 
as the diffusion-perfusion mismatch.
3.14  Conclusion
The accurate measurement of cerebral perfusion is a vital first step towards predicting 
regions that will go on to infarction if left untreated.  MR measurements of perfusion 
are  safely  obtained  and  easily  combined  with  diffusion  and  oxygenation 
measurements to indicate the underlying cerebral haemodynamics and structural (cell 
membrane and vessel) integrity.  Thus MRI provides the most comprehensive set of 
information,  which  can  potentially  improve  the  exclusion  of patients  who  may be 
harmed by treatment.  In fact, a lower haemorrhagic rate has been observed for MRI- 
selected patients (Fiebach et al. 2002).  The most common MR method for measuring 
perfusion  clinically  is  bolus  tracking  or  DSC-MRI.  Unlike  ASL,  there  is  no 
fundamental  limitation  preventing  its  utility  in  patients  with  abnormal  flow. 
However,  in  patients  with  cerebrovascular disease,  DSC-MRI perfusion  parameter 
measurements may be inaccurate because of dispersion of the intravascular tracer (see 
Section 4.7.2).  In  particular,  the broadened bolus in  major vessels  will  seemingly 
counteract the homogenisation of flow elements, i.e. the actual FH decrease due to 
vasodilation will be hard to detect.  Similarly, dispersion errors will underestimate the 
CBF,  and overestimate the MTT.  Predictions of tissue infarction made using these 
perfusion data are likely to be misleading.  Improved predictions may be possible by 
identifying regions where the perfusion measurements are potentially erroneous.  The 
work  in  this  thesis  investigates  approaches  to  improve  the  quantification  and 
interpretation of perfusion measurements using DSC-MRI.  Such work is essential in 
order to improve the selection of patients who would benefit from intervention.Chapter 4: DSC-MRI Perfusion Measurement -80-
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4.1  Introduction
The work presented in this thesis is based upon the technique of bolus-tracking or 
DSC-MRI.  This is currently the most robust clinical MR method for assessing the 
cerebral blood flow (CBF).  The technique involves the successive acquisition of MR 
images following a rapid intravenous injection of a paramagnetic contrast agent (usu­
ally Gd-DPTA).  Upon  reaching the brain,  the bolus  of contrast  agent passes  first 
through the major branches of the arterial tree, then through the capillary bed, finally 
draining  through  veins.  In  healthy  subjects,  the blood brain barrier (BBB)  of the 
vessels  is  intact,  so  that  the  contrast  agent  remains  at  all  times  intravascular. 
Consequently, the passage of the Gd-DPTA bolus is detected in the tissue because the 
intravascular  compartmentalisation  of  the  paramagnetic  material  results  in  a 
susceptibility  difference  between  the  intravascular  and  extravascular  space.  The 
resulting magnetic field gradients that extend out from the vessel edge promote the 
dephasing of the extravascular tissue water spins.  As the bolus passes through the 
capillary bed there is a measurable transient drop in the MR signal deriving from the 
tissue (Villringer et al.  1988; Rosen et al.  1990).  The measured signal time-course in 
the tissue can be used to extract perfusion related physiological parameters,  such as 
cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT) 
and flow heterogeneity (FH).  This chapter describes the theory and methodology of 
perfusion  quantification  by  means  of tracking  the  dynamic  susceptibility  contrast 
created by the passage of the paramagnetic contrast agent bolus.  The artefacts and 
potential problems associated with the technique are also discussed.
4.2  Im age C ontrast
The most commonly used contrast agent in DSC-MRI is the paramagnetic metal ion, 
Gadolinium, chelated to diethylenetriaminepentaacetic acid (Gd-DTPA) (Sorensen et 
al.  1997).  The BBB is impermeable to molecules of this size, and so, when the BBBChapter 4: DSC-MRI Perfusion Measurement -82-
is intact, Gd-DTPA can be regarded as an intravascular tracer.  Typically the injected 
dose  is  0.1-0.3  mmol/kg  body  weight.  Although  the  intravascular  compartment 
within  which  the  Gd-DTPA resides  represents  only  ~2-6%  of the brain tissue,  the 
susceptibility effect  (see  Section  4.2.1)  enables  the  detection  and quantification  of 
contrast  agent  via  a  suitable  MR  acquisition  (Rosen  et  al.  1990;  Villringer  et al. 
1988).
4.2.1  The Susceptibility Effect
Image  contrast  in  DSC-MRI  images  is  primarily  due  to  magnetic  susceptibility 
differences.  Magnetic  susceptibility  is  the  proportionality  constant  between  an 
applied  magnetic  field  and  the  resultant  magnetisation  established  within  the 
material.4 The Gd ions of the paramagnetic contrast agent possess electro-magnetic 
dipoles attributable to the unpaired electrons on the Gd ion.  These dipoles tend to 
align with an applied magnetic field (in the same way as the weaker nuclear magnetic 
dipoles  of  proton  spins),  therefore  reinforcing  the  applied  field  (the  magnetic 
susceptibility of a paramagnetic material is positive).  The compartmentalisation of 
the  paramagnetic  contrast  agent  within  the  capillaries  causes  a  susceptibility 
difference  between  the  intravascular  and  extravascular  space.  The  situation  is 
illustrated  schematically  in  Figure 4.1.  Since there can be no field  discontinuities 
(Bleaney  et  al.  1989),  there  is  a  magnetic  field  gradient  between  the  two 
compartments.  In vivo, these gradients extend out approximately the same distance as 
the vessel diameter.  Consequently, there is a distribution of resonant frequencies for 
protons in the voxels within this region, and hence a corresponding increase in the 
heterogeneity  of  the  phase  distribution  across  the  voxel  (Villringer  et  al.  1988; 
Boxerman  et al.  1995).  As  a  result,  the  transverse  T2/T2*  relaxation  time  of the 
extravascular tissue-water protons is shortened.  For a typical DSC-MRI acquisition,
4  M = %H , where  X  * s the susceptibility,  M  is the magnetisation of the material and H  is the 
applied filed.  The magnetic field in the material  B , is related to H  by the relationship 
B = //0 (l + x)H , where  //0 is the permeability of free space and  (l +  x) is the relative 
permeability of the material.Chapter 4: DSC-MRI Perfusion Measurement -83-
Figure  4.1:  Schematic  representation  of  the  effect  of  intravascular
compartmentalisation of contrast agent.  The resulting susceptibility gradients, which 
promote T2/T2* relaxation, extend out from the vessel edge and consequently cause a 
decreased signal intensity in the tissue.  If the BBB were damaged, the Gd ions would 
be  distributed  in  the  intravascular  and  extravascular  space,  and  therefore,  the 
susceptibility  gradients  would  be  smaller.  As  a result  Gd-  promoted Ti  relaxation 
would be the dominant effect.Chapter 4: DSC-MRI Perfusion Measurement -84-
the  MR  signal  from  the  tissue  at  the  echo  time  (TE)  depends  on  the  amount  of 
susceptibility induced dephasing, i.e.  the density  and distribution of capillaries  and 
the concentration of intravascular paramagnetic contrast agent.
As  a consequence of the  susceptibility effect,  the bolus  passage through the tissue 
results in  a transient change in image contrast.  Both  spin-echo  (SE)  and gradient- 
echo (GE) sequences can be used to acquire T2 and T2* weighted images respectively, 
with  echo-times  appropriate  to  measure  the  susceptibility-different  induced  signal 
loss.  Section  4.4  describes  the  different  sensitivities  of these  imaging  modalities. 
Sections 4.5  and 4.6 describe how the resulting signal time-course is used to derive 
haemodynamic parameters from the MR images.
4.2.2  Longitudinal Relaxation and Water Exchange
Usually, an intact BBB prevents the intravascular contrast agent from diffusing into 
the extravascular  space.  Consequently,  the  short-range  (~l/r6)  dipolar interactions 
between the protons and unpaired electrons on the Gd ions are only significant in the 
intravascular space.  The dipolar interactions promote longitudinal (Ti) relaxation of 
the  intravascular  blood-water  protons.  These  protons  can  approach  the  Gd  ions 
closely, such that an essentially linear relationship between the longitudinal relaxation 
rate of the protons and the concentration of contrast agent is observed (Rosen et al
1990).  Because the contrast  agent is  a plasma marker (i.e.  it occupies  the plasma 
volume),  the  intravascular Ti  relaxation  rate  is  also  dependent  on  the haematocrit 
levels in the blood (Kiselev 2001).
A small amount of Ti relaxation of the extravascular tissue-water protons is induced 
by water exchange between the capillaries  and the extravascular space.  Compared 
with  the  T2/T2*  image  contrast  (described  in  Section  4.2.1),  bolus  induced  Ti 
contrast in  the  tissue is  not  significant because the residence time  of water in  the 
capillaries is relatively long (~500msec) compared with the MR measurement timeChapter 4: DSC-MRI Perfusion Measurement -85-
(Boxerman  et  al.  1995).  The  situation  is  somewhat  different  when  the  BBB  is 
disrupted.  This is discussed in Section 4.7.1.
4.3  Im age Acquisition
The bolus is typically tracked through the brain by acquiring sequential echo planar 
images  (EPI)  with  a  short  repetition  time  (TR  <2s)  (see  Section  2.4.4).  A  fast 
imaging method is necessary to enable a high temporal resolution,  so that the time- 
course of the bolus-induced signal drop is well described.  In Figure 4.2, three distinct 
periods  are  labelled  on  the  signal  time-course  measured  in  a  particular  region  of 
interest (ROI) or voxel: the baseline (before the bolus has arrived in the ROI), the first 
passage of the bolus  (~14s) and the recirculation,  which corresponds to the second 
passage  of the contrast  agent  through  the brain.  The  signal  time-course the  takes 
approximately  two  sample  points  to  reach  the  equilibrium  baseline  value,  during 
which the tissue magnetisation is reaching a steady-state.
4.4  G radient-echoes and Spin-echoes
In a GE experiment (see Section 2.3.3),  signal loss is due to the decreased T2*; the 
dephasing derives from field inhomogeneities  (which cause local differences in the 
resonant  frequency)  and  also  diffusional  motion  through  these  inhomogeneities 
(Boxerman et al  1995).  In DSC-MRI, the static field inhomogeneities are primarily 
the result of the susceptibility-difference induced field gradients.  A SE experiment 
(see Section 2.3.2) can completely refocus the dephasing caused by these static field 
inhomogeneities.  Therefore in  the  absence of diffusion,  the tissue  contrast arising 
from a SE acquisition would be unchanged during the passage of the contrast agent. 
In practice however, during spin-echo time, tissue-water protons will diffuse through 
the region of field gradients, causing an irreversible loss of phase coherence.Chapter 4: DSC-MRI Perfusion Measurement -86-
800
750
Baseline First pas^  ^ Recirculatiop 700
650
600
550
500
450
400
350
15 30 0 5 10 20 25
time /TR
Figure  4.2:  The  signal  time-course  of  a  typical  dynamic  susceptibility  contrast 
imaging experiment.  Upon injection of contrast agent into a vein, the contrast agent 
reaches  the  brain,  causing  a  substantial  signal  drop  in  tissue  and  arteries.  The 
baseline section is the time before the bolus has arrived in the brain, the first passage 
is  the  signal  drop  resulting  from  the  passage  of  the  bolus  through  the  cerebral 
vasculature,  and  the  recirculation  is  the  second  passage  of  the  bolus  through  the 
cerebral vasculature.
If the  spin-echo  time  is  sufficient  to  allow  significant  diffusion  of the  tissue-water 
protons, the irreversible phase accumulation is  significant.  The MR signal decrease 
observed in the SE experiment is therefore sensitive to diffusion effects, and hence to 
the  diffusion-length  in  time  TE  (see  Section  2.3.6).  This  diffusion-length  is 
approximately  the  same  as  the  diameter of the  capillaries.  Since  the  susceptibility 
gradients extend out approximately the same distance as the vessel diameter (Kiselev
2001),  the gradients  in  the vicinity  of large  vessels  will  be  small  and  consequently 
there will be little dephasing.  Maximum irreversible dephasing occurs in the vicinity 
of capillaries,  where the  phase  accumulation  across the diffusion  length  of water is 
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Weisskoff and others (Weisskoff et al  1994; Boxerman et al  1995; Fisel et al  1991) 
used Monte Carlo modelling and experimental data to study microscopic relaxation 
effects.  They showed that the SE measurements are mainly sensitive to vessel sizes 
comparable to the water diffusion-length  during the time of echo  (-20  pm).  This 
effect is illustrated in Figure 4.3.
The change in transverse relaxation rate and hence the signal loss is larger for the GE 
than the SE acquisition for all vessel sizes.  Therefore, in practice, MR imaging using 
a SE acquisition requires a larger amount of contrast agent to achieve the same signal 
loss  as  a GE acquisition.  For this reason,  although the GE is  less  sensitive to the 
microvasculature, it is the more commonly used acquisition,  since a higher SNR is 
achievable.  In addition, GE-EPI sequences can be acquired faster, facilitating higher 
temporal resolution (or increased coverage) images compared with SE sequences.
The  change  in  T2/T2*  enables  perfusion  to  be  estimated  even  though  the  vessels 
themselves  are  too  small  to  image.  In  order  to  quantify  the  blood  flow,  the 
relationship between the change in T2/T2*  and the concentration of contrast agent (see 
Section 4.5) must be known.
4.5  Signal Intensity and Bolus C oncentration
Haemodynamic  perfusion  parameters  are  derived  from  DSC-MRI  data  using  an 
established  relationship  between  the  MR  signal  and  the  concentration  of contrast 
agent in the vessels.  In GE sequences, the signal intensity in the tissue during the
bolus  passage  St(t),  depends  on  the  transverse  relaxation  rate  R2*(t) = ^ - ,
longitudinal relaxation rate  Rx  (t) =  , the echo time TE and sequence repetition
timeTR.  For a 90° RF pulse:Chapter 4: DSC-MRI Perfusion Measurement -88-
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Figure 4.3: The transverse relaxation rate  AR2   (TE=60ms) and AR2  (TE= 100ms) as 
a function of vessel radius for a susceptibility difference of Ax = 10~7.  AR2   exceeds 
AR2   for all vessel sizes,  reaching a plateau at larger radii.  AR2   is greatest for vessel 
radii  in  the  range  of  capillaries.  Thus,  SE  sequences  are  most  sensitive  to 
microvsculature  while  GE  sequences  are  more  sensitive  to  larger  vessels. 
Reproduced from (Kiselev 2001).____________________________________________
S ,   ( 0 = 5,  fro)  r4'1 1
St(tQ )  is  the  baseline  signal,  and  R2 {tQ )  and  R{(t0)  are  the  transverse  and
longitudinal relaxation rates before the arrival of the contrast agent.  For a typical TE 
and TR,  and  assuming  an intact BBB,  the change in longitudinal relaxation rate is
negligible  (i.e.  j ------— —   «1).  Therefore,  the  measured  GE  signal  drop  in theChapter 4: DSC-MRI Perfusion Measurement -89-
tissue  is  predominantly  determined  by  the  change  in  T2*  relaxation  rate, 
1  1
AR2  = —— ----7 7— 7 .  Equation [4.1] simplifies to:
T2   (/)  r2 (/0)
Sl(r)=Sl(roy ™ ^ w   [4.2]
To derive haemodynamic parameters from DSC-MR images by tracer kinetic analysis 
(see  Section  4.6),  the  concentration  of contrast  agent  within  the  vessels  must  be 
known.  Therefore, the relationship between observed signal changes during the bolus 
passage and the corresponding concentration must be known in detail for the specific 
pulse  sequence  (SE  or  GE-EPI).  Empirical  measurements  (Villringer et al.  1988; 
Rosen  et al.  1990)  and  theoretical  simulations  (Fisel  et al.  1991;  Weisskoff et al. 
1994;  Boxerman  et  al.  1995;  Kennan  et  al.  1994),  suggest  that  with  the 
concentrations of Gd-DTPA used clinically, the change in relaxation rate measured in 
the tissue is approximately linearly proportional to the bolus concentration:
C,(t)=K,Mi2’(t)  [4.3]
Where  Kt  is a constant depending on tissue type, the contrast agent, the field strength,
and the pulse sequence (see Section 4.7.5).  This relationship is a central assumption 
in the subsequent kinetic analysis.
Using Equations  [4.2]  and  [4.3],  the  intravascular bolus  concentration  time-course 
Ct(t) may therefore be written:
C,(/) = -jt —  ln(  S,(0 
TE S X ).
[4.4]
St (t0)  is usually determined from the average baseline signal in the images prior to
the contrast bolus  arrival.  In vivo concentration time-course data are illustrated in 
Figure 4.4.Chapter 4: DSC-MRI Perfusion Measurement -90-
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Figure  4.4:  The  contrast  agent  concentration  time-course  of  a  typical  dynamic 
susceptibility contrast imaging experiment.  The baseline, first-pass and recirculation 
sections are labelled.
4.6  T racer K inetics
The  concentration  time-course  measured  in  the  tissue  and  in  an  artery  can  be 
combined  to  quantify  perfusion  in  the  tissue.  The  kinetics  describing  the 
concentration time-courses of a non-diffusible contrast agent (or tracer) is described 
by indicator dilution theory  (Zierler  1965;  Meier et al.  1954).  The theory  describes 
the behaviour of the bolus of contrast agent (indicator) in the vasculature, assuming it 
is  instantaneously  injected  into  the  blood  stream  and  subsequently  diluted  in  the 
circulation.  For  the  theory  to  be  applicable  it  is  essential  that  the  contrast  agent 
remains intravascular, since if the BBB were disrupted, the contrast agent would leak 
and become  diffusible.  The  following paragraphs  describe the  main  aspects  of theChapter 4: DSC-MRI Perfusion Measurement -91 -
indicator dilution theory, which is the basis for perfusion quantification using DSC- 
MRI.
4.6.1  Transport Function
The  distribution  of transit times  taken by  an  ideal  instantaneous  bolus  of contrast 
agent to travel from the tissue (arterial) input to the tissue (venous) output is given by 
the so call transport function h(t)  (0stergaard et al  1996b; 0stergaard et al  1996b)). 
The fraction of instantaneous bolus leaving the tissue system in the time interval t to t 
+  dt is  therefore  h(t)dt.  Since  all  of the  contrast  agent  entering  the  tissue  must 
eventually leave, these fractions must sum to one:
Accordingly,  the  output  concentration  Cout(t)  is  the  convolution  of  the  input
This expression can be understood by considering the input concentration  Ca(t)  as a
system at time r .  For each idealised bolus, the resultant output concentration at time 
d C jl), is determined by the proportion of the bolus leaving the tissue system at a
later time t-t,   h(t-r):
[4.5]
o
concentration  Ca (/)  with the probability density function of transit times  h(t)  (Meier
etal.  1954; Zierler 1965)
[4.6]
o
superposition of consecutive instantaneous boluses,  Ca{r)dz  injected into the tissue
dCm (t)^C a(t)h(t-T)dT [4.7]
The total measured output concentration  Cout(t) is the sum of all these contributions.Chapter 4: DSC-MRI Perfusion Measurement -92-
4.6.2  Residue Function
In DSC-MRI, rather than measuring the fraction of bolus leaving the tissue system in 
the time interval t to t + dt,  h(t)dt, the fraction of contrast agent present in the tissue 
system in the time interval  t to  t + dt is  measured  (0stergaard  et al  1996b).  For 
perfusion quantification,  the  ‘tissue  system’  is  often just one voxel in the capillary 
bed.
Assuming an instantaneously arriving bolus, the fraction of contrast agent remaining 
in a tissue voxel at time t is:
t
rt(f) = 1- jh(r)dT  [4.8]
0
I.e.  One  minus  the  fraction  that  has  left.  By  definition, R(0) = 1   and  R{°°) -  0. 
Equivalently,
^ ^  = -h(t)  [4.9]
dt
/?(r)  is known as the tissue residue function and is a positive decreasing function of 
time (0stergaard et al  1996b).  This function provides valuable information about the 
retention of tracer in the capillary bed.
4.63  Mean Transit Time
The mean transit time (MTT) of the contrast agent is the average time for the tracer to 
pass through the tissue from the arterial input to the venous output after an ideal bolus 
injection (Meier et al  1954).  It can be defined in terms of the probability density 
function of transit times as:Chapter 4: DSC-MRI Perfusion Measurement -93-
JV • h(t)dt
MTT = — [4.10]
o
Using Equations [4.8] and [4.10] it can be shown that the MTT is also the area under
The MTT is therefore longer for a broader  R{t), signifying prolonged retention of the 
blood within the capillary bed
4.6.4  M odels for the Residue Function
The exact  shape of  R(t)  is  unknown.  It is  likely to be dependent on the  specific 
arrangement of the capillary bed and the perfusion therein.  Several models have been 
proposed, which satisfy Equations [4.8] and [4.9].  The most simple of these models 
for the capillary bed is a single well-mixed compartment.  In this situation, the blood 
is thought to drain from the tissue into the veins in an exponential manner, so that the 
rate  at  which  the  tracer  concentration  in  the  tissue  is  decreasing  at  time  t,  is 
proportional to the tracer concentration remaining in the tissue at time t.  Assuming 
an  instantaneous  injection  of bolus  at  t=0,  R(t)  is  then  modelled  as  a  decaying 
exponential with a time constant equal to the mean time taken for the blood to pass 
through the tissue from the arterial input to the venous output (MTT) (0stergaard et 
al  1996b):
*(')•
[4.11]
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[4.12]
A  simple alternative model is that of plug flow,  whereby the blood remains in the 
tissue bed for a time MTT before instantaneously draining into the veins (0stergaard 
et al  1996b).  In this case:
fl  0<t< MTT
Rpiug (0 - 10  t >MTr  [4.13]
Although the red blood cells (RBC) do to some degree prevent mixing, it is unlikely 
that this  model  accurately represents  the tissue bed.  Nevertheless,  this  model  has 
been used in several simulation studies.
A compromise between these two extremes is the Lorentzian model (Calamante et al 
2003a).  In this situation, the blood would have a small residue time within the tissue 
before it starts draining into the veins.
K X t)=
1 +
1
m Y [4.14]
v2MTT
The shapes of the residue functions for an M7T=4s are illustrate in Figure 4.5.  Other 
models for R(t) have included a triangular function, a Gaussian and a Fermi Function 
(Andersen et al 2002; 0stergaard et al  1996b).
Physiological modelling of the vasculature has  also been investigated to obtain the 
form of R(t)  (Mouridsen et al 2006b; 0stergaard et al  1999; Kroll et al  1996).  In 
general, the capillary (tissue) system is modelled by N parallel tubes.  Each particle 
entering each  tube  has  a certain transit time.  When the blood is  delivered  to the 
capillaries from an artery, it is distributed among these tubes and a density function of 
the transit times is obtained.  Such models may provide a better description of tracer 
retention in the capillary bed, although at the expense of increasing complexity and 
introducing further parameters.Chapter 4: DSC-MRI Perfusion Measurement -95-
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Figure 4.5: Models for the Residue Function simulated for M7T=4s.  The blue curve 
is the Exponential, the green curve is the Lorentzian,  and  the red curve is the Plug 
Flow.
4.6.5  Arterial C oncentration
In  practice,  the  arrival  of the  contrast agent in the voxel is not instantaneous.  The 
measured concentration  time-course of the contrast agent in  a tissue  voxel  C,(r)  is 
dependent on the shape and amount of contrast that enters the capillary bed.  Ct (t)  is 
proportional  to  the  convolution  of the  arterial  input  concentration  Ca(t)  with  the 
idealised  (instantaneous  unit  input)  response  of the  tissue,  R(t)  (0stergaard  et al. 
1996b):Chapter 4: DSC-MRI Perfusion Measurement -96-
C, (/)« CBF •  Jc0 {r)R{t -  r)dr  [ 4.15 ]
0
The  proportionality  constant,  CBF  is  the  cerebral  blood  flow  (ml/100g/s):-  the 
amount of blood that arrives in the tissue voxel per 100 grams of tissue per unit time. 
The proportionality with CBF is intuitively clear: The concentration of contrast agent 
present in the tissue  Ct (r), at a given time t, is proportional to the amount of blood
(with tracer concentration  Ca (r)) passing through the tissue element per unit time.
Equation  [4.15]  can  be  understood by  considering  the  arterial  input  concentration 
Ca(t)  as  a  superposition  of consecutive  instantaneous  (impulse)  boluses,  Ca(r)dT 
injected into the system at tim er.  For each idealised bolus, the concentration present 
in the tissue voxel  at time t,  dCt(t), is  determined by the proportion of the (ideal)
arterial input bolus remaining the system at a later time t -  t  ,  R (t-t).
dCt (t) oc CBF •  Ca  (r)R(t -  r]dr  [ 4.16 ]
The total measured concentration of contrast in the tissue  Ct(t) is the sum of all these 
contributions.
4.6.6  Physiological Factors
For  a  quantitative  assessment  of  CBF,  it  is  necessary  to  take  into  account  the 
difference in the blood characteristics between the vessel in which the arterial  and 
tissue  concentrations  are  measured.  In  a large  artery, the percentage  of the blood 
volume occupied by RBC is greater than in the capillaries.  This percentage is known 
as  the  haematocrit  H,  which  is  approximately  45%  in  large  vessels,  Han  (i.e. 
approximately 45ml  of RBC per  100ml  of blood)  and  25%  for  small  vessels,  Htis 
(Larsen et al.  1964).  Because the capillaries hold a greater proportional of plasma, 
they  also  hold  a  greater  proportion  of  contrast.  Accordingly,  the  susceptibility 
induced MR  signal  drop  arising from the  capillaries  derives  from  a proportionallyChapter 4: DSC-MRI Perfusion Measurement -97-
larger concentration of contrast agent.  A correction factor  kH   must be included in 
Equation  [4.15]  to  indicate  the  plasma  volume  available  for  the  contrast  agent 
(Calamanteetal.  1999b):
4.6.7  Cerebral Blood Volume
The cerebral blood volume (CBV) is a measure of capillary density or microvascular 
blood  volume.  The  CBV units  of ml  blood  per  lOOg  tissue  (ml/lOOg),  are  often 
expressed  as  a  percentage,  on  the  assumption  that  the  density  of brain  tissue  is 
approximately  lg/ml.  CBV is  proportional  to  the  total  amount  of  intravascular 
contrast agent in the tissue (Meier et al.  1954). The area under the first pass of the 
concentration time-course gives the entire amount of contrast agent passing through 
the voxel, and is therefore an indication of the capability of the region to pass blood 
through it.  Absolute CBV, is calculated by normalising the area under the measured 
tissue  concentration  time-course  Ct{t)  to  the  area  under  the  arterial  contrast
concentration time-course,  Ca (t),  and  scaling by  kH (Calamante  et al.  1999b).  In 
order to obtain the correct units, the density of brain tissue  p   (100g/cm3) must also 
be accounted for:
.MJ
"  '  (i-f lj
[4.17]
[4.18]
Normalisation to  Ca(t)  ensures that the calculated CBV is independent of the amount
of tracer injected.  These integrals should be taken over the first pass over the bolus 
only in order to avoid bias introduced by the recirculation (see Section 4.7.8).Chapter 4: DSC-MRI Perfusion Measurement -98-
4.6.8  The Convolution Equation
The central equation for the quantification of blood flow using intravascular contrast 
agents is (0stergaard et al.  1996b):
C,(t) = -r-C B F -)ca(T)R(t-T)dt  [4.19]
k  J
For simplicity, the ratio  p/kH  is often taken to be equal to 1.0 (Grandin et al. 2001), 
although  in  reality  the  ratio  is  unlikely  to  be  constant  (see  Section  4.7.5). 
Deconvolution (see Section 4.8) of the concentration time-course yields  CBF  R(t), 
which  will  be  referred  to  as  the  impulse  response  function,  as  it  is  the  tissue 
concentration resulting from an infinitely short (“impulse”) input.
Quantitative  CBF is  estimated  from  the  initial  (r=0)  value  of this  function,  since 
R(t = 0) = 1,  which  has  been  shown  to  be  the  most  reliable  method  for  CBF 
quantification (Perthen et al. 2002).  In addition to CBV, CBF, and MTT, the impulse 
response function  CBF •  R(t)  can be utilised to extract additional information about 
the capillary blood flow characteristics of the voxel.  The actual shape of the residue 
function is of great importance for determining the flow heterogeneity (FH), which is 
another useful indicator of tissue viability (see Section 4.6.10).
4.6.9  Central Volume Theorem
With  the  above  definitions  of CBF and MTT the  Central  Volume  Theorem  states 
(Meier etal.  1954):
CBV
CBF = ——   [4.20]
MTT
Under  constant  perfusion  pressure,  there  is  a  direct  correlation  between  CBF  and 
CBV.. If the blood vessels dilate or contract, CBF and CBV will increase and decreaseChapter 4: DSC-MRI Perfusion Measurement -99-
accordingly.  The MTT is the characteristic time the time blood spends in the capillary 
bed, and since it is completely independent of the structure of the feeding vasculature, 
it is a useful indictor of physiologic tissue status.  It cannot be calculated without first 
deconvolving  Ca (r)  from  Ct (r).  There are however various issues  concerning the
deconvolution,  which  make  accurate estimates  CBF, MTT,  and  flow heterogeneity 
FH difficult (see Sections 4.7.2 and 4.8).
4.6.10  Flow Heterogeneity
Within a given voxel there will be a distribution of flow rates.  The heterogeneity of 
the relative flow values, /  (relative to the mean flow,  CBF), can be described by a 
probability  density  function  that  assigns  a  probability  w(f)  to  a  given  flow  /  
(0stergaard  et  al  1999).  In  normal  human  cerebral  capillaries,  the  flow 
heterogeneity  is  thought  to  indicate  the  tissue  oxygen  metabolism  regulation 
mechanism (see Section 3.3).  Cerebral blood flow heterogeneity can be measured in 
DSC-MRI by converting the distribution of transit times  h(t)  (given by the slope of 
R(t), Equation [4.9]) to the distribution of relative flow rates,  w(/) (0stergaard et al
I.e.  the  fraction  of  instantaneous  bolus  leaving  the  tissue  at  time  t  to  t  +  dt  is 
determined by the proportion of flow in the range/+  df.  Assuming all vascular paths 
have equal blood  volume,  the  Central Volume Theorem,  (Equation  [4.20])  can be 
used to relate the relative flow and transit time:
1999):
w\if)df=h{t)dt [4.21]
[ 4.22 ]
By  differentiating  Equation  [4.22]  with  respect  to  t,  and  substituting  for /,  the 
distribution of flow rates in Equation [4.21] can be re-expressed as:Chapter 4: DSC-MRI Perfusion Measurement -100-
A f)  = ~ jh (t)  [4.23]
Therefore  deconvolution  of Equation  [4.19]  allows  not  only  quantification  of the 
mean flow in each voxel (CBF), but also its distribution.
4.7  P erfusion Q uantification Issues
Many of the assumptions in the above theory may not be true in practice, and could 
cause  erroneous  perfusion  quantification.  In  addition,  image  artefacts  can  further 
complicate the interpretation and estimation of perfusion parameters.  The following 
paragraphs describe some of the issues that should be considered when analysing data 
from DSC-MRI experiments.  These include BBB breakdown, delay and dispersion, 
quantifying  the  contrast  concentration,  partial  volume  effects,  unknown  constants, 
signal saturation, recirculation effects and patient motion.
4.7.1  Blood Brain Barrier
One of the primary assumptions for perfusion quantification using DSC-MRI is that 
there  is  an  intact  blood-brain  barrier  (BBB).  The  contrast  agent  must  remain 
intravascular for the above theory (Section 4.6) to be valid.  An intact BBB ensures 
that the induced susceptibility difference between the intra and extra vascular space is 
the dominant effect.  A disrupted BBB is often found in brain tumours.  In  such a 
situation,  the  compartmentalisation  of  the  contrast  agent  is  reduced,  and 
correspondingly the related local field inhomogeneities  are decreased.  In  addition, 
the extravascular contrast agent causes local Ti  shortening.  Since the blood volume 
in a voxel is usually small  (~2-6%), even a small  amount of extravascular contrast 
agent  would  decrease  the  T2/T2*  effects  and  increase  the  Ti  effects  (Rosen  et al. 
1990).  This results in the tissue concentration time-course falling below the baseline,Chapter 4: DSC-MRI Perfusion Measurement -101-
introducing errors into the CBV calculation.  Figure 4.6 schematically illustrates the 
tissue concentration time-course in the situation where the BBB is leaking.
Insensitivity  to  Ti  enhancement  may  be  achieved  using  a  dual-echo  acquisition 
(Vonken et al  1999b). In this acquisition, since the Ti enhancement is the same for 
both TEs, the change in transverse relaxation rate can be isolated:
In
(S^TE,))  J S U«(TE,)
In
S2(TE2),  , S2 (T E 2 )
AR,  =  J-----  ’ p   '  [ 4.24 ]
2  TE, -TE 2
5, (TE,)  is  the  signal  intensity  at the  i*  echo,  TEt , during  the  bolus  passage  and
S ,,jT E t) is the average * ,th echo intensity before the contrast arrival.  When there is
BBB breakdown, T2*  image contrast is due to both intra and extravascular contrast 
agent, and consequently susceptibility-contrast is smaller.
For a disrupted BBB, a simple transfer constant can describe the leakage of contrast 
agent  between  the  intravascular  and  extravascular  compartments  (Vonken  et  al. 
1999b).  If a fast exchange of mobile protons within the tissue is assumed, the same
AR2*   can  be  attributed  to  the  intravascular  and  extravascular  contrast.  The  total
response function  vtot(t)  of the tissue, including the possible extravasation,  can be
obtained in the same manner as  CBF • /?(r), by deconvolution.
The extravascular contrast will prevent  vtot (t)  from returning to baseline (zero) after
the  first passage  of bolus  (this  is  a  direct  consequence  of the  shape  of the  tissue 
concentration  time-course,  see  Figure  4.6).  After  a  few  times  MTT,  the  response 
vtot(t)  will reach  a constant value.  The tissue response with extravasation can be
expressed as in terms of CBF • /?(r) as:Chapter 4: DSC-MRI Perfusion Measurement - 102-
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Figure 4.6: A schematic illustration of the concentration time-course when the BBB 
is leaking.  In this situation, the tissue signal will initially decrease, but subsequent 
overshoot  the  baseline.  This  effect  is  observed  because  there  is  a  significant 
reduction in Ti relaxation time, which is caused by the leakage of some contrast agent 
into the extravascular space.  The resulting signal increase causes an underestimation 
of the bolus concentration.
v„ (?) = CBF ■  R(t)+$ \CBF ■  R(t')dt'  [ 4.25 ]
0
The constant  g  indicates the proportion of contrast agent leaving the circulation and 
can  be  estimated  from  the  average baseline  elevation.  Using  an  initial  guess  for 
CBF •  R(t)  , Equation  [4.25] can be solved iteratively to obtain an estimate of CBF 
(Vonken etal.  1999b).Chapter 4: DSC-MRI Perfusion Measurement -103-
4.7.2  Delay and Dispersion
Delay  and  dispersion  of  the  bolus  are  a  major  source  of  error  in  perfusion 
quantification (Calamante et al.  2000).  A significant part of this thesis  focuses  on 
techniques  to  minimise  these  errors,  which  are  common  in  patients  with  cerebral 
arterial diseases, for example occlusions, stenosis or collateral flow (Calamante et al.
2002).  The errors are described in detail in this section.
In the standard theory described above (Section 4.6), the concentration of contrast in 
the artery directly feeding the tissue is known as the Arterial Input Function or AIF. 
If an  absolute  CBF measure is  required,  then  an  absolute AIF must be calculated. 
Typically, the AIF is estimated by measuring the signal time-course in voxels within 
a feeding artery.  In order to minimise partial volume effects (see Section 4.7.4), the 
AIF is  typically measured in  a large  artery  such  as  the carotid  or middle cerebral 
artery  (MCA)  (0stergaard  et al.  1996a;  Calamante  et al.  2002).  Voxels  typically 
chosen for the measurement are those with the earliest bolus arrival time and a high 
blood volume (Carroll et al.  2003).  However, measuring the AIF in a large artery 
distant to the tissue leads to quantification problems resulting from bolus delay and 
dispersion.  The delay of the bolus is the time taken to travel from the point of AIF 
measurement to the volume of interest.  Dispersion increases the width of the bolus 
due  for  example  to  differing  path  lengths  through  the  vascular  bed,  or  arterial 
stenosis.  Thus the AIF measurement is not the true input to the tissue volume of 
interest.
Delay-related perfusion measurement errors are purely a result of inaccuracies in the 
deconvolution  technique  used  (see  Section  4.8).  Dispersion-related  perfusion 
measurement  errors  are  present  regardless  of  the  accuracy  of  the  particular 
deconvolution technique employed.  Dispersion may be modelled using  a vascular 
transport  function  VTF(t),  which  describes  the  probability  distribution  of  transit 
times between the AIF measurement site and the tissue (Calamante et al.  2000).  IfChapter 4: DSC-MRI Perfusion Measurement -104-
Cesta(t)  is  the  AIF  estimated  in  a  large  vessel  such  as  the  MCA,  the  true  AIF, 
C,ruea(t)  may be expressed (cf. Equation [4.6]):
C,rma (t) = C‘s,a(t)® VJF{t)  [ 4.26 ]
This relationship can be interpreted in the same way as Equation [4.6].  Consider the 
estimated input concentration  Cesta(t) as a superposition of consecutive instantaneous 
boluses,  Cesta{t)dT, injected into the vascular system at time  t  .  For each idealised 
bolus, after travelling through the vasculature, the resultant output concentration, (that 
is the true input to the tissue) at time t,  dCtruea(t), is determined by proportion of the 
(ideal) bolus leaving the vascular system at a later time t -  t  , VTF(t -  t) .
dCtruea  (it) oc Cesta (r)VTF(r -  t)d t  [ 4.27 ]
The total true input concentration Ctruea(t) is the sum of all these contributions.
Using Equation  [4.26], the convolution equation central to perfusion quantification 
using DSC-MRI becomes (Calamante et al. 2000):
c,(t) =— CBF • (c"«(t)®VTF(t)®R{t)) 
kH
[4'28] C, (?) = f-CBF■  {C‘\  (r)®  (())
k„
where  Reff(t) = R(t)®VTF(t)  is the  effective residue function whose shape reflects 
the properties of both the vasculature and the tissue.  If the bolus suffers delay and/or 
dispersion,  the  deconvolution  analysis  with  Cesta(t)  will  not  give  the  true  scaled 
residue  function, CBF  R(t),  but  the  impulse  response  function  for  the  tissue  and 
arterial  system  becomes  CBF  R^(t).  In  this  situation,  the  initial  value  of  the 
deconvolved  function  CBF  Reff{t)  cannot  be  used  to  measure  CBF,  since 
Reff (r = 0) = 0.  The best estimate is  obtained from the maximum of  CBF  Reff{t),Chapter 4: DSC-MRI Perfusion Measurement -105-
although the effect of dispersion leads to an intrinsic underestimation.  It should be 
noted  that  if  the  estimated  AIF  is  inaccurate,  dispersion-related  perfusion 
measurement errors are always present, even if the particular deconvolution algorithm 
were  perfectly  accurate.  The  underestimation  is  wholly  a  consequence  of  the 
inaccurate estimation for the tissue arterial input function.
In  both  PET  and  MRI  a  simple  exponentially  decaying  VTF  (Iida  et  al.  1986; 
Calamante et al. 2000; Calamante et al 2003b) has often been assumed to model the 
vascular dispersion.
p   is the mean vascular transit time (MVTT) from the site of AIF measurement to the 
volume of interest.  In PET studies,  ft has often been estimated in the range 0-10s, by 
fitting the radioactivity curve of the sampled arterial blood with the exponential (e.g. 
(Meyer 1989).  Assuming the tissue can be represented as a well mixed compartment 
(Equation  [4.12]), the effective residue function in DSC-MRI is then (Calamante et 
al 2003a):
This  model  for dispersion  has been previously used to assess the  dispersion errors 
using  deconvolution  simulations.  It  was  found  that  dispersion  leads  to  an 
underestimation of CBF by 50% for  p  > 2.5 seconds and an MTT overestimation of 
200% (Calamante et al 2000).
MTT
[4.30]
MTT
Just as the exact form of R(t) is unknown, the function describing the transport of the 
bolus through the vasculature,  VTF(t) is also unknown.  The exact shape will depend 
on the specific configuration of the vascular network that the bolus passes through.Chapter 4: DSC-MRI Perfusion Measurement -106-
In particular, its shape will be dependent on stenosis and bifurcations of the vessels 
(Calamante et al.  2003b).  Since the commonly assumed VTF models have limited 
physiological motivation, an in vivo study of the VTF has been conducted in Chapter 
8.
Delay and/or dispersion result in four possible bolus states and corresponding  R^ (t):
No  delay  and  no  dispersion  (normal),  delay  and  no  dispersion,  dispersion  and  no 
delay, delay and dispersion.  The shape of Reff (t)  is illustrated in Figure  4.7 for each
state.  This  shape can be used to indicate the bias in CBF and MTT measurements. 
For example,  the  shape  can indicate whether a  low  CBF and  prolonged MTT is  a 
result of dispersion, or whether there is actually a true perfusion abnormality.  The 
characterisation  of the  shape  of  Reff{t)  is  particularly  important  in  patients  with
cerebral  arterial  disease  and  stroke,  where bolus  delay  and dispersion  are  common 
due to vessel occlusion, stenosis, or collateral flow.
Some of the common deconvolution approaches used to extract the impulse response 
function from Equation [4.28] are discussed in Section 4.8.  Many of these methods 
provide an unsatisfactory characterisation of the  Reff it) , and therefore it is difficult to
distinguish true hypoperfusion from the underestimation introduced by bolus  delay 
and dispersion.  The work in Chapters 6 and 7 seeks to minimise the errors introduced 
in  the  deconvolution  process  in  order  to  achieve  an  accurate  characterisation  of 
Reff{t) .  The work presented in Chapter 9 applies these developments to the perfusion
data  from  patients  with  cerebral  arterial  diseases,  and  uses  the  improved 
characterisation of Reff(t) to identify areas where the perfusion values are likely to be
inaccurate.Chapter 4: DSC-MRI Perfusion Measurement - 107-
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Figure 4.7:  The  Reff(t)  corresponding  to  the  four possible bolus  states  (delay  and
dispersion combinations) described in  Section 4.7.2) a)  No delay and no  dispersion 
(normal),  b)  delay  and  no  dispersion,  c)  dispersion  and  no  delay,  d)  delay  and 
dispersion._________________________________________________________________
4.7.3  R ela tio n sh ip  B etw een  C han ges in R2/R2* and
C oncentration
One of the main assumptions in perfusion quantification using DSC-MRI is that the 
relationship between the concentration of contrast agent  Ct{t) and the induced change 
in relaxation rate (R2/R2*) is  linear (see  Section 4.5).  Recent  studies  have  actually 
observed a quadratic dependency between  Ct(t)  and  AR2  / AR2*   (Figure 4.8).  Since a 
higher concentration of contrast agent is found in big arteries, there may beChapter 4: DSC-MRI Perfusion Measurement -108-
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Figure  4.8:  The  graph  shows  AR2*   as  a  function  of  Gd-DPTA  concentration  in 
human blood flowing in a phantom, fitted with a polynomial.  The linear relationship 
between  concentration  and  AR2*   given  in  Equation  [4.3]  is  not  valid  for  higher 
concentrations of Gd-DTPA.  Since high concentrations of Gd-DTPA may be present 
in the arteries,  significant error may be introduced into the calculation  of the AIF. 
Reproduced from (van Osch et al 2003).______________________________________
significant error in  the calculation  of AIF (van  Osch  et al.  2003).  This  quadratic 
dependency  was  also  found  to  be  dependent  on  the  haematocrit  levels,  and  will 
consequently vary between different patients and between different parts of the brain.
Although, not common practice, one potential way to avoid these complications is to 
use  the  phase  of the  signal,  6 ,  rather  than  its  magnitude.  A  linear  relationship
between the phase velocity  and the concentration  Ct(t)  has been measured
(van  Osch  et  al  2003).  However,  the  interpretation  of  phase  measurements  isChapter 4: DSC-MRI Perfusion Measurement -109-
complex if the artery is not parallel to the main field (van Osch et al 2003).  For this 
reason, this approach is usually only taken in the internal carotid arteries.
4.7.4  Partial Volume Effects
Even  if  the  linear  phase  relationship  is  used,  an  accurate  quantification  of  the 
concentration is difficult because of the limited spatial resolution of the MR images. 
Often  the AIF is  measured in  the MCA,  a location  chosen to  minimise  delay  and 
dispersion effects.  However, here partial volume effects may be problematic.  The 
total  signal  originating  from  a  voxel  containing  both  arterial  blood  and  tissue 
surrounding the artery is dependent on the radius of the vessel (which determines the 
size  of the  time-dependent  susceptibility  gradients),  the  angle  of the  vessel  with 
respect  to  the  magnetic  field  (which  determines  the  presence  and  direction  of the 
gradients), the size of the voxel and location of the voxel with respect to the vessel, 
(which determine the proportion of intravascular and extravascular signal).
For in vivo studies, the measured signal for the AIF is likely to be a complex sum of 
signal arising from the tissue outside the vessel and a contrast agent dependent blood 
signal.  If the artery in which the AIF is measured is parallel to the main field, the 
extravascular signal is constant throughout the measurement (Figure 4.9).  As a result, 
for  a  partial  volumed  voxel,  the  complex  blood  signal  will  spiral  around  the
contribution  from  the  surroundings.  For  magnitude  (AR2*)  measurements,  this 
constant offset will significantly distort calculated AIF; individual time points may be 
either over or underestimated,  potentially  giving  erroneous  peaks  (van  Osch  et al. 
2001).  By using the whole complex  signal, it is  simple to correct for the constant 
phase originating from the extravascular signal (van Osch et al 2001).
When the artery is not parallel to the main field  (such  as the MCA), the magnetic 
field distribution outside the artery changes as the contrast agent passes through the 
artery,  due  to  the  time  dependent  within-artery  susceptibility  (Figure  4.10).  The 
signal originating from the partial volumed voxel will spiral around a non-fixedChapter 4: DSC-MRI Perfusion Measurement - 110-
Figure 4.9:  Schematic representation of the magnetic field lines arising in the tissue 
surrounding and artery when the bolus travels through an artery parallel to the main 
magnet  field.  The  box  represents  a  voxel  located  to  measure  the  AIF,  which  has 
partial  volume  effects.  Since  the  intravascular  and  extravascular  field  lines  are 
parallel, extravascular field is unchanged by the passage of the contrast agent.  The 
AIF can be corrected  for the  static contribution  arising  from the tissue  surrounding 
the artery.___________________________________________________________________
origin,  since the contribution from the surroundings is no longer static (van Osch et 
al.  2001).  Consequently,  partial  volume  effects  cannot be  corrected  for  using  the 
spiral method in this situation.
Partial  volume  contamination  of  the  AIF  could  be  avoided  by  measuring  the 
concentration  time-course  in  an  artery  whose  diameter  fills  the  whole  voxel,  or 
corrected  for  by  measuring  in  an  artery  parallel  to  the  field  (such  as  the  internal 
carotid  artery).  However  these  arteries  are  far  away  from  the  tissue  volume  of 
interest, and so bolus delay and dispersion are likely to introduce errors in perfusion 
quantification.  Therefore, a compromise should be sought between these two sources 
of error (partial volume vs. delay and dispersion).Chapter 4: DSC-MRI Perfusion Measurement - Ill -
Figure 4.10: Schematic representation of the magnetic field lines arising in the tissue 
surrounding when the bolus travels through an artery that is not parallel to the main 
magnet  field.  The  transverse  view  is  illustrated  on  the  left  and  the cross  sectional 
view on the right.  The box represents a voxel located to measure the AIF, which has 
partial  volume effects.  As the  paramagnetic  contrast passes  through the  artery,  the 
intravascular field changes according to the concentration present at a particular time. 
Therefore,  the  density  of the  field  lines  within  the  artery  changes  during  the bolus 
passage.  Since field lines must be continuous, the field distribution in the vicinity of 
the  artery  (the  extravascular  field)  also  changes  during  the  passage  of the  contrast 
agent.  Consequently, the signal measured in the artery, cannot be corrected for partial 
volume effects, since the contribution from the surroundings is not static.
It is important to realise that partial volume effects may lead to both underestimation 
and overestimation of the individual AIF time-points.  For this reason, care must be 
taken  in  selecting  appropriate  voxels  for  the  AIF  measurement.  Voxels  are  often 
selected to have an early rise,  small width,  and high maximum.  However,  selection 
criteria such as these could misclassify voxels that suffer from partial volume effects 
as  suitable  for  AIF  measurement.  This  is  of  particular  relevance  for  automatic 
methods  for  AIF  voxel  selection  (Mlynash  et  al  2005;  Mouridsen  et  al  2006a; 
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4.7.5  UNKNOWN CONSTANTS
Absolute measurement of CBF requires knowledge of the proportionality constants in 
the relationship  between  the  change in  transverse  relaxation rates  and the contrast 
agent concentration (for example the linear relationship assumed in Equation [4.3]). 
In general these constants are assumed uniform throughout the brain tissue and for the 
AIF (Grandin et al  2001; Rempp et al  1994;  Schreiber et al  1998).  One method 
used  to  fix  these  unknown  constants  is  to  cross-calibrate  with  a  ‘gold-standard’ 
technique such as PET.  If a group of subjects are scanned with both MRI and PET, a 
global  conversion  factor  can  be  calculated  by  plotting  a  graph  of regional  PET 
perfusion values  against the corresponding DSC-MRI perfusion measurements,  and 
fitting a linear regression (0stergaard et al  1998a).  Only a single global conversion 
factor is  obtained  using  this  approach,  however  in  practice  it  likely  to  vary  with 
changes  in pathology,  tissue type  and  for different  subjects  (Johnson  et al  2000). 
Therefore  the  conversion  factor  is  likely  to  be  both  patient  specific  and  time 
dependent  (Lin  et  al  2001).  Although  these  common  assumptions  may  lead  to 
significant errors in the absolute quantification of CBF and CBV, it is interesting to 
note that using  a universal  constant has been  shown to give  fortuitously perfusion 
values consistent with the literature e.g. (Rempp et al  1994). In addition, the ratio of 
the haematocrit levels  ku  and  brain  density  p   is  often  taken  to be  equal  to  one 
(Grandin  et  al  2001;  Rempp  et  al  1994;  Schreiber  et  al  1998).  Furthermore, 
although it is assumed constant throughout the brain, the ratio is likely to change with 
pathology.
4.7.6  EPI Artefacts
An EPI acquisition can achieve good SNR combined with high temporal resolution. 
However, it is important to be aware of some artefacts associated with this acquisition 
method that are particularly relevant for DSC-MRI.Chapter 4: DSC-MRI Perfusion Measurement - 113-
Optimum sensitivity to T2/T2* changes in tissue is achieved with a relatively long TE, 
(~65ms).  However, because EPI uses a range of TE to acquire the data, the whole 
echo train cannot be optimally sensitive to the effect of the bolus, and each line of k- 
space  will  have  a  different  T2/T2*  weighting.  Although  T2/T2*  decay  along  the 
frequency-encoding  direction  of  k-space  is  negligible,  decay  along  the  phase- 
encoding  is  significant.  Each  line  in  k-space  along  the  phase-encode  direction  is 
modulated by the T2* envelope, so that the point-spread function (which determines 
the image resolution,  see Section 2.4.4.1) is degraded.  The time dependent T2/T2* 
during the bolus passage therefore causes a time-dependent point spread function and 
as a result a time-dependent resolution and partial volume effects.  Furthermore, in 
order  to  maintain  image  resolution,  the  whole  of k-space  must  be  obtained  with 
sufficient  signal.  Consequently,  the  echo-train  should  also  be  shorter  than  the 
shortest T2/T2* seen during bolus passage.
One  of  the  main  sources  of  artefact  in  EPI  imaging  is  related  to  the  very  low 
bandwidth per pixel in the phase-encoding direction (-10 Hz/pixel).  Consequently, at 
the  boundary  between  two  regions  with  different  susceptibilities  there  is  voxel 
misregistration,  whereby  the  voxels  values  are  “shifted”  in  the  phase-encoding 
direction.  In  DSC-MRI,  this  geometric  distortion  is  particularly  apparent  for the 
voxels  near  the  boundaries  of the  vessels,  where  the  paramagnetic  contrast  agent 
creates  local  field inhomogeneities  during the passage  of the bolus.  The resulting 
voxel misregistration distorts  concentration time-course  (Hou  et al  1999).  This is 
illustrated in Figure 4.11  for voxel located close to a large vessel.  Deconvolution of 
such  a  distorted  time-course  will  give  an  erroneous  impulse  response  function. 
Furthermore, in this voxel, the measured CBV (area under the first passage), will also 
be wrong due to the artificial negative contrast concentration.  It is important to be 
aware  that  the  signal  close  to big  vessels  may be  distorted,  and that these  voxels 
should be excluded from the measurement of the AIF.  In particular it is important to 
include criteria to exclude these voxels from automated AIF selection methods.Chapter 4: DSC-MRI Perfusion Measurement -114-
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Figure  4.11:  An  example  of  the  concentration  time-course  resulting  from  vessel 
misregistration cause by the passage of contrast agent in EPI.  The time-course data 
has a distorted and unrealistic shape with artificially negative concentration._________
4.7.7  Signal Saturation
Another common artefact that affects the measurement of the AIF is signal saturation. 
Because of the large concentration of contrast agent in the arteries and the relatively 
long TE used in DSC-MRI experiments, the signal intensity in the vessel during the 
first pass of the bolus can fall to the background noise levels, producing saturation in 
the  peak  of the  measured  AIF.  Underestimating  the  peak  of the  AIF  leads  to  an 
overestimation of CBF (Ellinger et al 2000).  Saturation effects can be minimised by 
using a dual echo sequence, in which the slice where the AIF measured is  acquired 
with  a shorter TE.  However, the tissue SNR will be reduced in this  slice.  A more 
common approach is to exclude from the calculation of the AIF those voxels whoseChapter 4: DSC-MRI Perfusion Measurement - 115-
intensities  have  saturated  (Ellinger  et al.  2000).  An  accurate  AIF can  be  defined 
provided there are sufficient remaining measurement voxels.
4.7.8  R e circu latio n  E ffe cts
Indicator dilution theory is only strictly valid for a single passage of the contrast agent 
through the tissue.  In practice the AIF and tissue concentration time-courses contain 
a  second  smaller  delayed  peak  that  overlaps  with  the  first  passage.  This  is  the 
recirculation of the bolus.  One way to minimise the recirculation effect is to truncate 
the time-course  such that the  deconvolution  analysis is  only performed on the part 
corresponding to the first passage.  A consequence of this method however, is that the 
area under the peak (and hence the  CBV)  will be underestimated,  and the impulse 
response function will be distorted.  Alternatively, the recirculation can be removed 
by fitting a model such as the gamma-variate function to the first passage (Thompson 
et al  1964).  Care must be taken only to fit the time points that are not contaminated 
by  the  recirculation.  Although  this  method  can  potentially  provide  reliable  CBV 
estimates,  it  assumes  that  a  gamma-variate  function  correctly  models  the  first 
passage.  If this  is  not  true,  it  may  lead  to  erroneous  perfusion  estimates  and  an 
inaccurate characterisation of the impulse response function (Levin et al.  1995).  In 
addition, errors can potentially arise from inaccuracies in the non-linear fitting, which 
is very sensitive to noise in the data (Boxerman et al.  1997).
4.7.9  Motion
Another potential artefact associated with standard 2D EPI is its sensitivity to through 
slice patient motion, which often occurs during bolus injection.  In 2D imaging, out- 
off-slice  spins  that  are  suddenly  shifted  into  the  in-slice  position  (due  to  patient 
motion) will first need to reach a steady-state longitudinal magnetisation in order for 
the T2* effect of the bolus passage to dominate the contrast.  The signal time-course 
cannot be used for perfusion quantification if it is distorted at the end of the baselineChapter 4: DSC-MRI Perfusion Measurement - 116-
leading into the bolus-induced signal drop or if motion occurs during the first passage 
itself.  However,  if there  is  significant time between  the  movement  and  when the 
bolus reaches the brain, the bolus passage itself is unaffected and so the data can still 
be used.  Care must be taken however to exclude non-steady-state images from the 
baseline  calculation.  Figure  4.12  illustrates  how  through-slice  motion  may  be 
manifest in the signal time-course.
4.8  Deconvolution
For perfusion quantification, Equation [4.28] must be solved for the impulse response 
function  CBF  R ^ t).  There are various ways of doing this deconvolution analysis.
Model-dependent approaches assume a model for  CBF • Reff (r) and calculate CBF by
a non-linear fitting (0stergaard et al  1996b; Mouridsen et al 2006b).  However, the 
model chosen may not be true for the entire brain, especially if there is pathology.  As 
a result,  model-independent  approaches  are  more  commonly used,  for  which both 
CBF and the shape of Reff (r) are not assumed.
Parametric  methods  fit  a  function  (such  as  the  gamma-variate)  to  the  contrast 
concentration time-course data.  In this situation the deconvolution is performed on a 
curve that is noiseless, and where there is no limitation on the temporal-resolution.  In 
addition,  the  recirculation  of  the  bolus  through  the  brain  is  removed  before  the 
deconvolution is performed, enabling an accurate determination of CBV.  However, 
as mentioned in  Section 4.7.8  the non-linear fitting of the gamma-variate model is 
very  sensitive  to  noise,  potentially  resulting  in  an  inaccurate  fit,  and  hence  in  an 
inaccurate  characterisation  of  the  deconvolved  CBF  Reff{t).  Furthermore,  the
validity of the parametric model in all situations cannot be assured.  For this reason, a 
wow-parametric deconvolution approach is more commonly use, and it is the approach 
taken in this work.Chapter 4: DSC-MRI Perfusion Measurement - 117 -
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Figure 4.12: An example of the signal time-course resulting from patient motion in a 
2D acquisition.  In this case, the motion occurs at the beginning of the first passage of 
bolus.  Consequently,  since the  new  in-slice  spins  are  still reaching  an  equilibrium 
magnetisation,  the  magnitude  of  the  bolus  induced  signal  drop  is  significantly 
reduced.  Such  motion  would  render  the  data  set  unusable  for  perfusion 
quantification._______________________________________________________________
Non-parametric methods use the actual concentration time-course data that is sampled 
at intervals of TR and is to some degree corrupted by noise.  The noise contribution 
can be explicitly written into Equation [4.28]:
noise  [ 4.31 ]
In DSC-MRI data, most of the noise in the system is present in  Ct(t), since  Ca(t) is 
often  an  average  over  many  voxels.  The  estimated  impulse  response  function 
r{t)=(CBF ■  Reff(t))e i  depends  both  on  the  quality  of  the  data  and  on  the
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4.8.1  An Ill-Posed Problem
The inversion of Equation [4.31] is ill posed.  This means that the solution it is highly 
sensitive to high-frequency perturbations,  and even a small  amount of noise in the 
input data  (Ct(t)  and  Ca(t)) will cause a large perturbation in the solution (CBF and
CBF  Reff(t)).  This instability can be understood by considering the frequency-space
representation of the data.
In most physical systems, the Fourier Transform of a noiseless signal  F[g(r)] = G(v), 
decays  towards  zero  as  v -> ©o.  However,  the  behaviour  of the  noise  does  not 
necessarily decay.  For Equation [4.31], the Fourier Transform of the solution can be 
expressed using the convolution theorem as:
F[r(«)] =
Thus, if F[C„(0] — >  0  as  v — >  oo, small changes in the high-frequency spectrum of 
F[Cr(/)+noise]  will  be  accompanied  by  large  changes  in  F[r(r)],  eventually 
swamping  the  true  solution  F[CBF *Re#(r)J.  Since  noise  is  present  across  all 
frequencies, any deconvolution of noisy data is ill-posed.
F[C,(f)+noise] 
F[C„(»
[4.32]
Inversion  of DSC-MRI  is  further  complicated because  of discrete  sampling.  The 
noisy sample  Ct (t)  and  Ca (t)  have a finite frequency bandwidth, so provided there
are  no  zero  values  in  the  discrete  Fourier Transform  of  Ca(t),  there  is  a  unique 
solution.  However,  the  solution  is  not  necessarily  accurate.  This  is  because 
information  is  lost  with  noise  and  in  sampling,  i.e.  the  Ct(t)  and  Ca(t)  data  are 
incomplete.  For the simplest inversion (Equation [4.32]), small changes in the noisy 
Ct(t)  are  still  significantly  amplified  in  r(f),  since  the  high-frequency  Fourier 
coefficients in the denominator are still small compared with those in the numerator.Chapter 4: DSC-MRI Perfusion Measurement -119 -
Therefore, to obtain  CBF  R^(t),  the inversion  of Equation  [4.31]  requires  some 
additional information.  This is known as regularisation.
A  stable and physically meaningful  solution can  only be realised using filtering or 
regularisation  (Hansen  1994).  Regularisation  suppresses  the  high-frequency 
components  in  the  data  and  enables  a  stable  solution  for  CBF  Reff(t)  to  be
recovered.  However, in addition to the loss of shape information introduced by the 
discrete sampling, suppression of high-frequency components can distort the shape of 
the  extracted  CBF  Reff(t)  further,  leading  to  an  underestimation  of  CBF.  Such
distortion is particularly apparent for the impulse response function deconvolved from 
a delayed bolus with no dispersion (see Figure 4.5).  The sharp edge associated with 
the  delay  and  defining  the  rise-to-maximum  (RTM)  is  characterised  by  higher 
frequencies, which may be removed in the regularisation.  In general, regularisation 
smoothes the edges, and in the context of DSC-MRI, causes a delayed  CBF • Reff (r)
to appear dispersed.
The development of stable and accurate deconvolution methods has been an active 
area of research in DSC-MRI, and it is one of the issues addressed in Chapters 6 and 
7 of this thesis.  The following paragraphs introduce some of the model-independent 
deconvolution methods in common use.  Each method has specific limitations, which 
are discussed in the context of their ability to characterise  CBF •  Reff (r)  and quantify
perfusion.
4.8.2  Deconvolution using the Fourier Transform
One  of  the  first  deconvolution  approaches  used  in  DSC-MRI  was  the  Fourier 
Transform  (FT)  (Gobbel  et  al  1994).  Since  the  FT  of  a  convolution  is  a 
multiplication, Equation [4.28] can be solved as:Chapter 4: DSC-MRI Perfusion Measurement -120-
(C B F R jt)  I  = F -
where F'1  the inverse FT of the function in [ ].  Because of noise in the data, a stable 
solution  to  this  equation  can  only be  achieved by  filtering  out the high-frequency 
components  that  correspond  to  the  small  Fourier  coefficients  in  the  denominator. 
However,  it  is  likely  that  when  suppressing  the  experimental  noise  in  this  way, 
physiological information will also be lost.  The FT approach to the deconvolution 
tends to underestimate CBF,  especially for high flows and rapidly decaying residue 
functions (short MTT) (0stergaard et al.  1996b).  One attraction of the FT method 
however,  is  that  it  is  insensitive  to  delay  between  the  AIF  and  tissue,  which  are 
common in patients with cerebrovascular disease.  The intrinsic delay insensitivity of 
the  Fourier  Transform  approach  can  be  explained  in  terms  of  the  Fourier  shift 
theorem:  If F[g(t)] = G(v), then  F[g(t -  t)\ = e~2myG(v).  I.e., for a shift in time, the 
magnitude of the Fourier Transform remains the same, only the phase has changed. 
Therefore, for any delay, the same high-frequency components will be removed in the 
filtering process to ensure an invariant and stable solution.
F{C,(f)}
F{C„W}
[4.33]
4.83  Matrix Algebra Formulation of Deconvolution
Other  model-independent  deconvolution  approaches  are  based  on  matrix  algebraic 
techniques.  If the arterial  and tissue concentrations  are  sampled at intervals of  At 
between t0  and tn, and assuming that  R^{t)  and  Ca(t) are constant over the  At  time
interval, the convolution equation  (Equation  [4.28]) can be discretised into matrix 
form (0stergaard et al.  1996b):
C„(f,)= 6t  CBF'El=0C‘s,a(ti)  R j t j -f,)  [4.34]
In practice this equation is reduced to a set of linear equations: 
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The matrix A has elements aij determined by the sampled AIF, vector c is the sampled 
tissue  concentration  Ct(t),  and  vector  r contains  the  unknown  discretised  product
CBF  Rtf(t).  In  reality,  Reff(t)  and  Ca(t)  are  not  constant  over  the  sampling
interval.  It is possible to modify the elements of matrix A to produce a more accurate 
approximation  of  Reff{t)  and  Ca(t)  between  the  sample  points.  This  is  discussed
further in Chapter 6.
4.8.4  Deconvolution using Singular Value Decomposition
Due  to  the  early  simulation  work  done  by  0stergaard  et  al.  comparing  different 
deconvolution  methods,  the  most  common  regularisation  approach  in  DSC-MRI 
studies is truncated Singular Valued Decomposition (SVD) (0stergaard et al.  1996b). 
In SVD, a convolution matrix A is a real  m xn  matrix (where  m > n) which can be 
decomposed into two orthogonal matrices U (m xn) and V (nxn \  and a diagonal 
matrix W  (nxn), such that
A = UW VT   [4.36]
and
A"1  = VW_1UT  [4.37]
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(  Mo,
W-1 [4.38]
0 1/<t
and  > a2 >... > < rn are the diagonal elements of W.
The columns of U are called the left-singular vectors, the columns of V the right- 
singular vectors, and the diagonal elements of W are the singular values of the matrix 
A.  The residue function is then found by solving for r
where u and v are the singular vectors corresponding to the orthogonal SVD matrices 
U and V respectively (Hansen 1994).
Because  of discrete  sampling,  the  slowly-varying portion  of the  arterial  data  (AIF 
time-course) is well described, while structures on fine scales or with high-frequency 
components  are poorly represented.  This is typical for all measurement processes. 
The singular vectors associated with the large singular values will tend to be smooth, 
while those associated with the small singular values will tend to be highly irregular 
or oscillatory (Hansen  1994).  Consequently, upon inversion, these high frequencies
(which  can  often  be  synonymous  with  noise)  are  amplified  by  their  cr,-1  factor,
resulting  in  a  very  large  random  component  that  can  completely  dominate  the 
solution.  In other words, it is the diagonal elements of W, which are near to or equal 
to zero, which cause the estimated solution  r  to be unstable.  The rate at which the 
singular values of A,  cr , decrease with index /, determines how ill-posed the problem
is, therefore indicating how much useful information can be reconstructed from the 
sampled noisy data.  If the singular values decrease rapidly, a high SNR is necessary 
for a good reconstruction.
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Discarding the small singular values and replacing the corresponding diagonal entries 
1/cr  in  W '1   with 0, restricts the inversion range of A (i.e. it reduces the number of 
possible  solutions),  yielding  a  more  robust  solution  with  smaller  residual  error 
((Ar5 1 ® —c  ).  This approach is known as truncated SVD or TSVD.
In the deconvolution of DSC-MRI data, a stable TSVD solution is achieved using a 
fixed (0stergaard et ah  1996b) or adaptive (Liu et ah  1999) singular value threshold 
that depends either on SNR, or seeks to minimise oscillation in  r  (Wu et al 2003). 
The optimum threshold will actually depend on many factors including the SNR and 
actual shape of the impulse response function being extracted.
Calamante et ah  (Calamante  et ah  2003a)  demonstrated using  simulations that the 
TSVD reconstructions  of a smoothly varying exponentially decaying  R(t),  and the 
smoothly  varying  dispersed  Reff(t)  are  not  particularly  accurate.  Figure  4.13
illustrates their findings.  It can be seen in Figure 4.13a that TSVD underestimates the 
maximum (and hence  CBF) for the true residue function  (undistorted by delay and 
dispersion in the vascular transport).  Figure 4.13 demonstrates that the truncation of 
the  high-frequency  components  in  TSVD  introduces  oscillations  in  the 
reconstruction,  adding  to  the  distortion  of reconstruction  in  both  simulations.  In 
addition,  the  accuracy  of the  CBF estimates  are  highly  dependent  on  blood  flow 
(0stergaard  et  ah  1996b)  and  the  presence  of  delay  (Calamante  et  ah  2000). 
Although the characterisation  of  Reff (?)  using TSVD  is not accurate enough to be
able to identify and distinguish delay and dispersion in perfusion measurements, in 
healthy tissue SVD has been shown to give a good estimate of CBF  (0stergaard et 
ah 1996b).
4.8.5  Deconvolution using Tikhonov Regularisation
Tikhonov regularisation is an alternative deconvolution method to measure CBF, first 
presented by Calamante et ah (Calamante et ah 2003a). The truncation of singularChapter 4: DSC-MRI Perfusion Measurement - 124-
a
0.8
0.6
0.4
0.2
5 10 0 15
0.8
b
0.7
0.6
0.5
0.4
0.3
0.2
0.1
-0.1
15 10
Figure 4.13:  Mean  solutions  (for  100  simulations,  CNR=20) for two models of the 
impulse response function calculated using the conventional TSVD.  a): exponential, 
b):  dispersed  exponential.  The  black  solid  lines  indicate  the  simulated  functions 
(M7T=4s,  CBF=60ml/100g/min),  the  red  solid  lines  the  mean  solutions,  and  the 
dashed  lines  a  single  standard  deviation  of  the  solutions.  The  horizontal  axes 
correspond to time (in seconds).  The vertical axes correspond to the residue function 
(dimensionless).  TSVD  solutions  exhibit  oscillations  and  a  poor  shape 
characterisation.  Reproduced from (Calamante et al 2003a).______________________
values  in  the  SVD  solution  may  be  described  in  terms  of filter  factors ft  for  each 
singular value that are either 0 or 1  depending on whether the singular value is below 
or above the chosen threshold.  The oscillations introduced by truncating the singular 
values may be attenuated using a smoother cut-off defined by filter factors  that tend 
to zero as the corresponding  cr  decreases (Hansen 1994; Tikhonov 1963).Chapter 4: DSC-MRI Perfusion Measurement -125-
In  Tikhonov  regularisation,  the  shape  of  the  low-pass  filter  is  determined  by 
balancing the residual error ||Ar -  c||  and the regularisation error, which in Tikhonov
regularisation, depends on the form of the additional side constraint used to stabilise 
the  least  squares  solution.  The  deconvolution  of Equation  [4.28]  is  expressed  as 
(Hansen 1992; Tikhonov 1963):
rx = minr j|Ar -  c||2 + /L 2  ||Lr ||2)  [ 4.40 ]
L is the regularisation matrix, whose form is chosen based on prior information, for 
example  to  minimise  oscillations  (by  using  a  first  order  difference  operator),  or 
simply  to  minimise  the  amplification  of the  solution  itself  (by  using  the  identity 
matrix,  I).  X  is  the  regularisation  parameter  that  determines  the  degree  of
regularisation.  The stabilising effect of the side constraint  ^2||Lr||2  can be seen most
clearly by comparing the method with the SVD expansion (cf. Equation [4.39])
V ;  [4.41] r
i=1
In the same way as SVD regularisation truncates the expansion with a singular value 
threshold,  Tikhonov  regularisation  uses  a  ^.-dependent  smooth  attenuation  for the 
high frequencies.  For example, for L = I (Hansen 1994):
Just as truncated SVD requires the selection of the singular value threshold, Tikhonov 
regularisation requires the regularisation parameter X to be chosen.  Various methods 
were proposed to determine this parameter.  One of the most common is the L-curve 
(Hansen  1992).  The  L-curve  is  an  L-shaped  curve  that  results  from  plotting  the 
residual  norm  ||Ar -  c||,  against  the  constraint  norm  ||Lr ||  and  is  schematicallyChapter 4: DSC-MRI Perfusion Measurement -126-
illustrated in Figure 4.14.  In the vertical section, the constraint norm  Lr  is very
sensitive to changes in the regularisation parameter X,  since the solution  rtikh  will 
change  to  fit  the  data better.  The  vertical  section  of the  ‘L’  corresponds  to  low 
filtering  (small  values  of  |A r-c||)  and  accordingly,  r  is  determined  from  the 
division by small singular values,  a , corresponding to inadequate regularisation.  In 
the horizontal section ||Lr||  is almost constant, i.e. the highly filtered solutions do not
change  much.  However,  the  residual  norm  ||A r-c||  increases  rapidly  with  more
filtering.  The comer of the L-curve has been proposed as the finding the solution that 
gives the best compromise.
It  has  been  shown  that  Tikhonov  regularisation  improves  the  characterisation  of 
CBF  Reff(t)  compared  with  TSVD  (Calamante  et  al.  2003a).  By  carefully
formulating  the  convolution  matrix  A,  the  maximum  of the  true  residue  function 
(undistorted by delay and dispersion in the vascular transport) is accurately recovered. 
In  addition,  the  smooth  low-pass  filter  minimises  the  oscillation  and  successfully 
characterises the shape in the presence of dispersion.  However, the characterisation 
of  CBF • Reff (/)  using Tikhonov regularisation deteriorates in the presence of bolus
delay,  retaining  the  smooth  characteristics  of  regularisation,  which  prevents  the 
accurate  characterisation  of delay.  Therefore,  the  characterisation  of  CBF ■  Reff (t)
using  Tikhonov  regularisation  is  not  accurate  enough  to  be  able  to  identify  and 
distinguish delay and dispersion in perfusion measurements.
4.8.6  Deconvolution using a Block Circulant Matrix
Bolus  delay is  common  in  patients  with  vascular  abnormalities  and  can  lead  to  a 
severe underestimation of perfusion.  Calamante et al. performed simulations using 
SVD and showed CBF is underestimated by 35% for 1.5-2 seconds delay (Calamante 
et al.  2000).  The above formulation  of the matrix  algebra problem is intrinsically 
sensitive to delay.  Wu et al. proposed a reformulation of the convolution matrix,Chapter 4: DSC-MRI Perfusion Measurement -127-
X * 0.0001
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Figure 4.14: Generic L-curve for standard form Tikhonov regularisation where L=I, 
plotted  for regularisation  parameters  X=l,  10*1,  10'2,  10'3,  10"4,  and  10'5.  A  good 
solution for x resides just right of the comer.  Reproduced from (Hansen 1992)._____
such that the maximum  of the  impulse  response  function  is  independent  of bolus 
delay (Wu et al 2003).
In delay sensitive methods, the deconvolution matrix ay of A take the basic form (cf. 
Equation [4.35]):
0  otherwise.
Using this  formulation,  all  matrix based  deconvolution  methods  such  as  SVD  and 
Tikhonov are sensitive to bolus delay.  Delay sensitivity can be overcome by using a 
block-circulant matrix.  Circular deconvolution is  achieved by zero-padding the n-Chapter 4: DSC-MRI Perfusion Measurement -128-
point time series  Ca (t) and  Ct (t) to double their length, and replacing matrix A with 
a block-circulant matrix D, whose elements are:
2N+i-j,0
j < i
otherwise
D =
[4.44]
C.(*„)  0  ;  :  0  0  c „(0  :  :  cAJ
cM   c„(h)  o  i  :  o  o  cjO  •  ;
:  cA) CM  0  :  :  0  0  CJO  ;
:   :   cA)  CM  0  ;  ;  0  0  c „(0
cA)  ■   :  c .(»,)  c„(f0)  o  :  ;  o  o
o  c.(» J   :  i  cA)  cAo)  o  ;  •  o
o  0  cAJ  :   :  c,(/.)  C„(r0)  0  !  I
;  o  0  CAJ  ■   :  c.(f,)  C„(f0)  0  :
:  :  0  0  C.(».)  ;  :  CA)  CAo)  0
0  :  i  0  0  CAJ  :  :  c.(»,)  c .( a
Although the block-circulant SVD yields delay-insensitive estimates of the CBF, the 
accuracy  of these  measurements  is  actually  dependent  on  the MTT of the  Reff (/)
being  recovered.  The  CBF  underestimation  is  greater  for  a  smaller  MTT.  For 
M7T=4s,  block-circulant  SVD  underestimated  CBF by  -40%,  independent  of the 
amount  of delay  (Wu  et  al.  2003).  In  addition,  the  Reff (?)  are  distorted  by  the
characteristic  TSVD  oscillations.  Consequently,  a  delayed  bolus  cannot  be 
distinguished  from  a  dispersed  bolus,  and  therefore  a  correction  of  the 
underestimation  would  be  difficult.  Nevertheless,  this  technique  is  useful  for 
obtaining relative perfusion measurements across the brain when delays are expected. 
It is however important to realise that these estimated perfusion values are likely to 
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4.8.7  Deconvolution using Maximum-Likelihood Expectation-
MAXIMISATION
A  different approach for the deconvolution  of Equation  [4.28]  is using maximum- 
likelihood expectation-maximisation (ML-EM), which seeks to improve the balance 
between the residual norm  and the regularisation error (Dempster AP et al  1977). 
Since  a major part of the work in this thesis is based  on this  approach,  it will be 
presented in more detail.
4.8.7.1  General Overview of ML-EM
A  set  of  parameters  describing  a  system  may  be  estimated  from  measurement 
observations of the system.  The problem becomes ill-posed when the observed data 
are incomplete,  for example due to  sampling  and corruption by noise (see  Section 
4.8.1).  The notion  of incomplete  data includes  the conventional  sense  of missing 
data, but  also  applies to  situations  where the complete data represents  what would 
have  been  available  from  some  hypothetical  experiment.  The  ML-EM  algorithm 
calculates the most likely set of parameters by iteratively adjusting estimates of the 
parameters  in  order  to  maximise  the  expectation  (probability)  of  the  data.  The 
algorithm consists of two steps. 1) The E-step, which calculates the expectation of the 
data given  an  estimate  for the  set  of unknown  parameters.  2) The M-step,  which 
updates the parameters in order to maximise the expectation of the data.  In DSC- 
MRI, the data are the concentration time-courses, and the set of unknown parameters 
is the impulse response function.
4.8.7.2  ML-EM for DSC-MRI Perfusion Quantification
For the specific problem of DSC-MRI data, the most likely form of r (the impulse 
response function  CBF •  Reff (t)) is iteratively determined by repeating the E- and M-
steps  (Vonken et al  1999a).  The observed incomplete data are the tissue contrastChapter 4: DSC-MRI Perfusion Measurement -130-
concentration time-course,  Ct (t) ,  and the AIF,  Ca (t), both of which contain noise
from the system and are discretely sampled at TR.  The observed data are contained 
in vector c and the convolution matrix A (Equation [4.35]).  The unknown parameters 
to be estimated are the elements of vector r.  c is governed by a probability density 
function  (pdf),  g(c|r,A),  which  describes  the  likelihood  of measuring  c given  the
parameters governing the system.  In DSC-MRI, the ‘parameters’ governing the form 
of c are the vector values of r, and matrix values of A.  A complete-data vector x, can 
be defined, which theoretically contains all the information necessary to determine r. 
The pdf for the complete data vector is f{x\r).
Because the observed data are incomplete, there is a many-to-one mapping from the 
complete-data  sample  space Xt  to the  observation  (incomplete-data)  space  Y.  The 
observations c and A, (represented here as observation vector y) are contained within 
the observation space  Y,  y a  Y  .  The complete data vector x (which is the inverse 
mapping  of y)  is  contained  within  the  subset  of X defined  by y,  x c  X (y)a X . 
Thus, the inverse of y has many possible mappings within  X(y)  (Moon 1996).  This 
situation is schematically illustrated in Figure 4.15.  Hence the pdf of the incomplete 
data  g(c|r, A) is the sum over the pdf of the complete data  f{x\r) for all the possible
mappings of the incomplete data  X (c, A).
g(c|r,A)= ^ ^  j{x\r)dx  [4.45 ]
Or in discrete form
g(c|r,A )= ^x(fAj/(x|r)  [4.46]
If  in  some  hypothetical  experiment  the  data  were  fully  observable,  the  system 
parameters  could  be  determined  by  maximising  the  log  likelihood  function  for  r, 
lx(r) = ln/(x|r).  Since jc is in fact unobservable, it is necessary to maximise In f(x\r)Chapter 4: DSC-MRI Perfusion Measurement - 131 -
Complete Data  Incomplete Data
(available from some  (actually observed in
hypothetical experiment)  a real experiment)
Figure 4.15:  Schematic  representation  of the  ‘many-to-one’  problem that is  the ill- 
posed  deconvolution  of  DSC-MRI  data.  The  right  hand  shaded  circle,  labelled  Y 
represents the  ‘incomplete-data’  (observation)  space,  from  which  the measurements 
of the dynamic contrast are made.  The realisation of the measurements is represented 
by the observation vector y (contained in  Y).  Because of sampling and noise in the 
data,  there  are  many  possible  inverse  mappings  of  these  observations  y  to  the 
solution.  The left hand white circle represents the  ‘complete-data’  space, labelled X, 
and  the  grey  circle  within  this  represents  the  possible  solutions  X(y),  given  the 
observation  vector  y.  The  complete  data  vector  x,  (contained  in  X(y))  is  the 
hypothetical  (true) solution to the inverse problem.  The arrow indicates the inverse 
mapping of y, to the true solution jc.  The pdf of the incomplete data  g(y\x) is the sum
of the complete data pdf f(x)  over all the possible mappings, X (y).
given  the  observations  y  (c  and  A),  and  the  current  estimate  for  r  (this  is  the 
conditional likelihood).
As mentioned before, the ML-EM algorithm consists of two steps, the expectation, E- 
step,  and  the  maximisation,  M-step.  The  E-step  uses  current  estimates  of  the 
parameters  r  to  reconstruct  an  estimate  of  the  unobservable  data  x.  Assuming  a 
distribution for f(x\r), the conditional likelihood function can then be estimated.  Let
r[k ]  be the estimate of the parameters at the  iteration.  The E-step calculates the 
conditional expectation function,  (the log likelihood  ln/(x|r),  given c, A  and  r m ) 
(Vonken et al.  1999a):Chapter 4: DSC-MRI Perfusion Measurement -132-
e(r,r'*])= E|ln/(*|r)|c,A,Fm]  [ 4.47 ]
In order to calculate this function it is first necessary to construct the complete-data 
subset  ic X (j)c X   from  the  AIF  convolution  operator  A  with  elements  ay 
(Vonken et al. 1999a):
xv =a9rj  [4.48]
Combining Equations [4.46] and [4.48] reveals that the data which would have been 
observed if r}[k] were the parameters is (Vonken et al  1999a):
[ 4.49 ]
In  the  ML-EM  algorithm  adapted  by  Vonken  et  al.  (Vonken  et  al.  1999a)  the 
conditional probability of the complete data xy, assuming Gaussian noise is stated as:
exp
where  AL  is  the  conditional  (upon  c  and  A  )  expectation  value  of x  (i.e 
2?[jtJc,r1 [il j), which in the work by Vonken et al. is stated as:5
2  a A
[4.50]
5  It  should  be  noted  that  the  Gaussian  distribution  of  the  complete  data  X y  should  in  fact  be
exp
2  a 1
,  leading  to  the  non-linear term  (a-fv1* 1 —  Xy'f.  For a more
accurate algorithm, this term should be expanded and expressions for both conditional expectations 
e [jc J c,r [*]J  and  E\xy2 c,r [*] J  should  be  used  in  the  calculation.  In  addition,  the  result,
[
I  1  *'  y
xr  c, r  J = N v  = — 33— , is taken directly from work by Lange et al. (Lange et al  1984) who
C i
applied the ML-EM technique to PET perfusion quantification.  The derivation of this result is based 
on  the  assumption  of a  Poisson  distribution  Xy  ~ Poisson[a,y,  )  rather than  the  Gaussian
distribution,  which is  more  appropriate  in  the  DSC-MRI  context.  The result however serves  as  aChapter 4: DSC-MRI Perfusion Measurement -133 -
[4.51]
Given c, A  and  r [*], the complete data pdf is:
[4.52]
Accordingly, the E-step of the ML-EM algorithm becomes:
[4.53]
The  M-step  uses  the  current  estimate  r [*]  to  revise  the  estimation  of  r.  The
This is calculated by taking partial derivatives of Equation [4.53] with respect to 
and equating to zero. If all a are equal (Vonken et al  1999a):
Equation  [4.55]  can  be  solved  using  a  Newton  Raphson  method  for  the  updated 
r [*+1].  The  E-  and  M-steps  of  the  ML-EM  algorithm  are  repeated  until  some
satisfactory approximation.  If the above two considerations were incorporated into the algebra, the 
resultant formula for the E-step and subsequent M-step are long and computationally difficult.
Given that Vonken et al found that the ML-EM algorithm using Equation [4.50] was successful in its 
recovery of the impulse response function, for ease of implementation, the same formulation will also 
be used in this thesis.  It should be noted however that the algorithm does harbour some instabilities 
and  an erroneous  impulse  in  the  end  of the  tail  of the extracted  impulse  response  function.  This 
impulse does  not however affect the previous  elements,  and  can be overcome by  setting  the  final 
elements to zero.  Such problems may be attributable to the incorrect formulation of the algorithm.
conditional expectation function  Q(r,rlk]) is maximised with respect to r while  rlk] 
is  known  and  regarded  as  fixed.  r[k+ 1]  is  the  value  which  maximises 
(Vonken et al  1999a) .
r lk+ 1 ] = argmaxr g(r,rm) = argmaxFtt] {^[ln/(x|r)|c, A,r'[*]]} [4.54]
a ij i a ij r j   ~   N ij ) =  0 [4.55]
convergence criteria are met, i.e. when  (r1 [*+ 1 ] - r m)/rm < £.Chapter 4: DSC-MRI Perfusion Measurement -134-
Theoretically, the optimum point to stop the iterations is when the root mean squared 
(RMS) error in r is minimised (Kontaxakis G et al.  1998).
This  criterion  cannot  be  used  when  the  ML-EM  reconstruction  is  from  real  data 
where r is not a priori known.  An  alternative measure is to calculate the residual 
norm (RN) agreement between the estimated and measure tissue (Kontaxakis G et al 
1998).
guess  r t0 1  (a small non-zero constant), the initial decrease in  RMS(r) is rapid, as the 
updated r increases in likelihood, as measured by Equation  [4.53].  In the ML-EM 
algorithm, low spatial frequencies converge faster than higher ones, so that after the 
initial  rapid  convergence,  the  higher frequency  components  are reconstructed,  and 
inevitably statistical noise starts to deteriorate the reconstruction as the least squares 
solution is realised.  At this point  RMS(r)  error begins  to increase.  The function 
RN(r) is a constantly decreasing function with iteration number (Kontaxakis G et al. 
1998).  Consequently it is not possible to measure the quality of the reconstruction of 
r  using  the  above  criteria.  Therefore,  a  key  step  in  the  ML-EM  method  is  the 
selection of stopping criteria for the iteration.  Further discussion of the convergence 
characteristics  and  suitable  stopping  criteria  for  ML-EM  applied  to  DSC-MRI  is 
given in Chapter 6.
The optimum number of iterations,  (which minimises RMS(r),  and hence gives the 
most accurate estimate of the impulse response function), is found to be dependent on 
the underlying shape of the function being reconstructed, on the signal to noise ratio 
and on the temporal  sampling resolution.  Chapters  6  and 7  propose two different
[4.56]
[4.57]
Minimising  RN{r)  yields the least squares solution.  Given an initial uniform (k=0)Chapter 4: DSC-MRI Perfusion Measurement -135-
automated ML-EM based methods which seek to minimise  RMS(r)  across the brain 
for a wide variety of pathologies.Chapter 5: Validation of Perfusion Analysis Methods -136-
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5.1  Introduction
DSC-MRI is the most common MR method used to quantify perfusion, and various 
methods  have  been  proposed  to  analyse  the  data.  However,  the  accuracy  of the 
various analysis techniques cannot be determined by applying them to clinical data, 
since the true perfusion  in  a  subject is  not known  in  vivo.  In  addition,  perfusion 
values can vary significantly between subjects, especially in the presence of vascular 
pathology, but also between normal volunteers.  Unless the true perfusion values are 
known, the reliability of the perfusion estimates is uncertain.
A comparison of DSC-MRI perfusion estimates with another established technique, 
such as positron emission tomography  (PET)  is  one means  of validating the DSC- 
MRI  analysis  method  (0stergaard  et  al.  1998a;  Kaneko  et  al.  2004).  PET  (see 
Section  3.4.1)  is  considered  to be the  in  vivo  'gold-standard'  of CBF measurement 
techniques,  but  is  not  in  widespread  clinical  use.  Moreover,  it  involves  ionizing 
radiation and is subject to other sources of error.  Therefore, an alternative means of 
validation is needed for techniques used to  analyse DSC-MRI data.  In  addition to 
validating the accuracy of the analysis, it is also important to know the technique’s 
limitations, robustness and requirements, which cannot be assessed using in vivo data 
alone.
For these reasons, DSC-MRI data are simulated to model an in vivo situation, using 
realistic  function  and  parameter  values  for  perfusion  (CBF,  MTT,  CBV,  R(t)), 
vascular transport (bolus delay, dispersion,  VTF(t)) and MR imaging (TE, TR, SNR 
etc).  Since in the simulated data the true values of these parameters and functions are 
known,  the  accuracy  and  robustness  of the  analysis  technique  in  recovering  them 
from the simulated data can be investigated over many iterations, and across a broad 
range of values.  In fact, testing on simulated data sets has become a crucial step in 
the  development  of  DSC-MRI  analysis  techniques  e.g.  (0stergaard  et  al.  1996b; 
Andersen et al. 2002; Liu et al.  1999; Wu et al. 2003; Wirestam et al. 2005; Vonken 
et al.  1999a; Calamante et al.  2000; 0stergaard et al.  1999; Calamante et al.  2003a;Chapter 5: Validation of Perfusion Analysis Methods -138 -
Sourbron  et al  2004;  Willats  et al  2006;  Mouridsen  et  al  2006b).  The  analysis 
methods developed in this thesis (Chapters 6 and 7) were tested on the simulated data 
set described in the first half of this chapter.
Although simulations provide the best means of validating  an  analysis method and 
determining the limitations and requirements, the method must also be applied to in 
vivo patient data.  While the true answer is not known in vivo, the analysis of such 
data  are  complementary  to  the  simulations,  since  the  findings  from  analysing 
simulated  data  can  be  used to help  interpret  clinical  cases.  In  addition,  since the 
simulated data are purely determined from models of the microvascular and arterial 
retention, analysis of patient data are important to either verify or refute the modelled 
behaviour (see Chapter 8).  The analysis methods developed in this thesis were also 
tested on a variety of in vivo data,  from  subjects with various cerebral  arterial  and 
perfusion  abnormalities.  Before  the  analysis  is  performed,  several  pre-processing 
steps are applied to the DSC-MRI data.  These steps are common to all the analyses 
and are described in the second half of this chapter.
5.2  Sim ulations
In order to simulate in vivo DSC-MRI data, models  are assumed for microvascular 
retention  (i.e.  the  residue  function  /?(/)),  the  arterial  transport  (i.e.  the  vascular 
transport  function  VTF),  and  the  measured  arterial  input  function  (AIF).  These 
models, together with the parameter ranges used in their simulation, are described in 
the following sections.
5.2.1  Residue Function
The  form  of  the  scaled  tissue  residue  function  CBF  R(t)  supplies  valuable 
information about the integrity of the tissue.  Provided the measured AIF accuratelyChapter 5: Validation of Perfusion Analysis Methods -139-
represents the true input to the tissue,  CBF • R(t) is extracted from the deconvolution 
of in vivo data.  However, because there are errors in the deconvolution (see Section 
4.7), the form of /?(r)  is not precisely known, even in this ideal situation.  Therefore 
its shape is still somewhat speculative (see Section 4.6.2), and has been an active area 
of research through simulation e.g. (0stergaard et al  1999; Mouridsen et al. 2006b) 
and in vivo measurement e.g.(Calamante et al. 2003a; Willats et al. 2006).
Although  the  function  describing  R(t)  in  vivo  is  not  known,  it  is  in  general 
recognised  to  be  a  decreasing  function  of  time  with  /?(0) = 1   and  R (< *> ) = 0 
(0stergaard et al.  1999; Mouridsen et al.  2006b; Calamante et al.  2003a; Willats et 
al.  2006).  The precise shape will vary significantly between regions of healthy and 
ischaemic  tissue,  and  between  different  subjects.  Common  models  for  R(t)  are 
described in Section 4.6.4.
For ease of comparison with other studies, the most commonly used  R(t) model was 
chosen for this work:  R(t)  has been modelled as a decaying exponential (Equation
where MTT is  the  mean  transit time  of blood through the tissue.  A  smaller MTT 
defines a sharper residue function.
for  a  realistic  range  of MTT values.  The  range  of MTT used  to  define  tf(f)  in 
Equation [5.1] were calculated from the central volume theorem (see Section 4.6.9) 
by varying the  CBF in the range  10-80ml/100g/min in steps of lOml/lOOg/min and 
the CBV in the range l-6ml/100g in steps of lml/lOOg.  In particular 4 combinations 
of CBF and CBV were considered:  CBF=60ml/100g/min and CBV=4ml/1 OOg were 
used  to  represent  healthy  (normal)  grey-matter  (GM)  perfusion  values;
[4.12]):
[5.1]
In order to simulate a broad range of physiological tissue states,  /?(/)  were simulatedChapter 5: Validation of Perfusion Analysis Methods -140-
CBF=20m\J 1 OOg/min  and  CBV=3ml/100g  for  ischaemic  GM  perfusion  values; 
CBF=20mV 1 OOg/min  and  CB V=3ml/1 OOg  for  healthy  (normal)  white-matter 
perfusion  values;  and  CBF=50mU 1 OOg/min  and  C£V=6ml/100g  for  autoregulated 
GM perfusion values (Baird et al  1998; Calamante et al  1999b; Rempp et al  1994; 
Schreiber et al 1998).
5.2.2  Arterial Input Function
A gamma-variate function has been proposed as a good model for the first pass of the 
AIF, (Thompson et al  1964).  The equation of the gamma-variate is:
Co  determines  the  amplitude  of the  AIF,  to  is  the  bolus  arrival  time,  a  primarily 
determines  how  steeply  the  AIF time-course  reaches  the  maximum,  and b  mainly 
determines the  shape of the tail  (in the absence  of recirculation).  The coupling of 
these a and b parameters enables a wide range of shapes to be defined.
Based on typical in vivo data, 0stergaard et al  (0stergaard et al  1996b) suggested 
that a typical  and realistic  shape for the first pass  of the AIF measured in  a major 
artery (such as the middle cerebral artery or MCA) is given by the curve
The arrival time of the bolus is defined as time zero.  Caest(t)  is only an estimate of
the  true  arterial  input  function  since  the  bolus  shape  may  become  distorted  in  its 
transit to the tissue (see Section 4.7.2).
In order to give a realistic representation of an AIF measured in vivo, the curve used 
in  the  deconvolution  must  be  sampled  at  intervals  of  TR.  Additionally,  the 
recirculation of the bolus must be included, which is usually seen as a second wider 
delayed  peak.  In  this  work  the  recirculation  was  simulated  by  numerically
[5.2]
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convolving  the  gamma-variate  first  passage  with  a  decaying  exponential  of time 
constant  of 30s,  delayed by  10s  with  respect  to  the  first bolus  (0stergaard  et al. 
1996b).  Figure 5.1 illustrates the simulated AIF with recirculation.
5.2.3  Vascular Transport Function
In vivo, it is difficult to measure the exact input function to the tissue.  Consequently, 
what is extracted from the deconvolution of the DSC-MRI concentration data with 
measured  AIF  is  the  scaled  effective  residue  function,  or  impulse  response, 
CBF • Reff (r).  This more realistic in vivo situation is simulated by defining a function
to describe the vascular transport.  The effective residue is the convolution of the true 
tissue residue function and the VTF (see Section 4.7.2):
The exact form of the VTF will depend on the arterial path that the bolus travels and 
on the presence and severity of any cerebral arterial abnormalities
The vascular transport model chosen to simulate the delay and dispersion of the bolus 
is a delayed exponential decay (see Section 4.7.2), which has been extensively used to 
correct for dispersion  in  MRI  and PET  studies  (Calamante  et al.  2000;  Iida et al. 
1986).
tdelay represents the bolus delay and  P  is the bolus dispersion parameter, or the mean 
vascular transit time (MVTT).  This parameter determines the distortion of the bolus. 
A larger  ft corresponds to a larger dispersion.
Reff(t)= R{l)®VTF(t) [5.4]
VTF{t-tddJ = y
(*  1  delay )
[5.5]
In order to simulate the effect of vascular transport through a range cerebral arterial 
abnormalities, the bolus dispersion,  ft was varied from 0-6s in intervals of IsChapter 5: Validation of Perfusion Analysis Methods - 142-
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Figure 5.1:  The blue  curve  is  the  AIF  simulated  from  the  gamma  variate function 
Equation  [5.3],  with  recirculation  (see  Section  5.2.2),  The  red  curve  is  the  tissue 
concentration time-course, simulated for M7T=4s, CBF=60mV 1  OOg/min, tdeiay=Os and 
p=  Os, TR=1.5s, SNR=100 (see Section 5.2.4).
(Calamante et al  2000), and the bolus delay tdeiay was varied independently from 0 -  
4s in intervals of 0.5s.
In practice,  for the formation  of the  simulated data set,  Reff (?)  was calculated from 
the analytical convolution of  Equations [5.3] and [5.1] (Calamante et al. 2000):Chapter 5: Validation of Perfusion Analysis Methods -143-
exp
t  delay )
P
-exp
/
MTT
t  delay )
MTT
[5.6]
Examples  of the  simulated  shapes  for  Reff (?)  used  in  this  thesis  are  illustrated  in
Figure 5.2.(
5.2.4  Concentration Tim e-Course
Representative  in  vivo  concentration  time-courses  Ct(t)  were  simulated  by 
performing  the  numerical  convolution  of  CBF •  Reff (t)  and  the  AIF  with 
recirculation, (Equation [4.28]):
C,(t) = -^-CBF ■  (c " '„ (t)® Rejf (/))  [ 5.7 ]
H
For simplicity, the ratio —   was taken as 1.0.  The convolution was implemented as a
kH
matrix multiplication (Equation 4.3.5) with a sampling interval of 0.01s in order to 
minimise  discretisation  errors.  Using  every  combination  of  the  11  delay,  7 
dispersion, 8 CBF and 6  CBV values described above, 1 Ix7x8x6 = 3696 unique tissue 
concentration time-courses  Ct (/) were calculated
6 It should be noted that the effective reside functions  Reff (t) simulated in this work have been chosen
to represent a physically realistic situation.  The true residue function R(t) is expected to be a 
decreasing function of time (no delay or dispersion) (Equation [5.1]).  Distortion of the bolus a due to 
vascular transport may result in a sharp rising edge cause by delay, and/or a skewed bell-shaped 
appearance caused by dispersion.  Another common model for the residue function is a top-hat.  This 
model has not been simulated because the plug flow that it represents is unlikely to occur in practice. 
The performance of an analysis technique to recover a top-hat shaped function would not be indicative 
of its accuracy in analysing in vivo DSC-MRI data.Chapter 5: Validation of Perfusion Analysis Methods -144-
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Figure 5.2:  An illustrative sample of some of the shapes simulated for  Reff(t)  using 
Equation  [5.6].  In  the  figure,  Reff (?)  is  simulated  with  M7T=4s,  and 
C£F=60ml/lOOg/min.  The dispersion parameter was ranged from from  /?=0s to 6s 
(as labelled in the legend) and delays, tdeiay = 0 and 3s are shown.__________________
In a DSC-MRI experiment, the measured in vivo data are actually signal intensities. 
In  order to  realistically  model  the  noise  in  the  data,  the  tissue  concentration  time- 
course curves  C,(t)  first be converted into  signal  intensity curves  St(/).  The  St(t) 
curves  were  generated  assuming  a  linear  relationship  between  the  vascular 
concentration of the tracer and the observed susceptibility contrast (see Section 4.5):
S, (r) = S0exp [5.8]
with 50=100 (arbitrary units),  TE=65ms and  K t =0.667.  The constant  K t  was chosen 
such  that  a  C£F=60ml/lOOg/min  and  C£V=4ml/100g  produces  a  40%  signal  dropChapter 5: Validation of Perfusion Analysis Methods -145-
relative to the baseline S0, which is typical for normal GM (Calamante et al.  2000; 
0stergaard et al.  1996a).  100 noisy  signal time-course  curves  were  generated for 
each parameter combination (CBF, CBV, tdelay  and J3) by adding random (zero mean) 
Gaussian noise to the signal curves.  Defining the baseline SNR as:
SNR = -^2-  [5.9]
a s
where  < JK   is the standard deviation in the baseline, data were simulated with SNR =
50,  100 and 500.  These SNR values corresponding to the typical noise levels found 
in our scanner and the  extremes  of the  SNR range  found  after denoising this  data 
using Independent Component Analysis (see Section 5.3.2 ) respectively.
The  noisy  signal  data  are  converted  back  into  concentration  time-course  data 
(Equation [4.4]).  In order to simulate the different temporal resolutions, separate data 
sets were created by sampling the curves at TR intervals in the range 0.5 -  3s at 0.5s 
steps.  The length of the simulated data was initially 6 8 s.7  In total, 3 (SNR) x 6  (TR) 
=  18 data sets of 3696 (parameters) x  100 (repetitions) were created in order to test 
the techniques presented in this work.  Figure 5.1  shows an example of a simulated 
tissue time-course.
Note  that  for  a  given  SNR,  different  perfusion  and  dispersion  values  will  give 
different contrast to noise ratios, CNR:
CNR = max(C|)  [5.10]
°c,
where  a r is the standard deviation in the concentration baseline..  For example, for
SNR=50,  normal  GM  perfusion  values  (M7T=4s,  CBF=60mV 1 OOg/min),  and 
dispersion /?=0, results in CNR=20.  When there is a dispersion of /?=4s, CNR-16.  In 
ischaemic GM (M7T=9s, CBF=2 0 ml/1  OOg/min), and a dispersion of/?=4s, the
7 A typical DSC-MRI study might acquire 45 images at TR=1.5sChapter 5: Validation of Perfusion Analysis Methods -146-
CNR  falls  still  further,  SNR=50  corresponds  to  CNR-9.  Thus,  the  accuracy  of 
deconvolution  for  a  given  SNR  is  also  dependent  on  the  perfusion  and  vascular 
transport parameters.8
The various steps involved in a simulation study are summarised in the flow chart in 
Figure 5.3.  The DSC-MRI analysis techniques presented in this thesis were assessed 
by  deconvolving  the  simulated  tissue  concentration  time-course  data  and  the 
simulated AIF sampled at the corresponding TR.
5.2.5  Im p lem en tatio n  Issues
When simulating an in vivo data set, it is important that any numerical convolution is 
performed  with  a very  small  sampling  interval,  At « T R .  In  this  way,  the  error 
between the true analytical solution and the numerical convolution is minimised.  In 
the numerical convolution, the function value at each sampling point is multiplied by 
the  sampling  interval.  Therefore  the  numerical  convolution  is  actually  the 
convolution of a function that is constant across the sampling interval, i.e. a function 
that progresses in a step-wise manner.  Since this situation is unrealistic, a very small 
sampling interval is desirable so that the discretely sampled function most accurately 
represents a continuous function.
If the numerical convolutions used to create the simulated data set were performed 
with  At = TR, fewer data points and therefore less information would be used in the 
formation  of  Ct (t).  Therefore,  there  would  be  correspondingly  fewer  degrees  of
freedom in the deconvolution  of the  simulated data,  and thus  the instability of the 
inversion is artificially reduced.  As a result, deconvolution using such a
8 The definition for SNR given in Equation [5.9] is chosen because it is independent of the magnitude 
of the signal drop AS .  This definition is more representative of an in vivo situation, where the 
baseline noise is constant regardless of the perfusion and dispersion.  Conversely, CNR is dependent 
on perfusion and dispersion, so for a given SNR it will be smaller for lower perfusion and longer 
dispersion.  Therefore, to realistically represent the in vivo situation it would be necessary to simulate 
different CNR values for healthy/abnormal tissue fed by healthy/abnormal vasculatureChapter 5: Validation of Perfusion Analysis Methods - 147-
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Figure 5.3:  Flow chart illustrating the steps involved in simulating a DSC-MRI data 
set and testing  a DSC-MRI  analysis technique.  The  steps  depicted in each row  are 
described in the sections indicated on the left hand side of the figure._______________
(mis)simulated  data  set  would  require  less  regularisation  and  would  consequently 
yield an artificially accurate characterisation of  CBF ■  Reff(t).  In real data there is a
many to one mapping between  CBF •  Reff{t)  and the sampled  Ct{t)  and  Caes'{t) (see 
Section 4.8.7.2), such that many different possible  CBF ■  Reff (t) could solve Equation 
[5.7].  Regularisation  is  necessary  to  suppress  the  noise  related  instabilities  (see 
Section 4.8).Chapter 5: Validation of Perfusion Analysis Methods -148-
In  vivo,  there  is  an  additional  distortion  in  the  extracted  CBF  Reff(t)  due  to
discretisation errors that stem from the discrete convolution matrix used in the matrix 
algebra formulation of deconvolution (see Section 4.8.3 and Chapter 6 ).  These errors 
could not be  simulated correctly if the  simulated data set were not created at high 
temporal resolution.
Since there is  limited  temporal  resolution  in  the  DSC-MRI  data  set,  there  will be 
perfusion quantification errors associated with misalignment of the data measurement 
points with the true end of the signal baseline/beginning of the signal drop.  This may 
mean that the true maximum of the  CBF • Reff (t) is not sampled, which will affect the
accuracy to which CBF can be estimated.  The situation is illustrated schematically in 
Figure 5.4.  In order to replicate this effect it is important to simulate delays of non­
integer multiples of TR.
In  vivo,  the  noise  distribution  in  the  signal  data  are  distorted  by  the  logarithmic 
conversion  of  signal  to  concentration  (Equation  [5.8]),  such  that  the  standard 
deviation of the noise in the peak is larger than the noise in the baseline (Smith et al. 
2003).  The distribution  of noise in the  concentration time-course data is  likely to 
have  significant  impact  on  the  ability  of the  various  deconvolution  techniques  to 
reconstruct  CBF  R ^(t)  accurately.  It  is  therefore  important  that  noise  in  the
simulated data  set is  added to the  signal  rather than the concentration time-course 
data.
5.3  A n aly sis o f  P a tie n t D a ta
The reliability of the analysed DSC-MRI patient data are to some extent dependent on 
the quality of the in vivo data and the care taken in implementing the analysis method. 
This next section describes the steps taken to prepare the in vivo DSC-MRIChapter 5: Validation of Perfusion Analysis Methods - 149-
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Figure  5.4:  The  figure  shows  the  effect  of  a  TR=1.5s  sampling  interval  on  the 
characterisation of the residue function delayed by  1.5s (green), 2.0s (blue) and 2.5s 
(red).  When the delay is not an integer multiple of TR, the sampling time-points are 
not  aligned  with  end  of  the  baseline  in  the  concentration  time-course  data. 
Consequently,  the  maximum  of  the  impulse  response  may  not  be  sampled. 
Underestimation is greatest when the delay is just greater than the integer multiple of 
TR.
data for analysis.  In this way, reasonable comparisons can be made between different 
DSC-MRI data sets.
5.3.1  Signal to C oncentration Data
The DSC-MRI signal data are first converted to tissue concentration time-course data 
using the experimental  TE  value  and  the baseline  value  So  (Equation  [4.4]).  So is 
calculated  by  averaging  the  first  few  points  of the  signal  before  the  arrival  of the 
bolus.  Care should be taken to avoid the first few images, during which time theChapter 5: Validation of Perfusion Analysis Methods - 150 -
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Figure 5.5: Typical in vivo signal time-course. Note that the first few images should 
be excluded from the calculation of the baseline signal.___________________________
protons have not reached a steady-state longitudinal magnetisation and the signal is 
artificially high.  A typical signal time-course is illustrated in Figure 5.5.
5.3.2  ICA DENOISING
Often the CNRs in the data are low especially in areas of white matter or where there 
is low perfusion.  This can make an accurate reconstruction of  CBF ■  Reff (/)  difficult.
Various  denoising  methods  are  available,  e.g.  (Awate  et al.  2005;  Wirestam  et al. 
2006;  Bydder et al  2006;  Kadah 2004; Wink et al  2004; Bao et al  2003).  In this 
work, noise in the concentration time-course data is minimised by decomposing the 
data  into  independent  components  using  Independent  Component  Analysis  (ICA) 
(Calamante  et al  2004;  McKeown  et al  2003).  ICA  is  a  well-known  denoising 
method  that  assumes  the  data  are  composed  of  a  superposition  of  independent 
components  and  Gaussian  noise.  A  Bayesian  information  criterion  is  used  to 
determine  the  most  likely  number  of independent  components  assuming  GaussianChapter 5: Validation of Perfusion Analysis Methods -151 -
noise (Calamante et al. 2004), and time-course data are decomposed into this number 
of independent components.  The components identified as artefact due to either noise 
or motion can be removed, and those thought to contribute to the shape of the true 
uncorrupted  Ct(t)  are  kept  and  recombined  to  give  the  denoised  signal.  The
discarded (artefact) time-courses have  a very low correlation with the first passage 
and/or recirculation.  For example,  they  might  be  a  slowly  increasing  function  of 
time, or an oscillatory function bearing no relation to the bolus passage (e.g. pulsation 
motion or noise).  In addition their spatial location might be around the periphery of 
the  image.  The  temporal  components  that  are  kept  in  this  denoising  process  are 
identified interactively based on the spatial and temporal characteristics (Calamante et 
al. 2004).  This methodology is illustrated in Figure 5.6.
Typically  for  the  patient  data  used  had  a  SNR  of  approximately  50,  which  after 
denoising improved to between  100 and 500, depending on the effectiveness of the 
denoising  The  improvement  in  SNR  is  affected  by  factors  such  as  motion  and 
perfusion  levels.  The  ICA  denoising  was  performed  using  Matlab  (the  code  is 
available from the web site http://isp.imm.dtu.dk/toolboxef).
53 3   G lo b a l AIF S e le c tio n  and N o rm alisatio n
There are various factors to consider when selecting the best site to measure the AIF 
(Conturo et al. 2005).  Ideally one would measure a unique AIF for each voxel in the 
image (i.e.  a local AIF)  (Calamante et al.  2004).  However, because of the limited 
resolution  of the  DSC-MRI images  (approx  2x2x5mm3),  physical  measurement  of 
such a local AIF is not possible.  For this reason a global AIF is often measured in a 
large vessel such as the MCA.Chapter 5: Validation of Perfusion Analysis Methods -152-Chapter 5: Validation of Perfusion Analysis Methods -153-
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Figure 5.6:  An  example  of ICA  denoising  applied to  in  vivo data  (1.5T Siemens 
Symphony  scanner  GE-EPI  sequence,  TE/TR=47/1500ms,  0.15mmol/kg  of  Gd- 
DPTA).  a) The maps show the spatial localisation of the nine maximum-likelihood 
components of the ICA decomposition.  The tenth component is the Gaussian noise, 
calculated by  subtracting the nine components  from the  original  data.  The higher 
intensity regions indicate  a larger contribution  from this  component,  b) The time- 
courses  of  ten  components.  Based  on  the  spatial  and  temporal  characteristics, 
components 7, 9 and 10 were discarded in this ICA decomposition, c) An example of 
the concentration time-course taken from a voxel in the left hemisphere before and 
after ICA denoising.___________________________________________
It  is  important  to  choose  the  vessel  in  which  to  measure  the  AIF  carefully.  A 
meaningful shape for  CBF • R ^ (t) cannot be achieved when causality is violated i.e.
if the global AIF is measured in  a vessel  where the bolus is more dispersed and/or 
later  than  in  any  tissue  voxels  (negative  dispersion  and/or  negative  delay).  A 
meaningful  deconvolution  is  only  possible  if  the  voxels  used  for  the  AIF 
measurement are carefully selected within an artery in the hemisphere contralateral to 
any  abnormality,  and whose concentration time-courses occur early and are narrow 
(minimum  dispersion).  (See  Chapter 7  for a brief investigation  into the effects  of 
negative dispersion)
In  practice  it  is  often  difficult  to  find  suitable  AIF  voxels  located  in  the  normal 
arteries  because  of partial  volume  effects,  EPI  artefacts,  or  signal  saturation  (see 
Sections  4.6.4,  4.6.6,  4.6.7).  In  this  work,  the  voxels  for  the  AIF  were  selected 
manually by carefully  considering each concentration time-course within the artery 
and choosing those unaffected by artefacts.
In order to compare the perfusion measurements calculated using different AIFs in 
the same subject (see e.g. Chapter 9), it is necessary that each AIF is normalised to a 
common area prior to the deconvolution.  In this work, this is achieved by fitting a 
gamma-variate model  (Equation  [5.2]) to the first passage of the measured AIF and 
integrating for the area.  This area is used to normalise the whole AIF.Chapter 5: Validation of Perfusion Analysis Methods -155 -
53.4  Parameter M aps
Deconvolution  of in  vivo  DSC-MRI  data prepared  as  described  above  will  extract 
voxel by voxel estimates for the impulse response function,  CBF •  Reff (/).  Any error
in the characterisation of this function should be purely a result of the regularisation 
and discretisation in the deconvolution.  CBF maps can be made by measuring the 
maximum of the impulse response function, although because of delay and dispersion 
this measure is likely to underestimate perfusion (see Section 4.7.2).  Cerebral blood 
volume, CBV maps can be estimated by fitting a gamma-variate function to the first 
passage  of the  concentration  time-course  in  each  voxel.9  MTT maps  can  then  be 
calculated from the ratio of the CBV to CBF in each voxel.  Since both CBV and CBF 
are likely  to be high  in  vessels,  it  can  be  difficult to identify regions  of abnormal 
perfusion using these measures.  It is often easier to identify abnormal regions from 
the MTT maps (see Chapter 9).
5.4  C om puter I m plem entation
A significant amount of the work for this thesis involved writing computer programs. 
For  each  chapter,  code  was  written  to  implement  the  proposed  techniques.  In 
particular, the simulated data were created so that the proposed novel deconvolution 
techniques could be tested,  and programs  were written to  analyse the  in vivo data, 
using various deconvolution techniques.  The codes were initially written and run in 
Matlab, but later transferred to C++ to improve the speed of implementation.
9 It should be noted that when the gamma-variate model (Equation [5.2]) is fitted to the first passage of 
in vivo concentration data, the fitted parameter t0 is not necessarily a good indication of the true bolus 
arrival time, since a relatively small to could be coupled with a relatively large value of a to give 
approximately the same fit as a relatively large value of to coupled with a relatively small value of a 
(Perthen 2003)Chapter 6: Characterising the Impulse Response Function - 156 -
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6.1  Introduction
Many MRI studies in acute stroke have shown the presence of a diffusion-perfusion 
mismatch:  namely  an  area  with  an  abnormality  in  perfusion  MRI,  but  normal 
diffusion properties.  This is tissue thought to be at risk of infarction but is potentially 
salvageable  using  clinical  intervention  such  as  thrombolytic  therapy.  Since  such 
clinical intervention is not without risks, it is important to differentiate with accuracy, 
the  ‘at risk’  tissue from the ischaemic core and from tissue not at risk.  An accurate 
quantification  of cerebral  blood  flow  (CBF)  is  necessary  to  identify  patients  who 
would benefit from  interventional  treatment.  However,  as  discussed in  Chapter 4, 
there are many problems associated with the quantification of CBF, particularly in the 
presence of abnormal vasculature (Section 4.7.2),  which can exaggerate a perfusion 
abnormality  (Calamante  et al.  2000).  In  order to  avoid  the  potentially  dangerous 
misclassification  of  ‘at  risk’  tissue,  it  is  important  to  recognise  and  interpret  the 
potential bias in the cerebral perfusion measurements made in such patients.
In DSC-MRI, cerebral blood flow (CBF) is commonly estimated from the maximum 
of the impulse response function,  CBF • R ^ (?)  obtained from the deconvolution of
DSC-MRI data (0stergaard etal.  1996b) (Equation [4.28]):
C, (f) = CBF ■  (Ca (t)® Reff (f))  [61]
The  contrast  concentration-time-course  is  measured  both  in  an  artery  feeding  the 
tissue  Ca(t),  and in the tissue,  Ct(t).  Because the arterial  input function (AIF) is
normally  measured  in  a  major  artery,  the  shape  of  C B FR ^(t)  often  reflects  the 
properties of both the vasculature and the tissue.  Abnormal vasculature can distort 
the  bolus,  and  consequently,  the  maximum  of  CBF  Reff{t)  may  be  an
underestimation  of  the  true  perfusion  (Calamante  et  al.  2000).  The  situation  is 
illustrated in Figure 6.1 (reproduced from Figure 4.5),Chapter 6: Characterising the Impulse Response Function - 158-
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Figure 6.1: Impulse response functions illustrating the four possible combinations of 
delay  and  dispersion  a)  No  delay  and  no  dispersion  (solid  blue),  b)  delay  and  no 
dispersion  (dashed  blue),  c)  dispersion  and  no  delay  (solid  red),  d)  delay  and 
dispersion (dashed red).  There is an intrinsic underestimation of CBF using impulse 
response  functions  derived  in  the  presence  of bolus  dispersion.  The  regularisation 
and discretisation  errors that accrue in  the  deconvolution can  also cause  CBF to be 
underestimated in the absence of dispersion._____________________________________
which shows the form of CBF •  Reff (f)  resulting from the four different combinations
of  bolus  delay  and  dispersion  in  the  vascular  transport.10  An  accurate 
characterisation  of  CBF •  Reff (f)  would  enable  the  identification  and  distinction  of
bolus  delay  and  dispersion,  which  may  accumulate  during  its  passage  through  the 
feeding arteries.  The CBF underestimation introduced by bolus dispersion is largely 
independent of the deconvolution method used.  If the bolus becomes distorted due to 
for example an arterial  stenosis, dispersion-related perfusion measurement error will 
always be present.  Conversely, the CBF underestimation arising from bolus delay is 
purely a consequence of the inaccuracies in the deconvolution.
10 Note that throughout this work the simulated  Reff (t) are formed according to Equation [5.6] in 
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As discussed in Section 4.8.1, an accurate characterisation of CBF • Reff (r) is difficult
to  achieve  because  the  deconvolution  of Equation  [6.1]  is  ill-posed  and  therefore 
highly sensitive to high-frequency perturbations.  Even a small amount of noise will 
cause  a  large  perturbation  in  the  solution.  A  stable  and  physically  meaningful 
solution  can  only be  realised using regularisation,  which  filters  the high-frequency 
components.  However,  regularisation  methods  introduce  additional  distortions  to 
CBF  Reff(t).  The  estimated  impulse  response  function  r(t) = (CBF ■  Reff (r))^
depends both on the quality of the data and on the deconvolution technique.  Several 
regularising  deconvolution  techniques  are  currently  being  used  for  perfusion 
quantification (e.g.  (0stergaard et al  1996b;  Liu et al  1999;  Vonken et al  1999a; 
Andersen et al  2002; Wu et al  2003; Calamante et al  2003a).  The limitations and 
caveats of some of the common regularisation methods in their ability to characterise 
CBF • Reff (t) and quantify perfusion are discussed in detail in Chapter 4 (Section 4.8).
In  brief,  the  most  common  is  Truncated  Singular Valued  Decomposition  (TSVD), 
which filters the noise using a singular value threshold (0stergaard et al  1996b; Liu 
et  al  1999).  The  truncation  of  the  high-frequency  components  introduces 
oscillations,  adding  to  the  distortion  of  CBF  R ^(t).  Another  related  method,
Tikhonov  regularisation  balances  the  data  misfit  and  regularisation  error  with  an 
appropriate  side  constraint  (Calamante  et  al  2003a).  The  smooth  low-pass  filter 
avoids  oscillation  and  successfully  characterises  dispersion.  In  the  absence  of 
dispersion,  both  TSVD  and  Tikhonov  provide  relatively  accurate  CBF  estimates 
when there is no bolus  delay.  However, the characterisation of  CBF ■  Reff (?)  and
accuracy  of  CBF  quantification  deteriorate  in  the  presence  of  bolus  delay.  In 
particular,  the  smoothing  that  is  synonymous  with  removing  the  high  frequencies 
causes a delayed  CBF ■  Reff (t)  to appear dispersed, since in order to define the sharp
edge  associated  with  the  delay  (see  Figure  6.1),  very  high  frequencies  must  be 
recovered.
Because  of deconvolution  errors,  it  is  difficult  to  interpret  the  contribution  of the 
vasculature  (i.e.  delay  and  dispersion)  to  the  shape  of  CBF  Reff(t),  and  thereforeChapter 6: Characterising the Impulse Response Function -160-
equally  difficult  to  assess  the  related  perfusion  measurement  errors.  If unreliable 
measurements of perfusion are used in predictor-models, the resulting classification 
of ‘at-risk’ tissue is likely to be erroneous.  Recognising the potential bias in the CBF 
estimates could avoid a misclassification of tissue at risk of infarction.  Furthermore, 
the  distinction  between  delay  and  dispersion  is  also  important  for  subsequent 
correction of CBF • Reff (/).  For example, a delay can be corrected simply, by shifting
Ct(t)  and  re-performing  the  deconvolution  e.g.  (Ibaraki  et al  2005).  Dispersion
correction is more difficult, requiring either a model of the vascular transport function 
(VTF), or a more accurate measurement of the AIF (see Chapters 8 and 9).
Since  the  shape  of  CBF ■  Reff (r)  is  crucial  in  the  interpretation  of  perfusion
measurements, and hence the selection of patients for treatment, a major part of this 
thesis focuses on the development of deconvolution techniques that are accurate in 
dealing with DSC-MRI perfusion data, particularly in patients with cerebrovascular 
abnormalities.  This work in this chapter proposes a method to minimise the artefacts 
associated with the deconvolution using a modified maximum-likelihood expectation- 
maximisation  (ML-EM)  method,  with  a  view  to  improving  the  characterisation  of 
C B F R jt).
6.2  M axim um  L ik e lih o o d  E x p e c ta tio n  M ax im isatio n
This section describes some of the observations concerning standard ML-EM  (sML- 
EM)  regularisation  (Dempster  AP  et  al  1977),  which  have  motivated  the 
modifications employed in this Chapter.
The shape  R ^ (t)  can be described in terms of a distribution of temporal frequency
components that define the  shape.  In order to characterise and distinguish all four 
bolus states defined in Figure 6.1, the regularised deconvolution method must be able 
to reconstruct a large range of frequencies.  In particular, the sharp edge of the delayChapter 6: Characterising the Impulse Response Function -161-
and non-dispersed  Reff (?)  is characterised by high frequencies.  The iterative method
of  ML-EM  is  able  to  extract  these  high  frequencies  (see  Section  4.8.7),  but  the 
optimum point to stop the iteration for the ill-posed DSC-MRI problem is ill-defined.
Vonken et al. (Vonken et al.  1999a) were the first to implement a sML-EM method to 
extract  R^fa).  This method is described in detail in Section 4.8.7.  In summary, the
sML-EM  algorithm  maximises  the  probability  of  measuring  the  observed 
(noisy/sampled)  tissue  concentrations  Ct(t),  given  the  estimated  AIF,  Ca(t),  an
estimation  of  the  impulse  response  function  r(?) = (CBF ^  R^(t)) s{,  and  a  noise
model.  Each  iteration  updates  r(t),  linearly  increasing  the  expectation  of  the 
measured data, such that each new estimate of r(?)  when convolved with  Ca (?), will
give an estimate  C, (?) that is increasingly similar to  Ct (t).  However, the expectation 
provides no indication of the quality of the reconstruction (Moon 1996; Kontaxakis G 
et  al.  1998).  The  low-frequency  components  defining  the  smooth  parts  of 
C B F R jt)  are  recovered  first,  while  higher  frequencies  defining  sharp  edges
converge only after further iteration.  During these later iterations, noise can cause the 
reconstruction to deteriorate.
The number of iterations used in the reconstruction can therefore be considered as the 
regularisation  filter.  Less  iteration  corresponds  to  greater  regularisation.  When 
deciding on  an  appropriate  fixed number of iterations,  there is  a trade-off between 
extracting  the  high-frequency  information  and  allowing  corruption  of the  parts  of 
Reff (?) characterised by low frequencies.  For example, the smooth tail of Reff (?) will
be recovered with few iterations.  Conversely, the rise-to-maximum (RTM) of Reff (?)
will be recovered with more.  The most appropriate number of iterations to use in the 
reconstruction  is  a  compromise  between  extracting  the  high  frequencies  and 
corrupting the  sections characterised by low frequencies.  Figure 6.2 illustrates the 
sML-EM reconstruction of  Reff (?)  with 2s delay and no dispersion, after 1, 3, 5, 9,
20, 30,40, 60 80,100, 150, 200 and 250 iterations.  The illustration in Figure 6.2Chapter 6: Characterising the Impulse Response Function  -162 -
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Figure 6.2: sML-EM reconstruction of Reff(t)  simulated with 2s delay, no dispersion
and A/7T=4s, reconstructed from SNR=50, TR=ls data.  The simulated  R^it)  is the
dashed black line and the reconstruction is the solid blue line.  The figures show the 
sML-EM reconstruction after a)  1, b) 3, c) 5, d) 7, e) 9, f) 20, g) 30, h) 40, i) 60, j) 80, 
k)  100,1)  150, m) 200, and n) 250 iterations respectively.  It can be seen that higher 
frequency  information  is  extracted  with  a  larger  number  of  iterations.  However, 
because  of the  noise  in  the  data,  the quality of the  reconstruction  of this  particular 
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indicates  that the  ‘ideal’  number of iterations  will  depend  on the  shape  and hence 
temporal frequency content of the  Reff (t)  being reconstructed, as well as the amount
of noise in the data.  The tail of the function is well characterised in between 3 and 9 
oscillations.  However, at this stage, the initial part of the function is over smoothed.
Since in vivo the shape of  Reff (f)  is not known a priori, the number of iterations is
commonly set at a fixed number that attempts to optimise this regularisation trade-off 
for the  specific  contrast-to-noise  ratio  (maximum  concentration  drop  over baseline 
noise),  CNR.  Often  smoothness  of  solution  is  prioritised,  which  in  the  case  of 
perfusion  quantification  can  lead  to  underestimation  of  blood  flow;  the  high 
frequencies defining the RTM of R ^ (r) will not have been fully recovered, and hence
the maximum is underestimated.  Consequently, there could be a misidentification of 
hypoperfusion,  through  misidentification  of  bolus  dispersion  and  inaccurate 
assessment of bolus delay.
6.3  M e th o d
The  technique  presented  in  this  chapter  develops  a  modified  maximum-likelihood 
expectation-maximisation  (mML-EM)  method,  which  aims  to  minimise 
regularisation-induced oscillations and discretisation errors in  CBF • Reff (f), to obtain
an accurate measure of the function maximum, and a good characterisation of shape.
In order to circumvent the problem of over or under iteration, the modified ML-EM 
(mML-EM)  method uses  a point-wise termination criterion  for the iteration.  Each 
time-point  within  Reff{t)  is  reconstructed  with  a  unique  number  of  iterations
depending on its position within  Reff (t)  and the convergence properties of the point.
In this way, high frequencies defining the steep section of  R ^it)  can be extracted,
whilst preventing the corruption of the smooth sections by the fitting of experimentalChapter 6: Characterising the Impulse Response Function -165-
noise.  The method for determining the number of iterations is described in Section 
6.3.2.
In  addition  to  the  error  introduced  through  the  necessary  regularisation  of  the 
deconvolution,  errors  also arise from the discretisation of the continuous functions 
Ct(t)  and  Ca (r), which in the DSC-MRI experiment are sampled at intervals of TR.
The  Nyquist  criterion  determines  the  maximum  frequency  component  that  can  be 
recovered, limiting the accuracy of delay and CBF quantification: it is not possible to 
reconstruct a frequency component that is higher than the  1/(2TR).  The shape and 
hence frequency composition of R ^ (t)  is governed by the MTT of the tissue;  Reff (t)
is  sharper in  shorter MTT tissue.  Consequently the accuracies of all deconvolution 
techniques are dependent on MTT, since regularisation removes the high frequencies. 
Despite  this  intrinsic  limitation,  the  errors  resulting  from  the  discretisation  can  be 
minimised by carefully constructing the convolution matrix (0stergaard et al  1996b). 
The  mML-EM  method  presented  in  this  chapter  implements  two  different 
convolution matrices in order to minimise the discretisation errors for the particular 
Reff (f) being reconstructed.  These are given in Section 6.3.1.
63.1  M inim ising Discretisation Errors
The  ML-EM  algorithm  performs  the  discrete  convolution  of  an  estimate  for  the 
impulse  response  function  r(t) = (CBF ■  Reff (r))^,  with  Ca (r),  to  get  an
approximation  to the  tissue  concentration  Ct(t).  This  can be  expressed in  matrix
form  c = Ar  (0stergaard et al  1996b) ( Equation [4.35], Section 4.8.3).  Since the 
sampling  interval  TR  of these  functions  is  of the  order  of  1-2  seconds,  there  are 
discretisation  errors  arising  from  the  discrete  convolution,  which  distort  the 
reconstruction  (see  also  Section  5.2.5).  These  errors  can  be  minimised  by 
formulating  the  elements  of the  A  matrix  to  assume  values  of  Ca(t)  and  Reff{t)
between measurement points, without subsampling.  For example, 0stergaard et alChapter 6: Characterising the Impulse Response Function -166 -
(0stergaard  et  al.  1996b)  assumed  that both  Ca(t)  and  Reff(r)  vary  linearly  with 
time.  The elements of the convolution matrix A become:
_ \&t(Ca(tj-j-i) + 4C0 (t,_j) + Ca ) ) / 6   0 < j< i< n -1
ii  i
[  0   otherwise.  [62]
Calamante et al.  (Calamante et al.  2003a) implemented a more generalised version 
for the Tikhonov regularisation method with elements of A:
M 2C o(J0) + C„(J, ) ) / 6   0< i = j< n
A/(C„  ) + 4Ca (t,_j) + C. (f  ))/ 6   0 < j  < i < n
A/(Ca(^ ,) + 2Ca(ri))/6  7 = 0;  0</<n
0   otherwise.  [63]
On  the  other  hand,  if  Ca(t)  is  assumed  to  vary  linearly  and  Reff{t)  is  assumed 
constant between sample points the matrix elements are:
a  f A/(C„ (‘i-j) + Ca  ))/ 2  0  < 7 < ( < n - 1  
,J   \  0   otherwise.  [64]
In this work, we denote the matrix in Equation [6.4] as Ai  and the matrix in Equation 
[6.3] as A2.
a-  =■ <
A continuous  Reff{t)  (i.e.  an impulse response function with no delay (with/without
dispersion), or one with delay and dispersion) is best reconstructed with matrix A2, 
which  assumes  a  linear  progression  between  measurement  points.  However,  the 
assumption  of linearity  between  sample  points  may  not  apply to  the  discontinuity 
associated with the instantaneous RTM of a delayed but non-dispersed  Reff (t)  (see
Figure 6.1).  In this situation matrix Ai may be more suitable.
Preliminary noiseless simulations were performed to determine the suitability of each 
matrix to reconstruct  Reff (r)  deriving from the different bolus  states represented in 
Figure 6.1.  In the absence of noise, the discretisation effects of the two matrices AiChapter 6: Characterising the Impulse Response Function -167-
and A2 can be isolated from regularisation error.  The  Reff (t)  were  simulated with
different combinations of delay and dispersion and reconstructed using both matrices. 
Figure 6.3 shows examples of the noiseless sML-EM reconstructions for delays of Os, 
2s, and 2.5s, and dispersions of Os, and 4s.  These are illustrative of the many delay 
and  dispersion  combinations  simulated.  It  was  found  that  matrix  A2  is  most 
appropriate  to  reconstruct  Reff{t)  with  no  delay  and  no  dispersion  (Figure  6.3a).
Matrix Ai is better able to reconstruct the  Reff (t) with no dispersion and a delay of an
integer multiple  of TR  (Figure  6.3b).  Matrix  A2 cannot recover the instantaneous 
RTM of Reff (/)  when there is a discontinuity across the sampling interval.  However,
matrix A2 gives the most accurate reconstruction for Reff (t)  with no dispersion and a
delay of TR plus half an integer TR (Figure 6.3c), i.e. when there is no measurement 
at  the  discontinuity.  Matrix  A2  was  also  found  to  give  the  most  accurate 
characterisation of the  Reff (r) with dispersion (Figures 6.3d and 6.3e).
In  in  vivo  data the  presence  of delay  and/or dispersion is unknown.  Therefore, to 
obtain  an  accurate  characterisation  of  the  impulse  response  function,  the  most 
appropriate matrix for the reconstruction  (Ai  or A2)  should be selected prior to the 
final deconvolution used for the perfusion estimates.  In order to establish a possible 
methodology to  select the matrix,  simulations were performed,  which extracted the 
sML-EM  reconstruction  of  CBF ■  Reff (t)  from  noisy  simulated  data,  with  various
degrees of delay, dispersion,  CBF and CBV (see Chapter 5).  In brief, the sML-EM 
estimated impulse response funtions  r(t)  were recovered using both Ai and A2.  The 
number of sample  points  between  the  end  of the baseline  (defined  as  1 0%  of the 
maximum) and the maximum of r (f), were measured for each of the curves, after  1 0  
and 100 iterations.  These measurements were found to be dependent on the choice of 
matrix,  and  the  delay  and  dispersion  combination.  Using  the  results  from  these 
simulations,  empirical  criteria  were  formed  to  identify  the  non-dispersed  R€ {t)
delayed by a near integer number of sample points, which are best reconstructed withChapter 6: Characterising the Impulse Response Function - 168-
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Figure  6.3:  sML-EM  reconstructions  of  Reff(t)  with  a)  /deiay=0s  delay,  /?=0s
dispersion,  b)  fdelay=2s,  /?=0s,  c)  fdelay= 2.5s,  /?=0s,  d)  ^delay=2s,  /?=4s,  e)  rdelay=2.5s, 
/?=4s.  Noiseless  data  were  simulated  with  CZ?F=60ml/100g/min,  M 7 T = 4 s ,  TR=ls. 
The  black  dashed  lines  are  the  simulated  Reff (t),  the  blue  solid  lines  are  the
reconstructions  using  matrix  Ai  and  red  solid  lines  are  the  reconstructions  using 
matrix A2.  It can be seen that matrix Ai gives the most accurate reconstruction in b), 
whereas matrix A2 gives the best reconstruction in a), c), d), e) and f).______________Chapter 6: Characterising the Impulse Response Function -169-
Ai.  The suggested criteria are given in the Appendix of this chapter.  For all other 
cases, the reconstruction is performed using A2.  Table 6.1 in the Appendix indicates 
the accuracy of the selection criteria for various degrees of delay and dispersion at 
SNR 50 and SNR 500, estimated from the TR=1  simulations for healthy grey-matter 
(GM) perfusion.  As can be expected, the accuracy improves with SNR.
Based  on  these  simulations,  in  the  mML-EM  method,  a  preliminary  sML-EM 
deconvolution is performed,  and these empirical criteria are used to select the most 
appropriate matrix for the final mML-EM deconvolution.
63.2  M L-EM  Iteration Stopping Criteria
The final mML-EM deconvolution is calculated identically to sML-EM, except for a 
modified stopping criterion.
To  design  the  stopping  criteria  for the  iteration,  exploratory  sML-EM  simulations 
were performed.  The sML-EM  algorithm was initiated (k=0) with a uniform guess 
for the impulse response function  r lk=0](t)  (a small non-zero constant).  The sML-
EM  inter-iteration  change  r l* 3(r,.)-rt*~11(^)|  was  measured  for  each  point  as  a
function of iteration number, k, and time point, U, for various delay, dispersion, CBF, 
CBV and SNR combinations (see Chapter 5).  It is assumed that a small inter-iteration 
change is indicative of convergence, and therefore an appropriate iteration stopping 
criterion is to define a threshold value for the inter-iteration change.  A typical pattern 
was  observed  for the  convergence  of the  individual  points,  which  is  illustrated  in 
Figure 6.4 for  CBF • Reff (/)  simulated with  CBF=  30ml/100g/min, M7T=4s, delayed
by 2s, for noiseless data (a), and SNR=30 data (b).Chapter 6: Characterising the Impulse Response Function - 170-
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of iteration number,  k ,  and time point,  for a) noiselesss  and b) SNR 30  sML-EM 
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delay=2s,  TR=ls.  The  inter-iteration  change  is  largest  for  points  defining  the 
maximum  and  sharp rise-to-maximum,  since these are defined by high frequencies 
that converge slowly. The inter-iteration change for the points defining the tail of the 
function (larger t,) is larger when noise is introduced.  For the SNR=30 simulations, 
adjacent points in the tail have different convergence characteristics, indicating that 
the high-frequency noise is being fitting in the later iterations.____________________
A  fixed  number  of  iterations  are  commonly  used  in  the  reconstruction  of 
CBF *  Rtf (t).  For this situation, Figure 6.4, shows that there is a large variation in
the inter-iteration change for a given iteration number,  suggesting that some points 
have  converged,  whilst  others  have  not.  There  are two  possible reasons  why the 
points that  still  have  a large inter-iteration  have not converged.  1) The points  are 
defining  a  sharp  edge  in  CBF  Rtf (t):  Figure  6.4a  shows  that  in  the  noiseless
simulation, the inter-iteration change is larger for the points defining the maximum 
(ti-2 ),  compared with the points within the tail  of  CBF  Rtf (t).  This is consistent
with  the  fact  that  the  higher  frequencies  defining  the  sharp  RTM take  longer  to 
converge.  2 ) The point values are the result of instabilities caused by noise: Figure 
6.4b  shows  the  situation  for  SNR=30  data,  where  compared  with  the  noiseless 
simulation  (Figure  6.4a),  a  larger  inter-iteration  change  is  observed  for  points 
defining the tail of the function.  This is presumably related to the fact that the tail 
now contains high frequencies associated with noise, which take longer to converge. 
Furthermore,  adjacent  points  within  the  tail  of  the  function  show  different 
convergence characteristics.  The fitting of such noise is undesirable since it corrupts 
the shape of r(t).  For situation 1, more iteration is desirable, whereas for situation 2 
less iteration is desirable
Equally, if a fixed inter-iteration change is used to determine the number of iterations 
in the reconstruction of CBF • Reff (t), Figure 6.4 indicates there would be a very large
variance in the number of iterations used to calculate each point in  CBF • Reff (t)  For 
the  noiseless  simulation  in  Figure  6.4a,  such  criteria  would  facilitate  the  accurateChapter 6: Characterising the Impulse Response Function -172-
reconstruction  of  any  sharp  edges  in  CBF  Reff{t).  However,  for  the  SNR=30
simulation in Figure 6.4b, using  a fixed inter-iteration change-threshold to  stop the 
iteration would cause the complete corruption of tail points contaminated with noise.
Therefore,  in  order to  minimise the  corruption  of  CBF ■  Reff (?),  and maximise the
reconstruction of the real high-frequency information actually defining the true shape, 
a point-wise inter-iteration change should be used.  For example, the inter-iteration 
change-threshold  defining the  stopping  criteria for the points  defining the RTM of 
CBF • Reff (?), should be smaller than the inter-iteration change-threshold defining the
stopping criteria for the tail points.  In this way, more iteration is used to reconstruct 
the RMT compared with the tail.  In this work, such point-wise stopping criteria are
formed by  making  the  inter-iteration  change-threshold  r m (?,.)-? 14-11 (?f)|  for each 
point dependent on both the point value  r m (?.), and the time point ?,.
Furthermore, the inter-iteration change for each point should also be scaled according 
to the actual  shape of  CBF • Reff (?)  being reconstructed.  A shorter MTT defines  a
sharper and steeper  Reff (?), with a smaller integrated area.  Because these shapes are
characterised by more slowly converging high frequencies, the number of iterations 
used to reconstruct  CBF • Reff (?)  should be inversely proportional to the integrated
area  of  Reff (?),  which  is  not  a  priori  known,  but  can  be  approximated  by 
X T m(O n  Therefore, for the point-wise stopping criteria used in this work, the 
inter-iteration  change  was  set  to  be  proportional  to  the  integrated  area  of  the 
reconstruction  r [k] (?.), enabling more iteration for the steeper and sharper Reff (?).
1 1 It should be noted that for a sharp steep Reff (?), the true maximum of the recovered CBF •  Reff (?) 
is  slowly  reconstructed,  so the  integrated  area of the reconstruction,  ^   r f  1 (?,•),  will  take  many 
more iterations to reach a good approximation to the CBV (which is the are under  CBF • Reff (?)) 
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Based  on  the  simulations  and  inference  described  above,  a point-wise  termination 
criterion  was  empirically  determined  from  preliminary  simulations  to  optimise the 
reconstruction  of the  various  shapes  of  CBF ■  Reff (t).  In  this  work,  iteration  on  a
particular point is stopped when the inter-iteration change in the value of that point is 
less than a threshold dependent on the position of the point  the value of the point 
(t{), as well as area of the reconstruction,  rj :
F(r,)-r “ - 1 1 (/,.)| < or ■  77?2 ■  (r,. •  F [‘](t,) f  • £ ? “>(«,)/#  *>10,  0</, <max(/,)
[6.5]
with k the iteration number, N the number of sampling points and a and /? empirically 
determined numerical constants.  For the results presented here, the values of a and ft 
were  0.01  and  0.33  respectively.  These  suggested  values  were  determined  by 
monitoring  (iteration  by  iteration)  the  sML-EM  reconstruction  of many  different 
simulated shapes for  CBF •  Reff (r), and changing the values of a and f$ to achieve the
most accurate recovery of the simulated  CBF • Reff (f).  The aim of the criteria given
in  Equation  [6.5]  is  to  allow  more  iteration  to  reconstruct  the  beginning  of  the 
function, and less for the tail and for functions with a large MTT (i.e broad functions).
The  preliminary  simulations  also  revealed  that  the  inter-iteration  change  for 
individual points in noisy data may not fall below the Equation [6.5] threshold.  For 
this reason, in order to avoid  severe corruption due to over-iteration, the maximum 
number  of  iterations  allowed  for  the  reconstruction  was  set  to  250/TR  for 
reconstructions using matrix Ai.  The smoother functions reconstructed with matrix 
A2 used a lower maximum of 100/TR iterations.
These stopping criteria are incorporated in the mML-EM algorithm as follows:  The 
algorithm is initiated (k=0 ) with a uniform guess for the impulse response function 
r [*= 0](r)  (a small  non-zero constant).  ML-EM iteration on a particular point,  U  is 
stopped at the k* iteration when the inter-iteration change in the value of that pointChapter 6: Characterising the Impulse Response Function -174-
r m(f( .) - r [*  11 (f.)|  is  less  than  the threshold  given  in  Equation  [6.5].  The current
value of the point,  r 1 *1^ )   is then placed in a separate vector and kept at this value 
until  the  inter-iteration  change  for  all  points  in  the  estimated  impulse  response 
function have fallen below their individual thresholds.  In order to extract the high- 
frequency information, the  sML-EM estimated  r lk](t)  is used to update the mML- 
EM  algorithm  at  each  iteration  step.  The  resulting  reconstruction  will  not  be 
maximum likelihood, but corruption of r (f) is minimised.
6 3 3   S im u la tio n s and P a tie n t D a ta
The  final  mML-EM  algorithm  combines  the  methodology  to  firstly  minimise  the 
discretisation  errors  (Section  6.3.1)  and  secondly  minimise  the  regularisation  and 
noise  induced  errors  (Section  6.3.2).  In  the  first  stage  a  preliminary  sML-EM 
reconstruction is performed and the criteria given in Equation  [6 .6 ]  (see Appendix) 
are  used  to  automatically  select the  appropriate  matrix,  Ai  or A2.  In the  second 
stage, the final ML-EM reconstruction is performed using the appropriate matrix and 
terminating the iteration with the point-wise convergence criteria, given in Equation
[6.5].  This methodology was tested on the simulated data set described in Chapter 5. 
For  comparative  purposes,  reported  in  the  results  (Section  6.4),  are  the 
reconstructions  after 50  and  200 iterations  (van  Osch et al.  2003) of the  sML-EM 
method.
For  illustrative  purposes,  the  mML-EM  technique  was  applied  to  real  image  data 
acquired from a patient with left internal carotid artery occlusion on a 1.5T Siemens 
Symphony scanner using a gradient-echo EPI sequence (TE/TR = 47/1500ms) after 
injecting 0.15mmol/kg of Gd-DPTA.  A global AIF was measured in the contralateral 
middle  cerebral  artery  (MCA).  Denoising  of  the  tissue  concentration  data  was 
performed using Independent Component Analysis (see Section 5.3.2).  sML-EM and 
mML-EM  deconvolution  analysis  were  used  to  extract  the  CBF  R^(t)  for  eachChapter 6: Characterising the Impulse Response Function -175-
voxel.  The matrix selection and point-wise termination criteria used for the in vivo 
data were the same as those determined and used in the simulations.
6.4  R e su l t s
6.4.1  Characterising the Impulse Response Function
The four rows of Figure 6.5 and Figure 6 .6  show the  CBF • Reff (?)  reconstruction of
the four different bolus  states described in Section 4.7.2 and illustrated Figure 6.1, 
from  data  simulated  at  SNR=50  and  500  respectively.  The  delay  and  dispersion 
combinations  shown  are  representative  of  the  many  combinations  for  which  the 
simulations were performed (see Chapter 5).  It should be noted that the vertical axis 
of the  first three columns  have units  in  ml/100 g/s  (healthy  GM  CBF= 60 ml/100 
g/min =  1  ml/ 1 0 0  g/s),  and the vertical  axis of the fourth column is the number of 
iterations.
At SNR 50 (Figure 6.5), 50 iterations of sML-EM (first column) recovers the smooth 
parts  of all  the  impulse  response  functions  well,  while  the  iteration  is  terminated 
before the high-frequency components have had a chance to converge.  The initial 
sections of the non-dispersed  CBF • Reff (r) (a and b) are poorly characterised because
of discretisation error (affecting both (a) and (b)) and because too few iterations have 
been used to recover the high-frequency information defining the steep RTM in (b). 
Continuing the  sML-EM iteration further causes the reconstructions  at SNR=50 to 
become  dominated  by  noise.  After  200  iterations  (second  column),  noise  has 
completely  corrupted  the  smooth  parts  of the  CBF ■  Reff (t).  200  iterations  is  not
therefore a suitable number of iterations to use for these SNR and flow parameters.Chapter 6: Characterising the Impulse Response Function  - 176 -
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Figure 6.5:  Impulse response functions reconstructed at TR=ls from data simulated 
with  SNR=50  and  healthy  GM  perfusion  CBF=60ml/100g/min,  C!?V=4ml/100g, 
M7T=4s.  From left to right, the columns show the reconstructions using 50 iterations 
of  sML-EM  (a-d),  200  iterations  sML-EM  (e-h),  mML-EM  (i-1),  and  the  average 
number  of  iterations  used  for  each  point  of  the  mML-EM  reconstruction  (m-p) 
(shown in (i-1) respectively).  From top to bottom the rows show the results from a 
bolus simulated with no delay and no dispersion (a,e,i,m), 2 s delay and no dispersion 
(b,f,j,n),  no  delay  and 4s  dispersion  (c,g,k,o),  2s  delay  and 4s  dispersion  (d,h,l,p). 
The curves  are  the  average of  100 repeats  with  error bars  equal  to  +/-  1   standard 
deviation.  The horizontal axes are labelled in seconds.  The vertical axis for the first 
three columns is  CBF • Reff (?), and for the fourth column is ‘number of iterations’.
The  mML-EM  method  (third  column)  gives  improved  characterisation  of 
CBF • Reff (?)  from  all  four bolus  states.  In  particular,  the  initial  part  of the  non­
dispersed  CBF •  Reff (?) with no delay, and delayed by 2 seconds (i and j respectively)
are  more  accurately  characterised.  This  improvement  is  a  result  of  minimising 
discretisation  errors  (by  means  of the  automatic  selection  of matrix  A2 for (i)  and 
matrix  Ai  for (j))  and  allowing  a greater number of iterations  to  recover the high 
frequencies resulting from the delayed bolus (j).  In all the mML-EM reconstructions 
(i-1) the error bars are small since the point-wise termination minimises corruption of 
the smooth sections of CBF • Reff (?).
Figure  6.5  and  Figure  6 .6   (fourth  column)  demonstrate  the  aim  of the  point-wise 
termination criteria, which is to terminate the iteration on points defining the smooth 
parts  of  CBF ■  Reff (?)  first  and  allow  many  more  iterations  to  recover  the  slowly
converging  high-frequency  information  that  characterises  the  sharp  edges.  At 
SNR=500 (Figure  6 .6 ), points  defining the sharp RTM of the delayed  CBF ■  Reff (?)
are  recovered using  around 250  iterations.  All  points  on the  smooth non-delayed 
residue functions are recovered with fewer than  100 iterations at SNR=50 and 500. 
The smooth tails may be characterised using as few as 10 iterations.  Further iteration 
on  these points  is  likely  to  distort them.  At SNR  500  (Figure  6 .6 ),  the  point-wise 
termination criteria designed to minimise noise corruption become less important.ML-EM 50 ML-EM 200
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Figure 6 .6 :  Impulse response functions reconstructed at TR=ls from data simulated 
with  SNR  500  and  healthy  GM  perfusion  CRF=60ml/100g/min,  C£V=4ml/100g, 
M7T=4s.  See Figure 6.5 legend for the labelling of the rows and columns.__________
Error bars for all the reconstructions (a-1) are small.  However, discretisation errors 
are still a problem for the sML-EM reconstruction of the non-dispersed  CBF •  Reff (r)
(a,  b,  e  and  f).  The  distorted  shape  of  the  delayed  CBF ■  Reff (r)  could  be
misinterpreted as a small dispersion.  In contrast, the selection of matrix Ai for the 
mML-EM  reconstruction  of the  delayed  CBF •  Reff (r)  (j)  enables  a more  accurate
reconstruction of the sharp edge.  This can easily be distinguished from dispersion. 
The  matrix  selection  method is  more  reliable  at high  SNR  (Table  6.1),  enabling  a 
more confident distinction between a delayed and dispersed bolus.
6.4.2  M TT EFFECT ON CBF QUANTIFICATION
Figure  6.5  and  Figure  6 .6   (b,  f,  j)  show  that  for  a  delayed,  non-dispersed 
CBF •  Reff (r), both sML-EM and mML-EM underestimate CBF when the MTT is 4s.
It is difficult to characterise properly the high flow rates associated with short MTT 
because the scale of the decay is approximately the same as the temporal sampling 
MTT ~ TR.  The accuracy of all the deconvolution techniques is therefore dependent 
on  MTT.  Figure  6.7  shows  the  estimated  CBF  for  typical  GM  (M7T=4s), 
autoregulated  tissue  (M7T=7.2s)  and  ischaemic  GM  (M7T=9s)  across  a  range  of 
bolus  delays,  demonstrating  the  difficulty in  properly  characterising  the  high  flow 
rates associated with short MTT.  CBF is most severely underestimated in the MTT = 
4s simulation (the dotted line (true CBF) is most distant from the solid line (estimated 
CBF)).  For  a  longer  MTT  =9s  (as  might  be  observed  in  ischaemic  tissue),  the 
intrinsic delay insensitivity of the ML-EM method is clearly demonstrated.Chapter 6: Characterising the Impulse Response Function  - 180 -
MTT
/ \
\ /
0.8 7.2s
0.2
6 0 2 3 4 5 1
delay /s
Figure 6.7: The graph  shows the maximum of the  CBF  Reff{t)  (vertical  axis units
ml/lOOg/s) reconstructed at TR=ls using mML-EM from data simulated (SNR 500) 
with  no  dispersion  and  delays  (horizontal  axis)  of 0-6s.  The  solid  lines  show  the 
maximum of the reconstructed  CBF.Reff(t)  for the MTT values indicated.  The dotted
lines  indicate  the  corresponding  maximum  in  each  case  of  the  true  CBF •  Reff (t) 
measured  at TR=ls.  The  periodicity is because the discrete  sampling interval does 
not sample the maximum of  CBF ■  Reff{t)  for delays which are non-integer multiples
of TR.  The figure shows the average of 100 iterations with error bars equal to two 
standard deviations
Although there is better characterisation of the CBF measured from impulse response 
functions  with  longer  MTT,  in  such  cases  another  artefact  associated  with  the 
truncation  of the concentration time-course  data may be present.  Simulations  were 
performed  to  assess  the  effect  of  truncating  the  recirculation  in  the  concentration 
time-course  data;  a  situation  that  commonly  occurs  for  longer-M7T  tissue  or  for 
adispersed bolus, especially for shorter sampling lengths.  It was found that found that 
a severe truncation of the recirculation produces an unphysical  step in the tail of the 
reconstructed  CBF  R^{t)  (data  not  shown).  However,  the  initial  part  of  theChapter 6: Characterising the Impulse Response Function -181 -
reconstructed  CBF  Reff(t)  and  therefore  the  estimated  CBF  are  unaffected  by 
truncation.
6.43  Effect of TR
Imaging  with  shorter  TR  has  the  potential  to  provide  more  accurate  delay 
quantification, improved recovery of the impulse response functions  (especially for 
short MTT functions), and smaller discretisation errors.  It should be noted, however, 
that at very short TRs the Ti weighting may not be negligible (see Section 2.3.3).  In 
practice,  the time resolution  of the  acquired  data is  limited by factors  such  as  the 
required SNR and number of slices.  It is therefore important to assess the robustness 
of this technique to a range  of TR values.  Figure  6 .8  demonstrates how the delay 
quantification  is  limited  by  the  resolution  of the  sampling.  The  accuracy  of the 
mML-EM  reconstructions  degrades  as  expected  with  increasing  TR.  Even  if 
CBF • Reff (t)  were reconstructed with infinite accuracy, the particular TR and delay
combination determine whether the delayed peak is actually sampled, and therefore 
accurate CBF estimates can only be obtained if the delay is an integer number of TRs 
(see Section 5.2.5).  In order to assess delays to within  1  second,  distinguish small 
dispersions,  and  enable  reasonably  accurate  CBF  estimates,  a  TR  of  1  second  is 
desirable.  At the more commonly used TR value of 1.5 s, it is more difficult to assess 
small dispersions (This issue is discussed further in Chapter 9).  The accuracy of the 
mML-EM reconstructions degrades as expected with increasing TR.
6.4.4  Patient Data
The mML-EM method was applied to the GE-EPI image data from a patient with left 
internal carotid artery occlusion.  The data collected had a baseline signal SNR= 50, 
which improved to -500 after denoising was performed.  The typical CNR in healthy 
GM was -600, and in the affected side it was -20 (compare with CNR -  200 in the 
SNR - 500 simulated data).  The CNR is not uniform across the image because of theChapter 6: Characterising the Impulse Response Function - 182 -
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Figure  6 .8 :  The  graphs  show  the  delay  estimated  (vertical  axis)  from  the  impulse 
response  functions  reconstructed  using  mML-EM  and  data  simulated  (SNR=500) 
with  no  dispersion  and  delays  (horizontal  axis)  CM-s,  for  healthy  GM  perfusion 
C£F=60ml/100g/min,  C£V=4ml/100g,  M7T=4s.  The  graphs  show  the  results  for 
sampling intervals 0.5s,  Is,  1.5s, 2s,  2.5s  and 3s.  The solid lines  are the mML-EM 
estimated  delay,  and  the  dashed lines  are  the  simulated  delay.  The  results  are  the 
average  of  100  iterations  with  error  bars  equal  to  two  standard  deviations.  The 
periodic  accuracy  is  caused  by  insufficient  sampling  to  sample  the  true  end  of 
baseline for delays which are non-integer multiples of TR.________________________
heterogeneity  in  the  perfusion  parameters  and  extent  of  delay  and  dispersion  in 
various  regions  (see  Section  5.2.4).  The  denoising  enables  a  reasonably  accurate 
selection of the appropriate deconvolution matrix, Ai or A2 (Table 6.1), and hence a 
good  characterisation  of  CBF  Reff(t)  in  all  areas  by  means  of  the  point-wise
termination criteria.Chapter 6: Characterising the Impulse Response Function -183-
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Figure 6.9:  The  results  from  the  analysis  of data acquired from  a patient  with  left 
internal carotid occlusion a) CBF map calculated using the maximum of the impulse 
response  function  reconstructed  using  mML-EM.  b)  Highlighted  pixels  have  been 
classified  as  delayed  and/or  dispersed  according  to  the  shape  of  the  mML-EM 
reconstruction,  as  described  in  the  Section  6.4.4.  c)  Example  mML-EM  recovered 
impulse response functions taken from i) a pixel where there is no delay or dispersion 
(dashed line), ii) a pixel where there is delay and dispersion (dotted line), iii) a pixel 
where there is delay but no dispersion (solid line), iv) a pixel with lower flow where 
there is delay but no dispersion (dashed-dot line).________________________________
Figure 6.9a is the CBF map measured from the maximum of CBF •  Reff (t)  calculated
using the mML-EM algorithm.  Various regions of severely reduced CBF can be seen 
in  the  left  hemisphere,  and  in  the  anterior  and  posterior  of the  right  hemisphere. 
Figure  6.9b  highlights  voxels  identified  (from  the  shape  of  the  reconstructed 
CBF ■  Reff (r)  as  suffering  from  bolus  delay  and/or  dispersion,  many  of which  also
show low  CBF.  If the maximum of the reconstructed  CBF ■  Reff(t)  did not occur atChapter 6: Characterising the Impulse Response Function -184-
?=  0,  CBF • Reff (?)  was classified as being delayed or dispersed.  In  some areas  of
large dispersion, the truncation artefact described in Section 6.4.2 was observed.  The 
r(t)  for four representative pixels in the GM of the affected side are shown in Figure 
6.9c.  The estimation of CBF from the dashed curve (i) taken from the affected left 
hemisphere is low but reliable (there is no delay or dispersion).  The estimation of 
CBF from  the  dotted  curve  (ii)  is  likely to be  severely  underestimated  due  to  the 
dispersion.  The estimation of CBF from the solid curve (iii) and the dashed-dot curve 
(iv) are likely to be slightly underestimated (there is delay, but no dispersion).  It is 
crucial to be able to distinguish the artificially low value measured from (ii) from the 
low flow values measured from the non-dispersed curves.  This is achieved through 
accurate characterisation of CBF •  (?).
6.5  Discussion
The methodology presented in this chapter has been shown to minimise the artefacts 
associated  with  the  deconvolution  algorithm,  and  provide  an  improved 
characterisation  of  CBF • R^(?).  Previous  studies  suggest  that  tissue  at  risk  of
infarction is  characterised by low  CBF and prolonged MTT (Powers  1991).  Since 
delay  and  dispersion  have  been  shown  to  bias  the  estimated  CBF  and  MTT,  an 
accurate  characterisation  of  CBF  Reff(t)  is  vital  to  assess  the  reliability  of these
estimates.
It was shown that the sML-EM algorithm can lead to an unrealistic reconstruction of 
CBF ■  Reff (?),  with  consequently  incorrect  CBF  estimates.  For  the  sML-EM
reconstruction  to  give  physically  meaningful  results,  the  number  of  iterations 
performed must take into account the CNR of the time-course, and the actual shape of 
the unknown  CBF •  Reff (?).  Since the contrast will not be uniform across the whole
brain, the number of iterations used in the reconstruction should change accordingly.Chapter 6: Characterising the Impulse Response Function -185 -
In order to avoid corruption due to noise, iteration is often terminated prematurely, 
resulting in smooth but biased reconstructions.  Early termination fails to extract all 
the  information  present,  biasing  the  low-frequency  information  and  neglecting  to 
extract any high-frequency information that may be present (Figure 6.5  and Figure
6 .6   (a-d)).
The  modified  ML-EM  method  presented  in  this  chapter  implements  point-wise 
termination  criteria.  The  new  termination  criteria  enable  the  recovery  of  high- 
frequency  information  associated  with  Reff (t)  whilst  preventing  corruption  due  to
noise fitting, thus preserving a smooth tail (Figure 6.5 and Figure 6 .6 (i-l)).  The point- 
wise termination criteria allow any slowly converging high frequencies occurring in 
the initial part of CBF • Reff (t) to be reconstructed using a large number of iterations
(Figure 6.5  and Figure  6 .6 (m-p)).  If the initial section of  CBF • Reff (f)  contains no
high-frequency information, this part of the function converges quickly and the point- 
wise  termination  criteria  allow  few  iterations  in  its  reconstruction  (Figure  6.5  and 
Figure  6 .6 (m)).  It  should  be  emphasised  that  no  prior  information  about  the 
delay/dispersion  state  of  Reff (/)  is  assumed in the termination criteria.  The point-
wise  termination  criteria  also  automatically  account  for  noise,  allowing  realistic 
reconstruction across a large range of SNR.
The  characterisation  of  CBF • Reff (t),  in  particular the  distinction  between  a bolus
dispersion  and  a  delay,  is  further  improved  by  the  automated  selection  of  the 
convolution matrix whose approximations best minimise the discretisation errors for 
the  particular  CBF  Reff(t)  being  reconstructed.  The  improvement  is  particularly
apparent comparing Figure 6.5 and Figure 6 .6  (b and j).  This distinction is important 
both  for  assessing  the  accuracy  of  the  CBF  estimate,  and  potential  subsequent 
correction  of the  CBF estimate.  Although, the effect of dispersion on the impulse 
response function cannot be corrected without knowing a vascular transport function 
(VTF) (0stergaard et al  1999; Calamante et al. 2003a), an improved characterisation 
of  CBF • Reff (r)  is an important first step towards this correction.  Furthermore, theChapter 6: Characterising the Impulse Response Function -186 -
identification of delay and dispersion is important for highlighting unreliable regions 
on the CBF maps, and may alter the prediction of areas thought to have increased risk 
of  infarction.  Without  knowledge  of  delay  and  dispersion,  it  is  not  possible  to 
separate  an  underestimation  of  CBF  from  a  true  perfusion  abnormality.  The 
information from maps indicating regions of delay and dispersion (such as the regions 
highlighted in Figure 6.9b) would therefore be a useful input into predictor-models 
(e.g.(Wu et al  2001),  see also Section 3.12), which assess the probability of tissue 
infarction using diffusion, perfusion  and T2 data.  Thus,  an improved  CBF • Reff (t)
could avoid a potentially dangerous misclassification of ‘at risk’ tissue.
A reliable interpretation of DSC-MRI perfusion maps is only possible through both 
an accurate characterisation and accurate interpretation of the shape of CBF • Reff (t). 
The CBF will be under-estimated when measured from the maximum of a dispersed 
CBF •   (/);  if the  shape of  CBF  Reff{t)  is not considered,  the error in the  CBF
could be overlooked.  If the CBF estimates are interpreted with reference to the shape 
of  CBF • Reff (?), the  accuracy of the characterisation must also be considered.  For
example, in ischaemic tissue, a long MTT is often combined with a low CBF.  If the 
ischaemic  CBF • Reff (r)  were delayed, care must be taken no to misidentify the long
MTT  as  dispersion  (for  example,  if  the  RTM  of  CBF  Reff(t)  is  not  accurately
reconstructed).  Such a misidentification could lead to the interpretation that the CBF 
estimate has been underestimated.  The tissue may in fact healthier than the CBF and 
dispersion  maps  suggest.  In  order  to  prevent  such  misdiagnosis,  an  accurate 
characterisation  of  CBF ■  Reff(t)  is  vital.  In  this  work  the  automatic  selection  of
either matrix Ai or A2 improves the reconstruction of the RTM of CBF •  Reff (r).  This
permits a more accurate distinction between an impulse response function with a long 
MTT and no dispersion from one which is dispersed.  In this way,  a truly low CBF 
can be separated from the case in which CBF is underestimated because of dispersion.
For  high  quality  data,  the  delayed/dispersed  regions  such  as  those  highlighted  in 
Figure 6.9b could be subcategorised into delayed and dispersed voxels.  For example,Chapter 6: Characterising the Impulse Response Function -187-
a reconstruction using matrix Ai would be classified as “non-dispersed and delayed 
by a near integer value of TR.”  A reconstruction using matrix A2 would be classified 
as “dispersed” if the RTM was greater than one measurement point, and “delayed by a 
near half integer value of TR” if the RTM was equal to one measurement point.  In 
Chapter 7,  a  method  of sub-categorisation  is  suggested  and  the  limitations  of this 
methodology are discussed.
In order to achieve an accurate characterisation of CBF •  Reff (t), care must be taken in 
selecting the AIF, so as to prevent negative delays (i.e.  Ct(r)  arriving before  Ca(t)).
When negative delays were simulated, the same effects were observed as reported in 
by Wu et al. (Wu et al.  2003).  Wu et al. circumvented this overestimation in SVD 
using a block-circulant matrix.  However, the block-circulant modification results a 
uniform underestimation of CBF from  CBF • Reff (t) with positive, negative, and zero
delays  for  normal  MTT  values  (it  is  in  this  sense  that  the  block-circulant  SVD 
algorithm is delay-insensitive).  The mML-EM method could be modified to use a 
block-circulant Ai  matrix.  However, matrix A2, which minimises the discretisation 
errors and hence achieves the most accurate CBF from  CBF • Reff (t)  with no delay or
dispersion, cannot be made block-circulant.  This matrix is deliberately formed in this 
way because  it  avoids  the  CBF underestimation  that is  intrinsic  to block-circulant 
methods  for normal  MTT values  when  tdeiay=  0.  In  healthy  vasculature,  the  most 
accurate  CBF estimates  can  therefore be  achieved through  careful  selection  of the 
AIF measurement site in order to avoid negative delays, and deconvolution using the 
non-block-circulant  matrices  Ai  and  A2.  If delay  and  dispersion  in  the  vascular 
transport  are  removed  from  the  concentration  time-course  data,  mML-EM 
deconvolution with matrix A2  permits a reliable CBF estimate.  In Chapter 9 a novel 
methodology is presented to minimise delay and dispersion in the concentration time- 
course data.  If this minimisation is successfully achieved, a deconvolution technique 
that  can  accurately  characterise  the  true  maximum  of the  tissue  impulse  response 
function is especially valuable.Chapter 6: Characterising the Impulse Response Function -188 -
The mML-EM methodology applied to the patient data (Figure 6.9) clearly highlights 
the  effect  of  the  internal  carotid  artery  occlusion  on  the  DSC-MRI  perfusion 
measurements.  Figure 6.9a and Figure 6.9b reveal that areas indicating low perfusion 
actually correspond to regions where there is dispersion and/or delay.  This suggests 
that the perfusion abnormality is exaggerated due to dispersion  and/or delay of the 
bolus through the occluded vessel to into the left hemisphere.  If this perfusion map 
were interpreted independently of the delay and dispersion map, a treatment plan may 
have  been  based  on  the  artificially  low  perfusion  estimates,  with  potentially 
dangerous  consequences.  Further  examples  highlighting  in  vivo  perfusion 
measurement errors are discussed in Chapter 9.
6.5.1  Lim itations
The  CBF  estimates  obtained  from  delayed  high  flow  regions  in  6.9a  should  be 
interpreted in the light of the possible underestimation for short MTT tissue illustrated 
in Figure 6.7.  The accuracy of CBF and delay quantification in regions of short MTT 
are Nyquist limited.  In addition, discretisation errors associated with deconvolution 
at  intervals  of  TR  are  manifest  most  strongly  for  short  MTT  delayed  and  non- 
dispersed  (/).  The mML-EM reconstructions shown in Figure 6.5 and Figure 6 .6
(i and j) demonstrate that these errors may be minimised by appropriately selecting 
the  matrix  Ai  or  A2.  Although  the  errors  associated  with  discretisation  are 
independent  of noise,  the  contrast-to-noise  will  affect  the  reliability  of the  matrix 
selection method used (see Table 6.1).
The  specific  point-wise  termination  criteria  shown  here  were  designed  in  the 
preliminary simulations to extract a physically meaningful shape for  Reff (/)  with and
without bolus delay and/or dispersion.  The simulations found that the values of a and 
p  in  Equation  [6.5]  gave  good reconstructions  across  a range  of impulse  response 
function shapes and CNRs.  However, these values were determined empirically, and 
thus they could potentially be improved by, for example, adapting them according toChapter 6: Characterising the Impulse Response Function -189-
the CNR of the pixel being deconvolved.  In  addition,  the empirically  determined 
criteria  for  selecting  the  Ai  or  A2  matrices  (also  determined  in  the  preliminary 
simulations, (Equation [6 .6 ] in the Appendix) could be optimised and generalised for 
various  scanner sequence parameters.  In particular,  the  sampling interval  TR will 
influence the accuracy of the reconstruction, especially across the initial rise, which is 
used  to  distinguish  delay  and  dispersion  in  the  preliminary  deconvolution. 
Optimisation and generalisation of all these criteria require further work.  In view of 
these limitations, Chapter 7 extends the ideas introduced in this chapter and presents 
an alternative methodology that is less reliant on user determined empirical criteria.
6 . 6   C o n c lu sio n
An improved characterisation of the impulse response function can be  achieved by 
selecting the most appropriate convolution matrix approximations and implementing 
point-wise termination criteria for the ML-EM iteration.  These modifications to the 
standard  ML-EM  method  enable  the  extraction  of  high-frequency  information 
associated with the impulse response function itself, whilst preventing corruption due 
to noise.  In particular, the sharp RTM of a delayed and non-dispersed  Reff (t)  can be
reconstructed, distinguishing it from a dispersed Reff (t) .  This distinction is important
for  assessing  the  accuracy  of CBF estimates,  and  therefore  should  have important 
implications for tissue outcome prediction models.
6.7  A ppendix
This  appendix  describes  in  outline  the  empirical  criteria  used  to  select  the  most 
appropriate matrix A.Chapter 6: Characterising the Impulse Response Function -190-
Definitions:
sML-EM solution calculated using matrix Ai after k iterations: r/*] 
Time point of maximum point in  r,1 *1: m \k]
Time point at end of baseline of  r/*]: b \k]
Number of time points for r/ * 1 to rise-to-maximum: mlk]= mi[k]- bi[k]
sML-EM solution calculated using matrix A2 after k  iterations: r2[k] 
Time point of maximum point in  r2[k]: m,2k]
Time point at end of baseline of  r2lk]: b ^
Number of time points for r2lk] to rise-to-maximum: nj-k] = mi[k]- bj-k]
Method:
The  sML-EM  solutions  after  10  and  100 iterations were calculated,  and the  above 
parameters m, b, and n were determined.
For the TR=ls simulations, the matrix selected was default set to A2.  If the criteria 
below  were  satisfied,  the  matrix  used  in  the  final  mML-EM  reconstruction  was 
selected to be Ai instead.  These criteria were found from preliminary simulations to 
be satisfied by impulse response functions with a near integer sampling interval delay 
and  no  dispersion,  and  these  impulse  response  functions  were  found  to  be  most 
accurately reconstructed using matrix Ai.
Default: A=A2
if  ^  = 2
if  /ij1 1 0 0 1  = 3  and
if  fh[m] ^ 3  and
unless > 0.85  or m [10] -  n  nh  =  0Chapter 6: Characterising the Impulse Response Function  - 191 - 
SNR 500  delay  /s
dispersion
/s
0 .0 0.5 1 .0 1.5 2 .0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6 .0
0 .0 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
1 .0 1.00 1.00 0.93 1.00 0.93 1.00 0.92 1.00 0.89 1.00 0.91 1.00 0.88
2 .0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 1.00 1.00 1.00 0.98
3.0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4.0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
5.0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
SNR50 delay  /s
dispersion
/s
0 .0 0.5 1 .0 1.5 2 .0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6 .0
0 .0 1.00 0.96 0.60 0.94 0.72 0.92 0.74 0.93 0.77 0.98 0.58 0.92 0.60
1 .0 0.80 0.66 0.90 0.63 0.71 0.65 0.77 0.65 0.82 0.64 0.76 0.65 0.79
2 .0 0.81 0.93 0.81 0.89 0.69 0.93 0.75 0.97 0.82 0.88 0.72 0.90 0.81
3.0 0.82 0.91 0.78 0.93 0.81 0.89 0.79 0.90 0.82 0.95 0.81 0.88 0.82
4.0 0.89 0.86 0.90 0.91 0.90 0.91 0.95 0.91 0.90 0.91 0.94 0.91 0.88
5.0 0.92 0.91 0.95 0.84 0.92 0.88 0.96 0.89 0.95 0.87 0.90 0.91 0.88
Table  6.1:  The  proportion  of  correctly  selected  matrices  (Ai  or  A2)  over  100 
simulations of delay (columns) and dispersion (rows) combinations for the mML-EM 
TR=ls  simulations  at  SNR  50  and  500  using  healthy  GM  perfusion  values.  The 
shaded cells are the delay and dispersion combinations requiring reconstruction with 
the Ai matrix.Chapter 7: Perfusion Quantification using oML-EM-wavelet -192-
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7.1  In tro d u c tio n
In  Chapter  6   a  modification  to  the  iterative  method  of  Maximum-Likelihood 
Expectation-Maximisation  (modified-MLEM  or  mMLEM)  was  described  for  the 
deconvolution  of DSC-MRI  data.  In  the  mMLEM  reconstruction,  suppression  of 
noise-derived  frequency  components  that  corrupt  the  impulse  response  function 
CBF • Reff (r)  was  achieved by means  of a point-wise  termination  criterion  for the
ML-EM iteration (Willats et al. 2006).  The point-wise termination criteria enable the 
smooth tail of CBF • Reff (?) to be reconstructed with less iteration than its sharp rise-
to-maximum (RTM), in situations where the bolus is delayed but not dispersed.  The 
point-wise termination criteria were shown to minimised the fitting of experimental 
noise in  the reconstruction,  whilst recovering physiologically  significant  frequency 
components that define the shape of CBF  Reff{t).  In this way, delay and dispersion
could be identified and distinguished (see Chapter 6  for more details).
In  a  clinical  situation  it  is  important  that  an  analysis  technique  is  adaptable  to 
different scanners and scanning sequences.  In addition, so it can be used in the every 
day scanning of patients, it should be robust, adaptable, and automated.  With this in 
mind, the work presented in this chapter builds upon the idea of temporally-selective 
preservation of the frequencies that define the true physiological shape of the impulse 
response  function  and  temporally-selective  suppression  of  those  frequency 
components that are associated with noise.  Whereas the termination criteria used for 
mML-EM iteration were empirically determined and dependent on various scanning 
parameters  (see  Section  6.5.1),  the  regularisation  approach  presented  here  uses 
criteria that are less dependent on the scanning parameters or quality of the data.  This 
is  achieved  by  combining  an  oscillation-index-regu\arised  ML-EM  reconstruction 
with subsequent wavelet decomposition and thresholding.
This  chapter begins  by  introducing  the  concept  of wavelet  decomposition  and  its 
implementation  as  a noise-suppressing  filter.  The  concept  of an  oscillation  indexChapter 7: Perfusion Quantification using oML-EM-wavelet -194-
regularised ML-EM is then explained.  Finally, the combination of these two methods 
as  an  accurate  and  robust  DSC-MRI  deconvolution  method  for  characterising 
CBF • Reff (t) is demonstrated using simulations.
7.2  W a v e le t T h e o ry
7.2.1  Tem poral and Frequency Resolution
Standard  deconvolution  techniques  are  based  on  the  Discrete  Fourier  Transform 
(DFT)  that  uses  complex  exponentials  of different  frequencies  as  basis  functions. 
Using this frequency-time formulation, frequency components of a signal cannot be 
localised in time.  The Short Term Fourier Transform (STFT) (Bracewell  1986) tries 
to localise the frequency components by windowing the signal over the interval which 
the transform is performed and then shifting this window to cover the whole signal. 
In accordance with the Uncertainty Principle, the width of the windowing function 
determines the trade-off between good frequency resolution and good time resolution. 
A wide window gives better frequency resolution but poor time resolution; a narrower 
window  (said  to  be  compactly  supported)  gives  good  time  resolution  but  poor 
frequency resolution.  In addition, there is no inverse transform for the STFT,  so it 
cannot be used in deconvolution techniques.
Restrictions  on temporal  localisation of frequencies may be circumvented with the 
wavelet transform (WT).  In the WT, the basis functions are no longer the complex 
exponentials used in the FT, but are wavelet functions that are oscillatory in the time 
domain and concentrated in both the time and frequency domains (see Section 7.2.2). 
Figure 7.1 illustrates some of the commonly used wavelet functions.Chapter 7: Perfusion Quantification using oML-EM-wavelet -195 -
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Figure  7.1:  Some  common  wavelets,  or  basis  functions  used  in  the  wavelet 
transform,  a)  Haar  wavelet,  b)  Daubechies  wavelet,  c)  Morlet  wavelet,  d)  Myer 
wavelet.
The STFT picks out different frequency components by keeping the window width 
constant  and  filling  it  with  sinusoidal  oscillations  of  different  frequencies. 
Conversely, the WT picks out different frequency components by keeping the number 
of  oscillations  constant  (i.e.  the  same  locally  concentrated  wavelet  function)  and 
varying the width of the “window” by means of contracting and dilating the wavelet. 
As a result, in the WT, high frequencies are characterised using a narrow window and 
the low frequencies using a wide window.  Although the Uncertainty Principle cannot 
be  overcome,  the  WT  offers  a  variable-resolution  time-ffequency  representation, 
which results in better temporal localisation of high frequencies and better frequency 
resolution  of  low  frequencies.  Figure  7.2  compares  the  coverage  of  the  time- 
frequency plane for the STFT and the WT.  In the FT, the time-frequency resolution 
is independent of time or frequency.  In the WT, the time-frequency resolution isChapter 7: Perfusion Quantification using oML-EM-wavelet -196-
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f
Figure 7.2: The 3 panels represent the time-frequency plane for the STFT (top row) 
and the WT (bottom row).  The frequency increases up the vertical axis and the time 
increases along the horizontal axis.  For the STFT, the left figure has better frequency 
resolution,  and the right figure has  better time resolution.  For the WT,  the higher 
frequencies  have  better  time  resolution,  and  the  lower  frequencies  have  better 
frequency  resolution.  In  all  diagrams,  the  area  of  each  box  (equal  areas)  is 
determined by Uncertainty Principle._________________________________________
dependent on the time and frequency.Chapter 7: Perfusion Quantification using oML-EM-wavelet -197-
7.2.2  The C ontinuous W avelet Transform
The  mathematic  formulation  of  the  continuous  WT  (CWT)  is  analogous  to  the 
continuous FT (Bracewell  1986).  The CWT is defined as the inner-product between 
the  signal f(t)  and  wavelet  (basis)  function  x Ps>r(f),  where  s  and  x  are  the  scale
(indicating the wavelet’s  width)  and translation  (indicating the wavelet’s  position) 
parameters  respectively,  (which  are  respectively  analogous  to  frequency  and  time 
variables in the FT).  The wavelet coefficients are defined:
J/M 'C W d t  [7.i]
Correspondingly, the inverse CWT (ICWT) is:
/(')=   [7.2]
Common terminologies for describing the WT are the Mother and Daughter wavelets. 
The  Mother  wavelet  function  *P(f)  is  the  basis  (wavelet)  function  (or  analysing
wavelet),  and  the  Daughter  wavelet  functions  'PJT(r)  are  created  by  scaling  and
translating the Mother wavelet:
[7.3]
The Mother wavelet is a continuous (real or complex) function that satisfies certain 
mathematical conditions:  These include 1) It must integrate to 0, i.e., it is oscillatory; 
2) It has finite energy, i.e., its oscillations are contained within a finite duration; 3) It 
satisfies  the  admissibility  condition,  i.e.,  it  has  a  band-pass  like  spectrum;  4)  It 
satisfies the regularity condition, i.e., it is oscillatory and finite in both the time and 
frequency domains.  Different wavelet families (see Figure 7.1) make different trade 
offs between how compactly the basis functions are localised and how smooth they 
are.  For example, the Haar wavelet (Figure 7.1a) is very compact (it can be defined 
using just  three  points),  but  it  is  not  very  smooth.  On  the  other hand,  the  MyerChapter 7: Perfusion Quantification using oML-EM-wavelet  -198 -
wavelet (Figure 7.1c) is smooth but less compact.  Subgroups within a wavelet family 
are categorised according to their number of vanishing moments m.  The number of 
vanishing  moments  is  essentially  the  half the number of zero-crossings  within  the 
wavelet function.  Formally, a wavelet has its m* vanishing moment if
jtmp(t)dt = 0  [ 7 .4 ]
In practice, the WT is computed by first choosing a function for the Mother wavelet. 
In general, the Mother wavelet is chosen to look similar to the patterns that are to be 
localised in the signal.  The first scale 5=1, is the most compressed Daughter wavelet. 
The Daughter wavelet is placed at t=0,  multiplied by signal  and integrated over all 
times.  It is then shifted along the positive time axis by small amount r, multiplied and 
integrated  as  before.  The  shifting  and  integration  are  repeated  until  the  wavelet 
reaches the end of the  signal.  A  second Daughter wavelet at a larger scale  5 = 2 is 
created,  and  the  shifting  and  integration  are  repeated  as  described  above.  This 
process is performed for every value of s.  As the wavelet is dilated, the transform 
picks up lower and lower frequencies, but these are present over a larger section of 
the signal  and so will have poorer temporal  localisation.  In  summary,  shifting the 
wavelet in time provides temporal localisation to the signal.  Changing the wavelet 
scale  localises  the  signal  in  scale  (providing  frequency  resolution).  The  wavelet 
coefficients will be large if the signal has a spectral component corresponding to the 
current value of s and at the temporal location corresponding to the current value of r.
7.23   T he D isc re te  W a v e le t T ran sfo rm
In most signal processing applications, the signal is discretely sampled.  Therefore a 
discrete form of the wavelet transform is necessary to analyse the signal.  In the DFT 
the  time-frequency  scale  is  sampled  at  a  uniform  rate.  Similarly  in  the  Discrete 
Wavelet  Transform  (DWT),  the  translation  and  scale  variables  are  sampled  at  a 
uniform rate.  Changing the frequency in the DFT enables a reduction in the samplingChapter 7: Perfusion Quantification using oML-EM-wavelet -199-
rate.  Similarly, the scale change in the DWT allows the sampling rate to be reduced. 
According to Nyquist’s rule, the sampling rate must be at least twice the bandwidth in 
order to represent the highest constituent frequency component unaliased.  At larger 
scales (lower frequencies), the sampling rate N can be decreased in proportion to the 
scale.  For example, if the Nyquist condition is satisfied at the smallest scale, j, the 
sampling rate Nj necessary for each successive scale is
If this condition is satisfied, the original continuous time-signal can be reconstructed 
unaliased from its discrete samples in the wavelet domain.
Discrete scale and translation steps (j and k respectively) can be defined such that the 
Daughter wavelets have the form:
j and k are integers, so is a fixed dilation step, and to is a fixed translation step.  The 
case for which s 0  = 2 ,  and to = 1   is known as dyadic sampling of frequency and time 
axis.  This  common  sampling  scheme  is  efficient  and  accurate.  The  Daughter 
wavelets in dyadic sampling are given by:
[7.6]
[7.7]
Note that increasing j  increases the wavelet scale.
The discrete wavelet coefficients of a signal  /(/) are:
[7.8]
And the inverse wavelet transform is:Chapter 7: Perfusion Quantification using oML-EM-wavelet -200-
[7.9]
In accordance with the FT shift theorem (Bracewell  1986), every time the wavelet is 
stretched in the time domain by a factor of two (double j) its bandwidth and central 
frequency are halved.  The  shape of the band-pass  spectrum for Mother wavelet is 
such  that  the  band-pass  spectrum  of each  successive  scaling  (Daughter  wavelets) 
overlap each other.  In this way there will be no unanalysed gaps in the spectrum. 
Since  at  each  Daughter-wavelet  stretch,  only  half  the  remaining  low-frequency 
spectrum is covered by its band-pass  spectrum, a Scaling function  0(0  with a low 
pass  spectrum  is  used  to  cover  this  lowest-frequency  region.  The  situation  is 
illustrated in Figure 7.3.
The Scaling function is essentially a signal with a low-pass spectrum.  Therefore its 
wavelet decomposition uses an infinite number of coefficients up to level jn.
Without  0(0,  an  infinite  set  of  wavelets  would  be  needed  to  cover  the  entire 
frequency spectrum.  Including a Scaling function, the signal  f(t) can be expressed:
where jn  is the chosen cut-off scale for the wavelet dilations, and scaling function 
coefficients are given by:
[7.10]
[7.11]
Mjn,k) = At'£d4(‘)V'Jn,k(t) [7.12]Chapter 7: Perfusion Quantification using oML-EM-wavelet -201 -
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Figure 7.3:  Coverage of the frequency spectrum using a finite set of wavelets and a 
Scaling function.  Each time the Daughter wavelet is stretched by a factor of two, the 
band-width  and  central  frequency  of  the  Daughter-wavelet  spectrum  are  halved. 
Consequently, at every wavelet stretch only half the remaining frequency spectrum is 
covered.  In  order to  use  a finite number of wavelets,  a Scaling function that has  a 
low-pass spectrum is used.____________________________________________________
For  illustrative  purposes,  the  Scaling  and  Mother  wavelet  functions  for  the 
Daubechies-4  wavelet family are  shown in Figure 7.4 together with their frequency 
responses.  The Daubechies-4 wavelet has m=2 vanishing moments.
7.2.3.1  Multiresolution Decomposition
Practically,  the  most  efficient  way  to  implement  DWT  is  using  the  wavelet 
decomposition  and  reconstruction  algorithm proposed by  Mallat  (Mallat  1989).  In 
this formulation,  the  signal  f(t)  is  separated into  ‘details’  and  ‘approximations’  by 
passing  it  through  an  iterated  filter  bank  of high-pass  and  low-pass  filters.  These 
filters  correspond  to  the  spectra  of  the  Daughter  wavelet  function  and  the 
corresponding Scaling function respectively.  The first high-pass and low-pass filters 
(or first level multiresolution decomposition) bisect the signal  spectrum into a high- 
pass  and  low-pass  band.  The  output  of each  filter  has  half the  bandwidth  of the 
original  signal,  and  can  therefore be  subsampled  without  loss  of information.  The 
subsampled  output  of  the  high-pass  filter  contains  the  smallest-scale  wavelet 
coefficients.  The subsampled output from the low-pass filter is split further, using aChapter 7: Perfusion Quantification using oML-EM-wavelet -202-
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Figure 7.4:  Top:  The Wavelet and Scaling functions for the Daubechies-4 wavelet. 
Bottom: The frequency response of the illustrated Daubechies-4 Wavelet and Scaling 
functions.  The Scaling function covers the zero-frequency region of the spectrum.
second  high-pass/low-pass  filter  pair,  into  a  high-pass  and  low-pass  band.  The 
subsampled  output  of the  resulting  high-pass  band  contains  the  next  smallest-scale 
wavelet coefficients.  The subsampled output of the resulting low-pass band is  split 
further using another filter pair, and so on until only one sample point remains.  The 
outcome  of  this  multiresolution  decomposition  operation  is  a  series  of  high-pass 
bands with doubling bandwidth (that form the signal details, or wavelet coefficients) 
and  one  low-pass  band  (that  forms  the  approximation,  or  Scaling  functionChapter 7: Perfusion Quantification using oML-EM-wavelet -203-
coefficient).  Figure  7.5  illustrates  the  wavelet  decomposition  from  the  signal 
processing perspective of multiresolution decomposition.  For signal of length n, the 
DWT consists of a maximum of J = log2 n  stages.  A signal of length n = 64 can be 
decomposed in six steps, resulting in six sets of wavelet coefficients:  1  at j=5,  2 at 
7 =4 , 4 at 7 =3 ,  8  at j - 2,  16  at 7= 1,  32 at 7 =0,  and 64  at j=-\  (which is the original 
signal).  For example,  the  decomposition of a  signal  sampled  at  1Hz (i.e.  TR=ls), 
can,  according to the Nyquist criterion, represent frequencies up to 0.5Hz.  The 32 
7 = 0 wavelet coefficients are the smallest scale and represent the signal in the 0.25Hz- 
0.5Hz range, the  1 6 7 = 1  wavelet coefficients represent the signal the 0.125Hz-0.25Hz 
range;  the  8 j=2  wavelet  coefficients  represent  the  signal  the  0.0625Hz-0.125Hz 
range; the 4 j=3  wavelet coefficients represent the signal the 0.0625Hz-0.03125Hz 
range; the 2 7 = 4  wavelet coefficients represent the signal the 0.03125Hz-0.015625Hz 
range;  the  1  j=5  wavelet  coefficient  represents  the  signal  the  0.015625Hz- 
0.0078125Hz  range,  In  each  successive  level  of coefficients,  half the  remaining 
frequency  spectrum  is  covered  (see  Figure  7.3).  Thus  the  frequency  resolution 
improves with decreasing frequency, whilst the temporal resolution degrades.
7.2.3.2  Wavelet Transform for Filtering
The  magnitude  of the  wavelet  coefficient indicates  the  contribution  that particular 
scale (frequency) component makes to the signal at that point.  The wavelet transform 
of  a  discretely  sampled  real  signal  (in  this  work  the  signal  is  the  ML-EM- 
deconvolved impulse response function  CBF •  Reff (r)) will generally be represented
by a small number of large coefficients, which determine the broad form of the signal, 
whilst  any  noise  in  the  signal  will  largely  be  mapped  to  many  small  small-scale 
coefficients.Chapter 7: Perfusion Quantification using oML-EM-wavelet -204-
Signal level 0 coefficients
level -1
level 0
level 1
level 2
//  32- 
f/16Hz
V = 4
level 3
//  64- 
T28Hz
//128H
level 4
h[»5]
fl  256- 
//128Hz 
”3=1___
level 5
Level 2 Level 1 level 0 coefficients DWT
Figure 7.5:  Multiresolution  Decomposition  analysis:  The  signal,  (also termed level 
j=-1  coefficients) (depicted at the top) is split in six stages into a 6-level j=0-5 DWT 
(depicted  at  the  bottom).  The  DWT  is  calculated  by  passing  the  signal  through  aChapter 7: Perfusion Quantification using oML-EM-wavelet -205-
series of high-pass filters, h[wj], and low-pass filters l[«j], where rij is the length of the 
filter at level j.  At each level, the output from the high-pass filters are subsampled to 
give the wavelet (or detail) coefficients.  Without subsampling, half the coefficients at 
each level would be redundant.  The subsampled output from the low-pass filters (the 
approximation coefficients) are split further by hfiij] and I[«j], to give the next level of 
detail and approximation coefficients.  The signal represented above has length n.\ = 
64,  so there can be  \og2(n^ ) = 6   levels of wavelet (detail) coefficients.  The final 
low-pass  (approximation)  coefficient  is  the  Scaling  function  coefficient.  The 
maximum frequency within the represented signal is/H z.  At each successive level, 
the  wavelet  coefficients  represent  the  signal  components  in  the  range
_ L ---->_Z_Hz,  where  /  is  the  decomposition  level.  Figure  7.3  is  helpful  in
27+2  27+1
visualising the band-pass spectrum of successive decomposition levels._____________
Denoising of a signal can be achieved in the wavelet domain by taking the wavelet 
transform  of  the  noise-corrupted  signal  and  then  setting  to  zero  a  subset  of  the 
coefficients  whose  values  fall  below  a  certain  threshold,  T.  An  inverse  wavelet 
transform is applied to the thresholded wavelet transform to yield a denoised estimate 
of the true signal.  Such a denoising scheme is based on the assumption that the signal 
is sparse in the wavelet domain; i.e., most of its energy is contained in a few large 
coefficients, which may be large or small-scale coefficients corresponding to the low- 
frequency features or to discontinuities or other local high-frequency features (such as 
those  present  in  a  delayed  and  non-dispersed  impulse  response  function). 
Thresholding the wavelet coefficients removes the small signal components that are 
likely  to  derive  from  noise,  whilst  preserving  the  large  signal  components.  It  is 
important that  significant coefficients  are identified and preserved in order that the 
wavelet thresholding preserves the important low and high-frequency features of the 
signal.  Therefore, the threshold must be carefully chosen to balance over-smoothing 
by  overestimating  the  threshold,  and  not  removing  enough  unphysical  small-scale 
noise  by  underestimating  the  threshold.  Wavelet  denoising  schemes  where  the 
below-threshold  coefficients  are  set  to  zero,  are  known  as  ‘hard-thresholding’ 
(Donoho  et  al  1994).  In  an  alternative  denoising  scheme  known  as  ‘soft- 
thresholding’,  the  coefficients  whose  magnitudes  fall  below  the  threshold  T  are 
reduced in magnitude rather than eliminated all together (Donoho et al.  1994).Chapter 7: Perfusion Quantification using oML-EM-wavelet -206-
7.3  M e th o d s
7.3.1  W a v e le t T h re sh o ld in g  A pplied t o  ML-EM
In this work, wavelet decomposition and hard thresholding are applied to the impulse 
response function reconstructed using standard ML-EM (Vonken et al.  1999a).  The 
formulation  and  convergence  properties  of the  ML-EM  algorithm  are  described in 
detail in Chapter 6 .  In summary, if a fixed number of iterations are used for the ML- 
EM  reconstruction,  it  is  likely  that  the  solution  will  be  either  over  or  under 
regularised  (if the  number  of iterations  used  is  too  low  or too  high  respectively). 
Over-regularisation will result in an unrealistically smooth solution and consequently, 
in application to DSC-MRI deconvolution, an underestimation of CBF.
If  few  ML-EM  iterations  are  used  to  reconstruct  the  impulse  response  function 
r = (CBF • Reff { t))estim ated, the wavelet transform will consist of a few large-scale (low
frequency)  coefficients.  This  case  is  desirable  for  an  impulse  response  function 
predominantly characterised by low temporal frequencies, for example one resulting 
from  a  dispersed  bolus.  However,  if  CBF  Reff(t)  contains  higher  frequency
information, for example to characterise a delay, a small number of iterations may be 
insufficient.  When few iterations are used wavelet denoising schemes such as those 
described in Section 1.2.3.2 are superfluous since the solution is already smooth.
A  discussed  in  Chapter  6 ,  a  larger number  of ML-EM  iterations  are  necessary  to 
recover  the  higher  frequency  components  defining  the  sharp  edge  of the  delayed 
Reff (r)  compared with the tail.  However, as the number of iteration increases,  r  is
more likely to become corrupted as the experimental noise is fitted and instabilities 
occur.  As  explained  in  Section  4.8.1  this  is because the inverse problem in bolus 
tracking MRI is ill-posed.  If too many ML-EM iterations are used, it is likely that 
unphysical  oscillations  and  noise  will  be  represented  by  large  magnitude  wavelet 
coefficients  across  all  scales.  Consequently,  the  wavelet  thresholding  regime 
described in  Section  1.2.3.2 is  unable to  recover the true  solution  since  few noiseChapter 7: Perfusion Quantification using oML-EM-wavelet -207-
coefficients  will  fall  below  the  threshold.  For  efficient  denoising,  the  ML-EM 
reconstruction should be sufficiently regularised to avoid corruption, but there should 
also  be  sufficient  iteration  to  recover  the  main  physically  significant  frequency 
components of the solution.
In this work, the iteration balance is achieved using an oscillation index (Wu et al 
2003) to indicate the quality of the impulse response function  r , reconstructed using 
the  standard ML-EM  (Vonken  et al.  1999a).  This  approach  will  be referred to  as 
oscillation  index  regularised  ML-EM  (oML-EM)  (see  Section  7.3.2).  Once  the 
oscillation index of  r  is exceeded the sML-EM iteration is stopped.  The aim of the 
oscillation index is to balance the number of ML-EM iterations such that in wavelet 
space,  the  solution  is  dominated  by  a  few  large-scale  components,  but  also  has 
information contained in the smaller scale coefficients.
In Chapter  6 ,  the four possible  delay  and dispersion combinations for  Reff{t)  were
illustrated (see Figure 6.1).  An effective deconvolution algorithm should be able to 
characterise these four distinct shapes and all shapes for intermediary values of delay 
and dispersion  accurately.  Figure  6.1  is  reproduced in  this  chapter in  Figure  7.6, 
illustrating a smooth decreasing function of time (no delay or dispersion of the bolus), 
a sharp-peaked delayed decreasing function of time (delay and no dispersion of the 
bolus),  and  a  peaked  smooth  bell-shape  (dispersion  with  of without  delay  of the 
bolus).  With  the  exception  of  the  delayed  and  non-dispersed  Reff(t),  very  little
information  should  be  contained  in  the  small-scale  wavelet  coefficients.  For  the 
delayed and non-dispersed Reff (r), the sharp RTM will be in part defined by the small-
scale  wavelet  coefficients.  It  is  likely  that  these  physically  meaningful  wavelet 
coefficients will be large.
In  this  work,  diadylic  wavelet  decompositions  have  been  performed  using  the 
Daubechies  wavelet  family  of maximum  phase  with  two  vanishing  moments  (see 
Figure 7.4).  The DWT algorithm was implemented in C++ using the GSL scientificChapter 7: Perfusion Quantification using oML-EM-wavelet  - 208 -
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Figure 7.6:  Impulse response functions illustrating the four possible combinations of 
delay  and  dispersion,  a)  No  delay  and  no  dispersion  (solid  blue),  b)  delay  and  no 
dispersion  (dashed  blue),  c)  dispersion  and  no  delay  (solid  red),  d)  delay  and 
dispersion (dashed red).________________________________________________________
library.  In  this  implementation,  the  maximum  level  (J = log2n)  decomposition  is 
calculated  and the  scaling coefficient  A  and wavelet coefficients  y  are  arranged in 
the following form
(A p -1,0),  yp -1.0)  rP -2 ,0 ),  y(j-2,1),  -3,0)  ...;Ho,2-'-‘-i))
[7.13]
where j is the  ‘scale’  index of the level j = 0 ... 7-1  and k is the  ‘translation’  index of 
the coefficient within each level, k = 0 ...  2J~j~ ]  —  1.  I.e., the first element of the array 
is the scaling (approximation) coefficient  A(j -1,0), followed by the wavelet (detail)
coefficients  y{j,k) for each level j.
For illustrative purposes, Figure 7.7 illustrates the wavelet decomposition of the four 
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Figure 7.7:  S ix   le v e l  w a v e le t  d e c o m p o sitio n   o f  th e  fo u r  im p u lse   r e sp o n se   fu n ctio n s 
sim u la te d   w ith   C 5 /7= 6 0 m l/1 0 0 g /m in   an d   C # V = 4 m l/1 0 0 g   fo r  a)  n o   d e la y ,  n o  
d isp e r sio n ,  b )  n o   d e la y ,  4   se c o n d   d isp er sio n ,  c )  2   se c o n d   d e la y ,  n o   d isp e r sio n ,  d )  2  
se c o n d   d e la y ,  4   se c o n d   d isp e r sio n .  In  ea ch   q u adrant,  th e  a x e s  fro m   to p   to   b o tto m  
d e p ic t  th e  j- 5  (to p ),  4 ,  3 ,  2 ,  1 , 0   (b o tto m )  le v e l  w a v e le t  c o e ffic ie n ts ,  i.e .  th e  sc a le  
d e c r e a se s  fro m   to p   to   b o tto m .  T h e   v ertica l  sc a le   in d ic a tes  th e  r ela tiv e   m a g n itu d e   o f  
th e   c o e ffic ie n ts .  T h e   h o r izo n ta l  a x e s  in d ic a te   th e  tra n sla tio n   k   o f  th e  w a v e le t  fo r  th e 
c o e ffic ie n t.  A n   in d ic a tio n   o f  th e  tem p o ra l  lo c a tio n   o f  th e  w a v e le t  c o e ffic ie n t is  g iv e n  
b y   d e c r e a sin g   th e  h o r izo n ta l  sc a le   in   p ro p o rtio n   to   th e  n u m b er  o f   c o e ffic ie n ts.  A n  
e q u iv a le n t  tem p o ra l  lo c a tio n  t fo r e a ch  tra n sla tio n   k  is  fo u n d  fro m   t = k  ■  2 J   TR .Chapter 7: Perfusion Quantification using oML-EM-wavelet -210-
sampled  at  TR=1.5s  and  therefore  contain  a  maximum  frequency  component  of 
0.33Hz.  Prior to decomposition, they were zero-padded to length 64, resulting in a 6  
level  decomposition  consisting of 63  wavelet coefficients  (1+2+4+8+16+32)  and  1 
scaling function coefficient.  The decompositions reveal that there is little information 
contained in the smallest scale (j=0) coefficients.  However, it is these highest-level 
coefficients that are significant in distinguishing the four different states of the bolus.
There will be a continuum of distributions for the wavelet coefficients as the delay 
and dispersion can take any positive number.  In addition, when the data are noisy, 
the distribution of wavelet coefficients may become distorted.  For this reason it was 
not possible to assess accurately the delay and dispersion characteristics of the bolus 
from  examining  the  distribution  of  wavelet  coefficients.  The  majority  of  the 
physically significant frequency components in  Reff (r)  will occur in the first half of
the  32  level j=0  coefficients,  since  unless  the  delay is  very  long,  the  RTM of the 
impulse  response  will  occur in  the first half of the  time  series.  In wavelet  space, 
location information can be used to distinguish the noise in the tail of the function 
from the wavelet coefficients defining the true uncorrupted shape of Reff(t).
The denoising  scheme used in this work is to hard-threshold the smallest scale j=0 
level  wavelet coefficients  of the  oML-EM  solution.  This  denoising  scheme has  a 
clear advantage over more traditional Fourier- based filtering methods, which cannot 
be localised to  a particular part of the function.  Such  a scheme will preserve  any 
large magnitude (j=0 ) wavelet coefficients defining the sharp peak of a delayed and 
non-dispersed  Reff(t),  but  suppress  the  small  magnitude  (j=0)  wavelet  coefficients
that may derive from noise.  All the larger-scale (j= 1  -  5) wavelet coefficients  are 
kept on the premise that the noise in the oMLEM reconstruction will be small-scale 
(high-frequency).  This  assumption  is  of  course  dependent  on  the  successful 
termination  of the iterations by means  of the oscillation index,  which prevents the 
complete  corruption  of  the  ML-EM  reconstruction  by  over  iteration.  The  hard- 
threshold  used  on  the  wavelet  decomposition  of the  oML-EM  reconstruction  was 
empirically chosen from simulations to be 5% of the value of the height of the largestChapter 7: Perfusion Quantification using oML-EM-wavelet -211-
coefficient  across  all  scales.  This  threshold  was  found  to  be  most  efficient  at 
removing any residual oscillations in the oML-EM solution whilst at the same time 
preserving the coefficients defining the RTM of the oML-EM recovered  r .  Figure 
7.8 shows two oML-EM reconstructions of r , one with delay and another with delay 
and  dispersion.  The  different  colour  curves  represent  thresholding  the  level j =0 
coefficients  at  different  levels  as  indicated  in  the  legends.  It  can  be  seen  that 
removing too many of the smallest scale wavelet coefficients can actually introduce 
additional  distortion  into  the  reconstruction.  However,  removing  a  few  of these 
coefficients  minimises  oscillations  in  the  tail  of  r }2  Although  the  simulations 
shown were performed at SNR=50, the oscillations index constrains the noise in the 
oML-EM  reconstruction  so  that  the  wavelet  denoising  thresholds  should  be 
independent of the actual noise in the data.
7.3.2  Oscillation Index
In  the  previous  section  reference  was  made  to  the  oscillation-index  regularised  or 
oML-EM solution.  In this section the oscillation index is described.
An oscillation index (01) that indicates the quality of the ML-EM reconstruction is 
calculated  after  each  iteration.  The  iteration  number p,  before  which  a threshold 
value for the OI is exceeded, becomes the number of iteration used in the oML-EM 
reconstruction.
The OI used in this work is based on the one proposed by Wu et al. in (Wu et al 
2003).  The  OI implemented  in  the  work  by  Wu  was  designed  to  determine  an 
appropriate threshold for the suppression of singular values in an SVD deconvolution 
of DSC-MRI  data  (see  Section  4.8.4  for  a  detailed  description  of SVD).  The  OI 
proposed  in  this  work  is  similarly  designed  to  optimise  the  regularisation  of the 
deconvolution algorithm, in this case ML-EM deconvolution.  The proposed OI is
1 2  Note that the reconstructions shown in Figure 7.8  have long MTT.  Consequently, there has been 
some truncation of the concentration time-course used in the deconvolution (45 time points were 
sampled at TR=1.5s), which results in an underestimation of points defining the tail of r .Chapter 7: Perfusion Quantification using oML-EM-wavelet -212-
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Figure 7.8:  The  oML-EM reconstructions of  r  (from TR=1.5s,  SNR=50  simulated 
data)  a)  CBF=20ml/100g/min,  C£V=3ml/100g,  delay=5s,  dispersion  /?=0s,  (see 
Chapter 5) b) CBF=50ml/100g/min, CBV=6ml/100g, delay=1.5s, /?=4s.  The different 
colour curves  represent thresholding the level j - 0 coefficients  at different  levels as 
indicated in the legends.  The dashed curve is the true shape of  CBF ■  Re ff (r).
subtly different from Wu’s OI in that it is designed to be sensitive to the shape of the 
impulse response being  recovered.  An  ideal  OI would  allow  sufficient iteration to 
recover the high frequencies  defining the less  dispersed  r ,  whilst at the same time 
preventing over iteration  and consequent corruption of the reconstruction.  Whereas 
Wu et al. measured the oscillations by summing over the change (between successiveChapter 7: Perfusion Quantification using oML-EM-wavelet -213-
points) in the gradient of the function; in this work we restrict the sum to the cases 
when the gradient changes sign.  For example, consider three consecutive time-points 
in the  r  curve ( ,   ri  and  rM ), which describe a section of the rise-to-maximum.  If
< rt  and  ri <ri+l, (i.e. the section is smoothly increasing), the modified OI  does 
not include them in the sum, since they do not constitute an oscillation.  However, if
< r.  and  rM < rt , (i.e. a section where  ri  is the maximum), the gradient between
consecutive  points  has  changed  sign,  indicating  an  oscillation.  Such  points  are 
included in  the modified  OI.  One might imagine  a situation  where  a fourth point 
rt +  2  satisfies  r  < ri+ 2  ,  continuing  the  rise-to-maximum.  Although  the  gradient
between  consecutive  points  (r.,  ri+ 1   and  ri+2)  had  changed,  the  gradient between
points  ri  and  rM  has  already  been  included  in  the  modified  OI  summation.
Therefore,  the  gradient  change  across  the immediately adjacent three points  is  not 
included in  the modified  OI summation.  In  summary,  the modified  OI only  sums 
over the gradient change between three consecutive points, where the middle point is 
the local maximum.  As a result of restricting the summation to local oscillations in 
r , the modified OI is in general smaller than that measured using the OI proposed in 
(Wu  et al  2003).  In  particular it is  significantly  smaller for more  steeply curved 
functions,  whose  large  inter-point  gradients  result in  a  large  OI using  the  method 
proposed by Wu et al.  The omission of points where there is no inter-point gradient 
change promotes comparatively more iteration for more steeply curved functions in 
using the modified OI summation.  Additionally, the maximum of r  is not included 
in the modified summation, leading to a smaller OI for sharper functions, such that 
they  will  be  recovered  with  more  iteration.  The  modified  summation  is  also 
multiplied by the full-width-half-maximum (FWHM) and divided by the maximum 
value of the recovered  r .  These modifications respectively cause a larger OI (and 
therefore less  iteration)  for broad  dispersed functions,  and  a  smaller OI for higher 
flows  (encouraging  more iteration to recover the high-frequency components  often 
associated with such functions).  The oscillation index used in this chapter is:Chapter 7: Perfusion Quantification using oML-EM-wavelet -214-
01  =
FWHM
V   \2r[k\ 
CBF  I  ^   1
[7.14]
where  k is the iteration number, / is the sample length, and FWHM is the width of 
r[k].  Scaling by the sample length naturally accounts for the TR of the data, since 
there will be fewer sampling points for data recorded at longer TR.  (In this chapter 
data simulated with TR=ls data contained 64 sample points, TR=1.5s data contained 
45 sample points, and TR=2s data contained 34 sample points).
The solution  r[ p ]   is the first iteration for which OI>a.  A range of a  ranging from 
0 .0 0 1 to  1 .0 was tested in order to find a value for  a  that balanced the least squares 
and regularisation  error.  In this  way,  the  subsequent wavelet denoising  should be 
effective.  The empirically chosen values of  a  used in this work are  a = 0.01  for 
CBF  Reff(t)  believed  to  have  no  delay  or  dispersion  (i.e.,  the  maximum  of the
reconstruction occurring at the first time point), and  a = 0.025  for  CBF •  R ^ (t)  in
all  other  cases.  Figure  7.9  illustrates  the  recovery  of a delayed impulse  response 
function and a delayed and dispersed impulse response function, at progressive values 
of the oscillation index from data simulated at SNR=50.Chapter 7: Perfusion Quantification using oML-EM-wavelet -215-
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Figure 7.9:  Effect of the oscillation  index  07:  sML-EM  reconstructions  of impulse 
response functions from SNR=50 TR=1.5s  data simulated with ischaemic perfusion 
parameters  CBF=20m\/1  OOg/min,  CBV=  3ml/100g,  for  delay=2s  and  no  dispersion 
(top) and for delay =ls and /?=3s (bottom).  The true  CBF ■  Reff(t)  shape is shown by
the orange dashed curve.  It can be seen that an OI-2.5 is too large and the ML-EM 
solution  is  severely corrupted.  An  07=0.001  solution  has  had  too  few  iteration  to 
properly characterise the shape.  07=0.025 was found to be a good balance between 
the  least-squares  and  regularisation  error  for  the  range  of  perfusion  and 
delay/dispersion parameters tested.____________________________________________Chapter 7: Perfusion Quantification using oML-EM-wavelet -216-
73.3  AIF M atrix Selection
As  discussed  in  Section  6.3.1,  discretisation  errors  are  significant  in  the 
reconstruction of  CBF •  (t) .  The shape distortion is particularly apparent when
the time scale of changes in  Reff (?) is as small as (or smaller than) TR, such as is the
case with a delayed  Reff (t).  In order to minimise these errors, two different matrices
are described in Section 6.3.1.  In summary, the integral approximation used in the 
matrix,  A2 (Equation  6.3),  assumes  that both  Reff (?)  and  the  AIF  evolve  linearly
between sample points.  This assumption is not appropriate for  Reff (?)  where there is
a  discontinuity  at  the  RTM  (when  the  bolus  is  delayed  but  not  dispersed).  An 
alternative  matrix  Ai  (Equation  6.4),  assumes  that  only  the  AIF  evolves  linearly 
between sample points and that  Reff (t)  is constant.  The reconstructions with Ai and
A2 are subtly different, particularly across the RTM, which is important in assessing 
dispersion.  Simulations performed  as part of the preliminary investigations  of the 
mML-EM method described in Chapter 6 suggested that matrix Ai best reconstructs 
R ^ (*)  with no dispersion and when the delay is close to an integer multiple of TR,
whereas matrix A2 best reconstructs  Reff (t) for all other situations.
In this chapter, the matrix-selection criteria used to decide which matrix to use in the 
final reconstruction are given in the Equation [7.16] in the Appendix to this chapter. 
As  with  the  criteria  given  in  Appendix  of  Chapter  6 ,  these  criteria  were  also 
determined empirically via simulations.  The new criteria were devised with a view to 
decrease the sensitivity to TR.  500 iterations of the standard ML-EM deconvolution 
were performed on the  simulated data  set (see  Chapter 5)  and  relevant parameter 
values  (CBF,  dispersion index  (DI)  (see Equation  [7.15],  Section 7.5.4)  and RTM) 
were recorded for combinations of CBF, CBV, delay and dispersion for each repeat at 
TR  =ls,  1.5s  and  2s.  The  results  of  a  subset  of  these  simulations 
(CBF=60ml/1 OOg/min, C£V=4ml/100g at SNR=100) are shown in Figures 7.16, 7.17 
and  7.18  in  the  Appendix.  The  patterns  observed  in  the  results  were  used  to 
determine  matrix-selection  criteria  given  in  Equation  [7.16].  Table  7.1  in  theChapter 7: Perfusion Quantification using oML-EM-wavelet -217-
Appendix  records  the  accuracy  of  these  criteria  for  the  perfusion  parameters 
CBF=60mV 1 OOg/min, CRV=4ml/100g at SNR=50 and 100.  Further discussion about 
the AIF matrix selection is given in the Discussion section.
73.4  oML-EM-w avelet Simulations
The  new  deconvolution  methodology  (oscillation-index  regularised  ML-EM  with 
subsequent wavelet decomposition and thresholding, or oML-EM-wavelet) was tested 
on simulated data, which were created to represent a range of physiological situations 
for typical  scanning parameters.  This  data  set is  described in  Chapter 5.  A  flow 
diagram  summarising  the  main  steps  in  the  oM-EM-wavelet  method  is  given  in 
Figure 7.10.
1 0 0  repeats  of  the  simulations  were  performed,  and  for  each  combination  of 
parameters (noise, TR, CBF, CBV, delay, dispersion).  The CBF was estimated from 
the  maximum  of  the  oML-EM-wavelet  solution,  r  and  the  mean  and  standard 
deviations for each point of  r were evaluated.  In order to achieve high-resolution 
measurements  of the  shape,  the  solution  r  was  subsampled  at  TR=0.01s  using  a 
linear interpolation between sample points.  The delay  tdelay  was estimated from the
length  of the  subsampled baseline  (defined  to  end  prior to  exceeding  1 0 %  of the 
maximum  of  rsubsam pled).  The  dispersion  characteristics  were  estimated  using  a
dispersion index (DI) defined as:
DI = FWHM { r , ^ d )x RTM (rsubsmpltd)  RTM  )>TR
DI = 0
FWHM  is  the  full-width-half-maximum  (in  seconds),  and  RTM  is  the  rise-to- 
maximum (in  seconds)  from baseline.  It  should be noted that  Reff{t)  with  a  long
MTT will have a large FWHM, as does a dispersed  Reff {t).  Therefore, the FWHM
alone cannot be used to identify dispersion.  Similarly, the RTM cannot be used as aChapter 7: Perfusion Quantification using oML-EM-wavelet -218-
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Two sML-EM deconvolution using the two AIF matrices Ai 
and A2 (Section 6.3.1)
two estimates  r . Select matrix (Equation 7.16 in 
Appendix)
oscillation-index  regularised ML-EM using selected matrix 
(Section 7.3.2) then zeropad  r  to length 64
6 level wavelet transform (W7) of r  using Daubechies-4 
wavelet (Section 7.3.1)
threshold smallest-scale wavelet 
coefficients (Section 7.3.1)
inverse wavelet transform
oML-EM-wavelet estimate  r
CBF
cv 0l(t)
AlFit)
oML-EM
(CBF  Reff(t)\
oML-EM-wavelet
if  A i = 0,k)< O.osl/O,*:)!^ then  A j = 0 ,*) = 0 .0
maximum  shape
value  parameters
Figure 7.10: Flow diagram summarising the oML-EM-wavelet method applied to the 
simulated data set.Chapter 7: Perfusion Quantification using oML-EM-wavelet -219-
measure  of dispersion,  since  for a  given  dispersion,  the RTM increases  with MTT. 
Nevertheless, by including the RTM in the definition for DI, only  r  reconstructed 
with a RTM greater than or equal to one TR are classified as dispersed.
7.3.5  Sim ulating the effects of Negative Dispersion
Simulations were also performed to determine the effect of negative dispersion on the 
shape of oML-EM-wavelet deconvolved  r .  In this situation the true AIF is sharper 
than the measured AIF.  This would occur if the global AIF used to deconvolve  a 
concentration  time-course  measured  in  tissue  fed  by  normal  vasculature,  were 
actually measured in an abnormal artery.  An AIF measured downstream of an arterial 
stenosis is likely to be dispersed compared with an AIF measured in a healthy artery. 
In practice, care should be taken to avoid such a situation in vivo, and the artery used 
to  measure  the  AIF  should  be  contralateral  to  any  abnormality.  It  is  however 
important to be aware of how such a mis-measured AIF distorts the reconstructed  r . 
To  simulate  this  situation,  the  AIF  used  in  the  deconvolution  was  generated  by 
convolving the  AIF used to  simulate the  tissue  with  an  exponential  model  for the 
vascular transport function,  VTF{t)=\.5e~tn s (see Section 4.7.2).  This simulates the 
situation of deconvolving tissue fed by a normal artery with an AIF measured in an 
abnormal  vessel,  where  the  mean  vascular  transit  time  is  1.5s.  The  situation  is 
illustrated in Figure 7.11.  The figure show that the AIF does not need to appear more 
dispersed than the tissue for negative dispersion to be present.  The oML-EM-wavelet 
method  described  in  Section  7.3.4  was  used  to  deconvolve  the  simulated  data  set 
described in Chapter 5 with the modified dispersed AIF.Chapter 7: Perfusion Quantification using oML-EM-wavelet  - 220 -
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Figure  7.11:  Illustration  of  negative  dispersion  in  the  bolus  concentration  time- 
course:  The dispersed AIF (blue curve) has been created by convolving the normal 
AIF (red curve), with an exponential VTF with time constant 1.5s.  The black curve is 
the  simulated  tissue  concentration  (SNR=100,  TR=1.5s)  for  healthy  tissue 
(Cl?F=60ml/100g/min, C^V=4ml/100g) fed by the normal AIF.____________________
7.4  R esults
7.4.1  Characterising the Impulse Response Function
The  average  over  100  oML-EM-wavelet  reconstructions  r ,  of  three  different 
simulated  CBF  Reff(t)  functions  are  shown  in  Figure  7.12  corresponding  to  a)
^   delay  =  °> ^=0s  >   b )  *   delay = 1 -5 s >   c )  t deiay =3s>  ^=6s  (simulated for healthy
GM  tissue perfusion  with  CB =60ml/100g/min, M7T=4s).  The error bars represent 
+/- one standard deviation (sd).  The size of these error bars was approximately 30% 
larger  at  SNR=50  compared  with  SNR=100;  this  trend  was  observed  for  all  the 
simulation  results  presented  here.  Representative  individual  reconstructions  are 
shown in the insert of Figure 7.12.  The figure demonstrates that the oM-EM-waveletChapter 7: Perfusion Quantification using oML-EM-wavelet -221 -
1
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Figure  7.12:  The  mean  (+/-  lsd)  of  the  oML-EM-wavelet  reconstruction  of  the 
impulse  response  function  r  for  three  combinations  of  simulated  delay  ^eiay  and 
dispersion /?  a) tdeiay=0s and /?=0s, b) fdeiay=1.5s and /?=0s, c) tdeiay=3s and /?=6s.  In 
all cases,  CBF= 60ml/100g/min  and M7T=4s.  The SNR  of the  simulated data was 
100  and  TR=1.5s.  The  insert  shows  a  single  result  of the  100  simulations.  The 
dashed lines are the true  CBF ■  R^ (r) and the solid lines the estimate  r .
method  enables  a  good  characterisation  of  a  wide  variety  of  possible  shapes 
for Ci?F •  Reff (r).  Good shape characterisation is necessary in order to determine the
reliability of CBF estimates.  In  particular the  oML-EM-wavelet  method  is  able  to 
characterise the sharp initial rise for the delayed and non-dispersed curves.
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7.4.2  CBF Q u a n tific a tio n
Figure  7.13  shows  the  mean  (+/-  1  sd)  CBF estimated  from  the  maximum  of the 
reconstructed  r  simulated  with  no  bolus  delay  or  dispersion  for  CBF-  10-80 
ml/lOOg/min (M77=4s (solid line) and  6 s (dash-dot line)).  When there is no bolus 
delay or dispersion, the oML-EM-wavelet method enables a good estimation of CBF 
across a large range of simulated CBF values.  The underestimation for larger flow 
values is more marked for shorter MTTs.  This is consistent with the observations in 
Chapter 6  (Figure 6.7).
7.4.3  Dispersion Index
The  accurate  characterisation  of  CBF  Reff(t)  permits  a  robust  estimation  of the
dispersion index (DI) for each case.  Figure 7.14 shows the mean DI (+/-  1  sd) for 
CBF  Reff(t)  simulated  with  dispersion  /?=0-6s,  (C5F=60ml/lOOg/min,  MTT=4s
(solid line) and Af7T=2s (dashed line)) over 100 reconstructed  r .  As expected, the 
DI increases with the simulated dispersion /?, but is also dependent on the perfusion 
parameters.
7.4.4  Effect of Negative Dispersion
Figure 7.15  shows  a typical  example  of the reconstructed  r  from the  simulations 
performed to assess the effect of negative dispersion, i.e. when the AIF used in the 
deconvolution  is  wider  than  the  true  AIF.  It  can  be  seen  that  when  a  wider 
(abnormal) AIF is used, the CBF for the tissue that is fed by a healthy vessel will be 
severely overestimated (solid line) and the estimated impulse response function has a 
very large negative initial slope compared with the true CBF •  R(t) (dashed line).Chapter 7: Perfusion Quantification using oML-EM-wavelet -223-
pu 40
simulated CBF /ml/100g/min
Figure 7,13; The mean (+/- Isd) CBF calculate from the maximum of r  across range 
of simulated flows CBF=10-80ml/100g/min, and MTT = 4s (solid line), and 6s (dash- 
dot line).  The SNR of the simulated data was 100 and TR=1.5s.
7.5  D iscussion
An  accurate  characterisation  of  the  impulse  response  function  CBF ■  Re ff (t),  is
essential  for  determining  the  reliability  of  perfusion  estimates.  Unless  the  shape 
CBF •  Re ff (f)  is known, it is  impossible to determine whether the bolus was delayed
and/or  dispersed.  Since  the  effect  of dispersion  is  to  cause  an  underestimation  of 
perfusion,  an  accurate  classification  of  hypoperfused  tissue  requires  information 
about  the  shape  of  CBF •  Reff(t).  Only  perfusion  measurements  taken  from
CBF ■  Re ff (t) with no delay or dispersion can be used as a reliable indicator of tissueChapter 7: Perfusion Quantification using oML-EM-wavelet -224-
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Figure 7.14: The mean (+/-  lsd) £>/ of  r  measured from across range of simulated 
dispersions /?=0-6s,  and for data  simulated with CBF=60mV 1 OOg/min  and M7T=4s 
(solid  line)  and  2s  (dashed  line).  The  SNR  of the  simulated  data  was  100  and 
TR=1.5s.
status.  This has particular relevance for predictor-models, which combine perfusion 
estimates with other MR parameters to predict tissue fate e.g. (Wu et al. 2001).  Bolus 
dispersion  will  lead  to  various  degrees  of  underestimation  for  the  perfusion 
measurements,  and these errors  will propagate in the predictor-models,  resulting in 
unreliable predictions.  Additional information regarding the vasculature would be a 
useful covariate in these models, since it may be able to counterbalance the perfusion 
measurement bias.  In  particular,  maps  indicating  regions  of delay  and  dispersion 
(which could be created using the methodology presented in this chapter), may help 
refine maps indicating the likelihood of infarction after stroke.
Accurate characterisation of the impulse response function is achieved in this work by 
combining an oscillation index regularised ML-EM and wavelet thresholding.  TheChapter 7: Perfusion Quantification using oML-EM-wavelet -225-
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Figure  7.15:  A  typical  oML-EM-wavelet  reconstruction  of  the  impulse  response 
function  r  (solid  line)  when  the  simulated  AIF is  dispersed  with  a  mean  vascular 
transit  time  of  1.5s  with  respect  to  the  tissue  (negative  dispersion),  such  that  the 
measured AIF is more dispersed than the true AIF.  The dashed line  shows the true 
shape of CBF ■  Re ff (r).
oscillation  index  constrains  the  noise  in  the  ML-EM  reconstruction  to  be 
approximately  the  same  for data  across  a  range  of SNRs  and  imaging  parameters. 
Although  the  oscillation  index  and  wavelet  threshold  have  been  empirically 
determined,  the  criteria  are  more  universal  than  those  found  for  our  previously 
proposed mML-EM reconstruction  (Chapter 6).  The convergence criteria in  mML- 
EM were found to be dependent on various imaging parameters, due to the fact that 
the  data  points  in  the  reconstruction  converged  at  different rates  depending  on  the 
imaging parameters  (e.g.  TR,  which  governs  the  maximum  represented  frequency). 
The  oscillation  index  in  oML-EM  constrains  the  distribution  and  magnitude  of 
wavelet coefficients such that the wavelet thresholding can be universal.  Without anChapter 7: Perfusion Quantification using oML-EM-wavelet -226-
oscillation index to constrain the noise, the wavelet thresholding may have no effect, 
or worse, could introduce additional distortion in the reconstruction.  Therefore, it is 
the combination of the oscillation-index and the wavelet-thresholding methods, which 
make the new method robust.
The use of the wavelet transform to improve perfusion quantification has previously 
been  implemented  by  Wirestam  et  al.  (Wirestam  et  al.  2005),  who  combined  a 
Weiner filtered Fourier Transform with wavelet thresholding.  In that previous work, 
a small amount of regularisation was performed on the FT deconvolution (see Section 
4.8.2) by using the Tikhonov regularised  solution (Tikhonov  1963) to estimate the 
best Weiner filter for each reconstruction.  This approach appears to over-regularise 
CBF •  (r) as indicated by the perfusion underestimation for C5F>30ml/100g/min
in Figure 2b in reference (Wirestam et al  2005).  In particular, for the exponential 
impulse response function  simulated with  CBF=60ml/100g/min  and M7T=4s,  their 
average estimated CBF was -45 ml/lOOg/min.  In comparison, Figure 7.13 shows that 
the  equivalent  estimate  with  oML-EM-wavelet  method  is  C5F~55ml/100g/min. 
Over-regularisation is largely avoided using the oML-EM-wavelet method, which can 
characterise  both  delayed  and  dispersed  CBF  R^(t)  (Figure  7.12),  and  leads  to
better CBF estimates (Figure 7.13).  Although the 01 used in this current study may 
cause the tail of  CBF •  Reff (t) to become corrupted, these unrealistic oscillations can
be removed with the wavelet thresholding.  As discussed in Chapter 6 , because the 
deconvolution  problem is  ill-posed,  it is  very  difficult to  recover delayed  impulse 
response functions,  and most methods fail.  However, the method presented in this 
work provides a good characterisation of delayed curves.
It should be noted that the severity of dispersion cannot be reliably estimated reliably 
from  r .  Although Figure 7.14 shows a positive correlation between the simulated 
dispersion (using an exponential VTF) and the measured DI, the relationship is highly 
dependent on the MTT of the tissue.  Therefore, although the DI can be used as an 
indication  of  the  presence  of  dispersion,  the  actual  quantitative  value  cannot  be 
determined reliably from this measure.Chapter 7: Perfusion Quantification using oML-EM-wavelet -227-
On  its  own,  DI  cannot  distinguish  a  prolonged  MTT  in  the  tissue  from  bolus 
dispersion  in  the  artery.  For  a  dispersed  Reff (t)  it  is  not  possible  to  determine
whether the shape is due to a prolonged MTT in the tissue and small dispersion of 
bolus in the feeding artery, or whether the shape is due to a large dispersion of bolus 
in the vessel  and a normal MTT in the tissue.  It is therefore difficult to develop a 
model of the vasculature purely from the shape of CBF •  Reff (r)  that will correct the
Reff (t)  for  perfusion  errors  caused  by  bolus  dispersion.  Over-compensating  for
dispersion  will  cause the true MTT to be underestimated  (see  Figure  7.15),  where 
negative dispersion artificially inflates the CBF.  An accurate correction of dispersion 
is possible with a suitable VTF model, whose specific form is likely to be strongly 
dependent  on  the  specific  vasculature  of  the  patient  (Calamante  et  al.  2003b; 
0stergaard  et  al.  1999;  Mouridsen  et  al.  2006b).  Separating  the  components  of 
microvascular  and  arterial  dispersion  is  a  difficult  task,  requiring  either  a  voxel- 
specific  model  for  the  VTF  or  a  voxel-specific  arterial  input  function  An 
investigation into a suitable model for the VTF is investigated in Chapter 8 using in 
vivo data from patients with a range of cerebral arterial abnormalities.  In Chapter 9 
two alternative means to correct dispersion are investigated.
In order for the DI and delay to be meaningful parameters, it is important that the 
global AIF is correctly measured.  The global AIF should be measured in an artery 
without any abnormality to ensure that it is not delayed and/or dispersed compared 
with the bolus concentration measured in tissue fed by a different artery.  If the global 
AIF were measured in an abnormal artery, then tissue that is fed by a normal artery 
could be deconvolved with a wider input function leading to an erroneous  r  being 
extracted  for  the  healthy  tissue  (see  Figure  7.15).  In  this  situation,  tissue  would 
mistakenly be classified  as having high  CBF and  short MTT.  In the  extreme case 
where the AIF is more dispersed than the bolus in the tissue itself, deconvolution does 
not  make  mathematical  sense.  In  practice,  the  risk  of  distorting  r  by  negative 
dispersion can be minimised by carefully selecting the global AIF from voxels within 
a  normal  artery  whose  concentration  time-courses  occur  early  and  are  narrow 
(minimum dispersion).Chapter 7: Perfusion Quantification using oML-EM-wavelet -228-
Figure 7.13  shows that in the ideal situation where there is no bolus distortion, the 
new  deconvolution  method can  recover  reasonable estimates  of the  true  perfusion 
values, especially so in the clinically interesting cases  where there  are long MTTs. 
These  perfusion  measurements  can  therefore  be  used  to  improve  the  reliably  of 
prediction  of tissue  that  is  likely  to  infarct.  This  is  essential  for  the  appropriate 
selection of patients for treatment.
Although a full correction of the dispersion errors may not be possible at present, the 
new deconvolution method presented here is the first step towards accurate perfusion 
maps,  as  it gives  an  accurate and robust reconstruction  of  CBF ■  Reff (t)  as  well  as
providing parameters indicating delay and dispersion, which indicate the reliability of 
the  estimated  perfusion  parameters.  Such  information  regarding  the  vasculature 
would be valuable information in models used to predict tissue outcome in  stroke. 
Chapter  9  investigates  the  application  of the  oML-EM-wavelet  method  to  patient 
data,  demonstrating  its  utility  in  identifying  regions  of  delay/dispersion-related 
perfusion measurement errors, and their subsequent correction.
7.6  A ppendix
This appendix gives the criteria used in this work to decide which AIF matrix use in 
the  oML-EM-wavelet  deconvolution.  These  criteria  were  determined  from 
simulations.
500 iterations of standard ML-EM deconvolution were performed on the  simulated 
data set (Chapter 5).  Parameter values (CBF, dispersion index (DI) and RTM) were 
measured from the extracted impulse response functions  r  for TR =ls,  1.5 s and 2s 
data.  Figures  [7.16],  [7.17],  and  [7.18]  show the measured parameter values  from 
SNR=50 data with TR =ls,  1.5s and 2s respectively.  They reveal that when there is 
no dispersion, and the delay is an integer multiple of TR, the CBF, DI and RTM are 
larger  using  matrix  A2.  These  trends  were  incorporated  into  the  matrix-selectionChapter 7: Perfusion Quantification using oML-EM-wavelet -229-
criteria  to  select  the  matrix  Ai  for  such  cases.  For  dispersed  impulse  response 
functions, the RTM is larger,  and it is desirable to reconstruct such functions using 
matrix A*  Similarly, when the RTM is zero (i.e. no delay or dispersion) matrix A2 
should be used.
The above described information was used to determine the matrix-selection criteria 
given in Equation [7.16] below:
The  accuracy  of these criteria is  given in Table  7.1.  The table indicates  that the 
criteria  give  a reasonably  accurate  selection  of the  Ai  matrix  for  a  non-dispersed 
response with an integer TR delay.  For the SNR=100 data (SNR=50 data), at TR=2s, 
there is  84%(61%) and 91%(64%)  success rate for 2s  and 4s  delay respectively,  at 
TR=1.5s,  there  is  84%(61%)  and  96%(68%)  success  rate  for  1.5s  and  3s  delay 
respectively,  at TR=ls,  there  is  93%(68%),  92%(67%),  90%(66%)  and  81%(60%) 
success rate for Is, 2s, 3s, and 4s delay respectively.  In general the accuracy is higher 
for the higher SNR simulations.
It was found that even at high SNR, the criteria were not very accurate in selecting 
the A2 matrix for impulse response functions  with  small dispersions  and particular 
values  of delay.  It is  very difficult to  distinguish  such  a  small  dispersion  from  a 
delay.  Example ML-EM reconstructions of impulse response functions with Is delay 
and  Is dispersion, from data simulated at TR=2s  and TR=ls,  are  shown in Figures 
7.19 and 7.20 respectively .  The figures reveal that although  r are different using Ai 
(red  curve)  and  A2  (blue  curve),  it  is  difficult  to  distinguish  which  one  better 
characterises the true impulse response function (black dashed curve).
A = A,
[7.16]
unless  RTMa  >2TR  or  RTMA  <TR A = A,
else A = A.
The accuracy of the selection criteria is therefore only of primary importance when 
there is no dispersion in the impulse response function.  Such a situation is illustratedChapter 7: Perfusion Quantification using oML-EM-wavelet -230-
in Figure 7.21.  The figure shows that matrix Ai provides the better characterisation 
of the delayed and non-dispersed impulse response function.  Table 7.1 shows that the 
matrix-selection  criteria  used  in  this  work  are  reasonably  accurate  in  correctly 
selection the Ai matrix to reconstruct non-dispersed impulse response functions that 
have an integer TR delay (first column), although the matrix selection is less accurate 
for lower SNR.  Typically, after denoising (with for example, independent component 
analysis (Calamante et al.  2004)) the SNR of in vivo data lies in the range  100-500 
depending on the quality of the initial  data,  (which itself depends  on the particular 
MRI scanner, the sequence parameters and amount of contrast).Chapter 7: Perfusion Quantification using oML-EM-wavelet  - 231 -
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Figure 7.16: The mean (+/-  1   sd)  CBF recorded as a function of delay for the ML- 
EM  (500  iterations)  reconstruction  of  CBF  Reff(t)  (C5F=60ml/100g/min,
CBV=4ml/100g, dispersion /?=0s) using matrix Ai (blue line) and matrix A2 (red line) 
for TR=2s (top), TR=1.5s (middle) and TR=ls (bottom) from SNR=50 simulated data 
over 100 repeats.  There is a periodicity in the measured CBF, which is dependent on 
the convolution matrix.Chapter 7: Perfusion Quantification using oML-EM-wavelet  - 232 -
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Figure 7.17: The mean (+/-  1   sd) DI recorded as a function of delay for the ML-EM 
(500  iterations)  reconstruction  of  CBFReff(t)  (C5F=60ml/100g/min,
CZ?V=4ml/100g, dispersion /?=0s) using matrix Ai (blue line) and matrix A2 (red line) 
for TR=2s (top), TR=1.5s (middle) and TR=ls (bottom) from SNR=50 simulated data 
over  100 repeats..  There is a periodicity in the measured DI, which is dependent on 
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Figure 7.18: The mean (+/-  1  sd) RTM recorded as a function of delay for the ML- 
EM  (500  iterations)  reconstruction  of  CBF ■  Reff(t)  (CBF=60m\l\OOg/min,
C£V=4ml/100g, dispersion /?=0s) using matrix Ai (blue line) and matrix A2 (red line) 
for TR=2s (top), TR=1.5s (middle) and TR=ls (bottom) from SNR=50 simulated data 
over 100 repeats..  There is a periodicity in the measured RTM which is dependent on 
the convolution matrix.Chapter 7: Perfusion Quantification using oML-EM-wavelet -234-
dispersion /s
TR=2.0s
SNR=100
0.00 1.00 2.00 3.00 4.00 5.00 6.00
delay /s  0.00 1.00 1.00 1.00 0.99 0.99 0.97 0.91
0.50 1.00 1.00 0.91 0.84 0.68 0.80 0.72
1.00 1.00 0.34 0.55 0.79 0.88 0.92 0.98
1.50 1.00 0.83 1.00 1.00 1.00 1.00 1.00
2.00 0.84 1.00 1.00 1.00 1.00 0.99 0.94
2.50 1.00 1.00 0.86 0.85 0.89 0.79 0.81
3.00 1.00 0.47 0.69 0.92 0.93 0.94 0.94
3.50 1.00 0.86 0.99 1.00 1.00 1.00 1.00
4.00 0.91 1.00 1.00 1.00 0.99 0.99 0.96
TR=1.5s
SNR=100
delay /s  0.00 1.00 0.99 0.93 0.87 0.82 0.79 0.85
0.50 1.00 0.69 0.33 0.80 0.90 0.98 0.95
1.00 1.00 0.64 1.00 1.00 0.99 0.99 0.98
1.50 0.84 1.00 0.99 0.96 0.88 0.81 0.81
2.00 1.00 0.77 0.25 0.93 0.86 0.90 1.00
2.50 1.00 0.46 0.99 1.00 0.99 0.99 0.99
3.00 0.96 1.00 1.00 0.97 0.94 0.87 0.86
3.50 1.00 0.76 0.29 0.93 0.90 0.95 0.96
4.00 1.00 0.31 1.00 1.00 1.00 1.00 1.00
TR=1.0s
SNR=100
delay /s  0.00 1.00 0.88 0.65 0.77 0.92 0.95 1.00
0.50 0.99 0.35 0.94 0.99 0.99 0.99 0.95
1.00 0.93 1.00 0.86 0.90 0.93 0.97 0.99
1.50 1.00 0.29 0.96 0.99 0.99 1.00 0.98
2.00 0.92 1.00 0.90 0.92 0.95 0.99 0.99
2.50 1.00 0.49 1.00 0.99 1.00 1.00 1.00
3.00 0.90 1.00 0.97 0.93 0.99 0.97 1.00
3.50 1.00 0.66 0.99 1.00 1.00 1.00 0.99
4.00 0.81 1.00 0.98 1.00 1.00 0.99 0.99Chapter 7: Perfusion Quantification using oML-EM-wavelet -235-
TR=2.0s
SNR=50
c
0.00
ispers
1.00
ion /s 
2.00 3.00 4.00 5.00 6.00
delay /s  0.00 1.00 1.00 0.95 0.87 0.95 0.90 0.92
0.50 1.00 0.98 0.74 0.79 0.83 0.86 0.93
1.00 1.00 0.47 0.76 0.91 0.88 0.95 0.99
1.50 0.99 0.87 1.00 1.00 0.98 0.99 0.98
2.00 0.61 1.00 0.98 0.92 0.91 0.93 0.88
2.50 1.00 1.00 0.86 0.70 0.83 0.85 0.90
3.00 1.00 0.53 0.80 0.91 0.91 0.97 1.00
3.50 1.00 0.85 0.98 1.00 1.00 0.99 1.00
4.00 0.64 1.00 1.00 0.97 0.97 0.93 0.96
TR=1.5s
SNR=50
delay /s  0.00 1.00 0.94 0.87 0.80 0.80 0.87 0.89
0.50 1.00 0.61 0.67 0.85 0.90 0.97 0.94
1.00 0.95 0.69 0.98 0.97 0.95 0.94 0.89
1.50 0.61 0.99 0.91 0.88 0.79 0.84 0.86
2.00 0.98 0.74 0.60 0.88 0.92 0.91 0.97
2.50 0.96 0.56 0.98 1.00 0.98 0.91 0.95
3.00 0.68 0.99 0.85 0.84 0.84 0.87 0.91
3.50 0.94 0.71 0.63 0.81 0.89 0.95 0.99
4.00 0.51 0.56 0.99 0.98 0.99 0.98 0.91
TR=1.0s
SNR=50
delay /s  0.00 1.00 0.72 0.69 0.83 0.95 0.94 0.96
0.50 0.98 0.72 0.96 0.92 0.89 0.95 0.95
1.00 0.68 0.83 0.71 0.90 0.93 0.98 0.98
1.50 0.97 0.66 0.97 0.95 0.93 0.94 0.97
2.00 0.66 0.93 0.72 0.85 0.94 0.99 1.00
2.50 0.96 0.63 0.96 0.99 0.93 0.93 0.94
3.00 0.67 0.95 0.85 0.91 0.92 0.98 0.98
3.50 0.97 0.64 0.95 0.98 0.94 0.94 0.96
4.00 0.60 0.98 0.88 0.95 0.97 1.00 0.93
Table  7.1:  The  proportion  of  ‘correctly’  selected  matrices  (Ai  or  A2)  (given  by 
Equation  7.1g)  over  100  simulations  of  delay  (rows)  and  dispersion  (columns) 
combinations for the oML-EM-wavelet at TR=2.0s, 1.5s and 1.0s simulations at SNR 
100  and  50  using  healthy  GM  perfusion  values  (CBF=  60ml/100g/s,  CBV  = 
4ml/100g).  The shaded cells are the delay and dispersion combinations for which it is 
desirable to use the Ai matrix.  __________________Chapter 7: Perfusion Quantification using oML-EM-wavelet -236-
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Figure 7.19: A single reconstruction of  r  from data simulated with /?=ls dispersion 
and  rdeiay=  Is,  C#F=60ml/100g/min,  CBV= 4ml/100g, TR=2s, SNR=100, using 500 
ML-EM iterations.  The red curve is the reconstruction using matrix Ai, and the blue 
curve is the reconstruction using matrix A2.  The true  CBF ■  Reff(t)  is shown with the
black  dashed  line.  Using  either  matirx  it  is  difficult  to  distinguish  the  small 
dispersion from a delay.  The ability to characterise the sharp shape of CBF ■  Reff (t) is
poor for both matrix reconstructions at this temporal resolution.___________________
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Figure  7.20:  A  single  reconstruction  of  r ,  from  data  simulated  with  with  Is 
dispersion  and  Is  delay,  CFF=60ml/100g/min,  CBV= 4ml/100g, TR=ls,  SNR=100, 
using 500  ML-EM  iterations.  The red  curve is the reconstruction  using  matrix  Ai, 
and the blue curve is the reconstruction using  matrix  A2.  The true  CBF ■  Reff (t)  is 
shown with the black dashed line.  Even at a high temporal resolution (TR=ls), it isChapter 7: Perfusion Quantification using oML-EM-wavelet  - 237 -
still  difficult  to  distinguish  the  small  dispersion  from  a  delay  using  either  matrix. 
Furthermore, there is little difference in the accuracy of the two reconstructions._____
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Figure 7.21:  A  single reconstruction  r  with no dispersion  and  Is delay,  from data 
simulated with TR=2s, SNR=100,  CBF=60ml/100g/min, CBV= 4ml/100g, using 500 
ML-EM iterations.  The red curve is the reconstruction using matrix Ai, and the blue 
curve is the reconstruction using matrix A2.  The true  CBF ■  Reff(t) is shown with the
black dashed line.  Using matrix Aj, it is possible to identify that there is delay and no 
dispersion.__________________________________________________________________Chapter 8: Vascular Transport and Perfusion Errors -238-
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8.1  In tr o d u ctio n
The novel ML-EM-based deconvolution techniques presented in Chapters 6 and 7 of 
this thesis  were tested using the  simulated DSC-MRI data described in Chapter 5. 
Although this  approach  is  now  well  accepted in the perfusion MRI field,  and it is 
considered an essential step in the development of analysis methods, the accuracy of 
these  simulated  data  in  replicating  an  in  vivo  situation  will  depend  on  specific 
assumptions  about  the  unknown  form  of  the  microvascular  and  arterial  retention 
models,  i.e.  the  R(t)  and  VTF.  It  is  important that  deconvolution  techniques  are 
tested  using  realistic  DSC-MRI  data  sets,  so  that  the  accuracy  and  robustness  of 
perfusion parameters maps can be extrapolated to the in vivo situation.
In order to simulate a realistic DSC-MRI data set, it is essential to know values for 
experimental  and  physiological  parameters.  There  is  little  difficulty  determining 
realistic values for the experiment parameters of signal intensity, noise, TR and TE, 
since these can either be measured directly from the DSC-MRI images, or determined 
from the scanning sequence.  Similarly, the parameters for the arterial input function 
(AIF)  model,  known  as  the  gamma-variate  model,  (Thompson  et  al.  1964)  were 
determined from patient data (0stergaard et al.  1996b).  A great deal of research has 
been conducted into values  for the physiological parameters,  CBF,  CBV,  and MTT 
under various haemodynamic and pathophysiological conditions e.g.  (Lythgoe et al. 
2000; 0stergaard et al.  1998b), and a realistic range has been established.  Similarly, 
although the form  of the tissue residue function  /?(*)  is  still  somewhat speculative 
(see  Section  4.6.2),  it  has  been  an  active  area  of research  through  simulation  e.g. 
(0stergaard  et  al.  1999;  Mouridsen  et  al.  2006b)  and  in  vivo  measurement  e.g. 
(Calamante et al. 2003a; Willats et al. 2006).  In contrast, very little research has been 
conducted into the form for the vascular transport of the bolus, given by the so called 
vascular transport  function  (VTF)  (see  Section  4.7.2).  Dispersion  in  the  vascular 
transport  can  however  introduce  significant  errors  into  perfusion  quantification 
(Calamante et al.  2000;  Calamante et al.  2003b),  since its contribution distorts theChapter 8: Vascular Transport and Perfusion Errors  - 240 -
shape of the  R(f), which is used to estimate CBF.  Therefore, it is very important that 
the form of the vascular transport and the  size of the resultant perfusion errors  are 
investigated.  A functional form for the VTF would facilitate the design of a realistic 
simulated data  set,  which in  addition to testing DSC-MRI analysis  methods  would 
enable investigation into dispersion and the related perfusion measurement errors.
The  shape  and  significance  of the  distortion  introduced  in  the  concentration  time- 
course  curves  because  of abnormal  arterial  flow  is  unknown.  The  simulated  data 
described  in  Chapter  5,  were  constructed  using  a  delayed  exponential  decay  to
J   ^   delay )
represent the vascular transport, VTF(t -  tdelay) = — e  p  , where tdeiay represents the
H
bolus  delay  and  p   the  bolus  dispersion.  This  exponential  model  has  been 
extensively used to correct for dispersion in PET studies.  However, in this case, the 
dispersion is primarily due to the cannula used to withdraw blood samples (Iida et al. 
1986),  so it is related to a different phenomenon from that found in arteries in vivo. 
In  work performed by Calamante et al.(Calamante et al.  2003b),  a patient specific 
fluid  dynamical  model  for  arterial  blood  flow  constructed  from  anatomical  and 
physiologic  MR  data,  found  that  a  single  exponential  model  could  properly 
characterise  the  dispersion  in  the  four  subjects  studied.  However,  this  study only 
included  patients  with  very  mild  stenosis  in  extracranial  arteries.  Therefore,  the 
validity of this  monoexponential  decay to model  intracranial  sources  of dispersion 
remains to be shown.
The implications in using an incorrect VTF model could be dangerous, since in vivo 
predictions based on inaccurate simulations might be misleading.  An incorrect model 
for  the  VTF  may  therefore  indirectly  contribute  to  misdiagnosis  of patients  with 
cerebral arterial disease.  It is therefore important to use a realistic form of the VTF in 
simulations.
In this chapter, a methodology was developed to extract the in vivo VTFs.  This was 
applied to a number of subjects with a diverse range of cerebral arterial abnormalitiesChapter 8: Vascular Transport and Perfusion Errors -241-
with  a  view  to  verify  whether  the  single  exponential  is  appropriate  to  model 
dispersion  in  all  situations.  Furthermore,  these  VTFs  were  used  to  propose  an 
improved  and  flexible  parameterised  mathematical  model,  with  the  potential  to 
simulate DSC-MRI data that accurately replicates a diverse range of cerebrovascular 
situations in vivo.
Once a suitable model is identified, it is essential to determine a realistic range for its 
parameters.  This  is  analogous  to determining  a realistic  in  vivo range for CBF in 
order to simulate realistic tissue states.  The commonly assumed single exponential 
model  for vascular transport has been  used by  Calamante  et al.  (Calamante  et al. 
2000) to gauge the severity of dispersion-related perfusion measurement error.  Their 
simulations  showed  that  a  dispersion  of  J3=  2.5  seconds  causes  CBF  to  be 
underestimated by 50% and MTT to be overestimated by 200%.  However, a realistic 
range  for the  ft  parameter  found  in  vivo  is  not  currently known.  The largest  ft 
measured in vivo in (Calamante et al.  2003b), was ~0.6s, resulting in CBF errors of 
the order 15-20%.  However, as mentioned before, this was a small group of patients 
all with mild stenosis, and an extensive investigation into the severity of dispersion 
and the related CBF errors has not yet been conducted in vivo.  Such an investigation 
is of great importance, since this potential source of bias could have very important 
implications; for example, some tissue areas with benign oligemia (areas with normal 
or slightly decreased perfusion that will  survive independently of treatment effects 
(Sobesky et al.  2005))  could be misclassified  as penumbral tissue,  with potentially 
serious  clinical  consequences  for  patient  management.  Therefore,  in  addition  to 
informing a mathematical model for vascular transport, the collection of in vivo VTFs 
was used to determine a realistic range of dispersion-related perfusion measurement 
errors encountered in vivo.
Simulations are a vital tool for understanding in vivo data; equally, in vivo data are 
needed  for the  simulation  of realistic  data  sets.  This  chapter investigates  vascular 
transport in a group of patients with a range of cerebral arterial abnormalities.  The 
chapter has three  aims:  1) to determine  a realistic model for the vascular transport 
function, 2) to determine the typical in vivo range for the model parameters, and 3) toChapter 8: Vascular Transport and Perfusion Errors -242-
investigate in vivo  the dispersion-related perfusion errors resulting from the vascular 
transport of the bolus through abnormal arteries.  An improved characterisation of the 
vascular transport will facilitate more accurate testing of analysis techniques, and an 
improved understanding of the impact of dispersion in vivo.
8.2  P a tie n t D a ta
An  in vivo investigation into vascular transport necessitates  a patient cohort with a 
diverse range of arterial abnormalities.  For this reason, the patients included in this 
study had various  unilateral  abnormalities  in  major cerebral  arteries  and had  areas 
with severe DSC-MRI abnormalities (as identified in time-to-peak (TTP) maps of the 
bolus concentration time-course).  The latter criterion was chosen to identify patients 
likely to have areas affected by bolus delay and dispersion (TTP maps are sensitive to 
these effect).  Fifteen patients were identified; their abnormalities included stenosis, 
occlusion or dissection of a major cerebral artery (see Table 8.1).  In some instances, 
the concentration time-course in different regions of the same patient were found to 
have different temporal characteristics.  In such cases, two regions of interest (ROIs) 
were  selected for the  analysis.  The  age of the patients ranged from 0.8-19.6 years 
(mean 8.3 years)13.  The MRI scans were done for clinical reasons and their analysis 
was approved by the local research ethics committee.
Data were acquired on a 1.5T Siemens Symphony scanner using a gradient-echo EPI 
sequence after the injection of a bolus of 0.15 mmol/kg of Gd-DTPA using an MR- 
compatible power injector (Medrad).  The following sequence parameters were used: 
TE/TR=47/1500 ms, 12 slices, 5 mm slice thickness, 128x128 matrix, 240 cm field of 
view.  The slices were acquired in an interleaved order with a gap of 4mm.  Prior to
13 In Chapter 6 , the mML-EM technique was found to be less accurate in quantifying higher CBF. (see 
e.g. Figure 6.7).  Although CBF is expected to be higher in children, (Biagi et al 2007), accurate CBF 
quantification is not important in this chapter.  The CBF values should not affect the characterisation 
of the vascular transport as this only requires information about the local and global AIFs.  However, 
due to the smaller arteries in children, partial volume effects may be more significant.  Care was taken 
to avoid voxels with partial volume contamination when selecting the global AIF.Chapter 8: Vascular Transport and Perfusion Errors -243-
Age
(years)
Left Right
ICA MCA PCA ACA ICA MCA PCA ACA
Patient 1 - ROI1 9.6 X X
Patient 1 - ROI 2 9.6 X X
Patient 2 0.8 X X X
Patient 3 3.2 X X
Patient 4 1.5 X
Patient 5 - ROI 1 9.9 X
Patient 5 - ROI 2 9.9 X
Patient 6 12.6 X
Patient 7 6.9 X
Patient 8 5.5 X X X
Patient 9 12.4 X
Patient 10 16.9 X X X
Patient 11 - ROI 1 9.8 X X X
Patient 11 - ROI 2 9.8 X X X
Patient 12 - ROI 1 4.3 X
Patient 12 - ROI 2 4.3 X
Patient 13 - ROI 1 5.3 X
Patient 13 - ROI 2 5.3 X
Patient 14 12.4 X X
Patient 15 13.5 X X
Table  8.1:  Location  of  vascular  abnormalities  in  each  patient.  The  symbol  x 
indicates an abnormality (detected by MR angiography). ICA: Internal carotid artery; 
MCA: middle cerebral artery; PCA: posterior cerebral artery; ACA: anterior cerebral 
artery.____________________________________________________________________
analysis,  ICA  denoising  was  performed  on  the  concentration time-course data (see 
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8.3  M eth o d s
8.3.1  M easuring of Vascular Transport
In  order  to  investigate  and  model  vascular  transport,  in  vivo  VTFs  must  be 
determined.  A methodology was developed to experimentally determined VTFs in 
each of the 15 patients given in Table 8.1.
As discussed in Section 4.7.2, the VTF is defined from the convolution relating the 
local AIF (the true input to the tissue) and the global AIF :
CasM (t) = C j“‘“(t)®VTF(t)  [gl]
where  Calocal (t)  is the local AIF, and,  Ca (?) is the estimated global AIF.
The  local  AIF  Calocal (t) ,  were  calculated  for  each  patient  using  an  Independent
Component  Analysis  technique  (Calamante  et  al  2004).  In  summary,  the 
concentration time-course of each voxel within the slice is decomposed into linearly 
independent components.  A Bayesian information criterion is used to select the most 
likely number of independent components.  Components are discarded (based on their 
spatial  and  temporal  characteristics)  if  they  are  identified  as  being  artefact  (e.g. 
motion  or  scanner  drift),  or  from  the  veins.  The  remaining  components  are 
thresholded to  select those  with  significant contribution  and  a clear arterial  spatial 
distribution.  A  Gaussian  weighting  factor  is  then  used  to  interpolate  the  arterial 
signal to all the voxels.  The resulting dataset is smoothed to represent the local AIF. 
A more detailed description of the AIF can be found in (Calamante et al 2004).
For each patient,  a global AIF,  Caglobal(t), was measured in the Ml  segment of the
contralateral  middle  cerebral  artery  (MCA).  This  estimation  of  the  AIF  can  be 
considered a good approximation to the true AIF in the ipsilateral hemisphere in the 
absence of dispersion.Chapter 8: Vascular Transport and Perfusion Errors -245-
In this work the VTFs were calculated directly from the deconvolution of Equation 
[8.1].  The  deconvolution  was  performed  using  the  modified  ML-EM  method 
described in Chapter 6.  This deconvolution technique was chosen because it has been 
shown to give a good characterisation of the impulse response function (in the present 
case, the VTF), even in the presence of bolus delay and/or dispersion, especially at 
high SNR.  The temporal resolution of the patient data was TR=1.5s.  Since the time 
scale  of  the  VTF  variations  can  be  in  the  order  of  1.5s,  deconvolution  at  this 
resolution  would  lead  to  discretisation  error,  possibly  biasing  the  fitting  of  a 
mathematical VTF model.  Moreover, if there are too few non-zero time-points within 
the experimental VTF, it becomes increasingly difficult to fit a parameterised model. 
For this reason, prior to deconvolution, the AIF curves (local and global) were fitted 
using a gamma-variate function (see Section 5.2.2.) and subsampled with a resolution 
of  0.1s.  This  methodology  is  further  discussed  in  the  Discussion  section.  The 
extracted VTFs are reported in Section 8.4.1.
83.2  Characterising Vascular Transport
The  random  variation  common  in  data  from  many  scientific  disciplines  is  often 
described by a skewed distribution.  Many studies have shown that these distributions 
often closely fit the lognormal distribution, which is characterised in terms of the log- 
transform  variable,  using  as  parameters  the  mean  and  standard  deviation  of  its 
distribution.  The next few paragraphs present  1)  a description of the mathematical 
form  of the  lognormal,  2)  the  physiological  reasoning  behind  why  the  lognormal 
distribution  might  be  an  appropriate  model  for  the  VTF  3)  a  derivation  of  the 
lognormal  parameter  combinations  used  to  describe  delay  and  dispersion.  In  the 
Appendix to this chapter, a physical description of the lognormal is given.
A  random  variable  t  is  lognormally  distributed  if ln(t)  has  a  normal  distribution. 
(Note  that  this  definition  is  base  on  natural  logarithms).  The  probability  density 
function of such a random variable is:Chapter 8: Vascular Transport and Perfusion Errors -246-
/(*)=
( t- t0)(j427C
exp
It7
[ 8.2 ]
Only positive values are possible for the shifted parameter (Mo).  The shape of the 
lognormal distribution can be thought of in terms of the skewness (given by  a ) the 
location (given by to) and the scale (given  by //).
A skewed distribution such as the lognormal is an appropriate model for distributions 
that have a mean value, a large variance, and values that cannot be negative.  This is 
the situation for a vascular network with asymmetric branching and random variation 
at each bifurcation (fractal modelling of the vascular tree).  It has been shown that 
with  a  large  enough  network  with  a  significant  number  of  generations,  fractal 
behaviour and lognormal flow distributions naturally arise from this model (Qian et 
al  2000;  Karch  et al  2003).  It has  also been  suggested that turbulent flow has a 
lognormal profile (Jung et al  2005).  Thus, the turbulent flow through the stenosis 
could also be considered as having a lognormal flow distribution.
The flow distribution that governs the VTF in MRI is drawn from a large network of 
bifurcations,  which  represent the  capillary network feeding the tissue (Figure  8.1). 
Thus, one would expect the VTF to have an approximately lognormal distribution of 
transit times.  The form of the VTF is dependent on the structure of the vascular bed 
and also on the pathology.  The parameters  fi  and  a  are therefore determined by the 
delay and dispersion of the bolus.
The  variance  of  the  VTF  (variance-vascular-transit-time  VVTT)  around  its  mean 
(mean-vascular-transit-time MVTT) can be used to quantify the spread of the VTF 
and hence provide a measure of the degree of dispersion.Chapter 8: Vascular Transport and Perfusion Errors -247-
Figure 8.1:  The vascular tree can be represented by a large network of bifurcations. 
Reproduced from (Karch et al. 2003).
]<t  -   MVTT  f   ■   VTF  (t)dt
WTT —  0 [8.3] V  V1 1  —  —
jVT  F(t)dt 
0
where the MVTT is given by the ratio of the first- to the zero-th moment of the VTF:
m  \t-VTF{t)dt
MVTT = ------7qT  = -----------------
VTF  f
^VTF(t)dt
0
[8.4]
Solving  these  equations  for  the  lognormal  function  (Equation  [8.2])  provides  the
following analytical expressions for MVTT and W T T  respectively:Chapter 8: Vascular Transport and Perfusion Errors -248-
(  < T 2}
MVTT = exp  ji + —   +t0
I  2
[8.5]
W TT = (exp(cr2)-l)exp(cr2 + 2  fi) [ 8.6 ]
The three parameter (< 7 , r0  and  //) lognormal distribution was fitted to the twenty 
VTF extracted from the patient group in this study (Table 8.1).  A multidimensional 
non-linear least-squares minimisation program was written in C++, implementing the 
Simplex  algorithm  from  the  GSL  library.  For  each  fitted  VTF,  in  addition  to 
recording the parameter values (a , t0 and ju), the MVTT and W TT were calculated. 
The quality of the lognormal fit to the in vivo VTF was  assessed and the range of 
lognormal parameter values  required  to characterise  a broad range of dispersion in 
this patient group was obtained (Section 8.4.2).
8 3 3   Sim ulating Vascular Transport
One  of  the  motivations  for  finding  a  mathematical  model  to  describe  vascular 
transport  was  to  design  simulated  data  sets  that  can  describe  a  variety  of 
cerebrovascular abnormalities.  Therefore  a realistic range  of lognormal  parameter 
values needs to be determined.  The values found for each set of parameters (a ,  ju 
and to) in the fitted in vivo data were analysed and realistic ranges were defined (see 
Section 8.4.2).  The shift parameter to does not influence the shape of the curve, but 
simply  shifts  the  origin.  For  this  reason,  since  the  simulations  were  primarily 
performed to investigate the influence of the lognormal parameters on the function 
shape, it was not necessary to simulate the entire experimental range of to values.  The 
values for MVTT and W T T  corresponding to the simulated lognormal parameters 
were also calculated.  The simulated VTF are reported Section 8.4.3.Chapter 8: Vascular Transport and Perfusion Errors -249-
83.4  Perfusion E rrors
Once  a  characterisation  of the  VTF  has  been  made,  a  measure  of the  degree  of 
dispersion  in  the  vascular transport  can  be  obtained  (as  measured by the  variance 
(Equation  [8.6]).  The  in  vivo  VTFs  enable  an  investigation into  a relationship
between dispersion and the related perfusion errors in vivo.
The perfusion errors introduced by the bolus dispersion in the vascular transport were 
assessed  using  a  similar  methodology  to  that  used  in  reference  (Calamante  et  al. 
2004) (see below).  It is important that perfusion errors related to delay (which are 
wholly a result of regularisation and discretisation error in the deconvolution) are not 
wrongly assigned to dispersion-related perfusion measurement errors.  If these errors 
are  not  made  distinct,  then  any  relationship  found  between  the  dispersion  in  the 
vascular  transport  and  dispersion-related  perfusion  measurement  errors  would  be 
biased by delay.  Consequently, if the relationship were used in vivo, it could result in 
an incorrect correction of the perfusion measurement errors.  In this analysis, in order 
to  ensure  that  any  CBF  bias  is  solely  a  consequence  of  dispersion,  delay  in  the 
concentration  time-courses  was  removed  prior  to  the  deconvolution.  This  was 
achieved by shifting the curves to common origin, taking into account the differences 
in slice acquisition time between the global AIF and local AIF measurement slices.
An  estimate  of  the  perfusion,  free  from  dispersion-related  bias,  was  obtained  by 
performing the mML-EM deconvolution (see Chapter 6) of Equation [8.7]:
Ct (t) = CBF ■  Calocal (r) ®R{t)  [ 8.7 ]
where  C,(r)  is the tissue concentration measured in a region  around the  place where
the local AIF was sampled, and  Calocal{t)  is the local AIF itself.  This deconvolution 
recovers an estimate of the residue function  R(t) scaled by CBF, which is assumed to 
be  the  true  CBF,  free  from  dispersion  error.  This  estimate  of perfusion  will  be 
referred to as  CBF]0 ca\, because it is calculated using the local AIF.  CBFg]0ha\ is the 
CBF estimation obtained by performing the deconvolution of Equation [8.8]:Chapter 8: Vascular Transport and Perfusion Errors -250-
C,(t) = C B F C /M (t)®Re/r(t)  [8.8]
where  Cas  (/) is the global AIF, which is measured in a contralateral branch of the
MCA,  and  Reff(t)= R(t)®VTF(t)  is  the  effective  residue  function  (see  Section
4.7.2).  In  this  situation,  because  of  dispersion,  CBFgi0bai  is  calculated  from  the 
maximum  of  the  extracted  response  function,  i.e.  CBFglobal = ( < CBF • Reff (*))  •
Based on the assumption that the local AIF provides a more accurate estimate of CBF 
(by  accounting  for  dispersion  effects),  the  %  CBF  error  introduced  by  bolus 
dispersion was defined as:
%CBFerror = — ~CBF' ° c °'^-1 0 0   [ 8.9 ]
C B F U *al
The results are reported in Section 8.4.4.
8.4  R esu lts
8.4.1  M easuring o f Vascular Transport
In the  15 patients, twenty estimates for the local AIF were obtained, and these were 
used to calculate twenty VTFs.  Some examples of the VTF calculated in the patients 
with abnormalities ranging from mild to severe dispersion are shown in Figure 8.2. 
All  the  VTFs  were  found  to  have  a  skewed  distribution  with  various  lengths  of 
baseline.
The in vivo results illustrated in Figure 8.2 indicate that a function that is zero at the 
baseline and decreasing for t > tdeiay (as the exponential model assumed previously in 
some MRI and PET studies (Calamante et al.  2000; Calamante et al.  2003b; Iida et 
al.  1986) is  a reasonable model  for mild  stenosis/small  dispersions  (e.g.  Patients 2 
and  12ROI1).  This  model  for  the  VTF  has  been  commonly  used  in  simulations 
performed to assess the effects of delay and dispersion on perfusion quantificationChapter 8: Vascular Transport and Perfusion Errors -251 -
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Figure 8.2:  Illustrative examples of the vascular transport functions (VTF) for eight 
patients (listed in Table 8.1  and indicated in the figure legend) ranging from mild to 
severe dispersion.  All curves are normalised to unit area._________________________
(see  Chapters  6  and  7).  However,  a  more  ‘peaked’  shaped  function  (as  also 
previously used (Calamante et al.  2003a; King et al.  1993; Bassingthwaighte  1966)) 
may  be  a  more  suitable  VTF  model  in  many  cases  with  moderate  and  severe 
dispersion  (e.g.  Patients  3  and  11ROI2).  The VTF extracted  from the patient data 
were found to be skewed to varying degrees according to the severity of the stenosis. 
This  is  consistent  with  the  lognormal  function  used  describe  random  variation  in 
many scientific disciplines.Chapter 8: Vascular Transport and Perfusion Errors -252-
G  /S //  /s to/s MVTT /s W TT /s2
Patient 1 - ROI1 0.843 -0.274 0.012 1.097 1.221
Patient 1 - ROI2 0.559 0.356 -0.299 1.369 1.020
Patient 2 1.048 -0.329 0.160 1.406 3.101
Patient 3 0.492 0.696 -0.460 1.804 1.402
Patient 4 0.369 1.032 -0.781 2.225 1.318
Patient 5 - ROI1 0.626 -0.580 0.058 0.739 0.222
Patient 5 - ROI2 0.730 0.309 0.782 2.559 2.221
Patient 6 0.664 0.189 -0.370 1.136 1.259
Patient 7 0.753 -0.145 0.625 1.773 1.006
Patient 8 0.565 1.149 0.270 3.970 5.142
Patient 9 0.935 -0.853 0.369 1.028 0.608
Patient 10 0.779 0.593 -0.506 1.945 5.019
Patient 11 - ROI1 0.476 0.406 0.170 1.851 0.717
Patient 11 - ROI2 0.304 1.497 -1.368 3.313 2.117
Patient 12 - ROI1 0.915 -0.667 0.536 1.316 0.797
Patient 12 - ROI2 0.517 1.571 -0.537 4.963 9.285
Patient 13 0.475 -0.079 0.240 1.274 0.270
Patient 14 - ROI1 0.673 -0.121 1.821 2.932 0.709
Patient 15 0.599 0.250 0.768 2.305 1.021
average 0.648 0.263 0.078 2.053 2.024
Table 8.2:  Lognormal parameter values  a , t0  , and  fi  fitted for the VTFs in each 
patient, and the corresponding derived values of MVTT and W TT._______________Chapter 8: Vascular Transport and Perfusion Errors -253-
8.4.2  Characterising Vascular Transport
Table  8.2  shows  the  fitted  lognormal  parameters  {a, fi, to)  for  the  15  subjects 
together with the average values.  The average values for these parameters were: for 
the skewness variable, < a  > = 0.65 (range 0.30 to 1.05); for the scale variable <ju> 
=0.26 (range -0.85 to  1.57s); for the shift variable <to> = 0.08 (range -1.37 tol.82s); 
for the mean, <MVTT> = 2.05s (range 0.74 to 4.96s); and for the variance, <VVTT> 
= 2.02s2  (range 0.22 to  9.29s2),  where o  indicates the  average.  The average was 
taken over  19 VTFs.  The lognormal parameters of the VTF for ROI2 of Patient 14 
converged with values  cr=0.00017s,  //=10.38,  and to= -32262.3s, which are very 
inconsistent  with  the  lognormal  parameter  values  fitted  for  the  other  patients. 
Inspection of the VTF curve for ROI2 of Patient 14 reveals there is a slight negative 
skew to this VTF, whereas the VTFs for the other patients all have varying degrees of 
positive skewness.
Figure 8.3 illustrates the lognormal function fitted to five of the in vivo VTF.  The 
lognormal model was found to be able to characterise broad range of dispersion.  For 
example,  a more  skewed  distribution can be reproduced using a larger  a , while a 
broader distribution requires a larger value of //.
The VTF for the 15 subjects show a large variation in shape, which is reflected in the 
large range of lognormal parameter values needed to fit the experimental VTF shapes.
8.4.3  Sim ulating Vascular Transport
Following the results of Section 8.4.2, VTFs were simulated for every combination of 
a  ranging 0.2 to 1.2s in steps of 0.2s, for //  ranging -1.5 to 2.0s in steps of 0.5s, and 
t0 ranging -1.0 to +1.0s in steps of 0.2.  This gave a very diverse range of VTF shapes. 
Not every combination of  a ,  to ,  and  ju  were found to give values of MVTT and 
W TT within the ranges found experimentally in the in vivo data (Section 8.4.2).  TheChapter 8: Vascular Transport and Perfusion Errors -254-
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Figure  8.3:  Five  empirically  determined  in  vivo  VTFs  (dashed  lines)  and  their 
lognormal fit (solid lines).  The legend indicates which subject the data were obtained 
from (Table 8.1  and Table 8.2).  _____________________________________________
simulated combinations of a  and  //, and the corresponding MVTT and VTTT values 
are given in Table 8.3.  The highlighted cells correspond to those combinations of o 
and  ju  that combine to give to a MVTT and W T T  consistent with the experimental 
ranges.  Figure 8.4 illustrates some of the simulated log-normal VTFs lying within the 
experimental range of parameters (highlighted cells in Table 8.3).  The VTFs shown 
in this figure were simulated with r0=0s.  Each graph shows the VTF simulated for a 
particular value of  a   ranging from  1.2 to 0.2s.  Each of the curves within the graph 
represents a particular value of //  that lies within the experimentally observed range 
and also gives rise to values for MVTT and W T T  that are consistent with the ranges 
observed in vivo.  It can be seen that the large values for  o   correspond to VTFs that 
decay from  a maximum to zero in  an  approximately exponential  manner.  As  a  is 
decreased, the VTF become more bell-shaped.  For each  a , the smallestChapter 8: Vascular Transport and Perfusion Errors -255 -
MVTT o   /s
0.2 0.4 0.6 0.8 1.0 1.2
M -1.5 0.228 0.242 0.267 0.307 0.368 0.458
/s -1.0 0.375 0.399 0.440 0.507 0.607 0.756
-0.5 0.619 0.657 0.726 0.835 1.000 1.246
0.0 1.020 1.083 1.197 1.377 1.649 2.054
0.5 1.682 1.786 1.974 2.270 2.718 3.387
1.0 2.773 2.945 3.254 3.743 4.482 5.585
1.5 4.572 4.855 5.366 6.172 7.389 9.207
2.0 7.538 8.004 8.846 10.176 12.182 15.180
W TT G  /S
0.2 0.4 0.6 0.8 1.0 1.2
-1.5 0.002 0.010 0.031 0.085 0.233 0.677
/s -1.0 0.006 0.028 0.084 0.230 0.632 1.840
-0.5 0.016 0.075 0.228 0.625 1.718 5.001
0.0 0.042 0.204 0.621 1.700 4.671 13.594
0.5 0.115 0.553 1.688 4.622 12.696 36.951
1.0 0.314 1.505 4.589 12.563 34.513 100.444
1.5 0.853 4.090 12.475 34.149 93.815 273.034
2.0 2.319 11.117 33.911 92.826 255.016 742.184
Table  8.3:  The  table  shows  the  MVTT  and  W T T   values  corresponding  to  the 
simulated lognormal  parameters.  The highlighted cells correspond to the parameter 
combinations  that  combine  to  give  experimentally  consistent  MVTT  and  W TT 
values.
(experimentally  consistent)  value  for  //  gives  rise  to  the  sharpest  VTF.  As  n  is 
increased the VTF become broader, and the maximum is shifted in time.Chapter 8: Vascular Transport and Perfusion Errors  - 256 -
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Figure  8.4:  The  graphs  illustrate  the  simulated  lognormal  VTFs  with  parameters 
corresponding to the highlighted cells in Table 8.3.  These VTF have realistic MVTT 
and W T T   when compared with in vivo data.__________________________________
The  orange  curves  in  Figure  8.4  correspond  to  the  lognormal  functions  with  the 
smallest W TT for the simulated  a .  The orange-curve W TT ranges from 0.115 s2Chapter 8: Vascular Transport and Perfusion Errors -257-
(<r=0.2s) to 0.233s2 (tr=l.2s).  I.e. the largest W TT corresponds to the largest  c . 
Similarly, the greens curves correspond to VTF with the largest W TT, ranging from 
11.117s2 (<t = 0 .2 s) to 13.954s2 (<t = 1 .2 s).  Both the MVTT and W TT increase with 
increasing  fi  for a given  cr.  Similarly, MVTT and W TT increase with increasing 
cr  for a given //.
With  reference  to  Table  8.3  and  Figure  8.4,  it  would  be  possible  to  select  the 
lognormal  VTF  appropriate  to  model  a  situation  within  a  broad  range  of 
cerebrovascular abnormalities.  For example the VTF for a mild stenosis could be 
modelled  with  a  lognormal  function  defined  with  (7=1.0s,  //=-1.0s  and  fo=0.5s, 
corresponding to a MVTT=0.607s and VVTT=0.632s2  The VTF for severe stenosis 
could be modelled with a lognormal function defined with  o =0.2s,  // =1,5s and t0=- 
1.1s,  corresponding  to  MVTT=4.572s  and  VVTT=0.853s2).  These  VTF  are 
illustrated in Figure 8.5.
8.4.4  Perfusion E rrors
The range of dispersion  observed in this group of patients introduced severe errors 
(underestimation) in CBF quantification when the contralateral global AIF was used. 
The degree of underestimation (as measured by Equation [8.9]) ranged from 13-70%. 
A scatter plot of the %CBF error as a function of corresponding degree of dispersion 
(as measured by Equation [8.6]) is shown in Figure 8.6.  The overall trend shows that 
the %CBF error increases with the degree of dispersion, and that this increase is more 
marked for variances up to ~4s2.  For comparison purposes, the figure also includes 
the results  found in  previous  numerical  simulations  (Calamante et al.  2000)  which 
used an exponential function to model the VTF.Chapter 8: Vascular Transport and Perfusion Errors -258-
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Figure 8.5: The figure exemplifies two simulated VTFs: The dashed line represents a 
mild  stenosis  (<7= 1.0s,  //=-1.0s  and  to=0.2s,  MVTT=0.607s  and  VVTT=0.632s2). 
The  solid  represents  a  more  severe  stenosis  ((7=0.2,  ju =1.5  and  fo=-l.ls, 
MVTT=4.572s and VVTT=0.853s2.
8.5  D iscussio n
The empirically determined VTF from the patients used in this study indicate that it is 
reasonable  to  model  the  VTF  for  a  mild  stenosis  with  an  exponentially  decaying 
function  (Calamante  et  al.  2000;  Calamante  et  al.  2003b;  Iida  et al.  1986).  This 
model for the VTF has been commonly used in  simulations studies.  However,  it is 
clear  from  the  experimental  data  that  this  model  is  not  appropriate  for  the  VTF 
describing  a  more  severe  stenosis  (see  Aim  1   in  the  Introduction).  This  work has 
demonstrated  that  a  lognormal  model  for the  VTF is  flexible  enough  to  define  the 
shape  of the  VTF for both  a  mild  and  severe  stenosis.  A  range  of values  for the 
lognormal parameters appropriate for modelling realistic VTFs for various degrees of 
dispersion has also been determined.  The example VTFs illustrated in Figure 8.4Chapter 8: Vascular Transport and Perfusion Errors -259-
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Figure 8.6:  %  CBF errors  (Equation  [8.9])  as  a  function  of degree  of dispersion 
(W TT, Equation [8.6]). The CBF errors correspond to the errors in the quantification 
when the contralateral global AIF is used for deconvolution of the concentration time- 
course,  i.e.  when  the  dispersion  effects  are  not  accounted  for.  Negative  errors 
correspond to  CBF underestimation.  The  solid dots  show the data collected in the 
present  work.  For  comparison  purposes,  the  solid  and  dashed  lines  indicate  the 
results  found  in  previous  numerical  simulations  (using  a  simple  exponential  VTF 
model) for a typical child and a typical adult AIF cases, respectively (Calamante et al. 
2000).  _________________________________________________________
demonstrate the versatility of the lognormal to model very different cerebral arterial 
abnormalities
The lognormal parameter values found for the VTF to one of the regions analysed in 
Patient  14 were not consistent with the parameters derived from all the other VTFs. 
This  suggests  that  there  could  be  a  bimodal  range  of  experimental  lognormal 
parameters  describing  the  in  vivo  VTF:  one  for  positively  skewed,  and  one  for
negatively skewed.  With the exception of ROI2 of Patient 14, all the extracted VTFsChapter 8: Vascular Transport and Perfusion Errors -260-
were found to have some degree of positive skewness.  Consequently, it was possible 
to  gauge  the  range  of  realistic  lognormal  parameters  in  this  case,  which  gave 
experimentally  consistent  values  for  MVTT  and  W TT.  Extracting  VTFs  and 
performing the lognormal analysis on data from many more subjects, may facilitate 
characterising a realistic lognormal parameter range for negatively skewed VTFs.  In 
addition, the prevalence of negative skewness could be investigated.
Despite the need for further investigation, the experimentally informed parameterised 
VTF model for dispersion presented in this chapter will be useful for creating realistic 
and flexible simulated data sets that model DSC-MRI data in various cerebrovascular 
situations.  Such simulated data are valuable for a comprehensive assessment of new 
methodologies such as the adapted ML-EM techniques presented in this thesis.
In  the  patient  group  studied,  CBF error was  found  to  increase  with  the  degree  of 
dispersion, with a more marked increase for VVTF values up to ~4s2 (see Figure 8.5). 
This  finding  is  consistent  with  the  results  from  previous  published  numerical 
simulations (Calamante et al 2000).  Although the errors are qualitatively similar, the 
single exponential VTF for t > tdeiay (as used in the numerical simulations (Calamante 
et al. 2000)) do not closely follow the in vivo trend.  The spread of %CBF error for a 
given dispersion should also be considered when assessing patient data.  Furthermore, 
smoothly decreasing function of time for t > tdeiay seems only appropriate for mild and 
moderate dispersion, while a more  ‘peaked’  shaped function is required to describe 
accurately  some  of the  moderate  and  severe  dispersion  cases  in  this  study  (Figure 
8.2).
In this study, and in this group of patients, the CBF bias (underestimation) introduced 
by the  unaccounted  dispersion  has  a  large range  (13-70%  underestimation).  This 
degree  and  range  of  dispersion-related  perfusion  measurement  errors  cannot  be 
neglected in the interpretation of perfusion maps obtained from DSC-MRI data.  A 
strategic use of these maps has been in combination with diffusion- and T2-weighted 
images.  The information is combined into models to predict the fate of the tissue in 
acute stroke (Section 3.12), with the final aim of identifying the patients that are moreChapter 8: Vascular Transport and Perfusion Errors -261-
likely to benefit from therapy.  However, this work and previous works have shown 
that  the  presence  of  bolus  dispersion  can  introduce  large  errors  in  CBF  (i.e. 
underestimation) and MTT (i.e.  overestimation) (Calamante et al.  2000), potentially 
biasing the prediction.
In light of the severity of the %CBF error in the patient data, predictive algorithms 
designed to assess the likelihood that ischaemic tissue will progress to infarction, (and 
which used the CBFgi0bai perfusion estimates), should also include information about 
dispersion.  Although  currently  it  may  not  be  practically  possible  to  correct  for 
dispersion  (since  this  requires  knowledge  of the  VTF for each  voxel),  information 
about the presence, extent and severity of dispersion, should be included.  In Chapter 
7  a  dispersion  index  is  proposed  to  indicate  the  presence,  extent,  and  severity  of 
dispersion.  The findings of this chapter indicate that such a measure would indeed be 
a  valuable  parameter,  for  example,  providing  a  measure  of  reliability  for  the 
predictions, or to use within the algorithm itself to improve the prediction.  In Chapter 
9 this dispersion index is utilised in a methodology to minimise the dispersion-related 
perfusion measurement errors.  Such minimisation may make accurate CBF estimates 
possible.  These would be a reliable input into predictor-models.
The main assumption in the assessment of dispersion and characterisation of the VTF 
in this study, is that they can be characterised using the locally defined AIF -  i.e. the 
estimated local AIF is  a good estimator of the true input to the tissue.  Despite the 
need  for  validation,  the  locally  defined  AIF  provides  the  best  method  currently 
available to estimate the VTF and the degree of bolus dispersion.
One  potential  means  to  validate  this  study  would  be  in  cross  validation  with  an 
alternative technique.  A method has recently been proposed to quantify the degree of 
dispersion in the renal blood flow of rabbits using a hyperpolarised tracer (Johansson 
et al. 2004).  Since there are similarities between the renal and cerebral perfusion (i.e. 
the compartmentalisation of the tracer), the use of such a technique could potentially 
complement  the  methodology  described  in  the  present  study.  However,  the 
requirement for such a tracer would limit the widespread used.Chapter 8: Vascular Transport and Perfusion Errors -262-
Another potential source of error in the methodology used to characterise the VTF, is 
that the  lognormal  function  was  fitted  to  pre-fitted  data.  The  in  vivo VTFs  were 
calculated  from  the  deconvolution  of the  local  and  global  AIFs  (Equation  [8.1]), 
which had already been fitted with a gamma-variate curve.  Based on the findings of 
the current study, the lognormal model has been suggested as a flexible and accurate 
characterisation of the vascular transport.  Further work could now be performed to 
confirm  this  finding  using  more  formal  methods.  For  example,  Mouridsen  et  al. 
(Mouridsen  et al.  2006b)  used  a Bayesian  deconvolution  approach to  estimate the 
parameters of a function describing the microvascular circulation.  A similar approach 
could be taken here to estimate the lognormal parameters for the VTF from the direct 
deconvolution  of the  measured  local  and  global  AIFs.  Such  a  model-dependent 
approach  has  the  advantage  of  improving  the  stability  of  the  deconvolution 
(compared with model-independent approaches) by reducing the degrees of freedom 
for function characterisation, and ensuring that the VTFs are smooth.
8.6  C onclusion
A simple mathematical function, the lognormal, has been  suggested to describe the 
vascular transport of the bolus in DSC-MRI.  As well as motivating the form of a 
mathematical  model,  the  in  vivo  data  were  used  to  determine  a  realistic  range  of 
parameter values for flow through a variety of cerebral arterial abnormalities.  This 
characterisation  should  facilitate  the  simulation  of  DSC-MRI  data  to  describe  a 
variety of cerebrovascular situations.  Testing on simulated data sets (where the true 
perfusion values are known) has now become a crucial stage in the development of 
any DSC-MRI  analysis  technique  (Chapter 5,  6  and 7).  In  addition  to testing the 
robustness  and  accuracy  of DSC-MRI analysis  techniques,  a realistic  model  of the 
VTF can facilitate further investigation into dispersion-related perfusion measurement 
errors.  An understanding of the severity of perfusion errors is of primary importance 
for the  assessment of patients  with  acute  stroke,  as well  as for the  accuracy of the 
predictor-models  currently being used for determining the tissue outcome in  strokeChapter 8: Vascular Transport and Perfusion Errors -263-
e.g.  (Wu et al.  2001).  This study confirms that it is very important to consider the 
effect of dispersion in the assessment and management of patients with acute stroke, 
since the  CBF errors can be  significant.  Neglecting these errors can lead to tissue 
misclassification and possibly to the inappropriate selection of patients for treatment, 
such as arterial thrombolysis.
8.7  A ppen dix: P hysical Description of the L ognormal
A  physical  model  for  the  normal  distribution  can  be  visualised  using  a  “Galton 
board”  (Figure  8.7a).  Particles  leaving  a  funnel  at the top  fall  down  the  slanting 
board and are deviated by rows of decision points (the tips of triangle obstacles) an 
equal distance c, left or right with equal probability p.  A particle leaving the funnel at 
the top meets the first row obstacle and is deviated left or right by a distance c with 
equal  probability.  It  then  meets  the  corresponding  triangle  in  the  second  row,  is 
deviated  again,  and  so  on.  The  deviated particle from one row to the next is the 
realisation of a random variable with possible values +c and -c, and equal probability 
for both.  After passing through r rows of triangles, the particle falls into one of r+1 
receptacles  at the bottom of the board.  The probability of ending up in receptacles 
numbered 0,1,...r follow a binomial law with parameters r and p=0.5.  When many 
particles  have  fallen  down  the  board,  the  height  of  the  particles  piled  in  the 
receptacles  will  be  approximately  proportional  to  the  binomial  distribution. 
According to the central limit theorem, for a larger number of rows of obstacles, the 
probabilities approach the normal distribution.  The central limit theorem states that 
the  sum of many independent identically distributed positive random variables has 
approximately a normal distribution as  r — >  .
If  the  Galton  board  is  modified  such  that  the  obstacles  are  scalene  rather  than 
equilateral triangles (Figure 8.7b), the deviation of the particles a certain distance left 
or right will no longer have equal probability.  The probability of particles falling into 
any particular receptacle at the bottom of the board follow the same binomial law, butChapter 8: Vascular Transport and Perfusion Errors -264-
with  parameters  r  and  q=(l-p).  The  height  of  the  accumulated  particles  is 
correspondingly  skewed.  For a large number of rows, the multiplicative version  of 
the  central  limit  theorem  determines  that  the  heights  approach  the  lognormal 
distribution.  The  multiplicative version  of the  central  limit theorem  states  that the 
product  of many  independent  identically  distributed  positive  random  variables  has 
approximately a lognormal distribution as  r — > < * > .
Figure  8.7:  Physical  models  illustrating  the  genesis  of the  normal  and  lognormal 
distributions.  Particles  fall  from  a  funnel  onto  tips  of  triangles,  where  they  are 
deviated to  the  left  or to  the  right  with  equal  probability  (0.5)  and  finally fall  into 
receptacles.  The  median  of the  distributions  remain  below  the  entry  points  of the 
particles.  If the tip of a triangle is  at a distance x  from the left edge of the board, 
triangle tips to the right and to the left below it are places at x + c and x -  c for the 
normal distribution (panel a), and x.c’  and x/c’  for the lognormal (panel b), c and c’ 
being constants.  The distributions are generated by many random effects (according 
to  the  central  limit  theorem)  that  are  additive  for  the  normal  distribution  and 
multiplicative for the lognormal.  Reproduced from (Limpert et al. 2001).___________Chapter 9: Correcting Dispersion Errors in DSC-MRI -265-
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9.1  Introduction
Although delay-related perfusion measurement errors have been recognised and are 
now accounted for in many studies (Rose et al 2004; Ibaraki et al 2005; Smith et al 
2004;  Wu  et  al  2003;  Wu  et  al  2004),  dispersion  errors  are  seldom  taken  into 
account when using DSC-MRI perfusion  data to predict the fate of brain tissue in 
acute stroke.  This is presumably related to the fact that it is difficult to correct for the 
effect  of bolus  dispersion.  In  Chapter  8,  the  size  of dispersion-related  perfusion 
measurement errors in vivo were found to be as large as 70%.  In view of the severity 
of  these  errors  and  potentially  dangerous  consequences  of  misguided  therapeutic 
decisions, this chapter investigates two approaches to correct for dispersion and as a 
result  minimise  the  corresponding  perfusion  errors.  The  first  method  investigates 
whether a relationship between delay and dispersion exists in vivo and subsequently 
whether  a  post-deconvolution  correction  of  dispersion  is  possible  using  such  a 
relationship.  The  second  method  seeks  to  improve  the  estimated  (global)  arterial 
input  function  (AIF),  using  a  regional AIF,  such  that the  dispersion  is  minimised 
before the deconvolution.
The first method is a preliminary exploration into the possibility of using the more 
easily  measured  bolus  delay  to  correct  for  the  dispersion  in  vivo.  An  extensive 
investigation of delay and dispersion has not yet been performed in vivo.  This work, 
which  uses  data  from  a  group  of patients  with  a  large  range  of cerebral  arterial 
abnormalities,  will  therefore  provide  new  and  useful  insight.  If  a  simple  delay- 
dispersion relationship  were identified, the degree of dispersion could be predicted 
from  the  more  easily  measured  delay.  In  Chapter  8,  the  lognormal  function  was 
shown to model the extracted in vivo vascular transport functions accurately.  If the 
lognormal  parameters  could  be  inferred  from  the  degree  of  delay,  one  could 
potentially correct for dispersion.  In  addition,  a  simple relationship between delay 
and dispersion would be useful for the further development of vascular models.Chapter 9: Correcting Dispersion Errors in DSC-MRI -267-
The second method is a natural extension of Chapter 7, where the oML-EM-wavelet 
deconvolution  technique  was  shown  to  characterise  the  tissue  impulse  response 
function with sufficient accuracy to identify bolus delay and dispersion.  When this 
deconvolution  technique  is  applied  to  DSC-MRI  data  from  patients  with  vascular 
abnormalities, regions of delay and dispersion can be identified.  An awareness of the 
potential  underestimation  of  CBF  in  these  regions  is  valuable  information  in  the 
assessment of patients.  In particular, the probability maps created using predictor- 
models can be interpreted with consideration to the potentially erroneous perfusion 
estimates.  Furthermore,  it  may  be  possible  to  refine  predictions  made  by  these 
models  if the  bias  was  first removed  from the  perfusion  measurements.  Previous 
studies have suggested that it is possible to minimise the errors introduced by delay 
and  dispersion  by  defining  the  AIF  closer  to  the  tissue,  either  using  a  local  or 
regional  AIF  (Calamante  et  al  2004;  Alsop  et  al  2002;  Knutsson  et  al  2006; 
Christensen et al 2004; Lorenz et al 2006).
In the local AIF method,  the concentration time-course in each individual voxel is 
deconvolved with a unique (local) AIF (Calamante et al  2004; Alsop et al  2002). 
Since the direct measurement of a local AIF is problematic due to for example partial 
volume  effects  (see  Section  4.7.4),  methods  have  been  proposed,  which  infer  the 
expected form of the local AIF in each voxel from the larger scale data (Alsop et al 
2002;  Calamante  et  al  2004).  The  main  limitation  of  such  techniques  is  their 
validation, due to a lack of a ‘gold-standard’ for the AIF.
The search for an improved AIF can be restricted by using a regional AIF method 
where, rather than defining the AIFs on a voxel by voxel basis, a smaller number of 
region-specific AIFs are used (Knutsson et al 2006; Christensen et al 2004).  In this 
chapter, a method is proposed to extract regional AIFs from regions where the bolus 
is identified as delay and/or dispersed.  By first identifying regions of delay and/or 
dispersion,  the  search  for  a  more  accurate  AIF is  restricted,  and  targeted to  areas 
known to have CBF errors.Chapter 9: Correcting Dispersion Errors in DSC-MRI -268-
The two  studies  reported in this  chapter examine two very different approaches to 
correct dispersion.  The first approach  seeks to establish a new methodology for a 
simple  dispersion  correction  in  vivo,  using  information  from  the  in  vivo  VTFs 
extracted  in  Chapter  8.  The  second  regional-AIF method  is  a development  of an 
already established theoretical  means of minimising dispersion, which uses  a more 
specific AIF.  These techniques were conducted at different stages of the PhD, and as 
a  result  there  is  only  a  small  overlap  in  the  group  of  patients  used  in  the 
investigations.
9.2  R elatio n ship betw een Bolus Delay and Dispersion
In this  study,  an in vivo investigation into bolus delay and dispersion is conducted, 
with a view to establish if there is a relationship between the two.  This investigation 
was performed using the patient group described in Chapter 8  (Section  8.2), which 
encompasses  patients  with  a  diverse  range  of  cerebral  arterial  abnormalities.  In 
Chapter 8, in vivo VTFs were extracted from these patients and fitted to a lognormal 
function in order to study vascular transport and the resulting perfusion errors.  In this 
present chapter, the fitted (lognormal) VTFs are used for an investigation into delay 
and  dispersion  in  the  vascular transport.  The  methodology for the  extraction  and 
fitting of the VTFs can be found in Section 8.3 of Chapter 8.
9.2.1  M ethods
For the  in  vivo  investigation  of delay,  two  different measurements  are  considered. 
The first measure is taken directly from the bolus concentration time-course and the 
second requires knowledge of the VTF itself.
The first delay parameter is defined as the difference in the bolus arrival times (BAT) 
measured for the global and local AIFs, delays  at, where the BAT is the length of theChapter 9: Correcting Dispersion Errors in DSC-MRI -269-
concentration  time-course  baseline.  This  definition  is  somewhat  artificial  since  it 
only  represents  the  delay  for  the fastest  transit.  Nevertheless,  it  is  a  parameter 
commonly used to assess brain haemodynamics.
An alternative and more representative delay parameter is the mean vascular delay, 
which  can  be  calculated  directly  from  the  VTF.  The  mean  vascular  transit  time 
(MVTT) is (cf. Equation [8.4]):
An  analytical  expression  can be  calculated  from the lognormal  fit to the VFT (cf. 
Equation [8.5]):
where a, fi and to are the lognormal parameters.
The MVTT  definition  of delay may be  considered to be of less practical use than 
delaysAT,  since its  quantification requires knowledge of the VTF,  or the local AIF 
(Calamante et al  2006).  If these are known then the dispersion itself is known, and 
so it is unnecessary to predict it from the delay.  Thus, even if a simple relationship 
were found, it would serve little practical use as a surrogate marker of dispersion.  It 
should be also noted that a correlation between the MVTT and the bolus dispersion as 
measured by the W T T  is to be expected, since a wider VTF will not only lead to a 
larger dispersion, but also a longer first moment.  The BAT definition of delay would 
therefore  be  of  a  more  practical  use  for  correcting  bolus  dispersion.  Since  both 
definitions  of  delay  have  specific  limitations,  both  have  been  included  with  the 
present work.
MVTT =
1/ ■  VTF(t)dt
[9.1]
0
f MVTT = exp  ju -\----- + 10
V  2   )
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An  interleaved  multi-slice  acquisition  order  was  used  in  the  DSC-MRI  sequence; 
accordingly the various  slices were acquired at different times relative to the bolus 
injection.  Therefore, for both definitions of delay, this extra time delay between the 
acquisitions  of the corresponding  slices  for the  global  and local AIF (or the tissue 
concentration) was included in the calculation of delay.
The in vivo estimate of dispersion is taken from Chapter 8 as the variance of the VTF 
(variance-vascular-transit-time, W TT) around its mean (MVTT) (cf. Equation [8.3]).
An  analytical  expression  can be  calculated  from the  lognormal  fit to the VFT (cf. 
Equation [8.6]):
where o, n and t0 are the lognormal parameters.
9.2.2  Results
The MVTT (Equation  [9.2]) and W TT (Equation  [9.4]) calculated from lognormal 
fit to the VTF data of the 15 patients (Table 8.1, Chapter 8) are recorded together with 
their  lognormal  parameters  o  (skewness),  n  (scale)  and  to  (shift)  in  Table  8.2  in 
Chapter  8.  These  values  are  reproduced  in  Table  9.1  with  the  addition  of  the 
corresponding  delays  a t   for  each  patient.  The  average  estimate  of  delaysAT  was 
<delayB A T> = l-34s (range 0.76 to 3.27s).  From Chapter 8, <MVTT> = 2.05s (range 
0.74 to 4.96s), <VVTT> = 2.02s2 (range 0.22 to 9.29s2), <a> = 0.65 (range 0.30 to 
1.05); for the scale variable <ju>  =0.26 (range -0.85 to  1.57s); for the shift variable
<r0> = 0.08 (range -1.37 tol.82s).
|(r -  MVTT)2 • VTF (t)dt
W TT = — [9.3]
o
W TT = (exp(<r2)- l)exp(<T2 + 2//) [9.4]Chapter 9: Correcting Dispersion Errors in DSC-MRI -271 -
a /s ju/s t0/  s MVTT /s WTT /s2 delayBAT/s
Patient 1 - ROI1 0.84 -0.27 0 .0 1 1 .1 0 1 .2 2 0.76
Patient 1 - ROI2 0.56 0.36 -0.30 1.37 1 .0 2 1.03
Patient 2 1.05 -0.33 0.16 1.41 3.10 0.91
Patient 3 0.49 0.70 -0.46 1.80 1.40 1.44
Patient 4 0.37 1.03 -0.78 2.23 1.32 1.85
Patient 5 - ROI1 0.63 -0.58 0.06 0.74 0 . 2 2 0.80
Patient 5 - ROI2 0.73 0.31 0.78 2.56 2 . 2 2 0.87
Patient 6 0 . 6 6 0.19 -0.37 1.14 1.26 0.97
Patient 7 0.75 -0.15 0.63 1.77 1 .0 1 1.95
Patient 8 0.57 1.15 0.27 3.97 5.14 1 .6 8
Patient 9 0.94 -0.85 0.37 1.03 0.61 1.05
Patient 10 0.78 0.59 -0.51 1.95 5.02 0.90
Patient 11 - ROI1 0.48 0.41 0.17 1.85 0.72 2 . 1 2
Patient 11 - ROI2 0.30 1.50 -1.37 3.31 2 . 1 2 3.28
Patient 12 - ROI1 0.92 -0.67 0.54 1.32 0.80 1.35
Patient 12 - ROI2 0.52 1.57 -0.54 4.96 9.29 1.24
Patient 13 0.48 -0.08 0.24 1.27 0.27 1.56
Patient 14 - ROI1 0.67 -0 . 1 2 1.82 2.93 0.71 0.77
Patient 15 0.60 0.25 0.77 2.31 1 .0 2 1.08
average 0.65 0.26 0.08 2.05 2 . 0 2 1.35
Table  9.1:  The  table  shows  the  lognormal  parameters  < 7 ,  //,  and  to,  dispersion 
parameter W TT and delay parameters, MVTT and delayBAT, for the 15 patients used 
to study bolus delay and dispersion in vivo.____________________________________
The relationships between the degree of dispersion and bolus delay, and between the 
lognormal  parameters  and  the  bolus  delay,  were  investigated  using  the  two  delay 
definitions.  Figure 9.1a shows a plot of W TT, as a function of the delayBA T -  There 
is  no  correlation  between  the  amount  of delay  (as  measured  by  delays  at)  and  theChapter 9: Correcting Dispersion Errors in DSC-MRI -272-
degree of dispersion (as measured by W TT); in particular, the longest delays did not 
correspond to the largest dispersions.  There is however a weak correlation between 
lognormal parameters cr, // and to and delayBAT, as shown in Figures 9.1b, 9.1c, and 
9.Id  respectively.  The  correlation  coefficients  of  cr,  fi  and  to  with  delayBAT  are 
respectively  R2=0.38,  0.28,  and  0.22.  Figure  9.2a  shows  a  plot  of  W TT  as  a 
function  of MVTT.  Using this  delay definition, there is  a correlation between the 
mean delay (as measured by MVTT) and the degree of dispersion (as measured by 
W TT), with correlation coefficient R2 = 0.58.  Figures 9.2b, 9.2c, and 9.2d show the 
lognormal parameters  cr, n  and to as  a function of MVTT.  There is  no correlation 
between  the  amount  of  delay  (as  measured  by  MVTT)  and  the  lognormal  shift 
parameter (as measured by to); in particular, the longest to did not correspond to the 
longest MVTT.  The correlation coefficients of < 7 , and n with MVTT are respectively 
R2=0.18,  and 0.62.  Although there is  a significant correlation in Figures 9.2a and 
9.2c, there is also a large scatter, so the prediction intervals are correspondingly large. 
Note that weak correlation and scatter in the other figures is not a consequence of the 
range of vascular abnormalities in the patients included in the study.  For example, in 
Figure 9.1a the six patients  (from whom seven VTF lognormal fittings were made) 
with vascular abnormalities restricted to their middle cerebral artery (MCA) (circled 
points) show no correlation with delayBAT-
9.2.3  Discussion
This study has revealed that for this group of patients with unilateral abnormalities in 
major  cerebral  arteries,  the  degree  of  dispersion  (as  measured  by  W TT)  that  is 
present in  any given patient cannot be inferred  reliably  from the  amount  of delay 
(measured either by delayBAT or MVTT).  The presence of a relationship between the 
degree of delay and dispersion might be expected since a longer transit of the bolus 
(e.g. due to abnormal blood supply) would most likely involve a larger spread of its 
width (the longer the transit, the longer the available time for the spread of the bolus). 
However, no significant correlation was found in the present study using the delayBATChapter 9: Correcting Dispersion Errors in DSC-MRI -273-
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Figure  9.1:  Graphs  a,  b,  c,  and  d  respectively  show  the  degree  of  dispersion 
(measured  by  the  variance  vascular  transit  time  (VVTT),  Equation  [9.3]),  the 
lognormal  skewness  parameter,  a,  the  lognormal  scale  parameter,  n,  and  the 
lognormal  shift parameter,  to  as  a function  of bolus  delay  (measured by the bolus 
arrival time, delayBAT).  Data were measured on patients with a range of abnormalities 
in major cerebral arteries (see Table 8.1, Chapter 8).  The circled points correspond to 
patients  with  abnormalities  restricted  to  their  middle  cerebral  arteries.  On  each 
graphs, the central line is the best linear fit to the data, the adjacent inner two lines are 
the  95%  confidence  intervals,  and  the  outer  two  lines  are  the  95%  prediction 
intervals.  There is no correlation between VVTT and delayBAT-  For  a, n, and t0 the 
correlation coefficients with delayBAT  are R2= 0.38,0.28, and 0.22 respectively._____
definition. As mentioned in Section 9.2.1, it is this definition of delay that would be 
most useful as a surrogate marker of dispersion.
The relationship between the lognormal parameters used to characterise the VTFs and 
delayBAT was  also investigated.  If a clear relationship were found, the form of the 
VTF could have been inferred from delayBAT, thus providing a means for dispersion 
correction using the lognormal model.  However, the correlations between a, n and to 
and  delayBAT  are  weak  and  there  is  large  scatter.  Consequently,  such  correction 
methodology would not be possible.
As expected, a significant correlation was found between the VVTT and the MVTT 
definition  of  delay.  However,  the  prediction  intervals  are  large.  Figure  8.4  of 
Chapter 8 indicates that a larger value of // results in a more ‘delayed’ (larger MVTT) 
VTF.  Accordingly,  a  significant  correlation  between  //  and  MVTT  is  expected. 
However,  there  is  large  scatter  in  the  correlations  between  all  the  lognormal 
parameters  and  MVTT.  Therefore,  although  MVTT  may  be  considered  a 
representative measure  of delay,  it cannot be used to  indicate the  skewness,  scale, 
shift or VVTT of the VTF.
One reason for the scatter in the figures may be the limited accuracy with which the 
delay, dispersion and lognormal parameters can be estimated in practice.  In addition, 
it is probable that the specific configuration of the vascular bed will influence bolusChapter 9: Correcting Dispersion Errors in DSC-MRI
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Figure  9.2:  Graphs  a,  b,  c,  and  d  respectively  show  the  degree  of  dispersion 
(measured  by  the  variance  vascular  transit  time  (VVTT),  Equation  [9.3]),  the 
lognormal  skewness  parameter,  a,  the  lognormal  scale  parameter,  //,  and  the 
lognormal  shift parameter,  to  as  a function  of bolus  delay  (measured by the bolus 
arrival time, MVTT (Equation [9.2]).  Data were measured on patients with a range of 
abnormalities in major cerebral arteries (see Table 8.1, Chapter 8).  The circled points 
correspond to patients with abnormalities restricted to their middle cerebral arteries. 
On each graphs, the central line is the best linear fit to the data, the adjacent inner two 
lines are the 95% confidence intervals, and the outer two lines are the 95% prediction 
intervals.  There is no correlation with MVTT for to.  For the VVTT, a,  and //, the 
correlation coefficients with MVTT  are R2= 0.58, 0.18, and 0.62 respectively.______
dispersion independently of the time taken for it to travel to the tissue of interest.  The 
degree of stenosis, the presence of arterial occlusion, vessel tortuosity, and degree of 
collateral flow will all contribute to the degree dispersion, although not necessarily to 
the  same  degree  as  they  contribute  to  the  mean  delay.  Furthermore,  the  precise 
vascular  path  will  determine  the  shape  distortion  of the  bolus,  and  therefore  the 
skewness, scale and shift parameters of the lognormal.
In this  group  of patients,  no  simple relationship  was  found between the  degree  of 
bolus delay and dispersion, or the degree of bolus delay and the lognormal parameters 
used  to  characterise  the  VTF.  Therefore  a  simple  correction  of dispersion  is  not 
possible.  However,  knowing  that  there  may  not  be  a  correlation  is  important 
information for the accurate interpretation of perfusion maps in patients with cerebral 
arterial abnormalities.  Since the presence of delay does not necessarily indicate the 
presence of dispersion, it might be possible to calculate an unbiased perfusion map 
simply by correcting for delay.  Conversely, a delay may have a dispersion associated 
with  it,  and  therefore,  delay-corrected  perfusion  could  still  be  inaccurate  due  to 
dispersion-related  errors.  For this  reason,  when  analysing DSC-MRI  data using  a 
global AIF, it is important to assess the delay and dispersion independently, since one 
is not necessarily related to the other.
In  light  of  the  severity  of  the  in  vivo  perfusion  error  found  using  a  global  AIF 
deconvolution (reported in Chapter 8), predictive algorithms designed to foretell theChapter 9: Correcting Dispersion Errors in DSC-MRI -279-
fate of ischaemic tissue e.g. (Gottrup et al 2005; Rose et al 2001; Wu et al 2007), 
(and which used the CBF% i0bai perfusion estimates), should also include information 
about the delay and dispersion.  Although it may not be practically possible to correct 
for dispersion using the  delay estimate, information  about the presence,  extent and 
severity of dispersion are likely to improve the accuracy of predictor-models.  Such 
information could be used to provide a measure of reliability to the predictions, or 
within the algorithm itself to improve the prediction.
9.3  R eg io n a l A r te r ia l In pu t F unctions
When using a global-AIF analysis of DSC-MRI data, abnormally low CBF and long 
MTT estimates may be a consequence of a delayed and/or dispersed bolus, while the 
true perfusion in the tissue may in fact be sufficient to maintain tissue viability.  Since 
the  reperfusion  treatments  may  increase  the  risk  of  cerebral  haemorrhage,  it  is 
undesirable  to  administer  such  treatment  in  cases  where  perfusion  is  already 
sufficient.  It is therefore important to separate the effect of vascular transport from 
the perfusion estimates.
In  Chapter  7,  a  new  algorithm  (oML-EM-wavelet)  was  proposed  for  the 
deconvolution of DSC-MRI data.  Simulations demonstrated that this deconvolution 
method is sufficiently accurate to distinguish and estimate delay and dispersion using 
the extracted impulse response function  CBF • Reff (r), the shape of which depends on
both the arterial vascular transport (given by the vascular transport function VTF) and 
microvascular retention  (given by the tissue residue function  /?(?)).  Separating the 
microvascular retention from the arterial retention in the impulse response function 
would  enable  the  correction  of vascular  transport  related  perfusion  measurements 
errors.  However, such methodology is difficult and impractical (e.g. Section 9.2).Chapter 9: Correcting Dispersion Errors in DSC-MRI -280-
In  this  second study,  the  perfusion  measurement errors resulting from the  vascular 
transport (delay and dispersion)  are minimised by lessening the contribution of the 
VTF to the shape of  This is achieved by improving the estimated AIF.  A
two-stage  methodology  is  proposed.  The  first  stage  estimates  perfusion  using  a 
global AIF and ascertains whether the perfusion estimates are likely to be inaccurate 
because  or  delay  and/or  dispersion.  The  second  stage  seeks  to  minimise  these 
potential  perfusion  measurement  errors  arising  from  the  vascular  transport  of the 
bolus.  The  perfusion  errors  present  in  the  regions  identified  in  stage  one  are 
minimised by finding a more accurate estimation for the arterial input to the tissue (a 
regional AIF) in stage 2.
93.1  M ethods
The methodology developed in this study is illustrated on data from six patients with 
severe vascular  abnormalities.  Two  adult14 patients  were imaged on each  of three 
different  scanners  1)  1.5T  Siemens  scanner GE-EPI  sequence:  TE/TR=47/1500ms, 
128*128  matrix,  0.15mmol/kg of Gd-DPTA.  2)  1.5T General Electric  scanner GE- 
EPI sequence: TE/TR=60/2000ms,  128*256 matrix, 0.15mmol/kg of GD-DPTA.  3) 
Siemens  scanner  GE-EPI  sequence:  TE/TR=40/2000ms,  128*128  matrix,
0.15mmol/kg of GD-DPTA.  The MRI scans were done for clinical reasons and their 
analysis was approved by the local research ethics committee.  The signal intensity 
data  were  pre-processed  as  described  in  Section  5.3.  Table  9.2  summarises  the 
arterial abnormalities in the six patients, the scanner with which they were imaged, 
and the phase of ischaemia.  In all patients, a global AIF was measured in a branch of 
the MCA contralateral to any abnormality (Section 5.3.3 describes the selection of a 
global AIF in vivo).
14 Although the accuracy of the oML-EM-wavelet CBF quantification is degrades slightly at higher 
flows (e.g. Figure 7.13), it reasonable to assume that the accuracy of  CBF quantification will be 
similar for all patients, since in adults CBF does not show much age dependency (Biagi et al 2007).Chapter 9: Correcting Dispersion Errors in DSC-MRI -281 -
Arterial Abnormality Scanner phase
Patient 11 Right MCA, PCA and ACA 1. Siemens chronic
Patient 12 Left ICA 1. Siemens chronic
Patient 16 Left  CCA 2. General Electric chronic
Patient 17 Left  ICA and CCA 2. General Electric subacute
Patient 18 Right  MCA 3. Siemens acute
Patient 19 Left  MCA 3. Siemens acute
Table 9.2: Patients analysed using the regional AIF method.  Patients 11 and 12 were 
also used in the delay/dispersion study described in Section 9.2.  The table indicates 
the arterial abnormalities and the scanner on which the data were acquired.  Details of 
the imaging sequence are given in Section 9.3.1.  MCA: middle cerebral artery, PCA: 
posterior cerebral artery, ACA:  anterior cerebral artery, ICA: internal carotid artery, 
CCA: common carotid artery  .______________________________________________
9.3.1.1  Stage 1: Identifying Regions
Stage  1  involves  calculating  perfusion  maps  using  a  global  AIF  and  identifying 
regions where the perfusion estimates  are likely to be unreliable.  The patient data 
were  analysed  using  the  oML-EM-wavelet  methodology  described  in  Chapter  7. 
Using  the  global  AIF,  the  impulse  response  function  r =(CBF 'Reff(t))est,  was
estimated  for  each  voxel,  and  maps  of blood  flow,  CBF = (? )m ax   and  MTT  (see 
Section 5.3.4) were created.
The first step in identifying regions where the perfusion estimates are unreliable is to 
identify delay and/or dispersion in the vascular transport.  This can be achieved by 
way of an accurate characterisation of the impulse response function  CBF ■  Reff (t) .
As described in Chapter 7, in order to achieve high resolution measurements of shape,Chapter 9: Correcting Dispersion Errors in DSC-MRI -282-
the  oML-EM-wavelet  solution  r  was  subsampled  at  TR=0.01s  using  a  linear 
interpolation between sample points.  The bolus delay,  tdelay  was estimated from the
length  of the  subsampled baseline  (defined to  end  at the last  subsampled baseline 
point  with  a  value  less  than  10%  of the  maximum  of  rsubsam pled).  The  dispersion 
characteristics were estimated using a dispersion index (.DI) defined in Chapter 7 as:
DI = FWHM frMtKmrU )x RTM  )  RTM  ) > TR
Di=o  s m i r ^ u U m   [95]
FWHM  is  the  full-width-half-maximum  (in  seconds),  and  RTM  is  the  rise-to- 
maximum (in seconds) from baseline.
For  the  global  AIF  deconvolution,  parameter  maps  of tdelay  and  DI were  created. 
When the dispersion index (DI) in a voxel was found to be greater than zero, the CBF 
estimated  in  that  voxel  was  identified  to  be  an  unreliable  indicator  of  the  true 
perfusion in that tissue.  Although the tdeiay parameter is used to indicate delay, the 
measurement cannot be entirely separated from dispersion.  This is because a small 
dispersion may result in the RTM of  r  having a value less than TR,  and therefore, 
although it will not be detected on the DI map, it will have a small value on the tdeiay 
map.  Consequently,  a  non-zero  tdeiay  may  also  indicate  the  presence  of  a  small 
dispersion, and therefore it is possible that the CBF measurements in these voxels are 
also underestimated.  Accordingly, the presence of delay and/or dispersion indicates 
that the  global AIF is not a good approximation to the true AIF for this region of 
tissue.
In order to minimise the effects of delay and dispersion it is desirable to define a new 
more  accurate  AIF  for  the  regions  identified  as  having  bolus  delayed  and/or 
dispersed.  In practice, the regions with significant clusters of delay and/or dispersion 
voxels were identified interactively and delineated by manually drawing around each 
region.  The voxels outside the region were masked.Chapter 9: Correcting Dispersion Errors in DSC-MRI -283-
9.3.1.2  Stage 2: Minimising Vascular Transport Effects
Stage 2 methodology seeks to correct delay and dispersion in the vascular transport 
by  finding  regional  AIFs  for  the  regions  defined  in  Stage  1,  thereby  minimising 
perfusion measurement errors.
A  regional  AIF  for  the  delayed/dispersed  masked  region  is  extracted  using 
Independent  Component Analysis  (ICA)  (Calamante  et al  2004)  of the  (non-ICA- 
denoised) concentration time-course data within the masked region.  The number of 
independent  components  in  the  decomposition  was  determined  using  a  Bayesian 
information  criterion  (Calamante  et  al  2004).  It  is  assumed  that  the  ICA 
decomposition will  decompose the concentration time-course data into artefact (i.e. 
noise  or  motion),  tissue,  venous,  and  arterial  components.  These  components  are 
identified  interactively  by  analysing  their  temporal  and  spatial  characteristics 
(Calamante et al 2004; Carroll et al 2002; Martel et al 2003):  Arterial components 
have a relatively early arrival time, narrow shape and spatial localisation within the 
vessels.  The component that is most arterial in nature is selected as a better estimate 
for the AIF feeding the tissue within the delay/dispersed region.
The regional AIF is then used to re-perform the oML-EM-wavelet deconvolution on 
the (ICA-denoised) concentration time-course data within the masked region only.  In 
order to avoid the possibility of negative dispersion in the remaining brain (outside 
the masked region), it is important to restrict the use of regional AIF to within the 
masked  region  from  which  it  was  defined.  In  (Section  7.4.4,  it  was  shown  that 
negative dispersion causes  an  overestimation  of CBF and underestimation of MTT. 
Within  the  masked  region,  new  estimates  of  r = (CBF •  Reff (f))^  ,  and  maps  of
CBF = (?)m ,  tdelay and DI  are computed.
The regional AIF provides a more reliable estimate of perfusion in the regional voxels 
where tdeiay and/or DI are smaller than those calculated using the global AIF.  If in 
some  voxels  tdeiay  and/or  DI  are  still  significant,  the  CBF  is  still  likely  to  beChapter 9: Correcting Dispersion Errors in DSC-MRI -284-
underestimated  in  these  voxels.  If these  voxels  are  clustered in  a  distinct  area,  a 
subregion can be defined within the original masked region.  A new regional AIF can 
be defined for this subregion in the same way as before; everywhere other than the 
subregion is masked out, and the ICA analysis is performed within the subregion to 
find  a  more  appropriate  (sub)regional  AIF,  which  is  then  used  to  calculate  new 
(sub)regional perfusion parameters.  This methodology may be repeated so that any 
residual delay/dispersion is minimised by iteratively improving the AIF (according to 
(sub)regional  arterial  ICA components),  within iteratively defined (sub)regions.  At 
each  iteration,  the  shape  of  the  deconvolved  impulse  response  functions  were 
inspected to ensure that negative dispersion had not been introduced.  For each region 
initially  identified  as  delayed/dispersed  from  the  global  AIF  analysis,  the  above 
procedure  was  typically  found to  converge  within  1-3  iterations.  Once the values 
within  and  area  of  the  delay/dispersion  regions  were  reduced  to  minimal  sizes, 
improved  perfusion  maps  were  calculated  for  the  whole  brain  by  combining  the 
global, regional, and subregional perfusion estimates.
The regional AIF methodology is summarised in the flow chart in Figure 9.3.
9.3.2  Results
The CBF and MTT maps calculated using the global AIF are shown in Figure 9.4 for 
each  of the  patients  in  Table  9.2.  These maps  reveal  areas  of apparent perfusion 
abnormality (identified by low CBF (dark areas) and prolonged MTT (bright areas). 
Figure 9.5 shows the corresponding parameter maps of tdeiay and DI.  In some patients 
a  single  region  of delay/dispersion  was  identified  (Patients  11,  and  19).  In  other 
patients  there  were  multiple  regions  of delay/dispersion,  displaying  different delay 
and dispersion characteristics (Patients  12,  17, and 18).  These areas are highlighted 
in Figure 9.5 with the pink ovals, and also indicated in column 2 of Table 9.3.
The regional AIF analysis was performed on the five of the six patients indicated in 
Table 9.2.  For Patient 16, the global AIF analysis failed for a significant number ofChapter 9: Correcting Dispersion Errors in DSC-MRI  - 285 -
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Figure  9.3:  Flow  chart  summarising  the  steps  involved  in  minimising  delay  and 
dispersion  effects  in  DSC-MRI  data by  means  of a regional  arterial  input  function 
analysis.  The left arrow  depicts  Stage  1  and the right arrow depicts  Stage 2 of the 
methodology.  An  initial  global  AIF  analysis  using  the  oML-EM-wavelet 
deconvolution,  enables  the  identification  of  regions  where  the  global  AIF  is  an 
inappropriate approximation for the input to the tissue.  These regions are delineated 
and an ICA decomposition is performed on the concentration time-course data withinChapter 9: Correcting Dispersion Errors in DSC-MRI -286-
the  regions.  The  most  arterial  component  in  this  decomposition  is  used  for  the 
regional AIF.  The analysis is repeated so that delay and dispersion in the data are 
minimised.
voxels  in  the  white  matter  (WM)  and  grey-matter  (GM)  of the  left  hemisphere, 
because too little contrast arrived in these voxels.  These voxels were assigned a value 
of zero on the CBF and MTT maps in Figure 9.4, explaining the pixelated appearance 
of the MTT map in Figure 9.4 and apparent lack of delay/dispersion in Figure 9.5. 
Since  there  is  insufficient bolus  arriving  in  these  voxels  to  produce  an  analysable 
signal  drop,  the  tissue  is  under  severe  hypoperfusion.  For  the  other  patients, 
examination of Figure 9.4 and Figure 9.5 reveals that many of the areas of apparent 
perfusion abnormality (observed on the CBF and MTT maps) correspond to regions 
identified  as  being  delayed  and/or  dispersed,  suggesting  that  the  perfusion 
abnormalities are exaggerated.
To illustrate the various steps of the regional AIF method in more detail, the manual 
delineation of the delayed/dispersed region is illustrated for Patient 11 in Figure 9.6. 
The  spatial  localisation  of the  arterial  component found  for this  masked region  is 
shown in Figure 9.7.  In this  figure,  the localised bright regions correspond to the 
spatial distribution of the arterial component.  This component is selected as a better 
estimate for the AIF feeding the tissue within this delay/dispersed region.  The time- 
course  of  the  ICA-defmed  (regional)  AIF  used  for  the  analysis  of Patient  11  is 
illustrated in Figure 9.8 together with the original global AIF.  As can be seen in this 
figure,  the  regional  AIF  is  delayed  and  dispersed  with  respect to  the  global  AIF. 
Column 3 of Table 9.3 reports the number of AIF iterations used to update the AIF 
within each region of each patient.
Figure 9.9 shows the CBF and MTT maps recalculated using the regional AIFs and 
the maps in Figure 9.10 indicate the residual delay and dispersion after this analysis. 
To assess the impact of the regional AIF method, Figure 9.9 should be compared with 
Figure 9.4, and Figure 9.10 should be compared with Figure 9.5.  In all five of theChapter 9: Correcting Dispersion Errors in DSC-MRI -287-Chapter 9: Correcting Dispersion Errors in DSC-MRI -288-Chapter 9: Correcting Dispersion Errors in DSC-MRI -289-
Figure 9.4: CBF (left column) and MTT (right column) maps calculated (using oML- 
EM-wavelet) for the six patients in Table 9.2 using a global AIF measured in a branch 
of the  MCA  in  the  healthy  hemisphere.  There  appear  to  be  significant  areas  of 
perfusion  abnormality  (identified  by  low  CBF  (dark  areas  of  left  column)  and 
prolonged  MTT  (bright  areas  of  right  column)).  The  images  are  displayed  in 
radiological convention: the left side of the image is the right side of the brain.______
analysed patients, the CBF and MTT maps in Figure 9.9 illustrate both a reduction in 
the  severity and extent of the perfusion  abnormalities compared with the  CBF and 
MTT maps in Figure 9.4.  In addition, the regions of tdeiay and/or DI are smaller in 
Figure 9.10 compared with the tdeiay and DI maps in Figure 9.5.  This suggests that the 
original  perfusion  deficits  are  partly  an  artefact  of  an  inappropriate  AIF  for  that 
region, and that the regional AIF is more appropriate.
Table 9.4 summarises the findings of the regional AIF and global AIF analyses for 
the six patients.  The values in the table were obtained by averaging the values  of 
voxels within a user-defined ROI drawn in the GM inside the mask where delay and 
dispersion were identified using the global AIF analysis.  For comparative purposes, 
regions  were  also  defined in  GM  in the normal hemisphere.  In combination with 
Figure  9.10,  columns  3  and 4  of Table  9.4  indicate  that the  residual  tdeiay  and  DI 
values are small for all patients with the exception of the DI in a small area in the 
posterior region of the left hemisphere of Patient 12.  The small residual tdeiay, and DI 
values indicate that in  general, the regional AIF method is effective in minimising 
delay and dispersion in the data.  For the left posterior region of Patient  12, there 
remains a significant dispersion.  However, in this patient, there has been a significant 
reduction  in  the  size  of the  delay/dispersed  region.  This  area  was  not  analysed 
further, since the regional AIF methodology is unlikely to be successful.  With fewer 
voxels there is  a decreased likelihood that a true arterial component will exist.  In 
particular,  for the  small regions in the deep white-mater (particularly in the border 
zone between two major arterial territories)  where residual delay and/or dispersion 
are probable, and the arteries are too small for the spatial resolution of MRI.Chapter 9: Correcting Dispersion Errors in DSC-MRIChapter 9: Correcting Dispersion Errors in DSC-MRI -291 -Chapter 9: Correcting Dispersion Errors in DSC-MRI -292-
Figure 9.5: DI (left column) and tdeiay (right column) maps calculated (using oML- 
EM-wavelet) for the six patients in Table 9.2 using a global AIF measured in a branch 
of the MCA in the healthy hemisphere.  With the exception of patient 16 where there 
is no distinct region of delay and/or dispersion, the regions of delay and/or dispersion 
correspond to the  abnormal  areas shown in the  CBF and MTT maps in Figure 9.4. 
The pink ovals highlight the regions where the regional AIF analysis was performed. 
The images are displayed in radiological convention: the left side of the image is the 
right side of the brain.______________________________________________________
The effectiveness of the regional AIF method in minimising delay and dispersion in 
the data is further demonstrated by the percentage difference between the tdeiay and DI 
parameter measurements using the global AIF and the regional AIF.  A negative % 
indicates a decrease in value using the regional AIF.  For all patients tdeiay and DI are 
smaller in the regional AIF analysis.  (In patient  18, the posterior region of the left 
hemisphere reported zero DI in both the global and regional AIF analyses, explaining 
the 0% change in DI).  In addition to minimising the magnitude of these parameters, a 
comparison  of  Figure  9.10  with  Figure  9.5  indicates  that  the  extent  of  the 
delayed/dispersed regions are also reduced in size or removed completely.
The  size  of the  percentage  reduction  of the  tdeiay and  DI parameter  measurements 
using the global AIF and the regional  AIF is  different for different regions  and in 
different patients.  This variance is  also reflected in the size of the %  difference in 
CBF between the global AIF and regional AIF analyses in the same region.  Column 
7  of Table  9.4 reports  that  for all  regions  in  all  the patients,  there is  a  significant 
increase in the CBF estimates made with the regional AIF method compared with the 
global AIF analysis.  The size of the percentage increase however, does not appear to 
be  directly  correlated  with  the  size  of the  percentage  decrease in  the  tdeiay  and DI 
parameter measurements (see Discussion).
It is informative to compare the CBF estimates in delayed/dispersed regions using the 
global  and  regional  AIFs  with  those  made in  a ROI of normal  GM  in  the  normal 
hemisphere (where there is no delay or dispersion).  This comparison gives anChapter 9: Correcting Dispersion Errors in DSC-MRI -293-
Number of
delay/dispersed regions
Number of iterations required 
for each region
Patient 11 1RHS 1
Patient 12 3:  2 LHS, 1 RHS 1 for each
Patient 16 N/A N/A
Patient 17 2: 1 LHS, 1 RHS 1 for each
Patient 18 2: 1  LHS, 1 RHS 2 for LHS, 1 for RHS
Patient 19 1  LHS 3
Table 9.3: Summary of the number of regional AIFs calculated for each patient and 
the number  of iterations  required to minimise the  delay  and  dispersion parameters 
using the regional AIF analysis.______________________________________________
indication  of  the  severity  of  the  perfusion  abnormality  in  the  abnormal  regions 
determined using each method.  The apparent perfusion abnormality in all the regions 
is smaller when using the regional AIF compared with the global AIF (columns 8 and 
9  of  Table  9.4).  Within  some  regions  (e.g.  in  Patients  12  and  17),  the  CBF 
measurements using the regional AIFs are still significantly lower than those in the 
normal  region,  even  though  delay  and  dispersion  (that  can  cause  CBF 
underestimation)  have  been  significantly  reduced.  Within  other  regions  (e.g.  in 
Patients  11,  18  and  19)  the  minimisation  of delay and  dispersion by means  of the 
regional AIF has resulted in regional CBF measurements that are comparable to the 
normal region.
As  an illustration of the oML-EM-wavelet characterisation of the impulse response 
functions  r = (CBF •  Reff it))  ,  examples  of  those  extracted  using  the  global  and
regional AIF analyses are shown in Figure 9.11 for Patient 12.  The three regions of 
delay /dispersion from which the  r  are taken are indicated in the figure.  AlthoughChapter 9: Correcting Dispersion Errors in DSC-MRI -294-
Figure  9.6:  Manually  drawn  mask 
for  the  delay  and  dispersed  region 
of Patient 11.
Figure  9.7:  Intensity  and  spatial 
distribution  of  the  arterial  ICA 
component  used  for  the  regional 
AIF in Patient 11.
for all three voxels chosen, the delay and dispersion have been completely eliminated 
using the  regional  AIF  method,  the maximum value  of  r ,  (used to  indicate blood 
flow)  is  still  low  in  the  right  hemisphere  compared  with  the  left.  The  simulations 
performed  in  Chapter 7  demonstrated  that the oML-EM-wavelet  method accurately 
quantifies  CBF when there is no delay or dispersion.  Therefore, the CBF and MTT 
measured  in  voxels  where there is  no residue delay or dispersion  should be  a good 
estimate of the true perfusion values.
9.3.3  Discussion
Decisions on therapeutic intervention are commonly based on a standard global AIF 
analysis of DSC-MRI data e.g.(Hjort et al. 2005; Ostrem et al 2004). However, since 
such therapeutic intervention is not without risk, it is important to realise the potentialChapter 9: Correcting Dispersion Errors in DSC-MRI -295-
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Figure 9.8: The global AIF (dashed line) and regional AIF (solid line) for Patient 11. 
The  regional  AIF  is  the  arterial  ICA  component  whose  spatial  distribution  is 
illustrated  in  Figure  9.7.  It  can  be  seen  that  the  region  AIF  is  both  delayed  and 
dispersed  with  respect to  the  global  AIF.  This  is  consistent  with  the  DI and  tdday 
maps for Patient 11 shown in Figure 9.5._______________________________________
bias in these perfusion estimates.  In the presence of arterial abnormalities, a standard 
global  AIF  analysis  can  lead  to  an  underestimation  of  perfusion  levels,  possibly 
leading  to  unnecessary  and  dangerous  treatment  (e.g.  increase  risk  or  cerebral 
haemorrhage).  This  study  has  demonstrated  a  regional  AIF  methodology  that 
identifies and minimises the biasing effects of vascular transport on the estimation of 
perfusion  parameters.  Such  methodology  can  be  used  to  minimise  the  risk  of 
misdiagnosis.
Using the global AIF analysis, all six patients would have been diagnosed as having 
severe perfusion deficits.  The CBF values in these regions were found to be between 
15% and 40% of those found in the normal side.  Such low blood flow is indicative of 
ischaemic tissue that will progress to infarction if flow is not restored (e.g. byChapter 9: Correcting Dispersion Errors in DSC-MRI -296-Chapter 9: Correcting Dispersion Errors in DSC-MRI -297-
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Figure  9.9:  CBF  (left  column)  and  MTT  (right  column)  maps  calculated  using 
regional AIFs.  In comparison with the global-AIF maps in Figure 9.4, many regions 
of abnormality (identified by low CBF and prolonged MTT) have been reduced.  The 
images are displayed in radiological convention: the left side of the image is the right 
side of the brain.Chapter 9: Correcting Dispersion Errors in DSC-MRI -298-Chapter 9: Correcting Dispersion Errors in DSC-MRI -299-
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Figure 9.10: DI (left column) and tdeiay (right column) maps calculated using regional 
AIFs.  In comparison with the global-AEF maps in Figure 9.5, delay and dispersion in 
the  grey  mater regions  has  been  reduced  or removed  completely.  The  images  are 
displayed in radiological convention: the left side of the image is the right side of the 
brain.Chapter 9: Correcting Dispersion Errors in DSC-MRI -300-
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Figure  9.11:  Example  impulse  response  functions  deconvolved  in  Patient  12 
using the global (dashed lines) and regional (solid lines) AIFs, corresponding to 
the delayed/dispersed regions A,  B and C indicated in the bottom right figure. 
For the voxels chosen, delay and dispersion have been eliminated.____________
thrombolysis).  However, a diagnosis based on these global AIF measurements would 
be unreliable, since reanalysis using the new regional AIF method found that in five 
of  the  nine  regions  CBF  values  were  greater  than  66%  of  those  found  in  the 
corresponding  normal  side.  This  level  of perfusion  is  likely  to  correspond  to  the 
clinical  state of oligemia  (see Chapter 3,  Section  3.3).  In this  state,  autoregulatory 
mechanisms  (i.e.  vasodilation  and increased oxygen extraction fraction)  are at work 
to preserve cerebral oxygen  metabolism at levels sufficient for neuron functionality. 
Such oligemic tissue is not at risk of infarction.residual % measurement change % 'normal' CBF
delayed/dispersed region tdelay Dl tdelay Dl CBF global regional
Patient 11 R 0.09 0.78 -88% -91% 131% 29% 66%
Patient 12 L anterior 0.05 0.00 -90% -100% 36% 40% 53%
L posterior 0.45 5.29 -56% -Wo 61% 15% 24%
R posterior 0.00 0.00 -99% -100% 67% 40% 67%
Patient 16 L 0.21 0.11 23%
Patient 17 L 0.15 0.26 -75% -82% 64% 21% 35%
R posterior 0.02 0.00 -80% -100% 63% 26% 42%
Patient 18 R 0.00 0.00 -100% -100% 237% 28% 95%
L posterior 0.01 0.00 -93% N/A 198% 30% 75%
Patient 19 L 0.32 0.20 -81% -98% 344% 21% 104%
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Table  9.4:  The  table  summarises  the  results  of the  regional  AIF  and  global  AIF 
analyses for the six patients.  The first two columns indicate the patient and identify 
the  delay/dispersed  regions  (these  regions  are  circled  in  Figure  9.5)  R=right 
hemisphere, L=left hemisphere.  The measurements given in this table were taken by 
averaging the values within a user-defined GM region of interest.  The columns under 
the heading  ‘residual’  indicate the remaining delay and dispersion after the regional 
AIF analysis (except for patient 16, where the values indicate the left hemisphere GM 
measurements).  The columns under the heading  ‘% measurement change’  show the 
percentage  difference  between  the  parameter measurements  of tdelay,  Dl,  and  CBF 
using  the  global  AIF  and  the  regional  AIF.  A  positive  %  indicates  an  increase, 
whereas a negative % indicates a decrease in value using the regional AIF compared 
with the global AIF.  The columns under the heading  ‘% normal CBF  compare the 
measurements of CBF in the ‘normal’ region of GM with no delay or dispersion, with 
the  CBF  measurements  taken  in  the  abnormal  GM  regions  using  the  global  and 
regional AIF deconvolution._________________________________________________
The global AIF apparent perfusion deficits (column eight Table 9.4) in the regions 
defined in Patient  11, the right hemisphere of Patient  12, Patient  18 and Patient  19, 
were significantly corrected using the regional AIF analysis (column nine Table 9.4). 
In  these  patients  small  perfusion  abnormality  remains  in  Patient  11,  the  right 
hemisphere  of Patient  12,  and  the  left hemisphere  of Patient  18.  However,  these 
perfusion levels  are likely to be sufficient to maintain tissue viability.  In the right 
hemisphere  of Patient  18  and  in  Patient  19,  the  perfusion  estimates  are  no  longer 
abnormal.  For the reanalysed regions in Patient 17 and the left hemisphere of Patient 
12,  the perfusion  abnormalities remain,  although  are less  severe using the regional 
AIF  analysis.  Therefore,  reanalysis  of the DSC-MRI data using  the  regional  AIF 
methodology would probably not change the diagnosis and treatment plans for Patient 
17  and  the  left  hemisphere  of  Patient  12.  However,  for  Patient  11,  the  right 
hemisphere of Patient 12, Patient 18 and Patient 19, the regional AIF analysis would 
suggest a different diagnosis and treatment plan.
This study highlights the fact that apparently abnormal perfusion values may be partly 
or fully a consequence of vascular transport.  Improving the estimate of the AIF can 
minimise or completely remove the apparent perfusion abnormality.  It is important to 
realise that the perfusion map created using a global AIF deconvolution analysis in aChapter 9: Correcting Dispersion Errors in DSC-MRI -303-
patient with  arterial  abnormalities is likely to be unreliable because of the vascular 
transport of the bolus.  Therefore, it is essential that diagnosis and treatment are not 
determined  on  the  basis  of the  global  AIF  deconvolution  analysis  alone.  These 
perfusion maps must be interpreted in conjunction with maps indicating the presence 
and  severity  of  delay  and  dispersion.  In  this  way,  the  reliability  and  potential 
underestimation of the perfusion estimates can be considered.  However, if the data 
are reanalysed using the regional AIFs, and if delay and dispersion are removed from 
the vascular transport, then the resulting perfusion maps are reliable and an accurate 
diagnosis  can  be made.  The perfusion  maps in Figure 9.9 therefore provide more 
reliable information about the tissue perfusion.
Recently there have been a number of clinical trials that utilise a global-AIF defined 
diffusion-perfusion  mismatch  region  (see  Section  3.10)  to  select  patients  for 
thrombolysis,  and to  assess  the response to this treatment e.g.  (Hacke  et al.  2005; 
Butcher et al.  2005).  The trial reported by Butcher et al.  found that the benefits of 
reperfusion could not be related to the mismatch volume.  This implies that some of 
the identified mismatch region was actually oligemic.  The regional AIF analysis of 
the  patient  data  in  this  chapter  suggests  that  a  global  AIF  analysis  is  likely  to 
underestimate the true perfusion values, and has shown that such methodology could 
in fact misidentify oligemic tissue as ischaemic.  Therefore, the hypothese of clinical 
trials  that  use  a  global-AIF  defined  diffusion-perfusion  mismatch  cannot  be 
accurately investigated.
It  should  be  noted  that  for the  TR  of the  in  vivo  data  analysed  in  this  study,  the 
measure  of  delay  tdeiay,  may  be  a  more  sensitive  measure  of  abnormal  vascular 
transport  than  the  dispersion  index  Dl.  As  discussed  in  Section  9.3.1.1,  the  tdeiay 
parameter could actually also indicate a small dispersion.  This is probably the case in 
the left hemisphere region of Patient 18, where the Dl was zero using the global and 
regional  AIF  analysis,  and  the  regional  AIF  minimisation  of  the  tdeiay  parameter 
significantly increased the CBF values.  Similarly, the lack of correlation between the 
size of the % Dl reduction and the %  CBF increase could also be because the tdeiay 
parameter accounts for some of the dispersion.Chapter 9: Correcting Dispersion Errors in DSC-MRI -304-
The  patient  data used  in  this  study  were  taken  from  three  different  scanners  with 
different  scanning  sequences;  consequently the  quality  of the  data is  varied.  The 
robustness of the oML-EM-wavelet method is demonstrated in this chapter, since in 
spite  of  this  variability,  the  method  was  effective  in  characterising  the  impulse 
response function and estimating the delay and dispersion parameters.
The proposed regional AIF methodology is specifically targeted to regions where the 
bolus  is  identified  as  being  distorted  in  transit  through  the  arterial  tree.  Since 
distorted  vascular  transport  has  been  shown  to  introduce  significant  errors  in 
perfusion  quantification,  it  is  in  these  regions  where  an  improved  estimate  of the 
arterial input to the tissue is most important.  Other regional AIF methods have also 
been proposed e.g. (Knutsson et al 2006) (Christensen et al 2004).  However, these 
methods do not selectively target areas of known perfusion measurement errors, and 
may  actually  fail  in  such  regions.  In  work by  Knutsson  et al.,  regional  AIFs  are 
defined for the whole brain using factor analysis of dynamic studies (FADS) on the 
concentration  time-courses.  A  subsequent  automatic  AIF  identification  algorithm 
selects the AIF voxels,  which are used to form the regional AIF within the FADS- 
defined regions.  In addition to complications arising from peak saturation, geometric 
distortion  and  partial  volume  effects  of the  concentration time-course  (see  Section 
4.7), the automated AIF identification algorithm in (Knutsson et al 2006) is likely to 
fail under certain circumstances, such as severe arterial delay or dispersion.  It is in 
these situations where an improved estimate of the AIF is most vital.  Christensen et 
al.,  proposed  a  regional  AIF  method  that  manually  selects  AIF  voxels  within 
presupposed major arterial territories.  Although the different timing of the vascular- 
territory-specific  AIFs  can  provide  information  about  major  vessel  abnormalities, 
these  AIFs  cannot  account for intra-region  delay  and  dispersion,  i.e.  if there is  an 
abnormality further down the arterial tree.
The main limitation of the ICA-defined regional AIF technique is the necessity for 
user input.  For example, the masking of the delay/dispersed regions, the selection of 
the  arterial  (ICA)  component,  and  checking  for  negative  dispersion.  Automated 
methods  are  necessary for the efficient  and robust implementation  of analysis in  aChapter 9: Correcting Dispersion Errors in DSC-MRI -305-
clinical environment.  To achieve this aim further work is required.  For example, a 
clustering  and  thresholding  algorithm  could  be  developed  to  delineate  the 
delay/dispersed  regions,  and  spatial-localisation/temporal-shape  criteria  could  be 
proposed for the automated selection of the ICA arterial component.  Although there 
is  no  ‘gold-standard’  with  which  to  validate  this  ICA-defined  regional  AIF 
methodology, the residual tdeiay and Dl parameters signify the reliability of the final 
perfusion maps.
9.4  G eneral Discussion
It has been shown that the presence of bolus delay and dispersion can introduce large 
errors in CBF (i.e. underestimation) and MTT (i.e. overestimation) (Calamante et al 
2000).  This potential source of bias can have very important implications for patient 
diagnosis and decisions concerning therapeutic intervention.  In particular, inaccurate 
estimates of perfusion will bias the predictions of tissue outcome made by predictor- 
models.  Since  therapeutic  intervention  risks  reperfusion  injury,  there is  a need to 
improve  therapeutic  decision  making.  In  this  chapter,  two  methods  have  been 
explored to correct for the perfusion errors.
Various  methods  have  been  proposed  to  correct  for  delay-related  perfusion 
measurement errors.  For example, the tissue concentration time-course and the AIF 
can be realigned to a common origin (i.e.  a common bolus arrival time) before the 
deconvolution analysis is performed (Calamante et al 2000; Ibaraki et al 2005; Rose 
et al  2004).  Alternatively, a delay-insensitive deconvolution algorithm can be used 
(Wu  et  al  2003;  Smith  et  al  2000).  Furthermore,  the  use  of these  methods  in 
predictor-models in stroke has been emphasised (Rose et al 2004; Ibaraki et al 2005; 
Wu etal. 2004)
The effect of bolus dispersion is more difficult to deal with; to account for dispersion 
requires  a model for the vascular bed (see Chapter 8),  or the use of a more locallyChapter 9: Correcting Dispersion Errors in DSC-MRI -306-
defined  AIF  (Calamante  et  al  2004;  Alsop  et  al  2002;  Knutsson  et  al  2006; 
Christensen  et al  2004;  Lorenz  et al  2006).  Neither approach is  commonly used, 
although both are being actively investigated.  Because dispersion errors are difficult 
to assess, they are not usually taken into account when using diffusion and perfusion 
MRI data to predict the fate of brain tissue in acute stroke, and to identify the patients 
at highest risk of infarction.
For this reason, the first part of this chapter (Section 9.2) sought to find a simple and 
quick correction of dispersion.  The simplicity and speed of the investigated method 
would  have  been  beneficial  for  widespread  routine  clinical  application,  enabling 
analysis  by a non-expert and prompt administration of treatment.  However, the  in 
vivo  investigation  into  delay  and  dispersion concluded  that the  delay could not be 
used to predict and correct for dispersion due to the lack of correlation and the spread 
between the parameter values.
Consequently,  the  second  part  of  the  chapter  (Section  9.3)  sought  an  alternative 
methodology to correct for dispersion by improving the estimated arterial input to the 
tissue.  This  regional-AIF  methodology  is  targeted  to  regions  known  to  have 
perfusion  measurement  errors.  Within  these  regions,  delay  and  dispersion  are 
minimised, resulting in more accurate perfusion estimates.  The comparisons between 
the global and regional AIF perfusion estimates emphasise the implications of using 
an inappropriate AIF for the deconvolution of DSC-MRI data.  The regions identified 
using the global AIF deconvolution as having dangerously low perfusion, were found 
to  have  higher  perfusion  using  the  regional  AIF  analysis.  In  some  patients  the 
reanalysed perfusion levels would likely result in alternative diagnoses.
It is important to realise that the a priori it is impossible to know which patients will 
have significant delay and dispersion-related errors.  Low perfusion values calculated 
using a global AIF analysis may be real in some patients, partly real in other patients 
and wholly artefact in other patients.  The distinction can only be made by further 
analysis of the impulse response function, i.e. by extracting parameters such as tdeiay 
and DLChapter 9: Correcting Dispersion Errors in DSC-MRI -307-
9.5  C onclusion
In conclusion, if the effects of delay and dispersion are not taken into account (e.g. by 
using an appropriate regional AIF), it is not possible to predict the extent of the error 
that  will  be  present  in  the  CBF  maps  reliably.  These  errors  can  lead  to  tissue 
misclassification, and finally to the inappropriate selection of patients for treatment, 
such  as  arterial  thrombolysis.  The findings from this  chapter have very important 
implications for assessment and management of patients with acute stroke, as well as 
for the  accuracy  of the  predictor-models  currently  being  used  for  determining  the 
tissue outcome in stroke.Chapter 10: General Discussion -308-
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10.1  O verview of W ork
In  recent  years  significant developments  have been  made in  both  the treatment  of 
acute ischaemic stroke and in neuroimaging methods.  These advances have focussed 
on  improving  the  simplicity,  robustness,  and  accuracy  of  the  diagnosis  and 
management of patients with  stroke.  Of all the neuroimaging techniques, MRI has 
emerged  as  a  powerful  way  to  assess  brain  pathophysiology  non-invasively,  and 
within the last decade or so it has gained widespread clinical acceptance.  Within this 
context, perfusion MRI has been shown to play a central role in identifying at an early 
stage  regions  of brain tissue that  are  compromised but likely to recover given  the 
appropriate treatment.  The only perfusion MRI technique that can currently be used 
easily in the clinical setting of acute stroke is DSC-MRI or bolus tracking.  However, 
current  methodology for perfusion  assessment  using  DSC-MRI is  prone  to  errors, 
which  could  lead  to  patient  misdiagnosis  with  potentially  dangerous  clinical 
consequences.
This thesis presented a detailed investigation of several limitations in the analysis and 
interpretation of perfusion DSC-MRI data that currently hinder the accurate diagnosis 
of patients with ischaemic stroke and cerebrovascular disease.  A first important step 
towards good patient management is to be able to identify regions on the DSC-MRI 
perfusion maps where the measurements are inaccurate, i.e. those regions where there 
is  delay  and  dispersion  of the  bolus.  Perfusion  in  these  regions  is  likely  to  be 
underestimated,  and  so  treatment  plans  based  on  these  erroneous  measurements 
would be inappropriate and potentially dangerous.  Identification of these regions can 
only be achieved with an accurate analysis method.  This is the motivation behind the 
methods  presented  in  Chapters  6  and  7,  which  minimise  the  regularisation  and 
discretisation  errors  manifest  in  the  deconvolution  of the  noisy  sample  DSC-MRI 
data.
In  order  to  determine  the  accuracy,  robustness,  and  limitations  of  new  analysis 
methods, they must be thoroughly tested using methodology as described in ChapterChapter 10: General Discussion -310-
5.  It is important that the testing is comprehensive and a realistic representation of in 
vivo situations.  Therefore in application to stroke, it is essential to know the degree 
and  extent  of  delay  and  dispersion,  and  also  the  size  of  the  related  perfusion 
measurement  errors  in  vivo.  The  in  vivo  investigation  conducted  in  Chapter  8 
provided some insight into this by characterising the vascular transport in a group of 
patients with cerebral arterial abnormalities.
In addition to identifying delay and dispersion, the analysis techniques presented in 
Chapters 6 and 7 aim to give an accurate quantification of perfusion in the absence of 
delay and dispersion (i.e. when the estimated input to the tissue accurately represents 
the true input).  Thus, if delay and dispersion of the bolus could be removed from the 
data,  accurate  perfusion  estimates  should  be  obtained.  The  use  of these  accurate 
perfusion  values  in  predictor-models  would  increase  the  model’s  specificity  and 
sensitivity to  ‘at-risk’ tissue.  Therefore, obtaining unbiased perfusion measurements 
is an important proceeding step towards the goal of improved patient diagnosis and 
management.  Methodology  for  the  correction  of  errors  introduced  by  vascular 
transport was developed in Chapter 9.
Improvements in perfusion imaging are expected to benefit a large number of patients 
presenting with stroke.  Clinical DSC-MRI data are commonly used in the prediction 
of  tissue  outcome.  Therefore,  if  implemented  in  a  clinical  context,  the 
methodological  developments  in  this  thesis  could  be  influential  in  improving  the 
diagnosis  and management of patients with stroke.  The use of these developments 
would  be  a  significant  step  towards  reducing  morbidity  and  disability.  Improved 
patient outcome would ultimately contribute to lessening the socio-economic impact 
of cerebrovascular diseases.Chapter 10: General Discussion -311 -
10.2  A bsolute Perfusion
Although the methodologies presented in Chapters 6, 7  8, and 9 make considerable 
progress towards improving the robustness, accuracy and interpretation of DSC-MRI 
perfusion measurements, the measurements  are still not quantitatively accurate,  and 
therefore cannot be used to define perfusion thresholds for ischaemia.  Even if a high 
accuracy is obtained in the data acquisition (i.e. good SNR, high temporal and spatial 
resolution, accurate AIF selection) and processing (i.e. accurate deconvolution), there 
are  still  some  fundamental  model  assumptions  which  prevent  absolute  perfusion 
measurements from being obtained (see Chapter 4, Section 4.7).  These include the 
simplification  of  the  relationship  between  transverse  relaxation  rate  and  tracer 
concentration, which takes different forms in the tissue and artery.  As a consequence 
there  are  significant  systematic  errors  in  the  perfusion  measurements  and 
characterisation of the impulse response function (Kiselev 2001).  The magnitude of 
the errors  depends  on microvascular architecture, properties  of the contrast agents, 
and  contribution  of  the  intra  and  extravascular  compartments  to  the  total  signal 
(Kiselev 2001).  Using DSC-MRI, the goal of absolute perfusion values can only be 
obtained  with  additional  information  regarding  the  blood  and  microvascular 
compositions.  Such  information  could potentially be  obtained through  monitoring 
blood  samples  and blood  pressure,  and by  acquiring  data using  a variety of pulse 
sequences together with fitting a multiparametric model of signal relaxation (Kiselev 
2005).  Absolute  DSC-MRI  perfusion  values  would  be  invaluable  for  defining 
thresholds  of irreversible  brain  damage.  In  combination  with  other  MR  imaging 
modalities they would greatly assist in understanding the underlying pathophysiology 
of ischaemic stroke.Chapter 10: General Discussion -312-
1 0 3   P redicting F uture Infarction
103.1  Perfusion-Diffusion Mismatch
Achieving  absolute  DSC-MRI  perfusion  values  is  very  challenging.  However, 
through  optimising  the  current  acquisition  and  analysis  methods,  robust  relative 
measurements  of perfusion can be  achieved.  Such measurements  are valuable  for 
example,  to  compare perfusion  values in  the normal  and  abnormal  hemispheres in 
patients  with  unilateral  arterial  abnormalities  (see  Chapter  9).  Furthermore,  their 
utility  in  combination  with  other  MR  imaging  modalities  such  a  DWI  has  been 
demonstrated  (Sobesky  et  al  2005;  Gonzalez  2006;  Kidwell  et  al  2004).  In 
particular, mismatch between a larger perfusion abnormality and a smaller diffusion 
lesion has been postulated to represent the ischemic penumbra, in which tissue is at 
risk of infarction but also potentially amenable to salvage (Kidwell et al 2003).  The 
identification  of  such  a  mismatch  region  does  not  necessitate  absolute  perfusion 
measures, rather an identification of an area that is abnormal compared with the rest 
of the brain.  However, there is currently no agreement what degree of hypoperfusion 
is dangerous, i.e. ischaemic rather than oligemic tissue.
Using the mismatch to identify penumbral tissue is further complicated by the lack of 
a standardised measure of perfusion.  Various perfusion parameters have been used, 
for example time-to-peak  (TTP)  concentration,  first-moment-transit time  (FMT)  of 
the impulse response, M7T,  CBF etc (Butcher et al  2005).  It has been shown that 
summary parameters such a TTP are highly dependent on the AIF and may therefore 
be an inaccurate indicator of the true perfusion (Perthen et al  2002).  Similarly, the 
tissue impulse response  function obtained from a global AIF deconvolution is  also 
prone to substantial error (see Chapters 8 and 9).  Since these error-prone perfusion 
parameters are commonly used in defining the mismatch region e.g.  (Butcher et al 
2005),  it  is  unsurprising  that  as  yet  the  mismatch  region  has  not  been  proved  a 
particularly sensitive or specific indicator of ischaemic tissue.Chapter 10: General Discussion -313-
The perfu si on-di  ffu si on mismatch has recently been the focus of several clinical trials 
that aim to select patients for thrombolysis and to predict the response of the tssue to 
the treatment (Butcher et al.  2005; Hacke et al.  2005).  A more robust definition of 
the  mismatch  region  could  potentially  reduce  some  of  the  uncertainty  currently 
associated  with  identifying  and  treating  penumbral  tissue.  The  methodologies 
described in Chapters 6, 7, and 9 of this thesis were shown to minimise many of the 
errors  in  the  perfusion  measurements  related  to  the  deconvolution  and  vascular 
transport,  and  consequently  present  significant  progress  toward  the  goal  of  an 
accurate and robust definition of the perfusion-diffusion mismatch.
10.3.2  P re d ic to r-M o d e ls
The development of multi-parametric algorithms that combine all the available MRI 
information is currently the forefront of research into predicting infarction in acute 
human cerebral ischaemia.  When applied in a voxel-by-voxel manner, these models 
have high spatial resolution, therefore enabling a detailed insight into the evolution of 
the ischaemic lesion, and sensitivity to detecting changes resulting from therapeutic 
intervention.
One of the most popular predictive methods uses a generalised linear model (GLM) 
(e.g (Wu et al.  2001).  In summary, this algorithm models the outcome of the tissue 
using a binary variable, where the value  1  indicates tissue infarction and the value 0 
indicates  tissue  viability.  The  probability  of tissue  infarction  is  represented  by  a 
sigmoid shaped function, which initially increases in an exponential manner, slows to 
linear  growth,  and  approaches  unity  with  an  exponentially  decaying  gap.  The 
parameter determining the precise curvature of this sigmoid is a function of the acute 
MRI data (e.g. T2, ADC,  CBF,  CBV, and A/77), which are weighted by a vector of 
coefficients.  The coefficients reflect the impact of the data from each modality to the 
final patient outcome, and are determined using training data sets comprising of acute 
and follow-up  data.  These GLM coefficients can then be used to estimate risk ofChapter 10: General Discussion -314-
infarction in a voxel-wise basis from acute data in a new patient.  Such predictions 
would valuably inform a patient-specific treatment plan.
Without increasing the complexity, these models have the potential to include more 
imaging and non-imaging parameters, such as delay, dispersion (see Chapter 7), time 
of scan, age of patient, site of arterial abnormality, etc.  More information is likely to 
improve the predictive accuracy of these models (Wu et al. 2005).
One  limitation  of  these  models  is  that  the  GLM  coefficients  are  specific  to  the 
training data set, i.e. the MR imaging parameters, the normalisation of the data, the 
analysis methods etc.  For example, in order to investigate if vascular transport is an 
important  covariate  of  tissue  outcome  above  and  beyond  the  induced  perfusion 
measurement errors, different GLM coefficients should be obtained for when bolus 
delay  and  dispersion  parameters  are  combined  with  corrected  perfusion 
measurements  (calculated  using  a  local  or  regional  AIF),  and  for  when  they  are 
combined with uncorrected perfusion measurements (calculated using a global AIF). 
This also highlights the importance of training data set, which should be acquired and 
analysed identically to the actual input data.  Therefore, in order for these models to 
have widespread clinical impact, it would be necessary to standardise the acquisition 
and analysis of the imaging data.
In addition to providing a promising metric for the diagnosis of individual patients, 
another potential  use of predictor-models is in the development of new therapeutic 
drugs.  A recent study (Wu et al. 2007) used a GLM to predict the tissue infarction in 
an  animal  stroke  model,  and  to  evaluate  the  value  of  therapeutic  intervention. 
Comparing  the  actual  outcome  after  therapy  with  the  model-predicted  outcome 
without therapy provides a means to determine the efficacy of the treatment, and to 
investigate effective dose levels  and therapeutic time-windows.  Such methodology 
could be used to speed up and improve drug development, with the only limitation 
being the accuracy of the predictor model.Chapter 10: General Discussion -315-
Currently, the prediction capability of these models remains limited in a significant 
number of cases, owing to errors in the perfusion quantification.  The methodologies 
described in Chapters 6, 7, and 9 of this thesis were shown to minimise many of the 
errors in the perfusion measurements, and furthermore provide additional parameters 
indicating the vascular transport.  The incorporation of these input data (perfusion, 
delay, and dispersion) could potentially improve the prediction of future infarction in 
patients  with  various  vascular abnormalities,  where currently the models  have low 
sensitivity and specificity.
10.4  E x te n d in g  th e  T im e-W indow
In most cases of ischaemic stroke, the lesion consists of small regions of complete 
ischaemia surrounded by a larger area of incomplete ischaemia where collateral flow 
is  able  to  preserve  the  tissue  for  a  limited  time-window.  This  ischaemic  by  not 
infarcted  region  is  at  risk  of irreversible  damage.  If flow  is  not restored  (e.g.  by 
thrombolysis),  or  if  the  toxic  biochemical  cascade  is  not  impeded  (e.g.  by 
neuroprotective agents), then the  ‘at-risk’  tissue progresses to irreversible infarction 
within a few hours (Hossmann  1994).  There is therefore thought to be a very short 
therapeutic time-window for thrombolytic therapy.
Although thrombolytic therapy has not been proven effective beyond 3 hours, there is 
some evidence that individual patients may respond to reperfusion strategies up to 6 
hours  after  symptom  onset  (Hacke  et  al  1999).  On  the  contrary,  some  patients 
treated at later times have suffered haemorrhage as a result of thrombolysis (Hacke et 
al.  1999).  Consequently, the use of thrombolysis has been the subject of considerable 
debate.  Treatment plans should therefore balance the potential benefits and risks of 
intervention.  The assessment of the patient specific risk requires accurate information 
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The precise time that tissue can  survive is  determined by the energy demands and 
residual blood flow,  which can either prolong or accelerate the progression to cell 
death in the penumbral tissue.  Given the logistic problem of treating patients within 
the short time-window, any approach that extends this period will lead to a significant 
increase in the number of identified patients that are likely to benefit from treatment. 
The  approach  taken  in  this  thesis  is  to  improve  the  accuracy  of  the  perfusion 
measurements, by minimising dispersion (Chapter 9) and combining with an accurate 
DSC-MRI analysis technique (Chapters 6 and 7).  Knowledge of the underlying tissue 
perfusion is important information for assessing the risk and time-scale of progression 
to infarction.
In a recent ASL study that investigated tissue outcome after reperfiision of ischaemic 
tissue in rats (Bardutzky et al. 2007), it was found that after reperfusion, a substantial 
amount  of  perfusion-diffusion  mismatch  tissue  was  salvaged  independent  of 
ischaemia duration.  The severity of CBF reduction during ischaemia appeared to be 
the  main  deciding  factor  for  determining  tissue  fate.  This  study  underlines  the 
importance  of  achieving  accurate  DSC-MRI  perfusion  information  in  a  clinical 
context, since residual perfusion levels play a crucial role in determining tissue fate. 
Therefore, the techniques presented in this thesis could be significant for improving 
patient management.
Interestingly, the same study (Bardutzky et al. 2007) also found that early reperfusion 
salvaged a substantial number of the initially defined core infarct voxels.  Therefore, 
whilst delayed reperfusion may in some cases be beneficial, early reperfusion is still 
likely to be more effective.
10.5  R e c e n t T e c h n o lo g ic a l A dvances
The  technical  developments  presented  in  this  thesis  focused  on  improving  the 
accuracy and robustness of the analysis of DSC-MRI data.  The implementation ofChapter 10: General Discussion -317-
such  techniques  on  standard  clinically  acquired  DSC-MRI  images  was  shown  in 
Chapter 9 to provide a better understanding of the haemodynamic status of the brain 
tissue.  However,  the  amount  and  the  accuracy  of  the  information  that  can  be 
extracted using the proposed analysis techniques is limited by the quality of the DSC- 
MRI data.  Noise, temporal and spatial resolutions, image artefacts, and suboptimal 
sequence  parameters,  are  all  contributing  factors  to  data quality.  In  particular,  as 
discussed  in  Chapter 4  (Sections  4.7),  the  arterial  input is  particularly  sensitive to 
partial  voluming  (i.e.  limited  spatial  resolution),  peak  saturation  (i.e.  suboptimal 
sequence parameters for AIF measurement), and voxel misregistration (i.e. EPI image 
artefacts).  Since a globally defined AIF will influence all the perfusion estimates, the 
accuracy  of  the  AIF  measurement  is  strategic  in  achieving  improved  perfusion 
quantification.  Furthermore, the temporal-resolution is a significant limitation in the 
characterisation of ischaemic tissue in patients with abnormal flow.  For example, in 
Chapter  5,  a  significant underestimation  of the  maximum  of the  impulse response 
function  was  illustrated  in  Figure  5.4,  which  was  purely  a  consequence  of  the 
temporal sampling15.
Although DSC-MRI acquisition strategies have not been investigated in this thesis, an 
understanding of the current limitations and recent advances in  scanner technology 
and data acquisition are fundamental to the development of good analysis techniques. 
Exciting developments in scanner technology such as higher field (3T compared with 
1.5T)  and  parallel  imaging  (PI),  provide  the  potential  to  improve  perfusion 
quantification (Newbould et al  2006).  PI enables the EPI readouts to be shortened, 
facilitating  higher  temporal  resolution  data,  and  thereby  reducing  temporal 
discretisation  artefacts.  In  addition,  using  PI there  is  an increased  bandwidth  per 
pixel in the phase-encoding direction, resulting in a reduction in EPI related image 
artefacts,  such as the spatial  shift of arterial voxels during the bolus passage.  This 
improvement is particularly relevant for higher field scanners, where these types of 
image  artefacts  are  more  prevalent.  Furthermore,  partial  volume  effects  can  be 
reduced because of the increase spatial resolution available at higher field and using
15 The sampling related perfusion measurement errors are in fact minimised if the delay is removed, by 
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PI.  The  minimisation  of these  artefacts  will  result  in  fewer  sources  of error  in 
calculating the arterial and tissue signals used in the deconvolution analysis.
For  high  temporal  resolution  short  TR  data,  there  is  a  danger  of introducing  Ti 
sensitivity.  However,  this  may  be  circumvented  using  multiple  echoes:  Ti 
enhancement is identical for all the TEs, and can therefore be removed (see Section 
4.7.1).  Multiple  echoes  provide  the  further  advantage  of  enabling  an  optimum 
contrast-to-noise ratio, CNR  (i.e. TE ~T2*) over the wide range of T2* values present 
in the tissue and arteries during the passage of the contrast.  The shorter EPI readout 
in PI techniques can enable the acquisition of multiple echoes.
At higher field strengths,  susceptibility effects are greater,  and consequently T2*  is 
shorter.  PI  can  enable  the  acquisition  of  images  with  the  necessarily  short  TE 
required for optimum CNR using gradient echo (GE) at high field.
Although not as significant as the T2*  shortening at 3T compared with  1.5T, it has 
been  shown  that  the  Gd-DTPA  promotes  shorter  T2  at  3T  compared  with  1.5T 
(Rohrer et al  2005), i.e. the relaxivity of Gd-DTPA is greater at 3T compared with 
1.5T.  Similarly, at 3T, the Gd-DTPA promotes a longer Ti  compared with at  1.5T 
(Rohrer et al. 2005).  These shorter T2 times at 3T suggest that the optimum CNR for 
spin-echo (SE) sequences is achieved using a shorter TE, which has the advantage of 
minimising  undesirable  signal  loss  caused  for  example  by  chemical  shifts  or 
susceptibility differences.  SE imaging also has the inherent advantage of improved 
microvascular  sensitivity  (see  Section  10.6).  At  3T,  in  addition  to  short  T2JT2* 
values,  the  higher Ti/T2  ratios  are  also  advantageous  in  T2/T2*-weighted imaging, 
since Ti enhancement is reduced.
In  DSC-MRI,  SNR  is  often  sacrificed  to  achieve  the  desired  short  TR  (there  is 
insufficient time available for signal  averaging).  However,  at higher field, there is 
intrinsically higher SNR.  Although PI usually sacrifices SNR for improved spatial 
resolution,  non-random  noise  in  the  form  of EPI related  susceptibility  artefacts  is 
substantially  reduced.  It  should  be  noted  that  although  in  principle  PI  enablesChapter 10: General Discussion -319-
improved  temporal  and  spatial  resolution,  reduced  image  artefacts,  and  improved 
brain coverage, simultaneous improvement is difficult, and consequently an optimum 
trade-off is sought.
As 3T scanners with PI technology are becoming more widespread in clinical centres, 
optimising the pulse sequence to make the most of these technological advances will 
facilitate  the  routine  acquisition  of  higher  quality  DSC-MRI  perfusion  data. 
Consequently, the accuracy of the data analysis (using such methods as proposed in 
Chapters  6,  7  and  9)  will  improve.  Since  perfusion  information  is  particularly 
influential  in  the  outcome  of predictor-models,  minimisation  of errors  in  the  data 
acquisition will improve their specificity and sensitivity in identifying areas of future 
infarction.
10.6  V essel-S ize S e n sitiv ity  o f G ra d ie n t-E c h o  E P I
In  this  thesis,  the proposed techniques  have been  applied to clinical  data acquired 
using GE-EPI.  This is the most common clinical acquisition because one can achieve 
greater brain coverage and greater SNR than when using SE-EPI.  Because SE-EPI 
has predominantly T2-weighted16, there is a much smaller change in signal intensity 
in response to the bolus, but there is also the inherent advantage of being weighted 
towards the microvasculature (Section 4.4).  A major concern using GE-EPI is that 
due  to  the  uniform  vessel-size  sensitivity,  it  will  lack  sensitivity to  microvascular 
transit of the bolus because of contrast arising from larger veins.
In a study comparing GE- and SE-EPI bolus tracking measurements, Simonsen et al. 
(Simonsen  et al.  2000)  found that GE-EPI detected the  same  (small)  difference in 
CBF and  CBV as  SE-EPI.  Furthermore,  the  GE-  and  SE-EPI  CBF measurements 
differed only by a proportionality factor.  Although this analysis was performed using 
the  standard  SVD  algorithm  (which  itself  is  subject  to  error  (Section  4.8.4)),  in
16 Because the SE has an EPI acquisition, it also has a small degree of T2*-weighting.Chapter 10: General Discussion -320-
general it appears that MTT values derived by GE-EPI are likely to be as sensitive as 
ones derived by SE-EPI.
Another, perhaps more important consideration in the current work, is the effect that 
the uniform vessel-size  sensitivity of the GE-EPI sequence has on the shape of the 
response function  r = (CBF • Reff (t))es{,  since this function is used to identify delay
and  dispersion  (Chapters  6,  7  and  9)  and  in  characterising  the  vascular  transport 
function  (VTF)  (Chapter  8).  Although  in  vivo  it  is  not  possible  to  validate  the 
accuracy of the shape of each the extracted  r  in each voxel, one can compare the 
shapes of the  r  extracted in a hemisphere unaffected by bolus delay and dispersion, 
with  those in  a hemisphere affected by bolus delay and dispersion,  and with those 
determined  in  computer  simulations.  It  was  found  that  the  GE-EPI  response 
functions  extracted  in  the  unaffected  hemispheres  closely  match  what  one  would 
expect for a single well-mixed compartment (Section 4.6.4).
It has also been reported that there are differences in the ICA decomposition of GE- 
and SE-EPI concentration time-course data (Calamante et al  2004).  The different 
arterial  and  tissue  contributions  are  presumably  related to the  different  vessel-size 
sensitivity of the MR sequences.  This could be an important consideration for both 
defining  the  VTF,  which  relies  on  an  ICA-defined  local-AIF  (Chapter  8)  and 
correcting  dispersion-related  perfusion  measurement  errors,  using  an  ICA-defined 
regional-AIF (Chapter 9).
In the regional-AIF analysis proposed Chapter 9, the shape of  r  is used to determine 
the regions of delay and dispersion.  It is therefore important that these shapes can be 
relied upon to identify delay and dispersion.  Furthermore, subtle differences between 
the GE- and SE-EPI concentration time course data may have an effect on the ICA- 
based  selection  of  a  new  regional-AIF  chosen  in  the  delay/dispersed  region. 
Similarly, in Chapter 8, the shape of  r  and the accuracy of the ICA-defined local- 
AIF are significant in defining a shape of the VTF.  Inaccuracies associated with the 
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prediction intervals found for the relationships between vascular delay, dispersion and 
the lognormal parameters (first half of Chapter 9).
A  comparison  of  GE-  and  SE-EPI  in  vivo  data  could  potentially  allow  an 
investigation into vessel-size sensitivity effects on the shape of  r .  In addition one 
could investigate the extent to which vessel-size sensitivity affects the selection and 
shape  of  the  ICA-defined  local/regional-AIFs,  and  the  consequent 
characterisation/correction of vascular transport.  However, since the SNR in SE-EPI 
data  is  lower,  the  inaccuracies  introduced  in  the  regularised  deconvolution  of the 
concentration  time-course  data  may  over-power  the  improved  microvascular 
sensitivity of the data.  Therefore, it may not be impossible to discern whether any 
detected  differences  are  real  or  an  artefact  of  the  regularised-deconvolution. 
Investigation into these effects is beyond the scope of this thesis, the main objective 
of  which  is  to  provide  a  methodology  of  improved  perfusion  quantification  in 
standard acquisition clinical data.
10.7  F u r th e r  W o rk
In  order  for  the  methodology  presented  in  this  thesis  to  impact  on  the  everyday 
management  of patients  with  stroke,  further  development is  needed.  Firstly,  it  is 
necessary to remove the need for human interaction.  Fully automated methods that 
generate  accurate  perfusion  maps,  and  if  necessary,  maps  indicating  where  the 
perfusion estimates are less reliable, would allow the analysis to be performed by a 
non-expert  and  ensure  consistency  of  results.  If  possible  the  regional  AIF 
methodology  presented  in  Chapter  9  should  be  developed  for  the  automated 
delineation  of  delayed/dispersed  regions  and  selection  of the  arterial  components 
from  within  these  regions.  This  would  complement  the  already  use-independent 
deconvolution methodology in  Chapters  6  and  7.  Automation would facilitate the 
routine  incorporation  of such  methodologies  in  the  assessment  of at-risk  tissue  in 
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Optimisation  of the  algorithms  would  improve  computational  speed.  This  would 
enable the results of the analysis to be available minutes after the acquisition.  The 
automated, convenient, and fast analysis of patient data would impact on the speed of 
diagnosis, and consequently assist in the appropriate treatment of patients within the 
projected therapeutic time-window.  Exactly how much brain is lost per unit time in 
acute cerebral ischaemia is unknown.  However, estimates suggest that each minute in 
which a large vessel ischaemic stroke is left untreated, the average patient loses  1.9 
million neurons,  13.8 billion synapses and  12km of axonal fibres (Saver 2006).  In 
light of this, computation speed is imperative.  Currently, several minutes are required 
to process one slice of data using the methodology in Chapter 7.  By optimising the 
C++ code, this time could be significantly reduced.
In  addition, it is necessary for the techniques to be robust for use on data acquired 
from any of the MRI manufacturers.  Such generalisation was sought in Chapter 7, 
and demonstrated in the analysis of patient data from various scanners in Chapter 9. 
Further refining and testing should be performed to ensure the method’s robustness in 
all situations.
Future work is therefore required to refine the techniques proposed in this thesis so 
that  they  are  completely  automated,  optimised,  and  generalised,  together  with  the 
development  of  a  user-friendly  interface.  Such  time-saving,  generalisation,  and 
convenience would greatly enhance the clinical usefulness of the techniques and the 
resulting perfusion maps, in particular in application to predictor-models.
In addition to simulated data, predictor-models themselves offer a means of validation 
for novel analysis methods.  If a GLM developed using the newly analysed data were 
found to give more accurate predictions of infarction, the new methodology would be 
beneficial in terms of patient management.  Further work to compare the accuracy of 
predictions made from acute patient data analysed using the regional AIF (Chapters 7 
and  9)  with  those  from  a  standard  analysis,  would  highlight  whether  or  not  the 
improvements observed by testing with the simulated data set (Chapter 5),  actuallyChapter 10: General Discussion -323-
correspond to significant improvement in terms of assessing patients likely to benefit 
from reperfusion treatments.
10.8  C o n c lu sio n
A significant increase in the availability of MRI scanners has taken place in the last 
decade, and accordingly MR is increasingly used to image acute ischaemic stroke.  In 
response, there has recently been  a  great deal of interest in combining multimodal 
MRI data to predict tissue outcome following stroke.  Achieving accurate input data 
for these models is the focus of active research,  and considerable progress is being 
made.  Accordingly, there is a promising future for MRI methods to fulfil their full 
potential in providing accurate diagnosis and management of stroke patients.Chapter 11: References -324-
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